{
"company_details": [
{
"company_id": "0001656472",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001656472.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001656472.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001656472.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001656472_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001656472_main_keyfigs.svg",
"name": "Cronos Group Inc",
"rank": 1,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001656472.svg",
"report_text": "The relative strengths and weaknesses of Cronos Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cronos Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 138% points.The greatest weakness of Cronos Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 17% points.
The company's Economic Capital Ratio, given in the ranking table, is 266%, being 126% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001656472_2024_Cronos_Group_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "5.96",
"Liabilities": "31.6",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "135",
"Liabilities, Non-Current": "22.7",
"Other Liabilities": "4.90",
"Goodwill": "2.25",
"Assets": "32.9",
"Other Assets": "1.83",
"Assets, Current": "27.0",
"Assets, Non-Current": "-1.70",
"Other Expenses": "-0.629",
"Expenses": "25.1",
"Revenues": "-24.5",
"Net Income": "12.4",
"Research and Development": "3.77",
"General and Administrative Expense": "22.1",
"Other Revenues": "-24.5",
"Comprehensive Net Income": "13.0",
"Other Net Income": "10.2",
"Economic Capital Ratio": "97.4"
},
"2021": {
"Liabilities, Non-Current": "24.6",
"Liabilities": "55.2",
"Stockholders Equity": "96.8",
"ECR before LimitedLiability": "77.8",
"Liabilities, Current": "28.9",
"Other Liabilities": "8.74",
"Assets, Current": "32.7",
"Assets": "21.9",
"Assets, Non-Current": "-3.28",
"Other Assets": "8.79",
"Goodwill": "-5.32",
"Other Expenses": "-36.3",
"Expenses": "-4.16",
"Revenues": "-28.2",
"Net Income": "-15.7",
"Research and Development": "6.60",
"General and Administrative Expense": "23.2",
"Other Revenues": "-28.2",
"Comprehensive Net Income": "-15.3",
"Other Net Income": "15.6",
"Economic Capital Ratio": "73.5"
},
"2022": {
"Liabilities, Non-Current": "22.8",
"Liabilities": "47.7",
"Stockholders Equity": "116",
"ECR before LimitedLiability": "102",
"Other Liabilities": "8.41",
"Liabilities, Current": "22.4",
"Other Assets": "5.31",
"Assets": "32.0",
"Assets, Current": "41.8",
"Property, Plant and Equipment, Net": "-1.94",
"Assets, Non-Current": "-2.15",
"Goodwill": "-3.18",
"General and Administrative Expense": "22.6",
"Expenses": "19.8",
"Revenues": "-20.4",
"Comprehensive Net Income": "-1.94",
"Research and Development": "5.29",
"Other Expenses": "-8.37",
"Other Revenues": "-20.4",
"Other Compr. Net Income": "-2.52",
"Economic Capital Ratio": "91.6"
},
"2023": {
"Liabilities, Non-Current": "24.2",
"Liabilities": "63.1",
"Stockholders Equity": "138",
"ECR before LimitedLiability": "141",
"Other Liabilities": "7.94",
"Liabilities, Current": "40.5",
"Other Assets": "2.02",
"Assets": "22.9",
"Goodwill": "-1.69",
"Assets, Current": "34.1",
"Assets, Non-Current": "-1.37",
"Other Expenses": "-1.55",
"Expenses": "22.9",
"Revenues": "-16.8",
"Net Income": "7.98",
"Research and Development": "3.69",
"General and Administrative Expense": "20.9",
"Other Revenues": "-16.8",
"Comprehensive Net Income": "9.28",
"Other Compr. Net Income": "1.33",
"Economic Capital Ratio": "126"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001656472_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "1,372,172",
"Assets, Non-Current": "29,011",
"General and Administrative Expense": "114,915",
"Goodwill": "249,242",
"Liabilities, Current": "206,834",
"Liabilities, Non-Current": "8,492",
"Other Assets": "87,658",
"Other Compr. Net Income": "17,294",
"Other Expenses": "92,132",
"Other Liabilities": "2,188",
"Other Net Income": "105,424",
"Other Revenues": "46,719",
"Property, Plant and Equipment, Net": "187,599",
"Research and Development": "20,366"
},
"output_variables": {
"Liabilities": "217,514",
"Assets": "1,925,682",
"Expenses": "227,413",
"Revenues": "46,719",
"Stockholders Equity": "1,708,168",
"Net Income": "-75,270",
"Comprehensive Net Income": "-66,623",
"BaseVar": "1,270,023",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "243%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,079,718",
"Assets, Non-Current": "25,746",
"General and Administrative Expense": "141,419",
"Goodwill": "19,177",
"Liabilities, Current": "54,454",
"Liabilities, Non-Current": "7,095",
"Other Assets": "199,027",
"Other Compr. Net Income": "7,963",
"Other Expenses": "469,848",
"Other Liabilities": "1,913",
"Other Net Income": "162,959",
"Other Revenues": "74,435",
"Property, Plant and Equipment, Net": "74,070",
"Research and Development": "23,331"
},
"output_variables": {
"Liabilities": "63,462",
"Assets": "1,397,738",
"Expenses": "634,598",
"Revenues": "74,435",
"Stockholders Equity": "1,334,276",
"Net Income": "-397,204",
"Comprehensive Net Income": "-393,222",
"BaseVar": "1,170,578",
"ECR before LimitedLiability": "196%",
"Economic Capital Ratio": "232%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "960,156",
"Assets, Non-Current": "21,221",
"General and Administrative Expense": "93,460",
"Goodwill": "27,737",
"Liabilities, Current": "68,116",
"Liabilities, Non-Current": "2,546",
"Other Assets": "143,338",
"Other Compr. Net Income": "-50,662",
"Other Expenses": "144,076",
"Other Liabilities": "1,383",
"Other Net Income": "-9,721",
"Other Revenues": "91,904",
"Property, Plant and Equipment, Net": "60,557",
"Research and Development": "13,381"
},
"output_variables": {
"Liabilities": "72,045",
"Assets": "1,213,009",
"Expenses": "250,917",
"Revenues": "91,904",
"Stockholders Equity": "1,140,964",
"Net Income": "-168,734",
"Comprehensive Net Income": "-194,065",
"BaseVar": "844,129",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "244%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "933,306",
"Assets, Non-Current": "20,889",
"General and Administrative Expense": "72,176",
"Goodwill": "22,135",
"Liabilities, Current": "41,399",
"Liabilities, Non-Current": "2,562",
"Other Assets": "104,287",
"Other Compr. Net Income": "22,065",
"Other Expenses": "90,792",
"Other Liabilities": "0",
"Other Net Income": "7,017",
"Other Revenues": "87,241",
"Property, Plant and Equipment, Net": "59,468",
"Research and Development": "5,843"
},
"output_variables": {
"Liabilities": "43,961",
"Assets": "1,140,085",
"Expenses": "168,811",
"Revenues": "87,241",
"Stockholders Equity": "1,096,124",
"Net Income": "-74,553",
"Comprehensive Net Income": "-63,520",
"BaseVar": "734,590",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "266%"
}
}
},
"top_rated": true,
"trend": 5.0,
"value": 2.6572741170530754,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001656472.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001656472.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001656472.svg"
},
{
"company_id": "0001141240",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001141240.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001141240.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001141240.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001141240_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001141240_main_keyfigs.svg",
"name": "Liquidmetal Technologies INC",
"rank": 2,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001141240.svg",
"report_text": "The relative strengths and weaknesses of Liquidmetal Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Liquidmetal Technologies INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 141% points.The greatest weakness of Liquidmetal Technologies INC is the variable Other Revenues, reducing the Economic Capital Ratio by 24% points.
The company's Economic Capital Ratio, given in the ranking table, is 265%, being 125% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001141240_2024_Liquidmetal_Technologies_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-40.4",
"Liabilities": "-11.9",
"Stockholders Equity": "-217",
"ECR before LimitedLiability": "76.3",
"Liabilities, Non-Current": "-1.08",
"Other Liabilities": "24.7",
"Property, Plant and Equipment, Net": "-17.8",
"Assets": "-57.7",
"Assets, Non-Current": "-8.47",
"Goodwill": "-3.55",
"Assets, Current": "-48.1",
"General and Administrative Expense": "21.1",
"Expenses": "36.6",
"Revenues": "-96.1",
"Net Income": "132",
"Research and Development": "4.07",
"Other Expenses": "9.81",
"Other Revenues": "-96.1",
"Comprehensive Net Income": "132",
"Other Net Income": "155",
"Economic Capital Ratio": "14.3"
},
"2012": {
"Liabilities, Current": "-5.03",
"Liabilities": "-5.65",
"Stockholders Equity": "-38.6",
"ECR before LimitedLiability": "-80.0",
"Liabilities, Non-Current": "0.726",
"Other Liabilities": "-1.25",
"Assets, Current": "-20.1",
"Assets": "-37.0",
"Assets, Non-Current": "-8.45",
"Property, Plant and Equipment, Net": "-17.1",
"Goodwill": "-13.3",
"Other Expenses": "-38.3",
"Expenses": "-23.8",
"Revenues": "-33.7",
"Net Income": "-22.7",
"Research and Development": "6.92",
"General and Administrative Expense": "18.0",
"Other Revenues": "-33.7",
"Other Net Income": "31.7",
"Comprehensive Net Income": "-22.6",
"Economic Capital Ratio": "-112"
},
"2013": {
"Liabilities, Current": "-0.728",
"Liabilities": "1.82",
"Stockholders Equity": "-43.7",
"ECR before LimitedLiability": "-107",
"Other Liabilities": "3.09",
"Goodwill": "-4.36",
"Assets": "-41.9",
"Assets, Non-Current": "-0.769",
"Property, Plant and Equipment, Net": "-6.88",
"Other Assets": "-2.06",
"Assets, Current": "-21.6",
"General and Administrative Expense": "-2.65",
"Expenses": "-17.3",
"Revenues": "-11.9",
"Net Income": "-50.1",
"Research and Development": "0.0995",
"Other Expenses": "-12.4",
"Other Revenues": "-11.9",
"Other Net Income": "-4.15",
"Comprehensive Net Income": "-50.1",
"Economic Capital Ratio": "-147"
},
"2014": {
"Liabilities, Non-Current": "0.616",
"Liabilities": "11.9",
"Stockholders Equity": "59.9",
"ECR before LimitedLiability": "57.7",
"Liabilities, Current": "33.2",
"Other Liabilities": "-24.2",
"Assets, Current": "65.1",
"Assets": "59.9",
"Goodwill": "-6.11",
"Assets, Non-Current": "-3.75",
"Property, Plant and Equipment, Net": "1.03",
"Other Expenses": "44.2",
"Expenses": "5.01",
"Revenues": "-33.1",
"Net Income": "-27.4",
"Research and Development": "-3.60",
"General and Administrative Expense": "-29.4",
"Other Revenues": "-33.1",
"Other Net Income": "1.48",
"Comprehensive Net Income": "-27.4",
"Economic Capital Ratio": "8.24"
},
"2015": {
"Other Liabilities": "1.58",
"Liabilities": "1.72",
"Stockholders Equity": "11.7",
"ECR before LimitedLiability": "-6.56",
"Liabilities, Current": "0.317",
"Liabilities, Non-Current": "-0.195",
"Assets, Current": "17.4",
"Assets": "10.8",
"Other Assets": "-0.931",
"Goodwill": "-0.854",
"Assets, Non-Current": "-0.520",
"Property, Plant and Equipment, Net": "2.23",
"Research and Development": "-1.99",
"Expenses": "-16.5",
"Revenues": "-26.8",
"Net Income": "-60.4",
"General and Administrative Expense": "-58.0",
"Other Expenses": "15.9",
"Other Revenues": "-26.8",
"Comprehensive Net Income": "-60.1",
"Economic Capital Ratio": "-52.4"
},
"2016": {
"Liabilities, Non-Current": "11.7",
"Liabilities": "32.8",
"Stockholders Equity": "123",
"ECR before LimitedLiability": "85.3",
"Liabilities, Current": "24.1",
"Other Liabilities": "-1.74",
"Property, Plant and Equipment, Net": "-4.41",
"Assets": "64.1",
"Assets, Non-Current": "-1.44",
"Assets, Current": "127",
"Goodwill": "-4.20",
"Research and Development": "4.75",
"Expenses": "17.7",
"Revenues": "-28.8",
"Net Income": "-15.9",
"General and Administrative Expense": "8.50",
"Other Expenses": "4.46",
"Other Revenues": "-28.8",
"Comprehensive Net Income": "-15.8",
"Other Net Income": "-5.41",
"Economic Capital Ratio": "65.3"
},
"2017": {
"Other Liabilities": "-11.1",
"Liabilities": "42.6",
"Stockholders Equity": "138",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "36.6",
"Liabilities, Non-Current": "17.4",
"Assets, Non-Current": "-0.937",
"Assets": "50.2",
"Assets, Current": "44.1",
"Goodwill": "-2.62",
"Property, Plant and Equipment, Net": "5.84",
"Research and Development": "4.02",
"Expenses": "23.8",
"Revenues": "-26.1",
"Net Income": "-3.48",
"Other Expenses": "12.9",
"General and Administrative Expense": "7.23",
"Other Revenues": "-26.1",
"Comprehensive Net Income": "-3.68",
"Other Net Income": "-2.78",
"Economic Capital Ratio": "89.4"
},
"2018": {
"Liabilities, Non-Current": "15.7",
"Liabilities": "41.9",
"Stockholders Equity": "136",
"ECR before LimitedLiability": "125",
"Other Liabilities": "-6.45",
"Liabilities, Current": "34.2",
"Property, Plant and Equipment, Net": "7.23",
"Assets": "45.7",
"Other Assets": "-0.0264",
"Assets, Current": "36.1",
"Goodwill": "-2.00",
"Assets, Non-Current": "-1.58",
"Other Expenses": "11.2",
"Expenses": "25.3",
"Revenues": "-27.3",
"Net Income": "-0.159",
"Research and Development": "1.35",
"General and Administrative Expense": "13.1",
"Other Revenues": "-27.3",
"Economic Capital Ratio": "104",
"Other Compr. Net Income": "0.155"
},
"2019": {
"Liabilities, Non-Current": "12.7",
"Liabilities": "48.2",
"Stockholders Equity": "135",
"ECR before LimitedLiability": "140",
"Other Liabilities": "12.4",
"Liabilities, Current": "28.9",
"Assets, Non-Current": "-2.37",
"Assets": "41.7",
"Goodwill": "-2.45",
"Property, Plant and Equipment, Net": "5.55",
"Other Assets": "8.87",
"Assets, Current": "20.6",
"Research and Development": "2.32",
"Expenses": "21.5",
"Revenues": "-24.7",
"Comprehensive Net Income": "1.08",
"Other Expenses": "1.24",
"General and Administrative Expense": "18.1",
"Other Revenues": "-24.7",
"Other Net Income": "2.75",
"Economic Capital Ratio": "111"
},
"2020": {
"Liabilities, Current": "33.3",
"Liabilities": "51.8",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "157",
"Liabilities, Non-Current": "19.0",
"Other Liabilities": "5.79",
"Goodwill": "-1.41",
"Assets": "24.8",
"Other Assets": "11.0",
"Assets, Current": "5.19",
"Property, Plant and Equipment, Net": "3.56",
"Other Expenses": "5.76",
"Expenses": "24.9",
"Revenues": "-23.5",
"Net Income": "8.37",
"Research and Development": "4.91",
"General and Administrative Expense": "14.8",
"Other Revenues": "-23.5",
"Comprehensive Net Income": "8.64",
"Other Net Income": "5.30",
"Economic Capital Ratio": "119"
},
"2021": {
"Liabilities, Non-Current": "14.7",
"Liabilities": "47.2",
"Stockholders Equity": "120",
"ECR before LimitedLiability": "106",
"Liabilities, Current": "30.0",
"Other Liabilities": "7.91",
"Assets, Current": "9.16",
"Assets": "25.2",
"Other Assets": "8.32",
"Goodwill": "-2.30",
"Property, Plant and Equipment, Net": "4.75",
"Other Expenses": "7.57",
"Expenses": "23.7",
"Revenues": "-24.0",
"Net Income": "3.81",
"Research and Development": "6.62",
"General and Administrative Expense": "10.0",
"Other Revenues": "-24.0",
"Comprehensive Net Income": "3.45",
"Other Net Income": "2.55",
"Economic Capital Ratio": "102"
},
"2022": {
"Liabilities, Non-Current": "14.1",
"Liabilities": "49.0",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "121",
"Other Liabilities": "8.45",
"Liabilities, Current": "32.2",
"Other Assets": "5.02",
"Assets": "27.6",
"Assets, Current": "13.6",
"Property, Plant and Equipment, Net": "4.55",
"Goodwill": "-2.06",
"General and Administrative Expense": "15.7",
"Expenses": "27.8",
"Revenues": "-26.7",
"Net Income": "7.09",
"Research and Development": "5.92",
"Other Expenses": "6.87",
"Other Revenues": "-26.7",
"Other Net Income": "3.86",
"Comprehensive Net Income": "6.84",
"Economic Capital Ratio": "110"
},
"2023": {
"Liabilities, Non-Current": "14.5",
"Liabilities": "59.5",
"Stockholders Equity": "141",
"ECR before LimitedLiability": "140",
"Other Liabilities": "7.49",
"Liabilities, Current": "44.6",
"Assets": "25.7",
"Property, Plant and Equipment, Net": "4.00",
"Goodwill": "-1.95",
"Assets, Current": "24.5",
"Assets, Non-Current": "-1.52",
"Other Expenses": "9.31",
"Expenses": "25.2",
"Revenues": "-24.4",
"Net Income": "7.15",
"Research and Development": "4.08",
"General and Administrative Expense": "12.4",
"Other Revenues": "-24.4",
"Other Net Income": "4.60",
"Comprehensive Net Income": "8.16",
"Economic Capital Ratio": "125"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001141240_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "811",
"Assets, Non-Current": "52",
"General and Administrative Expense": "4,616",
"Goodwill": "968",
"Liabilities, Current": "3,610",
"Liabilities, Non-Current": "609",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,803",
"Other Liabilities": "0",
"Other Net Income": "12,722",
"Other Revenues": "972",
"Property, Plant and Equipment, Net": "162",
"Research and Development": "1,120"
},
"output_variables": {
"Liabilities": "4,219",
"Assets": "1,993",
"Expenses": "7,539",
"Revenues": "972",
"Stockholders Equity": "-2,226",
"Net Income": "6,155",
"Comprehensive Net Income": "6,155",
"BaseVar": "13,722",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "168%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,915",
"Assets, Non-Current": "28",
"General and Administrative Expense": "5,204",
"Goodwill": "869",
"Liabilities, Current": "6,923",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "20,063",
"Other Liabilities": "2,766",
"Other Net Income": "11,535",
"Other Revenues": "650",
"Property, Plant and Equipment, Net": "161",
"Research and Development": "943"
},
"output_variables": {
"Liabilities": "10,545",
"Assets": "8,973",
"Expenses": "26,210",
"Revenues": "650",
"Stockholders Equity": "-1,572",
"Net Income": "-14,025",
"Comprehensive Net Income": "-14,025",
"BaseVar": "28,956",
"ECR before LimitedLiability": "-166%",
"Economic Capital Ratio": "46%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,689",
"Assets, Non-Current": "401",
"General and Administrative Expense": "5,931",
"Goodwill": "764",
"Liabilities, Current": "1,071",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,749",
"Other Liabilities": "4,921",
"Other Net Income": "-1,438",
"Other Revenues": "1,026",
"Property, Plant and Equipment, Net": "249",
"Research and Development": "1,156"
},
"output_variables": {
"Liabilities": "6,848",
"Assets": "4,103",
"Expenses": "13,836",
"Revenues": "1,026",
"Stockholders Equity": "-2,745",
"Net Income": "-14,248",
"Comprehensive Net Income": "-14,248",
"BaseVar": "13,626",
"ECR before LimitedLiability": "-329%",
"Economic Capital Ratio": "7.6%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "10,466",
"Assets, Non-Current": "31",
"General and Administrative Expense": "7,946",
"Goodwill": "669",
"Liabilities, Current": "860",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,327",
"Other Liabilities": "2,005",
"Other Net Income": "30",
"Other Revenues": "627",
"Property, Plant and Equipment, Net": "1,118",
"Research and Development": "1,596"
},
"output_variables": {
"Liabilities": "3,721",
"Assets": "12,284",
"Expenses": "7,215",
"Revenues": "627",
"Stockholders Equity": "8,563",
"Net Income": "-6,558",
"Comprehensive Net Income": "-6,558",
"BaseVar": "11,938",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "5,302",
"Assets, Non-Current": "31",
"General and Administrative Expense": "7,359",
"Goodwill": "570",
"Liabilities, Current": "1,974",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,942",
"Other Liabilities": "59",
"Other Net Income": "0",
"Other Revenues": "147",
"Property, Plant and Equipment, Net": "1,370",
"Research and Development": "2,047"
},
"output_variables": {
"Liabilities": "2,889",
"Assets": "7,273",
"Expenses": "7,464",
"Revenues": "147",
"Stockholders Equity": "4,384",
"Net Income": "-7,317",
"Comprehensive Net Income": "-7,317",
"BaseVar": "8,886",
"ECR before LimitedLiability": "-26%",
"Economic Capital Ratio": "83%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "59,698",
"Assets, Non-Current": "36",
"General and Administrative Expense": "8,025",
"Goodwill": "494",
"Liabilities, Current": "3,638",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,739",
"Other Liabilities": "2,047",
"Other Net Income": "-2,126",
"Other Revenues": "480",
"Property, Plant and Equipment, Net": "1,139",
"Research and Development": "2,342"
},
"output_variables": {
"Liabilities": "6,541",
"Assets": "61,367",
"Expenses": "17,106",
"Revenues": "480",
"Stockholders Equity": "54,826",
"Net Income": "-18,752",
"Comprehensive Net Income": "-18,752",
"BaseVar": "43,810",
"ECR before LimitedLiability": "166%",
"Economic Capital Ratio": "212%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "42,188",
"Assets, Non-Current": "14",
"General and Administrative Expense": "6,961",
"Goodwill": "408",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "143",
"Other Liabilities": "3,512",
"Other Net Income": "0",
"Other Revenues": "376",
"Property, Plant and Equipment, Net": "12,465",
"Research and Development": "1,962"
},
"output_variables": {
"Liabilities": "3,512",
"Assets": "55,075",
"Expenses": "9,066",
"Revenues": "376",
"Stockholders Equity": "51,563",
"Net Income": "-8,690",
"Comprehensive Net Income": "-8,690",
"BaseVar": "34,014",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "243%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "35,748",
"Assets, Non-Current": "14",
"General and Administrative Expense": "7,063",
"Goodwill": "322",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,267",
"Other Liabilities": "2,335",
"Other Net Income": "0",
"Other Revenues": "791",
"Property, Plant and Equipment, Net": "11,767",
"Research and Development": "2,429"
},
"output_variables": {
"Liabilities": "2,335",
"Assets": "47,851",
"Expenses": "8,225",
"Revenues": "791",
"Stockholders Equity": "45,516",
"Net Income": "-7,434",
"Comprehensive Net Income": "-7,434",
"BaseVar": "29,601",
"ECR before LimitedLiability": "219%",
"Economic Capital Ratio": "248%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "24,600",
"Assets, Non-Current": "14",
"General and Administrative Expense": "6,256",
"Goodwill": "239",
"Liabilities, Current": "907",
"Liabilities, Non-Current": "856",
"Other Assets": "7,659",
"Other Compr. Net Income": "3.0",
"Other Expenses": "1,665",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,832",
"Property, Plant and Equipment, Net": "8,819",
"Research and Development": "1,342"
},
"output_variables": {
"Liabilities": "1,763",
"Assets": "41,331",
"Expenses": "9,263",
"Revenues": "1,832",
"Stockholders Equity": "39,568",
"Net Income": "-7,431",
"Comprehensive Net Income": "-7,430",
"BaseVar": "27,096",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "247%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "17,018",
"Assets, Non-Current": "251",
"General and Administrative Expense": "4,419",
"Goodwill": "158",
"Liabilities, Current": "520",
"Liabilities, Non-Current": "899",
"Other Assets": "12,768",
"Other Compr. Net Income": "115",
"Other Expenses": "-35",
"Other Liabilities": "0",
"Other Net Income": "484",
"Other Revenues": "1,367",
"Property, Plant and Equipment, Net": "8,614",
"Research and Development": "110"
},
"output_variables": {
"Liabilities": "1,419",
"Assets": "38,809",
"Expenses": "4,494",
"Revenues": "1,367",
"Stockholders Equity": "37,390",
"Net Income": "-2,643",
"Comprehensive Net Income": "-2,586",
"BaseVar": "23,344",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "265%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "18,635",
"Assets, Non-Current": "306",
"General and Administrative Expense": "4,788",
"Goodwill": "102",
"Liabilities, Current": "414",
"Liabilities, Non-Current": "899",
"Other Assets": "8,267",
"Other Compr. Net Income": "-177",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "529",
"Other Revenues": "965",
"Property, Plant and Equipment, Net": "8,295",
"Research and Development": "84"
},
"output_variables": {
"Liabilities": "1,313",
"Assets": "35,605",
"Expenses": "4,872",
"Revenues": "965",
"Stockholders Equity": "34,292",
"Net Income": "-3,378",
"Comprehensive Net Income": "-3,466",
"BaseVar": "21,730",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "260%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "19,283",
"Assets, Non-Current": "353",
"General and Administrative Expense": "3,380",
"Goodwill": "73",
"Liabilities, Current": "394",
"Liabilities, Non-Current": "902",
"Other Assets": "5,646",
"Other Compr. Net Income": "-233",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "658",
"Other Revenues": "383",
"Property, Plant and Equipment, Net": "7,980",
"Research and Development": "55"
},
"output_variables": {
"Liabilities": "1,296",
"Assets": "33,335",
"Expenses": "3,435",
"Revenues": "383",
"Stockholders Equity": "32,039",
"Net Income": "-2,394",
"Comprehensive Net Income": "-2,510",
"BaseVar": "19,670",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "263%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "22,795",
"Assets, Non-Current": "223",
"General and Administrative Expense": "3,575",
"Goodwill": "52",
"Liabilities, Current": "344",
"Liabilities, Non-Current": "902",
"Other Assets": "1,098",
"Other Compr. Net Income": "487",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "1,037",
"Other Revenues": "510",
"Property, Plant and Equipment, Net": "7,668",
"Research and Development": "20"
},
"output_variables": {
"Liabilities": "1,246",
"Assets": "31,836",
"Expenses": "3,595",
"Revenues": "510",
"Stockholders Equity": "30,590",
"Net Income": "-2,048",
"Comprehensive Net Income": "-1,804",
"BaseVar": "19,356",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "265%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.653705188414061,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001141240.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001141240.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001141240.svg"
},
{
"company_id": "0000896264",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000896264.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000896264.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000896264.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000896264_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000896264_main_keyfigs.svg",
"name": "Usana Health Sciences INC",
"rank": 3,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000896264.svg",
"report_text": "The relative strengths and weaknesses of Usana Health Sciences INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Usana Health Sciences INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 117% points.The greatest weakness of Usana Health Sciences INC is the variable Other Expenses, reducing the Economic Capital Ratio by 60% points.
The company's Economic Capital Ratio, given in the ranking table, is 238%, being 98% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000896264_2024_Usana_Health_Sciences_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "67.6",
"Liabilities": "107",
"Stockholders Equity": "-19.3",
"ECR before LimitedLiability": "143",
"Liabilities, Non-Current": "28.7",
"Other Liabilities": "30.0",
"Property, Plant and Equipment, Net": "-0.726",
"Assets": "-19.1",
"Assets, Non-Current": "-3.29",
"Other Assets": "2.14",
"Assets, Current": "-18.2",
"General and Administrative Expense": "65.1",
"Expenses": "-30.3",
"Revenues": "150",
"Net Income": "95.7",
"Research and Development": "29.6",
"Other Expenses": "-152",
"Other Revenues": "150",
"Comprehensive Net Income": "95.6",
"Other Net Income": "-14.5",
"Economic Capital Ratio": "81.2"
},
"2012": {
"Liabilities, Current": "43.0",
"Liabilities": "98.2",
"Stockholders Equity": "-40.4",
"ECR before LimitedLiability": "108",
"Liabilities, Non-Current": "28.9",
"Other Liabilities": "45.8",
"Assets, Current": "-17.5",
"Assets": "-20.6",
"Assets, Non-Current": "-3.61",
"Property, Plant and Equipment, Net": "-1.72",
"Goodwill": "-2.28",
"Other Expenses": "-136",
"Expenses": "-26.7",
"Revenues": "146",
"Net Income": "111",
"Research and Development": "32.0",
"General and Administrative Expense": "54.8",
"Other Revenues": "146",
"Other Net Income": "-1.09",
"Comprehensive Net Income": "111",
"Economic Capital Ratio": "75.5"
},
"2013": {
"Liabilities, Current": "41.0",
"Liabilities": "90.3",
"Stockholders Equity": "-9.00",
"ECR before LimitedLiability": "117",
"Other Liabilities": "30.8",
"Liabilities, Non-Current": "35.4",
"Goodwill": "-3.54",
"Assets": "-16.9",
"Assets, Non-Current": "-2.34",
"Property, Plant and Equipment, Net": "-2.23",
"Assets, Current": "-10.9",
"General and Administrative Expense": "44.0",
"Expenses": "-18.0",
"Revenues": "119",
"Net Income": "91.4",
"Research and Development": "23.2",
"Other Expenses": "-98.7",
"Other Revenues": "119",
"Other Net Income": "-5.32",
"Comprehensive Net Income": "91.0",
"Economic Capital Ratio": "76.6"
},
"2015": {
"Other Liabilities": "39.5",
"Liabilities": "128",
"Stockholders Equity": "2.12",
"ECR before LimitedLiability": "129",
"Liabilities, Current": "65.0",
"Liabilities, Non-Current": "46.9",
"Assets, Current": "-17.0",
"Assets": "-24.9",
"Other Assets": "-5.78",
"Goodwill": "-6.26",
"Property, Plant and Equipment, Net": "-2.45",
"Research and Development": "22.2",
"Expenses": "-36.7",
"Revenues": "136",
"Net Income": "116",
"General and Administrative Expense": "35.7",
"Other Expenses": "-107",
"Other Revenues": "136",
"Comprehensive Net Income": "117",
"Other Net Income": "1.81",
"Economic Capital Ratio": "83.3"
},
"2016": {
"Liabilities, Non-Current": "45.2",
"Liabilities": "108",
"Stockholders Equity": "-28.9",
"ECR before LimitedLiability": "95.2",
"Liabilities, Current": "58.4",
"Other Liabilities": "21.8",
"Property, Plant and Equipment, Net": "-5.66",
"Assets": "-25.1",
"Assets, Non-Current": "-1.91",
"Assets, Current": "-18.2",
"Goodwill": "-7.74",
"Research and Development": "30.0",
"Expenses": "-34.2",
"Revenues": "137",
"Net Income": "94.3",
"General and Administrative Expense": "26.9",
"Other Expenses": "-103",
"Other Revenues": "137",
"Comprehensive Net Income": "93.8",
"Other Net Income": "-4.11",
"Economic Capital Ratio": "75.3"
},
"2017": {
"Other Liabilities": "27.8",
"Liabilities": "114",
"Stockholders Equity": "-15.8",
"ECR before LimitedLiability": "87.6",
"Liabilities, Current": "56.4",
"Liabilities, Non-Current": "48.8",
"Assets, Non-Current": "-2.84",
"Assets": "-25.2",
"Assets, Current": "-11.9",
"Goodwill": "-9.34",
"Property, Plant and Equipment, Net": "-9.93",
"Research and Development": "29.0",
"Expenses": "-47.5",
"Revenues": "135",
"Net Income": "72.7",
"Other Expenses": "-117",
"General and Administrative Expense": "26.5",
"Other Revenues": "135",
"Comprehensive Net Income": "73.2",
"Other Net Income": "-8.90",
"Economic Capital Ratio": "66.0"
},
"2018": {
"Liabilities, Non-Current": "45.3",
"Liabilities": "104",
"Stockholders Equity": "-37.9",
"ECR before LimitedLiability": "107",
"Other Liabilities": "29.0",
"Liabilities, Current": "49.9",
"Property, Plant and Equipment, Net": "-7.27",
"Assets": "-22.7",
"Assets, Current": "-11.0",
"Goodwill": "-7.07",
"Assets, Non-Current": "-6.15",
"Other Expenses": "-100",
"Expenses": "-39.6",
"Revenues": "145",
"Net Income": "98.5",
"Research and Development": "27.6",
"General and Administrative Expense": "21.7",
"Other Revenues": "145",
"Comprehensive Net Income": "98.1",
"Other Net Income": "0.533",
"Economic Capital Ratio": "86.1"
},
"2019": {
"Liabilities, Non-Current": "49.4",
"Liabilities": "107",
"Stockholders Equity": "-32.6",
"ECR before LimitedLiability": "122",
"Other Liabilities": "33.6",
"Liabilities, Current": "44.1",
"Assets, Non-Current": "-6.96",
"Assets": "-23.1",
"Goodwill": "-7.78",
"Property, Plant and Equipment, Net": "-6.49",
"Assets, Current": "-11.3",
"Research and Development": "20.7",
"Expenses": "-38.2",
"Revenues": "141",
"Net Income": "105",
"Other Expenses": "-96.5",
"General and Administrative Expense": "27.0",
"Other Revenues": "141",
"Other Net Income": "9.41",
"Comprehensive Net Income": "105",
"Economic Capital Ratio": "92.0"
},
"2022": {
"Liabilities, Non-Current": "52.5",
"Liabilities": "96.9",
"Stockholders Equity": "-32.1",
"ECR before LimitedLiability": "82.4",
"Other Liabilities": "20.7",
"Liabilities, Current": "39.6",
"Assets": "-23.2",
"Assets, Current": "-8.07",
"Property, Plant and Equipment, Net": "-6.87",
"Assets, Non-Current": "-6.29",
"Goodwill": "-10.6",
"General and Administrative Expense": "5.04",
"Expenses": "-46.0",
"Revenues": "110",
"Net Income": "62.8",
"Research and Development": "17.6",
"Other Expenses": "-73.0",
"Other Revenues": "110",
"Other Net Income": "3.17",
"Comprehensive Net Income": "62.3",
"Economic Capital Ratio": "71.9"
},
"2023": {
"Liabilities, Non-Current": "51.9",
"Liabilities": "117",
"Stockholders Equity": "20.8",
"ECR before LimitedLiability": "113",
"Other Liabilities": "17.7",
"Liabilities, Current": "69.3",
"Assets": "-14.5",
"Property, Plant and Equipment, Net": "-5.20",
"Goodwill": "-8.21",
"Assets, Current": "2.80",
"Assets, Non-Current": "-6.19",
"Other Expenses": "-59.6",
"Expenses": "-49.9",
"Revenues": "100",
"Net Income": "53.9",
"Research and Development": "11.1",
"General and Administrative Expense": "-2.86",
"Other Revenues": "100",
"Other Net Income": "1.50",
"Comprehensive Net Income": "53.6",
"Economic Capital Ratio": "97.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000896264_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "106,059",
"Assets, Non-Current": "6,273",
"General and Administrative Expense": "137,063",
"Goodwill": "60,377",
"Liabilities, Current": "59,696",
"Liabilities, Non-Current": "0",
"Other Assets": "11,033",
"Other Compr. Net Income": "0",
"Other Expenses": "394,346",
"Other Liabilities": "0",
"Other Net Income": "222",
"Other Revenues": "581,939",
"Property, Plant and Equipment, Net": "60,754",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "59,696",
"Assets": "244,496",
"Expenses": "531,409",
"Revenues": "581,939",
"Stockholders Equity": "184,800",
"Net Income": "50,752",
"Comprehensive Net Income": "50,752",
"BaseVar": "708,881",
"ECR before LimitedLiability": "200%",
"Economic Capital Ratio": "235%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "132,545",
"Assets, Non-Current": "7,128",
"General and Administrative Expense": "154,237",
"Goodwill": "59,975",
"Liabilities, Current": "70,844",
"Liabilities, Non-Current": "0",
"Other Assets": "5,956",
"Other Compr. Net Income": "1,097",
"Other Expenses": "428,303",
"Other Liabilities": "0",
"Other Net Income": "247",
"Other Revenues": "648,726",
"Property, Plant and Equipment, Net": "61,751",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "70,844",
"Assets": "267,355",
"Expenses": "582,540",
"Revenues": "648,726",
"Stockholders Equity": "196,511",
"Net Income": "66,433",
"Comprehensive Net Income": "66,982",
"BaseVar": "785,404",
"ECR before LimitedLiability": "199%",
"Economic Capital Ratio": "234%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "229,045",
"Assets, Non-Current": "14,154",
"General and Administrative Expense": "166,208",
"Goodwill": "60,572",
"Liabilities, Current": "95,871",
"Liabilities, Non-Current": "0",
"Other Assets": "5,519",
"Other Compr. Net Income": "-1,142",
"Other Expenses": "472,812",
"Other Liabilities": "0",
"Other Net Income": "-131",
"Other Revenues": "718,175",
"Property, Plant and Equipment, Net": "59,180",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "95,871",
"Assets": "368,470",
"Expenses": "639,020",
"Revenues": "718,175",
"Stockholders Equity": "272,599",
"Net Income": "79,024",
"Comprehensive Net Income": "78,453",
"BaseVar": "911,404",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "190,927",
"Assets, Non-Current": "23,667",
"General and Administrative Expense": "184,531",
"Goodwill": "58,893",
"Liabilities, Current": "108,705",
"Liabilities, Non-Current": "0",
"Other Assets": "5,933",
"Other Compr. Net Income": "-3,662",
"Other Expenses": "528,855",
"Other Liabilities": "0",
"Other Net Income": "-449",
"Other Revenues": "790,471",
"Property, Plant and Equipment, Net": "71,164",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "108,705",
"Assets": "350,584",
"Expenses": "713,386",
"Revenues": "790,471",
"Stockholders Equity": "241,879",
"Net Income": "76,636",
"Comprehensive Net Income": "74,805",
"BaseVar": "983,628",
"ECR before LimitedLiability": "177%",
"Economic Capital Ratio": "219%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "277,861",
"Assets, Non-Current": "22,158",
"General and Administrative Expense": "234,194",
"Goodwill": "51,064",
"Liabilities, Current": "138,491",
"Liabilities, Non-Current": "0",
"Other Assets": "18,292",
"Other Compr. Net Income": "-7,871",
"Other Expenses": "671,778",
"Other Liabilities": "0",
"Other Net Income": "-70",
"Other Revenues": "1,006,083",
"Property, Plant and Equipment, Net": "101,267",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "138,491",
"Assets": "470,642",
"Expenses": "905,972",
"Revenues": "1,006,083",
"Stockholders Equity": "332,151",
"Net Income": "100,041",
"Comprehensive Net Income": "96,106",
"BaseVar": "1,264,564",
"ECR before LimitedLiability": "181%",
"Economic Capital Ratio": "222%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "340,159",
"Assets, Non-Current": "20,833",
"General and Administrative Expense": "265,094",
"Goodwill": "52,571",
"Liabilities, Current": "141,183",
"Liabilities, Non-Current": "0",
"Other Assets": "2,859",
"Other Compr. Net Income": "10,221",
"Other Expenses": "721,772",
"Other Liabilities": "0",
"Other Net Income": "2,136",
"Other Revenues": "1,047,265",
"Property, Plant and Equipment, Net": "102,847",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "141,183",
"Assets": "519,269",
"Expenses": "986,866",
"Revenues": "1,047,265",
"Stockholders Equity": "378,086",
"Net Income": "62,535",
"Comprehensive Net Income": "67,646",
"BaseVar": "1,353,470",
"ECR before LimitedLiability": "177%",
"Economic Capital Ratio": "219%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "392,335",
"Assets, Non-Current": "18,129",
"General and Administrative Expense": "475,769",
"Goodwill": "48,626",
"Liabilities, Current": "148,686",
"Liabilities, Non-Current": "0",
"Other Assets": "3,348",
"Other Compr. Net Income": "-8,961",
"Other Expenses": "590,412",
"Other Liabilities": "0",
"Other Net Income": "3,157",
"Other Revenues": "1,189,248",
"Property, Plant and Equipment, Net": "92,025",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "148,686",
"Assets": "554,463",
"Expenses": "1,066,181",
"Revenues": "1,189,248",
"Stockholders Equity": "405,777",
"Net Income": "126,224",
"Comprehensive Net Income": "121,744",
"BaseVar": "1,485,348",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "230%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "329,279",
"Assets, Non-Current": "42,856",
"General and Administrative Expense": "455,234",
"Goodwill": "46,476",
"Liabilities, Current": "136,098",
"Liabilities, Non-Current": "0",
"Other Assets": "3,090",
"Other Compr. Net Income": "-3,514",
"Other Expenses": "509,448",
"Other Liabilities": "0",
"Other Net Income": "4,306",
"Other Revenues": "1,060,902",
"Property, Plant and Equipment, Net": "95,233",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "136,098",
"Assets": "516,934",
"Expenses": "964,682",
"Revenues": "1,060,902",
"Stockholders Equity": "380,836",
"Net Income": "100,526",
"Comprehensive Net Income": "98,769",
"BaseVar": "1,343,218",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "384,382",
"Assets, Non-Current": "54,795",
"General and Administrative Expense": "456,194",
"Goodwill": "49,800",
"Liabilities, Current": "143,833",
"Liabilities, Non-Current": "0",
"Other Assets": "9,799",
"Other Compr. Net Income": "-13,245",
"Other Expenses": "474,064",
"Other Liabilities": "0",
"Other Net Income": "1,007",
"Other Revenues": "998,601",
"Property, Plant and Equipment, Net": "97,773",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "143,833",
"Assets": "596,549",
"Expenses": "930,258",
"Revenues": "998,601",
"Stockholders Equity": "452,716",
"Net Income": "69,350",
"Comprehensive Net Income": "62,728",
"BaseVar": "1,341,746",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "224%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "417,746",
"Assets, Non-Current": "54,892",
"General and Administrative Expense": "433,682",
"Goodwill": "47,021",
"Liabilities, Current": "118,845",
"Liabilities, Non-Current": "0",
"Other Assets": "13,284",
"Other Compr. Net Income": "-908",
"Other Expenses": "432,922",
"Other Liabilities": "0",
"Other Net Income": "9,382",
"Other Revenues": "921,010",
"Property, Plant and Equipment, Net": "99,814",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "118,845",
"Assets": "632,757",
"Expenses": "866,604",
"Revenues": "921,010",
"Stockholders Equity": "513,912",
"Net Income": "63,788",
"Comprehensive Net Income": "63,334",
"BaseVar": "1,274,753",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "238%"
}
}
},
"top_rated": true,
"trend": 6.0,
"value": 2.37705152416478,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000896264.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000896264.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000896264.svg"
},
{
"company_id": "0001086303",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001086303.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001086303.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001086303.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001086303_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001086303_main_keyfigs.svg",
"name": "Hongchang International Co Ltd",
"rank": 4,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001086303.svg",
"report_text": "The relative strengths and weaknesses of Hongchang International Co Ltd are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hongchang International Co Ltd compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 141% points.The greatest weakness of Hongchang International Co Ltd is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 225%, being 85% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001086303_2024_Hongchang_International_Co_Ltd.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "15.5",
"Liabilities": "9.10",
"Stockholders Equity": "94.9",
"ECR before LimitedLiability": "124",
"Liabilities, Non-Current": "-16.9",
"Other Liabilities": "8.45",
"Property, Plant and Equipment, Net": "6.08",
"Assets": "57.0",
"Other Assets": "22.8",
"Goodwill": "7.32",
"Assets, Current": "3.22",
"General and Administrative Expense": "4.42",
"Expenses": "31.2",
"Revenues": "-35.4",
"Net Income": "9.31",
"Research and Development": "5.82",
"Other Expenses": "20.9",
"Other Revenues": "-35.4",
"Comprehensive Net Income": "9.28",
"Other Net Income": "12.0",
"Economic Capital Ratio": "62.3"
},
"2012": {
"Liabilities, Current": "6.04",
"Liabilities": "-0.784",
"Stockholders Equity": "86.2",
"ECR before LimitedLiability": "85.5",
"Liabilities, Non-Current": "-22.1",
"Other Liabilities": "12.6",
"Assets": "59.3",
"Other Assets": "27.9",
"Assets, Non-Current": "-1.80",
"Property, Plant and Equipment, Net": "7.03",
"Goodwill": "8.07",
"Other Expenses": "21.1",
"Expenses": "36.6",
"Revenues": "-21.9",
"Net Income": "11.9",
"Research and Development": "5.93",
"General and Administrative Expense": "9.23",
"Other Revenues": "-21.9",
"Other Net Income": "-2.96",
"Comprehensive Net Income": "12.0",
"Economic Capital Ratio": "53.0"
},
"2013": {
"Liabilities, Current": "40.8",
"Liabilities": "73.6",
"Stockholders Equity": "77.6",
"ECR before LimitedLiability": "44.1",
"Other Liabilities": "17.5",
"Liabilities, Non-Current": "20.4",
"Goodwill": "61.0",
"Assets": "28.7",
"Assets, Non-Current": "-6.05",
"Property, Plant and Equipment, Net": "-12.6",
"Assets, Current": "4.44",
"General and Administrative Expense": "-2.47",
"Expenses": "-33.3",
"Revenues": "-14.3",
"Net Income": "-62.4",
"Research and Development": "8.80",
"Other Expenses": "-38.9",
"Other Revenues": "-14.3",
"Other Net Income": "-16.6",
"Comprehensive Net Income": "-62.5",
"Economic Capital Ratio": "3.95"
},
"2014": {
"Liabilities, Non-Current": "42.0",
"Liabilities": "141",
"Stockholders Equity": "72.8",
"ECR before LimitedLiability": "153",
"Liabilities, Current": "96.7",
"Other Liabilities": "29.2",
"Assets, Current": "-12.4",
"Assets": "-10.6",
"Goodwill": "13.0",
"Other Assets": "4.63",
"Assets, Non-Current": "-3.20",
"Property, Plant and Equipment, Net": "-7.15",
"Other Expenses": "40.3",
"Expenses": "-39.7",
"Revenues": "103",
"Net Income": "66.0",
"Research and Development": "21.3",
"General and Administrative Expense": "-118",
"Other Revenues": "103",
"Comprehensive Net Income": "66.2",
"Economic Capital Ratio": "104"
},
"2018": {
"Liabilities, Non-Current": "-0.387",
"Liabilities": "5.22",
"Stockholders Equity": "-70.8",
"ECR before LimitedLiability": "-115",
"Other Liabilities": "-0.237",
"Liabilities, Current": "6.73",
"Property, Plant and Equipment, Net": "-9.97",
"Assets": "-44.0",
"Other Assets": "-0.0690",
"Assets, Current": "-14.7",
"Goodwill": "-7.30",
"Assets, Non-Current": "-4.88",
"Other Expenses": "-26.6",
"Expenses": "-5.82",
"Revenues": "-9.33",
"Net Income": "-18.8",
"Research and Development": "1.81",
"General and Administrative Expense": "5.45",
"Other Revenues": "-9.33",
"Comprehensive Net Income": "-18.9",
"Economic Capital Ratio": "-135"
},
"2023": {
"Liabilities, Non-Current": "-28.4",
"Liabilities": "17.9",
"Stockholders Equity": "93.4",
"ECR before LimitedLiability": "99.7",
"Other Liabilities": "5.70",
"Liabilities, Current": "33.7",
"Assets": "43.7",
"Property, Plant and Equipment, Net": "-4.59",
"Goodwill": "-4.78",
"Assets, Current": "-5.38",
"Assets, Non-Current": "141",
"Other Expenses": "8.12",
"Expenses": "28.7",
"Revenues": "-16.3",
"Net Income": "13.1",
"Research and Development": "3.56",
"General and Administrative Expense": "17.3",
"Other Revenues": "-16.3",
"Comprehensive Net Income": "14.0",
"Other Compr. Net Income": "0.908",
"Economic Capital Ratio": "84.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001086303_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "3,743",
"Assets, Non-Current": "0",
"General and Administrative Expense": "2,944",
"Goodwill": "1,946",
"Liabilities, Current": "972",
"Liabilities, Non-Current": "1,030",
"Other Assets": "3,190",
"Other Compr. Net Income": "0",
"Other Expenses": "-654",
"Other Liabilities": "0",
"Other Net Income": "1,526",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "1,815",
"Research and Development": "235"
},
"output_variables": {
"Liabilities": "2,002",
"Assets": "10,695",
"Expenses": "2,526",
"Revenues": "0",
"Stockholders Equity": "8,692",
"Net Income": "-1,000",
"Comprehensive Net Income": "-1,000",
"BaseVar": "8,375",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "216%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,865",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,965",
"Goodwill": "1,946",
"Liabilities, Current": "934",
"Liabilities, Non-Current": "1,167",
"Other Assets": "3,388",
"Other Compr. Net Income": "0",
"Other Expenses": "-544",
"Other Liabilities": "0",
"Other Net Income": "-242",
"Other Revenues": "1,082",
"Property, Plant and Equipment, Net": "1,781",
"Research and Development": "231"
},
"output_variables": {
"Liabilities": "2,100",
"Assets": "9,981",
"Expenses": "1,652",
"Revenues": "1,082",
"Stockholders Equity": "7,881",
"Net Income": "-811",
"Comprehensive Net Income": "-811",
"BaseVar": "7,529",
"ECR before LimitedLiability": "165%",
"Economic Capital Ratio": "211%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,369",
"Assets, Non-Current": "0",
"General and Administrative Expense": "2,147",
"Goodwill": "1,946",
"Liabilities, Current": "281",
"Liabilities, Non-Current": "0",
"Other Assets": "156",
"Other Compr. Net Income": "0",
"Other Expenses": "2,515",
"Other Liabilities": "0",
"Other Net Income": "-449",
"Other Revenues": "1,664",
"Property, Plant and Equipment, Net": "9.4",
"Research and Development": "236"
},
"output_variables": {
"Liabilities": "281",
"Assets": "4,480",
"Expenses": "4,898",
"Revenues": "1,664",
"Stockholders Equity": "4,199",
"Net Income": "-3,682",
"Comprehensive Net Income": "-3,682",
"BaseVar": "5,886",
"ECR before LimitedLiability": "87%",
"Economic Capital Ratio": "158%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "1,768",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,858",
"Goodwill": "1,946",
"Liabilities, Current": "394",
"Liabilities, Non-Current": "0",
"Other Assets": "366",
"Other Compr. Net Income": "0",
"Other Expenses": "5.1",
"Other Liabilities": "0",
"Other Net Income": "11",
"Other Revenues": "6,578",
"Property, Plant and Equipment, Net": "14",
"Research and Development": "225"
},
"output_variables": {
"Liabilities": "394",
"Assets": "4,094",
"Expenses": "7,088",
"Revenues": "6,578",
"Stockholders Equity": "3,700",
"Net Income": "-499",
"Comprehensive Net Income": "-499",
"BaseVar": "9,082",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "237%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "59",
"Assets, Non-Current": "0",
"General and Administrative Expense": "0",
"Goodwill": "0",
"Liabilities, Current": "296",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2.6",
"Other Expenses": "248",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "296",
"Assets": "59",
"Expenses": "248",
"Revenues": "0",
"Stockholders Equity": "-237",
"Net Income": "-248",
"Comprehensive Net Income": "-249",
"BaseVar": "303",
"ECR before LimitedLiability": "-323%",
"Economic Capital Ratio": "8.3%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "3,961",
"Assets, Non-Current": "46,255",
"General and Administrative Expense": "3,145",
"Goodwill": "3.2",
"Liabilities, Current": "1,055",
"Liabilities, Non-Current": "8,672",
"Other Assets": "-3.2",
"Other Compr. Net Income": "861",
"Other Expenses": "-66",
"Other Liabilities": "0",
"Other Net Income": "1.4",
"Other Revenues": "2,699",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,728",
"Assets": "50,216",
"Expenses": "3,080",
"Revenues": "2,699",
"Stockholders Equity": "40,488",
"Net Income": "-379",
"Comprehensive Net Income": "52",
"BaseVar": "33,292",
"ECR before LimitedLiability": "185%",
"Economic Capital Ratio": "225%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.24720046997672,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001086303.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001086303.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001086303.svg"
},
{
"company_id": "0000744218",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000744218.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000744218.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000744218.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000744218_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000744218_main_keyfigs.svg",
"name": "Celldex Therapeutics Inc",
"rank": 5,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000744218.svg",
"report_text": "The relative strengths and weaknesses of Celldex Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Celldex Therapeutics Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 135% points.The greatest weakness of Celldex Therapeutics Inc is the variable Research and Development, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 220%, being 80% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000744218_2024_Celldex_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "9.86",
"Liabilities": "-3.63",
"Stockholders Equity": "67.0",
"ECR before LimitedLiability": "60.1",
"Liabilities, Non-Current": "-3.93",
"Other Liabilities": "-9.89",
"Property, Plant and Equipment, Net": "0.343",
"Assets": "67.5",
"Assets, Non-Current": "-3.70",
"Goodwill": "40.9",
"Assets, Current": "26.4",
"General and Administrative Expense": "37.3",
"Expenses": "10.4",
"Revenues": "-30.9",
"Net Income": "-25.8",
"Research and Development": "-26.0",
"Other Expenses": "3.29",
"Other Revenues": "-30.9",
"Comprehensive Net Income": "-25.9",
"Other Net Income": "-4.47",
"Economic Capital Ratio": "-1.92"
},
"2012": {
"Liabilities, Current": "1.74",
"Liabilities": "4.57",
"Stockholders Equity": "78.6",
"ECR before LimitedLiability": "37.3",
"Liabilities, Non-Current": "-2.06",
"Other Liabilities": "4.88",
"Assets, Current": "49.6",
"Assets": "78.6",
"Assets, Non-Current": "-3.55",
"Property, Plant and Equipment, Net": "-3.08",
"Goodwill": "21.4",
"Other Expenses": "9.36",
"Expenses": "8.36",
"Revenues": "-32.0",
"Net Income": "-24.8",
"Research and Development": "-30.8",
"General and Administrative Expense": "33.5",
"Other Revenues": "-32.0",
"Other Net Income": "-0.401",
"Comprehensive Net Income": "-25.1",
"Economic Capital Ratio": "4.79"
},
"2013": {
"Liabilities, Current": "17.3",
"Liabilities": "31.9",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "114",
"Other Liabilities": "10.4",
"Liabilities, Non-Current": "6.72",
"Goodwill": "1.26",
"Assets": "65.4",
"Assets, Non-Current": "-1.30",
"Property, Plant and Equipment, Net": "-1.50",
"Assets, Current": "79.0",
"General and Administrative Expense": "23.7",
"Expenses": "22.1",
"Revenues": "-30.5",
"Net Income": "-8.50",
"Research and Development": "-17.4",
"Other Expenses": "15.1",
"Other Revenues": "-30.5",
"Other Net Income": "-1.65",
"Comprehensive Net Income": "-8.59",
"Economic Capital Ratio": "73.7"
},
"2014": {
"Liabilities, Non-Current": "3.49",
"Liabilities": "35.9",
"Stockholders Equity": "99.6",
"ECR before LimitedLiability": "96.9",
"Liabilities, Current": "24.3",
"Other Liabilities": "9.38",
"Assets, Current": "96.6",
"Assets": "96.4",
"Goodwill": "3.01",
"Assets, Non-Current": "-1.97",
"Property, Plant and Equipment, Net": "-2.60",
"Other Expenses": "14.6",
"Expenses": "4.42",
"Revenues": "-33.2",
"Net Income": "-27.9",
"Research and Development": "-38.6",
"General and Administrative Expense": "30.8",
"Other Revenues": "-33.2",
"Comprehensive Net Income": "-26.9",
"Other Compr. Net Income": "1.06",
"Economic Capital Ratio": "47.5"
},
"2015": {
"Other Liabilities": "12.8",
"Liabilities": "36.3",
"Stockholders Equity": "111",
"ECR before LimitedLiability": "105",
"Liabilities, Current": "21.4",
"Liabilities, Non-Current": "3.92",
"Assets, Current": "110",
"Assets": "78.5",
"Other Assets": "-3.01",
"Assets, Non-Current": "-1.32",
"Property, Plant and Equipment, Net": "-2.77",
"Research and Development": "-27.3",
"Expenses": "8.22",
"Revenues": "-26.9",
"Net Income": "-18.0",
"General and Administrative Expense": "16.9",
"Other Expenses": "18.9",
"Other Revenues": "-26.9",
"Comprehensive Net Income": "-17.5",
"Other Net Income": "0.613",
"Economic Capital Ratio": "58.7"
},
"2016": {
"Liabilities, Non-Current": "-30.8",
"Liabilities": "-2.70",
"Stockholders Equity": "70.5",
"ECR before LimitedLiability": "36.2",
"Liabilities, Current": "19.0",
"Other Liabilities": "6.30",
"Property, Plant and Equipment, Net": "-6.84",
"Assets": "71.0",
"Assets, Non-Current": "-2.15",
"Assets, Current": "18.5",
"Goodwill": "54.6",
"Research and Development": "-18.5",
"Expenses": "16.3",
"Revenues": "-28.3",
"Net Income": "-14.8",
"General and Administrative Expense": "16.5",
"Other Expenses": "19.6",
"Other Revenues": "-28.3",
"Comprehensive Net Income": "-14.0",
"Other Net Income": "-1.35",
"Economic Capital Ratio": "16.2"
},
"2017": {
"Other Liabilities": "8.57",
"Liabilities": "9.71",
"Stockholders Equity": "84.0",
"ECR before LimitedLiability": "47.5",
"Liabilities, Current": "18.3",
"Liabilities, Non-Current": "-18.9",
"Assets, Non-Current": "-2.08",
"Assets": "64.0",
"Assets, Current": "16.1",
"Goodwill": "55.7",
"Property, Plant and Equipment, Net": "-7.96",
"Research and Development": "-22.9",
"Expenses": "13.1",
"Revenues": "-22.2",
"Net Income": "-12.6",
"Other Expenses": "19.0",
"General and Administrative Expense": "18.1",
"Other Revenues": "-22.2",
"Comprehensive Net Income": "-12.8",
"Other Net Income": "-3.01",
"Economic Capital Ratio": "26.0"
},
"2018": {
"Liabilities, Non-Current": "-6.30",
"Liabilities": "19.8",
"Stockholders Equity": "26.6",
"ECR before LimitedLiability": "-19.4",
"Other Liabilities": "12.7",
"Liabilities, Current": "19.5",
"Property, Plant and Equipment, Net": "-19.9",
"Assets": "20.8",
"Assets, Current": "20.7",
"Goodwill": "20.8",
"Assets, Non-Current": "-12.7",
"Other Expenses": "-54.4",
"Expenses": "-50.5",
"Revenues": "-42.9",
"Net Income": "-85.9",
"Research and Development": "-43.3",
"General and Administrative Expense": "21.8",
"Other Revenues": "-42.9",
"Comprehensive Net Income": "-85.6",
"Other Compr. Net Income": "0.343",
"Economic Capital Ratio": "-39.8"
},
"2019": {
"Liabilities, Non-Current": "-12.7",
"Liabilities": "12.8",
"Stockholders Equity": "80.2",
"ECR before LimitedLiability": "63.2",
"Other Liabilities": "11.0",
"Liabilities, Current": "13.9",
"Assets, Non-Current": "-5.39",
"Assets": "59.5",
"Goodwill": "41.0",
"Property, Plant and Equipment, Net": "-7.58",
"Assets, Current": "27.2",
"Research and Development": "-30.4",
"Expenses": "5.15",
"Revenues": "-25.4",
"Net Income": "-17.6",
"Other Expenses": "7.13",
"General and Administrative Expense": "31.4",
"Other Revenues": "-25.4",
"Other Net Income": "3.09",
"Comprehensive Net Income": "-17.5",
"Economic Capital Ratio": "33.7"
},
"2020": {
"Liabilities, Current": "24.1",
"Liabilities": "41.0",
"Stockholders Equity": "96.8",
"ECR before LimitedLiability": "93.4",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "5.51",
"Goodwill": "2.53",
"Assets": "36.7",
"Assets, Current": "66.0",
"Assets, Non-Current": "-4.34",
"Property, Plant and Equipment, Net": "-7.27",
"Expenses": "14.4",
"Net Income": "-8.83",
"Research and Development": "-15.2",
"General and Administrative Expense": "29.7",
"Other Revenues": "-27.5",
"Revenues": "-27.5",
"Other Compr. Net Income": "-15.0",
"Comprehensive Net Income": "-24.0",
"Other Net Income": "4.06",
"Economic Capital Ratio": "55.6"
},
"2021": {
"Liabilities, Non-Current": "15.3",
"Liabilities": "39.4",
"Stockholders Equity": "114",
"ECR before LimitedLiability": "90.5",
"Liabilities, Current": "20.9",
"Other Liabilities": "7.24",
"Assets, Current": "64.4",
"Assets": "34.8",
"Assets, Non-Current": "-2.18",
"Goodwill": "-1.33",
"Property, Plant and Equipment, Net": "-2.88",
"Other Expenses": "6.67",
"Expenses": "18.7",
"Revenues": "-25.2",
"Net Income": "-4.73",
"Research and Development": "-9.54",
"General and Administrative Expense": "21.2",
"Other Revenues": "-25.2",
"Comprehensive Net Income": "-4.84",
"Other Net Income": "0.414",
"Economic Capital Ratio": "86.1"
},
"2022": {
"Liabilities, Non-Current": "15.5",
"Liabilities": "40.8",
"Stockholders Equity": "116",
"ECR before LimitedLiability": "76.9",
"Other Liabilities": "7.75",
"Liabilities, Current": "21.2",
"Assets": "46.5",
"Assets, Current": "102",
"Property, Plant and Equipment, Net": "-5.14",
"Assets, Non-Current": "-3.62",
"Goodwill": "-1.91",
"General and Administrative Expense": "22.1",
"Expenses": "4.22",
"Revenues": "-27.4",
"Net Income": "-21.8",
"Research and Development": "-23.0",
"Other Expenses": "4.35",
"Other Revenues": "-27.4",
"Other Net Income": "1.08",
"Comprehensive Net Income": "-21.6",
"Economic Capital Ratio": "66.4"
},
"2023": {
"Liabilities, Non-Current": "18.9",
"Liabilities": "50.9",
"Stockholders Equity": "128",
"ECR before LimitedLiability": "95.1",
"Other Liabilities": "6.82",
"Liabilities, Current": "30.2",
"Other Assets": "-0.587",
"Assets": "46.4",
"Property, Plant and Equipment, Net": "-5.49",
"Goodwill": "-3.16",
"Assets, Current": "135",
"Assets, Non-Current": "-4.89",
"Other Expenses": "6.42",
"Expenses": "1.09",
"Revenues": "-22.0",
"Net Income": "-21.0",
"Research and Development": "-28.0",
"General and Administrative Expense": "21.5",
"Other Revenues": "-22.0",
"Comprehensive Net Income": "-20.8",
"Economic Capital Ratio": "79.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000744218_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "54,684",
"Assets, Non-Current": "329",
"General and Administrative Expense": "9,243",
"Goodwill": "33,888",
"Liabilities, Current": "14,298",
"Liabilities, Non-Current": "5,966",
"Other Assets": "0",
"Other Compr. Net Income": "-99",
"Other Expenses": "12,778",
"Other Liabilities": "9,008",
"Other Net Income": "396",
"Other Revenues": "9,265",
"Property, Plant and Equipment, Net": "9,093",
"Research and Development": "32,439"
},
"output_variables": {
"Liabilities": "29,272",
"Assets": "97,994",
"Expenses": "54,460",
"Revenues": "9,265",
"Stockholders Equity": "68,722",
"Net Income": "-44,799",
"Comprehensive Net Income": "-44,848",
"BaseVar": "95,743",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "152%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "85,114",
"Assets, Non-Current": "424",
"General and Administrative Expense": "10,016",
"Goodwill": "32,798",
"Liabilities, Current": "17,685",
"Liabilities, Non-Current": "6,336",
"Other Assets": "0",
"Other Compr. Net Income": "-953",
"Other Expenses": "11,865",
"Other Liabilities": "5,746",
"Other Net Income": "0",
"Other Revenues": "11,202",
"Property, Plant and Equipment, Net": "7,205",
"Research and Development": "47,398"
},
"output_variables": {
"Liabilities": "29,767",
"Assets": "125,541",
"Expenses": "69,279",
"Revenues": "11,202",
"Stockholders Equity": "95,774",
"Net Income": "-58,077",
"Comprehensive Net Income": "-58,554",
"BaseVar": "118,371",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "163%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "305,189",
"Assets, Non-Current": "148",
"General and Administrative Expense": "14,805",
"Goodwill": "31,785",
"Liabilities, Current": "20,350",
"Liabilities, Non-Current": "6,950",
"Other Assets": "0",
"Other Compr. Net Income": "-185",
"Other Expenses": "3,347",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,111",
"Property, Plant and Equipment, Net": "9,973",
"Research and Development": "67,401"
},
"output_variables": {
"Liabilities": "27,300",
"Assets": "347,095",
"Expenses": "85,553",
"Revenues": "4,111",
"Stockholders Equity": "319,795",
"Net Income": "-81,442",
"Comprehensive Net Income": "-81,534",
"BaseVar": "232,122",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "204,985",
"Assets, Non-Current": "1,722",
"General and Administrative Expense": "20,622",
"Goodwill": "30,772",
"Liabilities, Current": "24,491",
"Liabilities, Non-Current": "11,863",
"Other Assets": "0",
"Other Compr. Net Income": "4,272",
"Other Expenses": "1,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "3,586",
"Property, Plant and Equipment, Net": "10,535",
"Research and Development": "104,381"
},
"output_variables": {
"Liabilities": "36,354",
"Assets": "248,014",
"Expenses": "126,016",
"Revenues": "3,586",
"Stockholders Equity": "211,660",
"Net Income": "-122,430",
"Comprehensive Net Income": "-120,294",
"BaseVar": "209,121",
"ECR before LimitedLiability": "119%",
"Economic Capital Ratio": "181%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "294,936",
"Assets, Non-Current": "1,428",
"General and Administrative Expense": "33,837",
"Goodwill": "29,759",
"Liabilities, Current": "30,240",
"Liabilities, Non-Current": "17,239",
"Other Assets": "0",
"Other Compr. Net Income": "2,061",
"Other Expenses": "1,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,480",
"Property, Plant and Equipment, Net": "11,461",
"Research and Development": "100,171"
},
"output_variables": {
"Liabilities": "47,479",
"Assets": "337,584",
"Expenses": "135,021",
"Revenues": "5,480",
"Stockholders Equity": "290,105",
"Net Income": "-129,541",
"Comprehensive Net Income": "-128,510",
"BaseVar": "263,812",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "195%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "195,569",
"Assets, Non-Current": "2,134",
"General and Administrative Expense": "35,979",
"Goodwill": "172,463",
"Liabilities, Current": "35,223",
"Liabilities, Non-Current": "82,704",
"Other Assets": "0",
"Other Compr. Net Income": "4,620",
"Other Expenses": "997",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,786",
"Property, Plant and Equipment, Net": "13,192",
"Research and Development": "102,726"
},
"output_variables": {
"Liabilities": "117,927",
"Assets": "383,358",
"Expenses": "139,702",
"Revenues": "6,786",
"Stockholders Equity": "265,431",
"Net Income": "-132,916",
"Comprehensive Net Income": "-130,606",
"BaseVar": "326,196",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "163%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "144,756",
"Assets, Non-Current": "1,929",
"General and Administrative Expense": "25,003",
"Goodwill": "158,567",
"Liabilities, Current": "27,736",
"Liabilities, Non-Current": "51,519",
"Other Assets": "0",
"Other Compr. Net Income": "23",
"Other Expenses": "-11,186",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "16,957",
"Property, Plant and Equipment, Net": "10,372",
"Research and Development": "96,171"
},
"output_variables": {
"Liabilities": "79,255",
"Assets": "315,624",
"Expenses": "109,988",
"Revenues": "16,957",
"Stockholders Equity": "236,369",
"Net Income": "-93,031",
"Comprehensive Net Income": "-93,020",
"BaseVar": "260,924",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "179%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "99,079",
"Assets, Non-Current": "1,929",
"General and Administrative Expense": "19,269",
"Goodwill": "48,690",
"Liabilities, Current": "12,602",
"Liabilities, Non-Current": "19,147",
"Other Assets": "0",
"Other Compr. Net Income": "19",
"Other Expenses": "79,491",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "14,025",
"Property, Plant and Equipment, Net": "6,111",
"Research and Development": "66,449"
},
"output_variables": {
"Liabilities": "31,749",
"Assets": "155,809",
"Expenses": "165,209",
"Revenues": "14,025",
"Stockholders Equity": "124,060",
"Net Income": "-151,184",
"Comprehensive Net Income": "-151,174",
"BaseVar": "183,406",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "66,698",
"Assets, Non-Current": "3,514",
"General and Administrative Expense": "15,426",
"Goodwill": "48,690",
"Liabilities, Current": "11,643",
"Liabilities, Non-Current": "17,264",
"Other Assets": "0",
"Other Compr. Net Income": "36",
"Other Expenses": "506",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,726",
"Property, Plant and Equipment, Net": "4,031",
"Research and Development": "42,672"
},
"output_variables": {
"Liabilities": "28,907",
"Assets": "122,933",
"Expenses": "58,604",
"Revenues": "7,726",
"Stockholders Equity": "94,026",
"Net Income": "-50,878",
"Comprehensive Net Income": "-50,860",
"BaseVar": "109,103",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "197,843",
"Assets, Non-Current": "3,490",
"General and Administrative Expense": "14,456",
"Goodwill": "30,690",
"Liabilities, Current": "14,206",
"Liabilities, Non-Current": "12,275",
"Other Assets": "0",
"Other Compr. Net Income": "-59,810",
"Other Expenses": "12,615",
"Other Liabilities": "0",
"Other Net Income": "-30",
"Other Revenues": "9,825",
"Property, Plant and Equipment, Net": "3,815",
"Research and Development": "42,534"
},
"output_variables": {
"Liabilities": "26,481",
"Assets": "235,838",
"Expenses": "69,605",
"Revenues": "9,825",
"Stockholders Equity": "209,357",
"Net Income": "-59,810",
"Comprehensive Net Income": "-89,715",
"BaseVar": "200,794",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "202%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "410,839",
"Assets, Non-Current": "3,074",
"General and Administrative Expense": "20,488",
"Goodwill": "27,190",
"Liabilities, Current": "16,528",
"Liabilities, Non-Current": "8,650",
"Other Assets": "0",
"Other Compr. Net Income": "-695",
"Other Expenses": "1,868",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,156",
"Property, Plant and Equipment, Net": "3,551",
"Research and Development": "53,311"
},
"output_variables": {
"Liabilities": "25,178",
"Assets": "444,654",
"Expenses": "75,667",
"Revenues": "5,156",
"Stockholders Equity": "419,476",
"Net Income": "-70,511",
"Comprehensive Net Income": "-70,858",
"BaseVar": "275,675",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "245%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "317,693",
"Assets, Non-Current": "4,105",
"General and Administrative Expense": "27,195",
"Goodwill": "27,190",
"Liabilities, Current": "18,610",
"Liabilities, Non-Current": "7,921",
"Other Assets": "0",
"Other Compr. Net Income": "-634",
"Other Expenses": "8,138",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,266",
"Property, Plant and Equipment, Net": "3,747",
"Research and Development": "82,258"
},
"output_variables": {
"Liabilities": "26,531",
"Assets": "352,735",
"Expenses": "117,591",
"Revenues": "5,266",
"Stockholders Equity": "326,204",
"Net Income": "-112,325",
"Comprehensive Net Income": "-112,642",
"BaseVar": "251,378",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "219%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "431,693",
"Assets, Non-Current": "2,684",
"General and Administrative Expense": "30,914",
"Goodwill": "27,190",
"Liabilities, Current": "31,125",
"Liabilities, Non-Current": "5,331",
"Other Assets": "0",
"Other Compr. Net Income": "2,048",
"Other Expenses": "12,500",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "19,996",
"Property, Plant and Equipment, Net": "4,060",
"Research and Development": "118,011"
},
"output_variables": {
"Liabilities": "36,456",
"Assets": "465,627",
"Expenses": "161,425",
"Revenues": "19,996",
"Stockholders Equity": "429,171",
"Net Income": "-141,429",
"Comprehensive Net Income": "-140,405",
"BaseVar": "342,776",
"ECR before LimitedLiability": "178%",
"Economic Capital Ratio": "220%"
}
}
},
"top_rated": true,
"trend": 5.0,
"value": 2.2004173381028744,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000744218.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000744218.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000744218.svg"
},
{
"company_id": "0000885462",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000885462.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000885462.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000885462.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000885462_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000885462_main_keyfigs.svg",
"name": "GULF Resources INC",
"rank": 6,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000885462.svg",
"report_text": "The relative strengths and weaknesses of GULF Resources INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of GULF Resources INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 116% points.The greatest weakness of GULF Resources INC is the variable Other Net Income, reducing the Economic Capital Ratio by 26% points.
The company's Economic Capital Ratio, given in the ranking table, is 218%, being 78% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000885462_2024_GULF_Resources_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "58.2",
"Liabilities": "78.6",
"Assets": "1.19",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "196",
"Liabilities, Non-Current": "18.5",
"Other Liabilities": "15.1",
"Property, Plant and Equipment, Net": "2.06",
"Assets, Non-Current": "2.81",
"Other Assets": "-0.918",
"General and Administrative Expense": "5.94",
"Expenses": "32.9",
"Revenues": "28.8",
"Net Income": "52.7",
"Research and Development": "15.6",
"Other Expenses": "12.3",
"Other Revenues": "28.8",
"Comprehensive Net Income": "55.8",
"Other Net Income": "-7.64",
"Other Compr. Net Income": "3.57",
"Economic Capital Ratio": "134"
},
"2012": {
"Liabilities, Current": "33.6",
"Liabilities": "57.9",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "152",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "19.3",
"Assets, Current": "0.692",
"Assets": "9.77",
"Other Assets": "-4.46",
"Assets, Non-Current": "14.7",
"Property, Plant and Equipment, Net": "11.6",
"Goodwill": "-0.899",
"Other Expenses": "19.7",
"Expenses": "36.6",
"Revenues": "2.24",
"Net Income": "38.3",
"Research and Development": "12.9",
"General and Administrative Expense": "5.14",
"Other Revenues": "2.24",
"Comprehensive Net Income": "38.6",
"Economic Capital Ratio": "119"
},
"2013": {
"Liabilities, Current": "43.0",
"Liabilities": "68.3",
"Assets": "4.81",
"Stockholders Equity": "122",
"ECR before LimitedLiability": "169",
"Other Liabilities": "15.4",
"Liabilities, Non-Current": "21.8",
"Assets, Non-Current": "5.03",
"Property, Plant and Equipment, Net": "4.00",
"Other Assets": "-2.12",
"General and Administrative Expense": "1.75",
"Expenses": "35.7",
"Revenues": "8.78",
"Net Income": "41.5",
"Research and Development": "11.6",
"Other Expenses": "23.2",
"Other Revenues": "8.78",
"Other Net Income": "-2.47",
"Comprehensive Net Income": "43.4",
"Other Compr. Net Income": "2.17",
"Economic Capital Ratio": "129"
},
"2014": {
"Liabilities, Non-Current": "23.9",
"Liabilities": "82.0",
"Stockholders Equity": "148",
"ECR before LimitedLiability": "200",
"Liabilities, Current": "59.8",
"Other Liabilities": "13.0",
"Assets, Current": "2.40",
"Assets": "5.67",
"Other Assets": "-1.62",
"Assets, Non-Current": "3.31",
"Property, Plant and Equipment, Net": "2.58",
"Other Expenses": "15.6",
"Expenses": "36.2",
"Revenues": "7.48",
"Net Income": "44.2",
"Research and Development": "13.0",
"General and Administrative Expense": "8.84",
"Other Revenues": "7.48",
"Other Net Income": "1.45",
"Comprehensive Net Income": "44.1",
"Economic Capital Ratio": "150"
},
"2015": {
"Other Liabilities": "22.3",
"Liabilities": "88.5",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "188",
"Liabilities, Current": "57.0",
"Liabilities, Non-Current": "29.4",
"Assets, Current": "2.57",
"Assets": "6.69",
"Other Assets": "-3.71",
"Assets, Non-Current": "8.19",
"Property, Plant and Equipment, Net": "4.00",
"Research and Development": "11.0",
"Expenses": "31.3",
"Revenues": "21.4",
"Net Income": "51.9",
"General and Administrative Expense": "-3.26",
"Other Expenses": "24.0",
"Other Revenues": "21.4",
"Comprehensive Net Income": "48.2",
"Other Compr. Net Income": "-4.21",
"Economic Capital Ratio": "142"
},
"2016": {
"Liabilities, Non-Current": "28.1",
"Liabilities": "78.6",
"Assets": "4.77",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "155",
"Liabilities, Current": "53.9",
"Other Liabilities": "10.9",
"Other Assets": "-2.26",
"Assets, Non-Current": "4.53",
"Assets, Current": "2.39",
"Research and Development": "14.7",
"Expenses": "34.2",
"Revenues": "14.3",
"Net Income": "45.5",
"General and Administrative Expense": "-2.38",
"Other Expenses": "22.6",
"Other Revenues": "14.3",
"Comprehensive Net Income": "41.2",
"Other Net Income": "-1.90",
"Other Compr. Net Income": "-4.95",
"Economic Capital Ratio": "135"
},
"2017": {
"Other Liabilities": "16.1",
"Liabilities": "79.4",
"Assets": "4.55",
"Stockholders Equity": "132",
"ECR before LimitedLiability": "152",
"Liabilities, Current": "55.5",
"Liabilities, Non-Current": "22.5",
"Assets, Non-Current": "3.08",
"Other Assets": "-1.46",
"Assets, Current": "2.85",
"Research and Development": "13.2",
"Expenses": "28.4",
"Revenues": "2.51",
"Net Income": "26.9",
"Other Expenses": "7.51",
"General and Administrative Expense": "8.43",
"Other Revenues": "2.51",
"Comprehensive Net Income": "31.1",
"Other Net Income": "-4.14",
"Other Compr. Net Income": "4.48",
"Economic Capital Ratio": "130"
},
"2018": {
"Liabilities, Non-Current": "15.0",
"Liabilities": "53.4",
"Stockholders Equity": "147",
"ECR before LimitedLiability": "121",
"Other Liabilities": "10.5",
"Liabilities, Current": "34.6",
"Property, Plant and Equipment, Net": "9.60",
"Assets": "47.1",
"Other Assets": "-9.33",
"Assets, Current": "24.4",
"Assets, Non-Current": "19.8",
"Other Expenses": "-20.2",
"Expenses": "20.0",
"Revenues": "-31.6",
"Net Income": "-9.64",
"Research and Development": "9.00",
"General and Administrative Expense": "29.9",
"Other Revenues": "-31.6",
"Comprehensive Net Income": "-14.0",
"Other Compr. Net Income": "-4.21",
"Economic Capital Ratio": "100"
},
"2019": {
"Liabilities, Non-Current": "7.47",
"Liabilities": "42.8",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "146",
"Other Liabilities": "12.1",
"Liabilities, Current": "27.7",
"Assets, Non-Current": "37.4",
"Assets": "38.6",
"Property, Plant and Equipment, Net": "22.0",
"Other Assets": "-11.5",
"Assets, Current": "6.17",
"Research and Development": "6.39",
"Expenses": "30.9",
"Revenues": "-24.1",
"Net Income": "11.6",
"Other Expenses": "-2.47",
"General and Administrative Expense": "27.2",
"Other Revenues": "-24.1",
"Other Net Income": "2.84",
"Comprehensive Net Income": "10.4",
"Economic Capital Ratio": "116"
},
"2020": {
"Liabilities, Current": "34.0",
"Liabilities": "52.5",
"Assets": "17.6",
"Stockholders Equity": "117",
"ECR before LimitedLiability": "159",
"Liabilities, Non-Current": "18.6",
"Other Liabilities": "6.42",
"Other Assets": "-7.18",
"Assets, Non-Current": "25.1",
"Property, Plant and Equipment, Net": "13.5",
"Other Expenses": "2.75",
"Expenses": "28.0",
"Revenues": "-17.5",
"Net Income": "15.8",
"Research and Development": "5.87",
"General and Administrative Expense": "19.9",
"Other Revenues": "-17.5",
"Comprehensive Net Income": "20.5",
"Other Net Income": "4.02",
"Other Compr. Net Income": "4.89",
"Economic Capital Ratio": "121"
},
"2021": {
"Liabilities, Non-Current": "17.0",
"Liabilities": "46.2",
"Stockholders Equity": "97.1",
"ECR before LimitedLiability": "107",
"Liabilities, Current": "25.8",
"Other Liabilities": "9.14",
"Assets": "15.7",
"Assets, Non-Current": "27.6",
"Other Assets": "-8.98",
"Goodwill": "-2.58",
"Property, Plant and Equipment, Net": "17.4",
"Other Expenses": "-12.2",
"Expenses": "24.9",
"Revenues": "-6.81",
"Net Income": "19.2",
"Research and Development": "8.03",
"General and Administrative Expense": "28.5",
"Other Revenues": "-6.81",
"Comprehensive Net Income": "20.8",
"Other Compr. Net Income": "1.65",
"Economic Capital Ratio": "103"
},
"2022": {
"Liabilities, Non-Current": "19.3",
"Liabilities": "55.5",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "119",
"Other Liabilities": "10.7",
"Liabilities, Current": "33.4",
"Other Assets": "-9.26",
"Assets": "15.8",
"Assets, Current": "3.41",
"Property, Plant and Equipment, Net": "16.4",
"Assets, Non-Current": "24.6",
"General and Administrative Expense": "34.8",
"Expenses": "28.4",
"Revenues": "-3.84",
"Net Income": "26.3",
"Research and Development": "7.90",
"Other Expenses": "-15.2",
"Other Revenues": "-3.84",
"Comprehensive Net Income": "21.1",
"Other Compr. Net Income": "-5.62",
"Economic Capital Ratio": "108"
},
"2023": {
"Liabilities, Non-Current": "14.3",
"Liabilities": "54.0",
"Stockholders Equity": "116",
"ECR before LimitedLiability": "92.8",
"Other Liabilities": "7.44",
"Liabilities, Current": "37.1",
"Other Assets": "-22.6",
"Assets": "35.9",
"Property, Plant and Equipment, Net": "40.4",
"Goodwill": "-6.98",
"Assets, Current": "9.27",
"Assets, Non-Current": "59.2",
"Other Expenses": "-11.5",
"Expenses": "23.9",
"Revenues": "-13.7",
"Net Income": "-14.5",
"General and Administrative Expense": "30.5",
"Other Revenues": "-13.7",
"Other Net Income": "-25.6",
"Comprehensive Net Income": "-16.0",
"Economic Capital Ratio": "77.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000885462_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "105,517",
"Assets, Non-Current": "152,811",
"General and Administrative Expense": "107,413",
"Goodwill": "0",
"Liabilities, Current": "12,178",
"Liabilities, Non-Current": "0",
"Other Assets": "-147,201",
"Other Compr. Net Income": "12,493",
"Other Expenses": "26,274",
"Other Liabilities": "3,037",
"Other Net Income": "57",
"Other Revenues": "164,980",
"Property, Plant and Equipment, Net": "147,201",
"Research and Development": "399"
},
"output_variables": {
"Liabilities": "15,215",
"Assets": "258,328",
"Expenses": "134,085",
"Revenues": "164,980",
"Stockholders Equity": "243,113",
"Net Income": "30,953",
"Comprehensive Net Income": "37,199",
"BaseVar": "292,579",
"ECR before LimitedLiability": "271%",
"Economic Capital Ratio": "287%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "107,259",
"Assets, Non-Current": "170,934",
"General and Administrative Expense": "80,231",
"Goodwill": "0",
"Liabilities, Current": "11,016",
"Liabilities, Non-Current": "0",
"Other Assets": "-165,943",
"Other Compr. Net Income": "733",
"Other Expenses": "6,622",
"Other Liabilities": "2,953",
"Other Net Income": "313",
"Other Revenues": "101,701",
"Property, Plant and Equipment, Net": "165,943",
"Research and Development": "165"
},
"output_variables": {
"Liabilities": "13,969",
"Assets": "278,193",
"Expenses": "87,018",
"Revenues": "101,701",
"Stockholders Equity": "264,224",
"Net Income": "14,996",
"Comprehensive Net Income": "15,362",
"BaseVar": "240,963",
"ECR before LimitedLiability": "258%",
"Economic Capital Ratio": "278%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "158,073",
"Assets, Non-Current": "151,172",
"General and Administrative Expense": "92,772",
"Goodwill": "0",
"Liabilities, Current": "11,306",
"Liabilities, Non-Current": "0",
"Other Assets": "-146,400",
"Other Compr. Net Income": "9,258",
"Other Expenses": "4,851",
"Other Liabilities": "2,944",
"Other Net Income": "340",
"Other Revenues": "118,392",
"Property, Plant and Equipment, Net": "146,400",
"Research and Development": "140"
},
"output_variables": {
"Liabilities": "14,250",
"Assets": "309,245",
"Expenses": "97,764",
"Revenues": "118,392",
"Stockholders Equity": "294,995",
"Net Income": "20,967",
"Comprehensive Net Income": "25,597",
"BaseVar": "274,624",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "283%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "194,128",
"Assets, Non-Current": "128,854",
"General and Administrative Expense": "88,899",
"Goodwill": "0",
"Liabilities, Current": "8,082",
"Liabilities, Non-Current": "0",
"Other Assets": "-124,351",
"Other Compr. Net Income": "-1,078",
"Other Expenses": "7,035",
"Other Liabilities": "2,826",
"Other Net Income": "280",
"Other Revenues": "113,660",
"Property, Plant and Equipment, Net": "124,351",
"Research and Development": "134"
},
"output_variables": {
"Liabilities": "10,909",
"Assets": "322,982",
"Expenses": "96,068",
"Revenues": "113,660",
"Stockholders Equity": "312,073",
"Net Income": "17,872",
"Comprehensive Net Income": "17,333",
"BaseVar": "272,488",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "284%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "190,821",
"Assets, Non-Current": "165,922",
"General and Administrative Expense": "115,705",
"Goodwill": "29,559",
"Liabilities, Current": "16,076",
"Liabilities, Non-Current": "0",
"Other Assets": "-157,430",
"Other Compr. Net Income": "-21,741",
"Other Expenses": "12,589",
"Other Liabilities": "2,556",
"Other Net Income": "275",
"Other Revenues": "162,317",
"Property, Plant and Equipment, Net": "127,871",
"Research and Development": "231"
},
"output_variables": {
"Liabilities": "18,632",
"Assets": "356,743",
"Expenses": "128,524",
"Revenues": "162,317",
"Stockholders Equity": "338,111",
"Net Income": "34,068",
"Comprehensive Net Income": "23,198",
"BaseVar": "344,116",
"ECR before LimitedLiability": "259%",
"Economic Capital Ratio": "278%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "221,767",
"Assets, Non-Current": "143,924",
"General and Administrative Expense": "100,564",
"Goodwill": "27,669",
"Liabilities, Current": "13,945",
"Liabilities, Non-Current": "0",
"Other Assets": "-136,400",
"Other Compr. Net Income": "-24,931",
"Other Expenses": "12,536",
"Other Liabilities": "2,285",
"Other Net Income": "313",
"Other Revenues": "149,275",
"Property, Plant and Equipment, Net": "108,731",
"Research and Development": "262"
},
"output_variables": {
"Liabilities": "16,230",
"Assets": "365,691",
"Expenses": "113,362",
"Revenues": "149,275",
"Stockholders Equity": "349,461",
"Net Income": "36,226",
"Comprehensive Net Income": "23,760",
"BaseVar": "334,901",
"ECR before LimitedLiability": "263%",
"Economic Capital Ratio": "281%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "241,513",
"Assets, Non-Current": "145,986",
"General and Administrative Expense": "71,972",
"Goodwill": "29,375",
"Liabilities, Current": "3,666",
"Liabilities, Non-Current": "7,273",
"Other Assets": "-124,489",
"Other Compr. Net Income": "24,157",
"Other Expenses": "33,195",
"Other Liabilities": "0",
"Other Net Income": "392",
"Other Revenues": "107,522",
"Property, Plant and Equipment, Net": "95,115",
"Research and Development": "195"
},
"output_variables": {
"Liabilities": "10,939",
"Assets": "387,499",
"Expenses": "105,363",
"Revenues": "107,522",
"Stockholders Equity": "376,560",
"Net Income": "2,551",
"Comprehensive Net Income": "14,630",
"BaseVar": "317,937",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "284%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "187,344",
"Assets, Non-Current": "111,203",
"General and Administrative Expense": "12,645",
"Goodwill": "0",
"Liabilities, Current": "2,624",
"Liabilities, Non-Current": "2,070",
"Other Assets": "-82,283",
"Other Compr. Net Income": "-18,641",
"Other Expenses": "60,414",
"Other Liabilities": "0",
"Other Net Income": "501",
"Other Revenues": "2,595",
"Property, Plant and Equipment, Net": "82,283",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,693",
"Assets": "298,547",
"Expenses": "73,060",
"Revenues": "2,595",
"Stockholders Equity": "293,853",
"Net Income": "-69,964",
"Comprehensive Net Income": "-79,284",
"BaseVar": "199,018",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "244%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "107,203",
"Assets, Non-Current": "172,048",
"General and Administrative Expense": "18,716",
"Goodwill": "0",
"Liabilities, Current": "6,306",
"Liabilities, Non-Current": "9,838",
"Other Assets": "-137,995",
"Other Compr. Net Income": "-5,014",
"Other Expenses": "18,128",
"Other Liabilities": "0",
"Other Net Income": "447",
"Other Revenues": "10,597",
"Property, Plant and Equipment, Net": "137,995",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,144",
"Assets": "279,251",
"Expenses": "36,843",
"Revenues": "10,597",
"Stockholders Equity": "263,107",
"Net Income": "-25,800",
"Comprehensive Net Income": "-28,307",
"BaseVar": "174,148",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "252%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "107,311",
"Assets, Non-Current": "186,727",
"General and Administrative Expense": "29,698",
"Goodwill": "0",
"Liabilities, Current": "7,102",
"Liabilities, Non-Current": "9,911",
"Other Assets": "-148,948",
"Other Compr. Net Income": "19,945",
"Other Expenses": "7,221",
"Other Liabilities": "0",
"Other Net Income": "291",
"Other Revenues": "28,207",
"Property, Plant and Equipment, Net": "148,948",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "17,014",
"Assets": "294,038",
"Expenses": "36,918",
"Revenues": "28,207",
"Stockholders Equity": "277,024",
"Net Income": "-8,420",
"Comprehensive Net Income": "1,552",
"BaseVar": "198,207",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "267%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "115,435",
"Assets, Non-Current": "194,422",
"General and Administrative Expense": "9,588",
"Goodwill": "0",
"Liabilities, Current": "13,890",
"Liabilities, Non-Current": "9,328",
"Other Assets": "-162,658",
"Other Compr. Net Income": "7,406",
"Other Expenses": "46,667",
"Other Liabilities": "0",
"Other Net Income": "300",
"Other Revenues": "55,031",
"Property, Plant and Equipment, Net": "162,658",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "23,218",
"Assets": "309,857",
"Expenses": "56,255",
"Revenues": "55,031",
"Stockholders Equity": "286,639",
"Net Income": "-925",
"Comprehensive Net Income": "2,778",
"BaseVar": "226,033",
"ECR before LimitedLiability": "237%",
"Economic Capital Ratio": "262%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "119,425",
"Assets, Non-Current": "173,006",
"General and Administrative Expense": "6,091",
"Goodwill": "0",
"Liabilities, Current": "11,776",
"Liabilities, Non-Current": "9,037",
"Other Assets": "-149,917",
"Other Compr. Net Income": "-24,886",
"Other Expenses": "50,230",
"Other Liabilities": "0",
"Other Net Income": "286",
"Other Revenues": "66,094",
"Property, Plant and Equipment, Net": "149,917",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "20,813",
"Assets": "292,431",
"Expenses": "56,321",
"Revenues": "66,094",
"Stockholders Equity": "271,618",
"Net Income": "10,059",
"Comprehensive Net Income": "-2,384",
"BaseVar": "230,416",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "261%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "86,070",
"Assets, Non-Current": "140,602",
"General and Administrative Expense": "4,300",
"Goodwill": "0",
"Liabilities, Current": "12,585",
"Liabilities, Non-Current": "8,838",
"Other Assets": "-122,188",
"Other Compr. Net Income": "-5,026",
"Other Expenses": "41,278",
"Other Liabilities": "0",
"Other Net Income": "-46,261",
"Other Revenues": "30,044",
"Property, Plant and Equipment, Net": "122,188",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "21,423",
"Assets": "226,672",
"Expenses": "45,578",
"Revenues": "30,044",
"Stockholders Equity": "205,248",
"Net Income": "-61,795",
"Comprehensive Net Income": "-64,308",
"BaseVar": "187,502",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "218%"
}
}
},
"top_rated": true,
"trend": -4.0,
"value": 2.177421903171251,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000885462.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000885462.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000885462.svg"
},
{
"company_id": "0000037785",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000037785.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000037785.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000037785.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000037785_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000037785_main_keyfigs.svg",
"name": "FMC CORP",
"rank": 7,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000037785.svg",
"report_text": "The relative strengths and weaknesses of FMC CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of FMC CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 56% points.The greatest weakness of FMC CORP is the variable Liabilities, Current, reducing the Economic Capital Ratio by 8.8% points.
The company's Economic Capital Ratio, given in the ranking table, is 215%, being 75% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000037785_2024_FMC_CORP.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "1.10",
"Liabilities": "-12.3",
"Stockholders Equity": "20.1",
"ECR before LimitedLiability": "9.42",
"Liabilities, Current": "-15.4",
"Other Liabilities": "1.64",
"Property, Plant and Equipment, Net": "6.68",
"Assets": "10.3",
"Other Assets": "4.39",
"Assets, Current": "-1.53",
"Goodwill": "0.287",
"General and Administrative Expense": "-28.3",
"Expenses": "12.9",
"Revenues": "-12.5",
"Comprehensive Net Income": "-0.188",
"Other Expenses": "39.8",
"Research and Development": "-0.0822",
"Other Revenues": "-12.5",
"Other Net Income": "-0.721",
"Other Compr. Net Income": "-0.157",
"Economic Capital Ratio": "8.70"
},
"2010": {
"Other Liabilities": "4.05",
"Liabilities": "23.4",
"Stockholders Equity": "10.1",
"ECR before LimitedLiability": "29.8",
"Liabilities, Current": "-21.9",
"Liabilities, Non-Current": "36.5",
"Other Expenses": "15.1",
"Expenses": "-3.63",
"Net Income": "14.6",
"General and Administrative Expense": "-24.5",
"Research and Development": "5.36",
"Other Revenues": "14.0",
"Revenues": "14.0",
"Goodwill": "-7.02",
"Property, Plant and Equipment, Net": "5.42",
"Assets, Current": "-4.49",
"Assets, Non-Current": "-2.70",
"Other Assets": "8.69",
"Other Net Income": "4.20",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "31.8"
},
"2011": {
"Liabilities, Current": "12.1",
"Liabilities": "38.3",
"Assets": "6.77",
"Stockholders Equity": "44.3",
"ECR before LimitedLiability": "130",
"Liabilities, Non-Current": "14.6",
"Other Liabilities": "15.3",
"Property, Plant and Equipment, Net": "7.10",
"Other Assets": "4.07",
"Assets, Current": "-3.03",
"General and Administrative Expense": "-12.1",
"Expenses": "20.0",
"Revenues": "34.4",
"Net Income": "46.8",
"Research and Development": "12.0",
"Other Expenses": "19.8",
"Other Revenues": "34.4",
"Comprehensive Net Income": "45.3",
"Other Net Income": "-8.00",
"Other Compr. Net Income": "-1.42",
"Economic Capital Ratio": "67.9"
},
"2012": {
"Liabilities, Current": "-7.79",
"Liabilities": "29.0",
"Stockholders Equity": "36.6",
"ECR before LimitedLiability": "92.7",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "23.0",
"Assets, Current": "-2.45",
"Assets": "6.71",
"Other Assets": "2.78",
"Property, Plant and Equipment, Net": "7.17",
"Goodwill": "-1.11",
"Other Expenses": "22.5",
"Expenses": "21.3",
"Revenues": "28.7",
"Net Income": "49.1",
"Research and Development": "12.8",
"General and Administrative Expense": "-14.3",
"Other Revenues": "28.7",
"Other Net Income": "-1.30",
"Comprehensive Net Income": "48.7",
"Economic Capital Ratio": "60.2"
},
"2013": {
"Liabilities, Current": "-25.8",
"Liabilities": "9.70",
"Assets": "8.11",
"Stockholders Equity": "21.7",
"ECR before LimitedLiability": "76.7",
"Other Liabilities": "14.8",
"Liabilities, Non-Current": "17.2",
"Goodwill": "-1.19",
"Property, Plant and Equipment, Net": "8.49",
"Assets, Current": "1.89",
"General and Administrative Expense": "-8.10",
"Expenses": "24.7",
"Revenues": "21.8",
"Net Income": "41.9",
"Research and Development": "9.95",
"Other Expenses": "22.8",
"Other Revenues": "21.8",
"Other Net Income": "-5.58",
"Comprehensive Net Income": "43.9",
"Other Compr. Net Income": "1.68",
"Economic Capital Ratio": "36.5"
},
"2014": {
"Liabilities, Non-Current": "20.0",
"Liabilities": "31.7",
"Stockholders Equity": "48.3",
"ECR before LimitedLiability": "108",
"Liabilities, Current": "-0.642",
"Other Liabilities": "13.5",
"Assets, Current": "2.63",
"Assets": "12.9",
"Goodwill": "-2.79",
"Other Assets": "2.87",
"Property, Plant and Equipment, Net": "9.21",
"Other Expenses": "17.0",
"Expenses": "24.0",
"Revenues": "24.5",
"Net Income": "50.4",
"Research and Development": "12.0",
"General and Administrative Expense": "-5.11",
"Other Revenues": "24.5",
"Comprehensive Net Income": "48.5",
"Other Compr. Net Income": "-1.64",
"Economic Capital Ratio": "58.5"
},
"2015": {
"Other Liabilities": "19.8",
"Liabilities": "50.9",
"Stockholders Equity": "72.7",
"ECR before LimitedLiability": "133",
"Liabilities, Current": "13.3",
"Liabilities, Non-Current": "23.8",
"Assets, Current": "2.04",
"Assets": "14.1",
"Goodwill": "6.74",
"Assets, Non-Current": "1.84",
"Property, Plant and Equipment, Net": "2.65",
"Research and Development": "7.85",
"Expenses": "19.6",
"Revenues": "14.5",
"Net Income": "46.5",
"General and Administrative Expense": "-9.50",
"Other Expenses": "21.0",
"Other Revenues": "14.5",
"Comprehensive Net Income": "46.0",
"Other Net Income": "12.5",
"Economic Capital Ratio": "87.6"
},
"2016": {
"Liabilities, Non-Current": "21.5",
"Liabilities": "33.8",
"Stockholders Equity": "57.3",
"ECR before LimitedLiability": "91.4",
"Liabilities, Current": "4.70",
"Other Liabilities": "9.94",
"Property, Plant and Equipment, Net": "0.974",
"Assets": "14.6",
"Other Assets": "2.15",
"Assets, Non-Current": "2.19",
"Goodwill": "7.93",
"Research and Development": "10.9",
"Expenses": "19.8",
"Revenues": "15.8",
"Net Income": "33.3",
"General and Administrative Expense": "-11.3",
"Other Expenses": "20.1",
"Other Revenues": "15.8",
"Comprehensive Net Income": "33.3",
"Other Net Income": "-2.37",
"Economic Capital Ratio": "71.5"
},
"2017": {
"Other Liabilities": "11.5",
"Liabilities": "25.4",
"Stockholders Equity": "66.5",
"ECR before LimitedLiability": "89.0",
"Liabilities, Current": "-6.92",
"Liabilities, Non-Current": "20.9",
"Assets, Non-Current": "0.578",
"Assets": "22.6",
"Other Assets": "1.42",
"Assets, Current": "2.27",
"Goodwill": "19.8",
"Property, Plant and Equipment, Net": "-2.44",
"Research and Development": "9.65",
"Expenses": "25.0",
"Net Income": "28.6",
"Other Net Income": "3.70",
"Other Expenses": "12.4",
"General and Administrative Expense": "3.10",
"Comprehensive Net Income": "29.7",
"Other Compr. Net Income": "1.12",
"Economic Capital Ratio": "67.4"
},
"2018": {
"Liabilities, Non-Current": "18.2",
"Liabilities": "11.1",
"Stockholders Equity": "42.4",
"ECR before LimitedLiability": "81.2",
"Other Liabilities": "11.2",
"Liabilities, Current": "-21.1",
"Property, Plant and Equipment, Net": "-2.50",
"Assets": "18.3",
"Other Assets": "1.61",
"Goodwill": "24.4",
"Assets, Non-Current": "-1.85",
"Other Expenses": "7.35",
"Expenses": "24.4",
"Revenues": "10.3",
"Net Income": "33.5",
"Research and Development": "7.98",
"General and Administrative Expense": "8.87",
"Other Revenues": "10.3",
"Comprehensive Net Income": "33.3",
"Other Net Income": "-1.47",
"Economic Capital Ratio": "60.7"
},
"2019": {
"Liabilities, Non-Current": "21.0",
"Liabilities": "18.4",
"Stockholders Equity": "47.4",
"ECR before LimitedLiability": "103",
"Other Liabilities": "13.9",
"Liabilities, Current": "-19.0",
"Assets, Non-Current": "-2.12",
"Assets": "17.1",
"Goodwill": "22.1",
"Property, Plant and Equipment, Net": "-3.70",
"Other Assets": "1.90",
"Research and Development": "5.34",
"Expenses": "23.4",
"Revenues": "10.9",
"Net Income": "37.5",
"Other Expenses": "3.72",
"General and Administrative Expense": "14.3",
"Other Revenues": "10.9",
"Other Net Income": "2.81",
"Comprehensive Net Income": "37.0",
"Economic Capital Ratio": "73.6"
},
"2020": {
"Liabilities, Current": "-17.1",
"Liabilities": "20.5",
"Stockholders Equity": "37.8",
"ECR before LimitedLiability": "103",
"Liabilities, Non-Current": "28.6",
"Other Liabilities": "6.25",
"Goodwill": "20.3",
"Assets": "10.9",
"Assets, Current": "-1.36",
"Assets, Non-Current": "-1.52",
"Property, Plant and Equipment, Net": "-4.38",
"Other Expenses": "2.60",
"Expenses": "13.0",
"Revenues": "11.7",
"Net Income": "29.0",
"Research and Development": "3.88",
"General and Administrative Expense": "6.53",
"Other Revenues": "11.7",
"Comprehensive Net Income": "29.7",
"Other Net Income": "4.20",
"Economic Capital Ratio": "64.9"
},
"2021": {
"Liabilities, Non-Current": "23.9",
"Liabilities": "4.87",
"Stockholders Equity": "14.7",
"ECR before LimitedLiability": "45.2",
"Liabilities, Current": "-33.3",
"Other Liabilities": "8.24",
"Assets, Current": "-1.27",
"Assets": "5.63",
"Assets, Non-Current": "-3.36",
"Other Assets": "1.90",
"Goodwill": "15.3",
"Property, Plant and Equipment, Net": "-4.43",
"Other Expenses": "6.33",
"Expenses": "15.8",
"Revenues": "13.1",
"Net Income": "29.2",
"Research and Development": "5.98",
"General and Administrative Expense": "3.40",
"Other Revenues": "13.1",
"Comprehensive Net Income": "29.1",
"Economic Capital Ratio": "40.8"
},
"2022": {
"Liabilities, Non-Current": "25.3",
"Liabilities": "11.9",
"Stockholders Equity": "21.9",
"ECR before LimitedLiability": "55.5",
"Other Liabilities": "9.30",
"Liabilities, Current": "-27.1",
"Other Assets": "1.09",
"Assets": "6.94",
"Assets, Current": "3.72",
"Property, Plant and Equipment, Net": "-5.41",
"Assets, Non-Current": "-4.26",
"Goodwill": "14.1",
"General and Administrative Expense": "3.82",
"Expenses": "15.4",
"Revenues": "14.4",
"Net Income": "30.8",
"Research and Development": "5.60",
"Other Expenses": "5.84",
"Other Revenues": "14.4",
"Comprehensive Net Income": "30.5",
"Economic Capital Ratio": "45.0"
},
"2023": {
"Liabilities, Non-Current": "23.2",
"Liabilities": "22.3",
"Stockholders Equity": "56.3",
"ECR before LimitedLiability": "89.9",
"Other Liabilities": "7.31",
"Liabilities, Current": "-8.83",
"Other Assets": "5.72",
"Assets": "19.5",
"Property, Plant and Equipment, Net": "-3.49",
"Goodwill": "11.9",
"Assets, Current": "8.71",
"Assets, Non-Current": "-4.10",
"Other Expenses": "16.2",
"Expenses": "21.4",
"Revenues": "9.51",
"Net Income": "30.0",
"Research and Development": "1.90",
"General and Administrative Expense": "3.34",
"Other Revenues": "9.51",
"Comprehensive Net Income": "30.2",
"Economic Capital Ratio": "74.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000037785_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "1,487,700",
"Assets, Non-Current": "211,400",
"General and Administrative Expense": "2,265,900",
"Goodwill": "209,500",
"Liabilities, Current": "709,200",
"Liabilities, Non-Current": "0",
"Other Assets": "263,100",
"Other Compr. Net Income": "-13,400",
"Other Expenses": "213,000",
"Other Liabilities": "0",
"Other Net Income": "-15,700",
"Other Revenues": "2,826,200",
"Property, Plant and Equipment, Net": "964,500",
"Research and Development": "92,800"
},
"output_variables": {
"Liabilities": "709,200",
"Assets": "3,136,200",
"Expenses": "2,571,700",
"Revenues": "2,826,200",
"Stockholders Equity": "2,427,000",
"Net Income": "238,800",
"Comprehensive Net Income": "232,100",
"BaseVar": "4,636,200",
"ECR before LimitedLiability": "185%",
"Economic Capital Ratio": "225%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,646,200",
"Assets, Non-Current": "223,700",
"General and Administrative Expense": "2,476,800",
"Goodwill": "194,400",
"Liabilities, Current": "963,400",
"Liabilities, Non-Current": "0",
"Other Assets": "337,100",
"Other Compr. Net Income": "-44,900",
"Other Expenses": "323,400",
"Other Liabilities": "0",
"Other Net Income": "36,500",
"Other Revenues": "3,116,300",
"Property, Plant and Equipment, Net": "918,500",
"Research and Development": "100,500"
},
"output_variables": {
"Liabilities": "963,400",
"Assets": "3,319,900",
"Expenses": "2,900,700",
"Revenues": "3,116,300",
"Stockholders Equity": "2,356,500",
"Net Income": "252,100",
"Comprehensive Net Income": "229,650",
"BaseVar": "5,190,850",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,869,400",
"Assets, Non-Current": "198,900",
"General and Administrative Expense": "2,653,000",
"Goodwill": "413,200",
"Liabilities, Current": "919,900",
"Liabilities, Non-Current": "0",
"Other Assets": "275,200",
"Other Compr. Net Income": "-94,600",
"Other Expenses": "208,400",
"Other Liabilities": "0",
"Other Net Income": "-29,100",
"Other Revenues": "3,377,900",
"Property, Plant and Equipment, Net": "986,800",
"Research and Development": "105,200"
},
"output_variables": {
"Liabilities": "919,900",
"Assets": "3,743,500",
"Expenses": "2,966,600",
"Revenues": "3,377,900",
"Stockholders Equity": "2,823,600",
"Net Income": "382,200",
"Comprehensive Net Income": "334,900",
"BaseVar": "5,565,800",
"ECR before LimitedLiability": "180%",
"Economic Capital Ratio": "221%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,181,800",
"Assets, Non-Current": "312,500",
"General and Administrative Expense": "2,934,200",
"Goodwill": "510,100",
"Liabilities, Current": "1,135,400",
"Liabilities, Non-Current": "0",
"Other Assets": "233,300",
"Other Compr. Net Income": "-38,400",
"Other Expenses": "230,200",
"Other Liabilities": "0",
"Other Net Income": "-30,400",
"Other Revenues": "3,748,300",
"Property, Plant and Equipment, Net": "1,136,200",
"Research and Development": "117,800"
},
"output_variables": {
"Liabilities": "1,135,400",
"Assets": "4,373,900",
"Expenses": "3,282,200",
"Revenues": "3,748,300",
"Stockholders Equity": "3,238,500",
"Net Income": "435,700",
"Comprehensive Net Income": "416,500",
"BaseVar": "6,304,300",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "219%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,945,000",
"Assets, Non-Current": "288,800",
"General and Administrative Expense": "3,050,200",
"Goodwill": "661,700",
"Liabilities, Current": "1,986,700",
"Liabilities, Non-Current": "0",
"Other Assets": "91,400",
"Other Compr. Net Income": "192,900",
"Other Expenses": "238,900",
"Other Liabilities": "0",
"Other Net Income": "-160,000",
"Other Revenues": "3,874,800",
"Property, Plant and Equipment, Net": "1,248,300",
"Research and Development": "117,700"
},
"output_variables": {
"Liabilities": "1,986,700",
"Assets": "5,235,200",
"Expenses": "3,406,800",
"Revenues": "3,874,800",
"Stockholders Equity": "3,248,500",
"Net Income": "308,000",
"Comprehensive Net Income": "404,450",
"BaseVar": "7,428,200",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "191%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "2,934,400",
"Assets, Non-Current": "298,100",
"General and Administrative Expense": "3,283,900",
"Goodwill": "599,400",
"Liabilities, Current": "1,910,400",
"Liabilities, Non-Current": "0",
"Other Assets": "200,100",
"Other Compr. Net Income": "-188,500",
"Other Expenses": "213,300",
"Other Liabilities": "0",
"Other Net Income": "-90,100",
"Other Revenues": "4,037,700",
"Property, Plant and Equipment, Net": "1,308,500",
"Research and Development": "128,300"
},
"output_variables": {
"Liabilities": "1,910,400",
"Assets": "5,340,500",
"Expenses": "3,625,500",
"Revenues": "4,037,700",
"Stockholders Equity": "3,430,100",
"Net Income": "322,100",
"Comprehensive Net Income": "227,850",
"BaseVar": "7,596,350",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "192%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "2,971,900",
"Assets, Non-Current": "437,600",
"General and Administrative Expense": "2,939,000",
"Goodwill": "1,613,100",
"Liabilities, Current": "1,453,300",
"Liabilities, Non-Current": "0",
"Other Assets": "286,900",
"Other Compr. Net Income": "-91,000",
"Other Expenses": "372,800",
"Other Liabilities": "0",
"Other Net Income": "677,500",
"Other Revenues": "3,276,500",
"Property, Plant and Equipment, Net": "1,016,400",
"Research and Development": "143,700"
},
"output_variables": {
"Liabilities": "1,453,300",
"Assets": "6,325,900",
"Expenses": "3,455,500",
"Revenues": "3,276,500",
"Stockholders Equity": "4,872,600",
"Net Income": "498,500",
"Comprehensive Net Income": "453,000",
"BaseVar": "7,639,850",
"ECR before LimitedLiability": "183%",
"Economic Capital Ratio": "223%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,849,200",
"Assets, Non-Current": "472,300",
"General and Administrative Expense": "2,612,100",
"Goodwill": "1,570,900",
"Liabilities, Current": "1,438,200",
"Liabilities, Non-Current": "0",
"Other Assets": "244,800",
"Other Compr. Net Income": "-23,700",
"Other Expenses": "284,500",
"Other Liabilities": "0",
"Other Net Income": "-32,600",
"Other Revenues": "3,282,400",
"Property, Plant and Equipment, Net": "1,002,100",
"Research and Development": "141,500"
},
"output_variables": {
"Liabilities": "1,438,200",
"Assets": "6,139,300",
"Expenses": "3,038,100",
"Revenues": "3,282,400",
"Stockholders Equity": "4,701,100",
"Net Income": "211,700",
"Comprehensive Net Income": "199,850",
"BaseVar": "6,977,150",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,652,700",
"Assets, Non-Current": "445,000",
"General and Administrative Expense": "2,395,900",
"Goodwill": "3,830,700",
"Liabilities, Current": "2,209,400",
"Liabilities, Non-Current": "0",
"Other Assets": "252,700",
"Other Compr. Net Income": "235,500",
"Other Expenses": "425,500",
"Other Liabilities": "0",
"Other Net Income": "622,700",
"Other Revenues": "2,878,600",
"Property, Plant and Equipment, Net": "1,025,200",
"Research and Development": "141,500"
},
"output_variables": {
"Liabilities": "2,209,400",
"Assets": "9,206,300",
"Expenses": "2,962,900",
"Revenues": "2,878,600",
"Stockholders Equity": "6,996,900",
"Net Income": "538,400",
"Comprehensive Net Income": "656,150",
"BaseVar": "9,057,700",
"ECR before LimitedLiability": "179%",
"Economic Capital Ratio": "221%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,030,200",
"Assets, Non-Current": "465,900",
"General and Administrative Expense": "3,492,100",
"Goodwill": "4,172,400",
"Liabilities, Current": "2,993,400",
"Liabilities, Non-Current": "0",
"Other Assets": "273,200",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "290,800",
"Other Liabilities": "0",
"Other Net Income": "-141,900",
"Other Revenues": "4,727,800",
"Property, Plant and Equipment, Net": "1,032,600",
"Research and Development": "291,500"
},
"output_variables": {
"Liabilities": "2,993,400",
"Assets": "9,974,300",
"Expenses": "4,074,400",
"Revenues": "4,727,800",
"Stockholders Equity": "6,980,900",
"Net Income": "511,500",
"Comprehensive Net Income": "472,500",
"BaseVar": "10,994,900",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "204%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,074,800",
"Assets, Non-Current": "686,000",
"General and Administrative Expense": "3,319,100",
"Goodwill": "4,096,500",
"Liabilities, Current": "2,723,900",
"Liabilities, Non-Current": "0",
"Other Assets": "257,400",
"Other Compr. Net Income": "-91,800",
"Other Expenses": "451,000",
"Other Liabilities": "0",
"Other Net Income": "-61,400",
"Other Revenues": "4,609,800",
"Property, Plant and Equipment, Net": "758,000",
"Research and Development": "298,100"
},
"output_variables": {
"Liabilities": "2,723,900",
"Assets": "9,872,700",
"Expenses": "4,068,200",
"Revenues": "4,609,800",
"Stockholders Equity": "7,148,800",
"Net Income": "480,200",
"Comprehensive Net Income": "434,300",
"BaseVar": "10,713,900",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "209%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,375,600",
"Assets, Non-Current": "715,400",
"General and Administrative Expense": "3,319,800",
"Goodwill": "4,094,100",
"Liabilities, Current": "2,829,000",
"Liabilities, Non-Current": "0",
"Other Assets": "229,600",
"Other Compr. Net Income": "130,700",
"Other Expenses": "455,600",
"Other Liabilities": "0",
"Other Net Income": "-28,200",
"Other Revenues": "4,642,100",
"Property, Plant and Equipment, Net": "771,700",
"Research and Development": "287,900"
},
"output_variables": {
"Liabilities": "2,829,000",
"Assets": "10,186,400",
"Expenses": "4,063,300",
"Revenues": "4,642,100",
"Stockholders Equity": "7,357,400",
"Net Income": "550,600",
"Comprehensive Net Income": "615,950",
"BaseVar": "10,939,850",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "211%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "4,937,600",
"Assets, Non-Current": "623,000",
"General and Administrative Expense": "3,587,600",
"Goodwill": "3,985,200",
"Liabilities, Current": "3,520,300",
"Liabilities, Non-Current": "0",
"Other Assets": "218,500",
"Other Compr. Net Income": "-31,000",
"Other Expenses": "350,700",
"Other Liabilities": "0",
"Other Net Income": "-68,200",
"Other Revenues": "5,045,200",
"Property, Plant and Equipment, Net": "817,000",
"Research and Development": "304,700"
},
"output_variables": {
"Liabilities": "3,520,300",
"Assets": "10,581,300",
"Expenses": "4,243,000",
"Revenues": "5,045,200",
"Stockholders Equity": "7,061,000",
"Net Income": "734,000",
"Comprehensive Net Income": "718,500",
"BaseVar": "11,744,500",
"ECR before LimitedLiability": "147%",
"Economic Capital Ratio": "200%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "5,438,600",
"Assets, Non-Current": "575,000",
"General and Administrative Expense": "4,250,700",
"Goodwill": "4,097,400",
"Liabilities, Current": "3,799,600",
"Liabilities, Non-Current": "0",
"Other Assets": "210,700",
"Other Compr. Net Income": "-139,100",
"Other Expenses": "398,700",
"Other Liabilities": "0",
"Other Net Income": "-97,200",
"Other Revenues": "5,802,300",
"Property, Plant and Equipment, Net": "849,600",
"Research and Development": "314,200"
},
"output_variables": {
"Liabilities": "3,799,600",
"Assets": "11,171,300",
"Expenses": "4,963,600",
"Revenues": "5,802,300",
"Stockholders Equity": "7,371,700",
"Net Income": "741,500",
"Comprehensive Net Income": "671,950",
"BaseVar": "12,986,550",
"ECR before LimitedLiability": "144%",
"Economic Capital Ratio": "197%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "5,129,100",
"Assets, Non-Current": "509,300",
"General and Administrative Expense": "3,390,100",
"Goodwill": "4,058,700",
"Liabilities, Current": "3,384,600",
"Liabilities, Non-Current": "0",
"Other Assets": "1,336,600",
"Other Compr. Net Income": "53,600",
"Other Expenses": "-651,600",
"Other Liabilities": "0",
"Other Net Income": "-98,500",
"Other Revenues": "4,486,800",
"Property, Plant and Equipment, Net": "892,500",
"Research and Development": "328,800"
},
"output_variables": {
"Liabilities": "3,384,600",
"Assets": "11,926,200",
"Expenses": "3,067,300",
"Revenues": "4,486,800",
"Stockholders Equity": "8,541,600",
"Net Income": "1,321,000",
"Comprehensive Net Income": "1,347,800",
"BaseVar": "11,508,500",
"ECR before LimitedLiability": "170%",
"Economic Capital Ratio": "215%"
}
}
},
"top_rated": true,
"trend": 10.0,
"value": 2.1483363509820768,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000037785.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000037785.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000037785.svg"
},
{
"company_id": "0001442999",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001442999.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001442999.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001442999_main_keyfigs.svg",
"name": "Alterola Biotech INC",
"rank": 8,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001442999.svg",
"report_text": "The relative strengths and weaknesses of Alterola Biotech INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Alterola Biotech INC compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 204% points.The greatest weakness of Alterola Biotech INC is the variable Other Revenues, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 207%, being 67% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001442999_2024_Alterola_Biotech_INC.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities, Non-Current": "21.5",
"Liabilities": "40.2",
"Stockholders Equity": "102",
"ECR before LimitedLiability": "44.6",
"Other Liabilities": "4.62",
"Liabilities, Current": "16.2",
"Other Assets": "186",
"Assets": "53.4",
"Assets, Current": "-20.3",
"Property, Plant and Equipment, Net": "-9.32",
"Assets, Non-Current": "-7.00",
"Goodwill": "-9.93",
"General and Administrative Expense": "36.5",
"Expenses": "-13.5",
"Revenues": "-31.6",
"Net Income": "-44.2",
"Research and Development": "3.84",
"Other Expenses": "-52.4",
"Other Revenues": "-31.6",
"Comprehensive Net Income": "-43.9",
"Economic Capital Ratio": "34.1"
},
"2023": {
"Liabilities, Non-Current": "17.5",
"Liabilities": "19.2",
"Stockholders Equity": "98.6",
"ECR before LimitedLiability": "81.7",
"Other Liabilities": "2.45",
"Liabilities, Current": "-0.525",
"Other Assets": "204",
"Assets": "56.3",
"Property, Plant and Equipment, Net": "-6.01",
"Goodwill": "-6.26",
"Assets, Current": "-10.9",
"Assets, Non-Current": "-5.25",
"Other Expenses": "-8.32",
"Expenses": "17.8",
"Revenues": "-22.6",
"Net Income": "-4.84",
"Research and Development": "1.93",
"General and Administrative Expense": "24.3",
"Other Revenues": "-22.6",
"Comprehensive Net Income": "-4.66",
"Economic Capital Ratio": "66.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001442999_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "128",
"Assets, Non-Current": "0",
"General and Administrative Expense": "93",
"Goodwill": "0",
"Liabilities, Current": "1,037",
"Liabilities, Non-Current": "0",
"Other Assets": "12,000",
"Other Compr. Net Income": "0",
"Other Expenses": "6,037",
"Other Liabilities": "164",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "341"
},
"output_variables": {
"Liabilities": "1,202",
"Assets": "12,128",
"Expenses": "6,471",
"Revenues": "0",
"Stockholders Equity": "10,926",
"Net Income": "-6,471",
"Comprehensive Net Income": "-6,471",
"BaseVar": "9,900",
"ECR before LimitedLiability": "128%",
"Economic Capital Ratio": "186%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "46",
"Assets, Non-Current": "0",
"General and Administrative Expense": "68",
"Goodwill": "0",
"Liabilities, Current": "2,130",
"Liabilities, Non-Current": "0",
"Other Assets": "12,000",
"Other Compr. Net Income": "53",
"Other Expenses": "1,783",
"Other Liabilities": "155",
"Other Net Income": "-38",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "182"
},
"output_variables": {
"Liabilities": "2,285",
"Assets": "12,046",
"Expenses": "2,033",
"Revenues": "0",
"Stockholders Equity": "9,761",
"Net Income": "-2,071",
"Comprehensive Net Income": "-2,045",
"BaseVar": "8,228",
"ECR before LimitedLiability": "158%",
"Economic Capital Ratio": "207%"
}
}
},
"top_rated": true,
"trend": 14.0,
"value": 2.0665304111676877,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001442999.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001442999.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001442999.svg"
},
{
"company_id": "0000009326",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000009326.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000009326.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000009326.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000009326_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000009326_main_keyfigs.svg",
"name": "Balchem CORP",
"rank": 9,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000009326.svg",
"report_text": "The relative strengths and weaknesses of Balchem CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Balchem CORP compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 40% points.The greatest weakness of Balchem CORP is the variable Other Liabilities, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 199%, being 58% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000009326_2024_Balchem_CORP.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "39.3",
"Liabilities": "70.0",
"Stockholders Equity": "61.8",
"ECR before LimitedLiability": "134",
"Liabilities, Non-Current": "19.9",
"Other Liabilities": "24.1",
"Assets, Current": "3.11",
"Assets": "2.38",
"Assets, Non-Current": "-1.45",
"Property, Plant and Equipment, Net": "0.767",
"Goodwill": "0.209",
"Other Expenses": "27.0",
"Expenses": "15.7",
"Revenues": "48.0",
"Net Income": "61.6",
"Research and Development": "18.3",
"General and Administrative Expense": "-32.2",
"Other Revenues": "48.0",
"Other Net Income": "-0.697",
"Comprehensive Net Income": "61.7",
"Economic Capital Ratio": "102"
},
"2013": {
"Liabilities, Current": "44.6",
"Liabilities": "74.2",
"Stockholders Equity": "71.5",
"ECR before LimitedLiability": "146",
"Other Liabilities": "16.4",
"Liabilities, Non-Current": "27.4",
"Goodwill": "-0.644",
"Assets": "3.47",
"Assets, Non-Current": "-1.24",
"Other Assets": "-0.777",
"Assets, Current": "6.39",
"General and Administrative Expense": "-30.5",
"Expenses": "14.5",
"Revenues": "47.8",
"Net Income": "57.8",
"Research and Development": "14.8",
"Other Expenses": "27.9",
"Other Revenues": "47.8",
"Other Net Income": "-3.56",
"Comprehensive Net Income": "57.9",
"Economic Capital Ratio": "106"
},
"2014": {
"Liabilities, Non-Current": "16.9",
"Liabilities": "-5.56",
"Stockholders Equity": "21.9",
"ECR before LimitedLiability": "75.4",
"Liabilities, Current": "36.8",
"Other Liabilities": "-76.0",
"Assets, Current": "-20.0",
"Assets": "20.3",
"Goodwill": "70.7",
"Assets, Non-Current": "-3.54",
"Property, Plant and Equipment, Net": "3.19",
"Other Expenses": "16.5",
"Expenses": "32.0",
"Revenues": "13.1",
"Net Income": "48.9",
"Research and Development": "12.9",
"General and Administrative Expense": "1.39",
"Other Revenues": "13.1",
"Other Net Income": "1.31",
"Comprehensive Net Income": "48.7",
"Economic Capital Ratio": "26.0"
},
"2015": {
"Other Liabilities": "-61.5",
"Liabilities": "8.99",
"Stockholders Equity": "27.7",
"ECR before LimitedLiability": "82.6",
"Liabilities, Current": "37.0",
"Liabilities, Non-Current": "19.7",
"Assets, Current": "-16.3",
"Assets": "13.8",
"Other Assets": "-5.07",
"Goodwill": "55.2",
"Assets, Non-Current": "-2.35",
"Property, Plant and Equipment, Net": "4.85",
"Research and Development": "9.27",
"Expenses": "23.7",
"Revenues": "19.7",
"Net Income": "46.6",
"General and Administrative Expense": "-8.86",
"Other Expenses": "23.5",
"Other Revenues": "19.7",
"Comprehensive Net Income": "46.8",
"Economic Capital Ratio": "36.7"
},
"2016": {
"Liabilities, Non-Current": "-25.3",
"Liabilities": "-1.50",
"Stockholders Equity": "15.8",
"ECR before LimitedLiability": "49.3",
"Liabilities, Current": "30.5",
"Other Liabilities": "-10.7",
"Property, Plant and Equipment, Net": "0.860",
"Assets": "10.8",
"Assets, Non-Current": "-2.55",
"Assets, Current": "-20.0",
"Goodwill": "61.8",
"Research and Development": "12.7",
"Expenses": "23.7",
"Revenues": "14.2",
"Net Income": "37.2",
"General and Administrative Expense": "-10.9",
"Other Expenses": "22.2",
"Other Revenues": "14.2",
"Comprehensive Net Income": "37.4",
"Other Net Income": "-1.82",
"Economic Capital Ratio": "29.3"
},
"2017": {
"Other Liabilities": "1.29",
"Liabilities": "17.6",
"Stockholders Equity": "32.4",
"ECR before LimitedLiability": "65.0",
"Liabilities, Current": "29.3",
"Liabilities, Non-Current": "-15.5",
"Assets, Non-Current": "-2.58",
"Assets": "10.4",
"Assets, Current": "-13.1",
"Goodwill": "43.0",
"Property, Plant and Equipment, Net": "-0.510",
"Research and Development": "12.1",
"Expenses": "18.2",
"Revenues": "21.4",
"Net Income": "36.1",
"Other Expenses": "19.6",
"General and Administrative Expense": "-13.4",
"Other Revenues": "21.4",
"Comprehensive Net Income": "36.0",
"Other Net Income": "-4.22",
"Economic Capital Ratio": "43.4"
},
"2019": {
"Liabilities, Non-Current": "20.3",
"Liabilities": "8.95",
"Stockholders Equity": "27.9",
"ECR before LimitedLiability": "88.3",
"Other Liabilities": "-34.7",
"Liabilities, Current": "17.3",
"Assets, Non-Current": "-6.33",
"Assets": "11.8",
"Goodwill": "45.4",
"Property, Plant and Equipment, Net": "1.87",
"Assets, Current": "-12.1",
"Research and Development": "7.89",
"Expenses": "22.2",
"Revenues": "15.4",
"Net Income": "41.9",
"Other Expenses": "7.40",
"General and Administrative Expense": "6.57",
"Other Revenues": "15.4",
"Other Net Income": "3.09",
"Comprehensive Net Income": "41.9",
"Economic Capital Ratio": "58.8"
},
"2020": {
"Liabilities, Current": "22.6",
"Liabilities": "27.4",
"Stockholders Equity": "27.1",
"ECR before LimitedLiability": "102",
"Liabilities, Non-Current": "31.6",
"Other Liabilities": "-34.0",
"Goodwill": "35.8",
"Assets": "3.42",
"Assets, Current": "-13.4",
"Assets, Non-Current": "-5.34",
"Property, Plant and Equipment, Net": "0.977",
"Other Expenses": "6.17",
"Expenses": "6.90",
"Revenues": "22.1",
"Net Income": "33.8",
"Research and Development": "6.72",
"General and Administrative Expense": "-6.02",
"Other Revenues": "22.1",
"Comprehensive Net Income": "34.3",
"Other Net Income": "4.61",
"Economic Capital Ratio": "63.9"
},
"2021": {
"Liabilities, Non-Current": "28.6",
"Liabilities": "28.6",
"Stockholders Equity": "13.4",
"ECR before LimitedLiability": "60.0",
"Liabilities, Current": "13.2",
"Other Liabilities": "-14.7",
"Assets, Current": "-12.8",
"Assets": "-2.27",
"Assets, Non-Current": "-5.78",
"Other Assets": "0.677",
"Goodwill": "23.3",
"Property, Plant and Equipment, Net": "1.38",
"Other Expenses": "9.00",
"Expenses": "5.59",
"Revenues": "28.5",
"Net Income": "34.7",
"Research and Development": "9.41",
"General and Administrative Expense": "-13.0",
"Other Revenues": "28.5",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "55.7"
},
"2022": {
"Liabilities, Non-Current": "21.1",
"Liabilities": "2.11",
"Stockholders Equity": "4.76",
"ECR before LimitedLiability": "39.8",
"Other Liabilities": "-48.5",
"Liabilities, Current": "20.3",
"Assets": "1.86",
"Assets, Current": "-15.8",
"Property, Plant and Equipment, Net": "-0.955",
"Assets, Non-Current": "-7.48",
"Goodwill": "45.3",
"General and Administrative Expense": "-2.72",
"Expenses": "13.6",
"Revenues": "16.9",
"Net Income": "32.2",
"Research and Development": "8.08",
"Other Expenses": "8.16",
"Other Revenues": "16.9",
"Other Net Income": "0.795",
"Comprehensive Net Income": "32.5",
"Economic Capital Ratio": "29.3"
},
"2023": {
"Liabilities, Non-Current": "24.8",
"Liabilities": "28.7",
"Stockholders Equity": "34.4",
"ECR before LimitedLiability": "73.6",
"Other Liabilities": "-39.3",
"Liabilities, Current": "34.6",
"Other Assets": "-0.945",
"Assets": "6.59",
"Goodwill": "39.6",
"Assets, Current": "-9.17",
"Assets, Non-Current": "-7.70",
"Other Expenses": "11.1",
"Expenses": "9.11",
"Revenues": "21.8",
"Net Income": "29.8",
"Research and Development": "4.78",
"General and Administrative Expense": "-6.73",
"Other Revenues": "21.8",
"Other Net Income": "-1.47",
"Comprehensive Net Income": "30.2",
"Economic Capital Ratio": "58.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000009326_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "211,909",
"Assets, Non-Current": "538",
"General and Administrative Expense": "247,194",
"Goodwill": "47,373",
"Liabilities, Current": "30,234",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "179",
"Other Expenses": "19,849",
"Other Liabilities": "9,299",
"Other Net Income": "77",
"Other Revenues": "310,393",
"Property, Plant and Equipment, Net": "52,725",
"Research and Development": "3,422"
},
"output_variables": {
"Liabilities": "39,533",
"Assets": "312,545",
"Expenses": "270,465",
"Revenues": "310,393",
"Stockholders Equity": "273,012",
"Net Income": "40,005",
"Comprehensive Net Income": "40,094",
"BaseVar": "466,596",
"ECR before LimitedLiability": "235%",
"Economic Capital Ratio": "260%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "277,774",
"Assets, Non-Current": "541",
"General and Administrative Expense": "267,949",
"Goodwill": "43,641",
"Liabilities, Current": "35,753",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "957",
"Other Expenses": "20,968",
"Other Liabilities": "9,761",
"Other Net Income": "240",
"Other Revenues": "337,173",
"Property, Plant and Equipment, Net": "54,916",
"Research and Development": "3,622"
},
"output_variables": {
"Liabilities": "45,514",
"Assets": "376,872",
"Expenses": "292,539",
"Revenues": "337,173",
"Stockholders Equity": "331,358",
"Net Income": "44,874",
"Comprehensive Net Income": "45,352",
"BaseVar": "526,648",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "261%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "181,302",
"Assets, Non-Current": "4,341",
"General and Administrative Expense": "454,430",
"Goodwill": "544,040",
"Liabilities, Current": "95,522",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,849",
"Other Expenses": "29,371",
"Other Liabilities": "373,851",
"Other Net Income": "54",
"Other Revenues": "541,383",
"Property, Plant and Equipment, Net": "131,588",
"Research and Development": "4,810"
},
"output_variables": {
"Liabilities": "469,373",
"Assets": "861,271",
"Expenses": "488,611",
"Revenues": "541,383",
"Stockholders Equity": "391,898",
"Net Income": "52,826",
"Comprehensive Net Income": "51,402",
"BaseVar": "1,181,770",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "160%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "198,829",
"Assets, Non-Current": "5,062",
"General and Administrative Expense": "452,546",
"Goodwill": "518,817",
"Liabilities, Current": "81,120",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,463",
"Other Expenses": "33,934",
"Other Liabilities": "336,398",
"Other Net Income": "-300",
"Other Revenues": "552,492",
"Property, Plant and Equipment, Net": "158,515",
"Research and Development": "5,990"
},
"output_variables": {
"Liabilities": "417,518",
"Assets": "881,223",
"Expenses": "492,470",
"Revenues": "552,492",
"Stockholders Equity": "463,705",
"Net Income": "59,722",
"Comprehensive Net Income": "58,490",
"BaseVar": "1,173,233",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "173%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "188,442",
"Assets, Non-Current": "7,135",
"General and Administrative Expense": "455,041",
"Goodwill": "587,295",
"Liabilities, Current": "101,008",
"Liabilities, Non-Current": "226,490",
"Other Assets": "0",
"Other Compr. Net Income": "-1,735",
"Other Expenses": "34,227",
"Other Liabilities": "100,095",
"Other Net Income": "-639",
"Other Revenues": "553,204",
"Property, Plant and Equipment, Net": "165,754",
"Research and Development": "7,325"
},
"output_variables": {
"Liabilities": "427,593",
"Assets": "948,626",
"Expenses": "496,593",
"Revenues": "553,204",
"Stockholders Equity": "521,033",
"Net Income": "55,972",
"Comprehensive Net Income": "55,104",
"BaseVar": "1,214,195",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "176%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "199,336",
"Assets, Non-Current": "5,073",
"General and Administrative Expense": "488,230",
"Goodwill": "569,434",
"Liabilities, Current": "108,396",
"Liabilities, Non-Current": "183,964",
"Other Assets": "0",
"Other Compr. Net Income": "5,207",
"Other Expenses": "5,961",
"Other Liabilities": "54,395",
"Other Net Income": "-1,223",
"Other Revenues": "594,790",
"Property, Plant and Equipment, Net": "189,793",
"Research and Development": "9,305"
},
"output_variables": {
"Liabilities": "346,755",
"Assets": "963,636",
"Expenses": "503,496",
"Revenues": "594,790",
"Stockholders Equity": "616,881",
"Net Income": "90,071",
"Comprehensive Net Income": "92,674",
"BaseVar": "1,207,554",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "197%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "254,946",
"Assets, Non-Current": "15,955",
"General and Administrative Expense": "529,775",
"Goodwill": "667,922",
"Liabilities, Current": "148,689",
"Liabilities, Non-Current": "4,827",
"Other Assets": "0",
"Other Compr. Net Income": "-1,962",
"Other Expenses": "16,807",
"Other Liabilities": "258,499",
"Other Net Income": "-6,075",
"Other Revenues": "643,705",
"Property, Plant and Equipment, Net": "216,859",
"Research and Development": "11,377"
},
"output_variables": {
"Liabilities": "412,015",
"Assets": "1,155,682",
"Expenses": "557,959",
"Revenues": "643,705",
"Stockholders Equity": "743,667",
"Net Income": "79,671",
"Comprehensive Net Income": "78,690",
"BaseVar": "1,388,699",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "195%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "266,888",
"Assets, Non-Current": "11,326",
"General and Administrative Expense": "582,165",
"Goodwill": "651,123",
"Liabilities, Current": "145,787",
"Liabilities, Non-Current": "0",
"Other Assets": "8,410",
"Other Compr. Net Income": "9,737",
"Other Expenses": "21,794",
"Other Liabilities": "191,823",
"Other Net Income": "-4,730",
"Other Revenues": "703,644",
"Property, Plant and Equipment, Net": "228,096",
"Research and Development": "10,332"
},
"output_variables": {
"Liabilities": "337,610",
"Assets": "1,165,843",
"Expenses": "614,291",
"Revenues": "703,644",
"Stockholders Equity": "828,233",
"Net Income": "84,623",
"Comprehensive Net Income": "89,492",
"BaseVar": "1,417,928",
"ECR before LimitedLiability": "163%",
"Economic Capital Ratio": "210%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "322,232",
"Assets, Non-Current": "18,603",
"General and Administrative Expense": "657,997",
"Goodwill": "618,614",
"Liabilities, Current": "190,257",
"Liabilities, Non-Current": "4,811",
"Other Assets": "2,359",
"Other Compr. Net Income": "-9,166",
"Other Expenses": "29,129",
"Other Liabilities": "127,242",
"Other Net Income": "-2,269",
"Other Revenues": "799,023",
"Property, Plant and Equipment, Net": "237,517",
"Research and Development": "13,524"
},
"output_variables": {
"Liabilities": "322,310",
"Assets": "1,199,325",
"Expenses": "700,650",
"Revenues": "799,023",
"Stockholders Equity": "877,015",
"Net Income": "96,104",
"Comprehensive Net Income": "91,521",
"BaseVar": "1,516,372",
"ECR before LimitedLiability": "170%",
"Economic Capital Ratio": "214%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "335,803",
"Assets, Non-Current": "32,212",
"General and Administrative Expense": "784,981",
"Goodwill": "982,804",
"Liabilities, Current": "202,826",
"Liabilities, Non-Current": "40,620",
"Other Assets": "2,338",
"Other Compr. Net Income": "-2,161",
"Other Expenses": "28,382",
"Other Liabilities": "442,782",
"Other Net Income": "-11,437",
"Other Revenues": "942,358",
"Property, Plant and Equipment, Net": "271,355",
"Research and Development": "12,191"
},
"output_variables": {
"Liabilities": "686,228",
"Assets": "1,624,512",
"Expenses": "825,554",
"Revenues": "942,358",
"Stockholders Equity": "938,284",
"Net Income": "105,367",
"Comprehensive Net Income": "104,286",
"BaseVar": "2,046,125",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "182%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "314,242",
"Assets, Non-Current": "34,710",
"General and Administrative Expense": "748,197",
"Goodwill": "970,119",
"Liabilities, Current": "200,537",
"Liabilities, Non-Current": "14,601",
"Other Assets": "2,101",
"Other Compr. Net Income": "15,845",
"Other Expenses": "28,718",
"Other Liabilities": "328,089",
"Other Net Income": "-21,932",
"Other Revenues": "922,439",
"Property, Plant and Equipment, Net": "276,039",
"Research and Development": "15,049"
},
"output_variables": {
"Liabilities": "543,227",
"Assets": "1,597,211",
"Expenses": "791,964",
"Revenues": "922,439",
"Stockholders Equity": "1,053,984",
"Net Income": "108,543",
"Comprehensive Net Income": "116,466",
"BaseVar": "1,946,309",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "199%"
}
}
},
"top_rated": true,
"trend": 14.0,
"value": 1.985693192744101,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000009326.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000009326.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000009326.svg"
},
{
"company_id": "0000787253",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000787253.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000787253.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000787253.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000787253_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000787253_main_keyfigs.svg",
"name": "Natural Alternatives International Inc",
"rank": 10,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000787253.svg",
"report_text": "The relative strengths and weaknesses of Natural Alternatives International Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Natural Alternatives International Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 68% points.The greatest weakness of Natural Alternatives International Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 193%, being 53% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000787253_2024_Natural_Alternatives_International_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "62.5",
"Liabilities": "88.8",
"Stockholders Equity": "49.0",
"ECR before LimitedLiability": "164",
"Liabilities, Non-Current": "23.3",
"Other Liabilities": "19.7",
"Property, Plant and Equipment, Net": "3.33",
"Assets": "-2.70",
"Assets, Non-Current": "-1.64",
"Other Assets": "1.14",
"Goodwill": "-3.98",
"Assets, Current": "-0.823",
"Other Revenues": "75.4",
"Revenues": "75.4",
"Net Income": "65.3",
"General and Administrative Expense": "65.6",
"Comprehensive Net Income": "65.2",
"Research and Development": "22.0",
"Other Net Income": "-10.7",
"Other Expenses": "-107",
"Economic Capital Ratio": "102"
},
"2012": {
"Liabilities, Current": "45.7",
"Liabilities": "88.2",
"Stockholders Equity": "23.3",
"ECR before LimitedLiability": "120",
"Liabilities, Non-Current": "24.5",
"Other Liabilities": "36.6",
"Assets, Current": "-2.03",
"Assets": "-7.96",
"Other Assets": "1.11",
"Assets, Non-Current": "-2.53",
"Property, Plant and Equipment, Net": "1.14",
"Goodwill": "-6.11",
"Other Expenses": "-126",
"Expenses": "-9.87",
"Revenues": "81.9",
"Net Income": "71.6",
"Research and Development": "25.5",
"General and Administrative Expense": "67.7",
"Other Revenues": "81.9",
"Comprehensive Net Income": "72.3",
"Economic Capital Ratio": "87.9"
},
"2014": {
"Liabilities, Non-Current": "34.7",
"Liabilities": "105",
"Stockholders Equity": "60.1",
"ECR before LimitedLiability": "146",
"Liabilities, Current": "65.3",
"Other Liabilities": "23.0",
"Assets, Current": "3.27",
"Assets": "-6.77",
"Goodwill": "-8.57",
"Other Assets": "1.71",
"Assets, Non-Current": "-2.24",
"Other Expenses": "-119",
"Expenses": "-10.1",
"Revenues": "80.3",
"Net Income": "71.7",
"Research and Development": "23.0",
"General and Administrative Expense": "67.4",
"Other Revenues": "80.3",
"Other Net Income": "2.09",
"Comprehensive Net Income": "71.8",
"Economic Capital Ratio": "96.9"
},
"2015": {
"Other Liabilities": "31.2",
"Liabilities": "116",
"Stockholders Equity": "49.8",
"ECR before LimitedLiability": "144",
"Liabilities, Current": "66.5",
"Liabilities, Non-Current": "40.9",
"Assets, Current": "3.86",
"Assets": "-10.6",
"Other Assets": "-3.08",
"Goodwill": "-8.35",
"Property, Plant and Equipment, Net": "-1.84",
"Research and Development": "18.3",
"Expenses": "-22.4",
"Revenues": "96.6",
"Net Income": "74.8",
"General and Administrative Expense": "50.8",
"Other Expenses": "-107",
"Other Revenues": "96.6",
"Comprehensive Net Income": "75.1",
"Other Net Income": "1.93",
"Economic Capital Ratio": "97.9"
},
"2016": {
"Liabilities, Non-Current": "36.9",
"Liabilities": "83.2",
"ECR before LimitedLiability": "91.8",
"Liabilities, Current": "43.5",
"Other Liabilities": "14.1",
"Property, Plant and Equipment, Net": "-3.32",
"Assets": "-17.5",
"Other Assets": "1.50",
"Assets, Non-Current": "-2.83",
"Assets, Current": "-5.92",
"Goodwill": "-10.1",
"Research and Development": "24.1",
"Expenses": "-16.3",
"Net Income": "69.3",
"General and Administrative Expense": "44.6",
"Other Expenses": "-96.0",
"Other Revenues": "89.9",
"Revenues": "89.9",
"Comprehensive Net Income": "69.8",
"Other Net Income": "-1.41",
"Economic Capital Ratio": "71.8"
},
"2017": {
"Other Liabilities": "25.5",
"Liabilities": "123",
"Stockholders Equity": "21.5",
"ECR before LimitedLiability": "114",
"Liabilities, Current": "74.5",
"Liabilities, Non-Current": "50.7",
"Assets, Non-Current": "-2.45",
"Assets": "-12.8",
"Assets, Current": "-2.81",
"Goodwill": "-7.80",
"Property, Plant and Equipment, Net": "-3.67",
"Research and Development": "28.2",
"Expenses": "-43.6",
"Revenues": "118",
"Net Income": "66.4",
"Other Expenses": "38.2",
"General and Administrative Expense": "-129",
"Other Revenues": "118",
"Comprehensive Net Income": "65.6",
"Other Net Income": "-8.63",
"Economic Capital Ratio": "92.8"
},
"2018": {
"Liabilities, Non-Current": "39.2",
"Liabilities": "93.3",
"Stockholders Equity": "3.38",
"ECR before LimitedLiability": "107",
"Other Liabilities": "17.9",
"Liabilities, Current": "52.0",
"Property, Plant and Equipment, Net": "-2.52",
"Assets": "-15.7",
"Assets, Current": "-2.02",
"Goodwill": "-8.53",
"Assets, Non-Current": "-5.91",
"Other Expenses": "14.8",
"Expenses": "-29.8",
"Revenues": "96.4",
"Net Income": "66.3",
"Research and Development": "23.4",
"General and Administrative Expense": "-74.7",
"Other Revenues": "96.4",
"Comprehensive Net Income": "67.0",
"Other Net Income": "1.37",
"Economic Capital Ratio": "86.4"
},
"2019": {
"Liabilities, Non-Current": "-5.51",
"Liabilities": "92.0",
"Assets": "-7.74",
"Stockholders Equity": "32.1",
"ECR before LimitedLiability": "137",
"Other Liabilities": "62.1",
"Liabilities, Current": "46.4",
"Goodwill": "-6.43",
"Property, Plant and Equipment, Net": "-1.88",
"Assets, Current": "-0.792",
"Research and Development": "16.1",
"Expenses": "-15.5",
"Revenues": "72.0",
"Net Income": "65.9",
"Other Expenses": "14.6",
"General and Administrative Expense": "-50.0",
"Other Revenues": "72.0",
"Other Net Income": "8.75",
"Comprehensive Net Income": "66.4",
"Other Compr. Net Income": "0.577",
"Economic Capital Ratio": "107"
},
"2020": {
"Liabilities, Current": "17.5",
"Liabilities": "33.0",
"Stockholders Equity": "-17.1",
"ECR before LimitedLiability": "68.6",
"Liabilities, Non-Current": "11.9",
"Other Liabilities": "4.85",
"Goodwill": "-13.0",
"Assets": "-20.0",
"Assets, Current": "-4.67",
"Assets, Non-Current": "0.545",
"Property, Plant and Equipment, Net": "-5.26",
"Other Expenses": "-5.56",
"Expenses": "-15.9",
"Revenues": "47.0",
"Net Income": "35.5",
"Research and Development": "10.3",
"General and Administrative Expense": "-20.3",
"Other Revenues": "47.0",
"Comprehensive Net Income": "35.0",
"Other Net Income": "6.54",
"Economic Capital Ratio": "30.8"
},
"2021": {
"Liabilities, Non-Current": "19.4",
"Liabilities": "60.7",
"Stockholders Equity": "-55.9",
"ECR before LimitedLiability": "47.2",
"Liabilities, Current": "34.0",
"Other Liabilities": "12.8",
"Assets, Current": "-13.2",
"Assets": "-29.4",
"Assets, Non-Current": "-4.23",
"Other Assets": "1.18",
"Goodwill": "-15.9",
"Property, Plant and Equipment, Net": "-5.86",
"Other Expenses": "3.35",
"Expenses": "-31.8",
"Revenues": "92.2",
"Net Income": "52.7",
"Research and Development": "16.8",
"General and Administrative Expense": "-53.5",
"Other Revenues": "92.2",
"Comprehensive Net Income": "53.0",
"Economic Capital Ratio": "42.9"
},
"2022": {
"Liabilities, Non-Current": "11.9",
"Liabilities": "41.7",
"Stockholders Equity": "-23.8",
"ECR before LimitedLiability": "46.8",
"Liabilities, Current": "31.5",
"Assets": "-22.0",
"Assets, Current": "-9.53",
"Property, Plant and Equipment, Net": "2.96",
"Assets, Non-Current": "-1.56",
"Goodwill": "-15.9",
"General and Administrative Expense": "-28.3",
"Expenses": "-14.1",
"Revenues": "60.5",
"Net Income": "45.9",
"Research and Development": "13.0",
"Other Expenses": "1.41",
"Other Revenues": "60.5",
"Other Net Income": "2.14",
"Comprehensive Net Income": "47.4",
"Other Compr. Net Income": "1.27",
"Economic Capital Ratio": "36.4"
},
"2023": {
"Liabilities, Non-Current": "12.9",
"Liabilities": "68.2",
"Stockholders Equity": "6.78",
"ECR before LimitedLiability": "68.0",
"Other Liabilities": "-3.48",
"Liabilities, Current": "60.5",
"Other Assets": "-1.45",
"Assets": "-18.4",
"Property, Plant and Equipment, Net": "9.93",
"Goodwill": "-15.7",
"Assets, Current": "-6.91",
"Assets, Non-Current": "-3.98",
"Other Expenses": "8.57",
"Expenses": "-24.1",
"Revenues": "66.7",
"Net Income": "36.9",
"Research and Development": "8.57",
"General and Administrative Expense": "-41.6",
"Other Revenues": "66.7",
"Comprehensive Net Income": "36.1",
"Economic Capital Ratio": "52.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000787253_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "27,828",
"Assets, Non-Current": "453",
"General and Administrative Expense": "8,304",
"Goodwill": "0",
"Liabilities, Current": "4,947",
"Liabilities, Non-Current": "0",
"Other Assets": "1,452",
"Other Compr. Net Income": "50",
"Other Expenses": "42,517",
"Other Liabilities": "719",
"Other Net Income": "25",
"Other Revenues": "55,882",
"Property, Plant and Equipment, Net": "11,411",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,666",
"Assets": "41,144",
"Expenses": "50,821",
"Revenues": "55,882",
"Stockholders Equity": "35,478",
"Net Income": "5,086",
"Comprehensive Net Income": "5,111",
"BaseVar": "76,794",
"ECR before LimitedLiability": "230%",
"Economic Capital Ratio": "256%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "34,519",
"Assets, Non-Current": "471",
"General and Administrative Expense": "9,251",
"Goodwill": "0",
"Liabilities, Current": "6,836",
"Liabilities, Non-Current": "0",
"Other Assets": "1,560",
"Other Compr. Net Income": "464",
"Other Expenses": "59,455",
"Other Liabilities": "493",
"Other Net Income": "42",
"Other Revenues": "72,822",
"Property, Plant and Equipment, Net": "10,647",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,329",
"Assets": "47,197",
"Expenses": "68,706",
"Revenues": "72,822",
"Stockholders Equity": "39,868",
"Net Income": "4,158",
"Comprehensive Net Income": "4,390",
"BaseVar": "98,280",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "246%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "40,903",
"Assets, Non-Current": "951",
"General and Administrative Expense": "9,961",
"Goodwill": "0",
"Liabilities, Current": "9,600",
"Liabilities, Non-Current": "0",
"Other Assets": "1,593",
"Other Compr. Net Income": "-39",
"Other Expenses": "61,878",
"Other Liabilities": "220",
"Other Net Income": "-109",
"Other Revenues": "73,942",
"Property, Plant and Equipment, Net": "8,811",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,820",
"Assets": "52,258",
"Expenses": "71,839",
"Revenues": "73,942",
"Stockholders Equity": "42,438",
"Net Income": "1,994",
"Comprehensive Net Income": "1,974",
"BaseVar": "104,004",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "230%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "43,600",
"Assets, Non-Current": "920",
"General and Administrative Expense": "10,180",
"Goodwill": "0",
"Liabilities, Current": "9,093",
"Liabilities, Non-Current": "21",
"Other Assets": "1,663",
"Other Compr. Net Income": "-297",
"Other Expenses": "66,130",
"Other Liabilities": "842",
"Other Net Income": "148",
"Other Revenues": "79,508",
"Property, Plant and Equipment, Net": "7,633",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,956",
"Assets": "53,816",
"Expenses": "76,310",
"Revenues": "79,508",
"Stockholders Equity": "43,860",
"Net Income": "3,346",
"Comprehensive Net Income": "3,198",
"BaseVar": "110,018",
"ECR before LimitedLiability": "198%",
"Economic Capital Ratio": "234%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "55,882",
"Assets, Non-Current": "899",
"General and Administrative Expense": "13,000",
"Goodwill": "0",
"Liabilities, Current": "19,205",
"Liabilities, Non-Current": "0",
"Other Assets": "2,227",
"Other Compr. Net Income": "86",
"Other Expenses": "92,969",
"Other Liabilities": "1,244",
"Other Net Income": "1,314",
"Other Revenues": "114,201",
"Property, Plant and Equipment, Net": "15,167",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "20,449",
"Assets": "74,175",
"Expenses": "105,969",
"Revenues": "114,201",
"Stockholders Equity": "53,726",
"Net Income": "9,546",
"Comprehensive Net Income": "9,589",
"BaseVar": "158,097",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "51,699",
"Assets, Non-Current": "774",
"General and Administrative Expense": "112,244",
"Goodwill": "0",
"Liabilities, Current": "10,270",
"Liabilities, Non-Current": "0",
"Other Assets": "2,002",
"Other Compr. Net Income": "-225",
"Other Expenses": "2,876",
"Other Liabilities": "1,193",
"Other Net Income": "409",
"Other Revenues": "121,946",
"Property, Plant and Equipment, Net": "18,136",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "11,463",
"Assets": "72,611",
"Expenses": "115,120",
"Revenues": "121,946",
"Stockholders Equity": "61,148",
"Net Income": "7,235",
"Comprehensive Net Income": "7,122",
"BaseVar": "160,887",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "246%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "65,183",
"Assets, Non-Current": "734",
"General and Administrative Expense": "122,904",
"Goodwill": "0",
"Liabilities, Current": "14,280",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "327",
"Other Expenses": "5,562",
"Other Liabilities": "2,679",
"Other Net Income": "1,080",
"Other Revenues": "132,437",
"Property, Plant and Equipment, Net": "19,290",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,959",
"Assets": "85,207",
"Expenses": "128,466",
"Revenues": "132,437",
"Stockholders Equity": "68,248",
"Net Income": "5,051",
"Comprehensive Net Income": "5,214",
"BaseVar": "182,238",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "230%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "71,386",
"Assets, Non-Current": "21,793",
"General and Administrative Expense": "132,329",
"Goodwill": "0",
"Liabilities, Current": "15,370",
"Liabilities, Non-Current": "20,897",
"Other Assets": "0",
"Other Compr. Net Income": "870",
"Other Expenses": "1,412",
"Other Liabilities": "-18,861",
"Other Net Income": "1,992",
"Other Revenues": "138,290",
"Property, Plant and Equipment, Net": "21,085",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "17,406",
"Assets": "114,264",
"Expenses": "133,741",
"Revenues": "138,290",
"Stockholders Equity": "96,858",
"Net Income": "6,541",
"Comprehensive Net Income": "6,976",
"BaseVar": "203,282",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "243%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "79,024",
"Assets, Non-Current": "19,460",
"General and Administrative Expense": "100,005",
"Goodwill": "0",
"Liabilities, Current": "27,806",
"Liabilities, Non-Current": "18,782",
"Other Assets": "196",
"Other Compr. Net Income": "-1,347",
"Other Expenses": "20,287",
"Other Liabilities": "2,240",
"Other Net Income": "-229",
"Other Revenues": "118,876",
"Property, Plant and Equipment, Net": "21,523",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "48,828",
"Assets": "120,203",
"Expenses": "120,292",
"Revenues": "118,876",
"Stockholders Equity": "71,375",
"Net Income": "-1,645",
"Comprehensive Net Income": "-2,318",
"BaseVar": "204,888",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "177%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "80,348",
"Assets, Non-Current": "17,448",
"General and Administrative Expense": "148,078",
"Goodwill": "0",
"Liabilities, Current": "22,072",
"Liabilities, Non-Current": "16,481",
"Other Assets": "214",
"Other Compr. Net Income": "622",
"Other Expenses": "18,127",
"Other Liabilities": "1,645",
"Other Net Income": "-1,547",
"Other Revenues": "178,520",
"Property, Plant and Equipment, Net": "22,271",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "40,198",
"Assets": "120,281",
"Expenses": "166,205",
"Revenues": "178,520",
"Stockholders Equity": "80,083",
"Net Income": "10,768",
"Comprehensive Net Income": "11,079",
"BaseVar": "253,686",
"ECR before LimitedLiability": "151%",
"Economic Capital Ratio": "202%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "76,746",
"Assets, Non-Current": "24,684",
"General and Administrative Expense": "140,457",
"Goodwill": "0",
"Liabilities, Current": "25,115",
"Liabilities, Non-Current": "21,413",
"Other Assets": "0",
"Other Compr. Net Income": "2,260",
"Other Expenses": "19,777",
"Other Liabilities": "10,955",
"Other Net Income": "-20",
"Other Revenues": "170,966",
"Property, Plant and Equipment, Net": "44,573",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "57,483",
"Assets": "146,003",
"Expenses": "160,234",
"Revenues": "170,966",
"Stockholders Equity": "88,520",
"Net Income": "10,712",
"Comprehensive Net Income": "11,842",
"BaseVar": "268,483",
"ECR before LimitedLiability": "131%",
"Economic Capital Ratio": "189%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "57,010",
"Assets, Non-Current": "22,946",
"General and Administrative Expense": "135,857",
"Goodwill": "0",
"Liabilities, Current": "15,884",
"Liabilities, Non-Current": "18,965",
"Other Assets": "355",
"Other Compr. Net Income": "-1,782",
"Other Expenses": "14,478",
"Other Liabilities": "10,531",
"Other Net Income": "-1,158",
"Other Revenues": "154,015",
"Property, Plant and Equipment, Net": "53,841",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "45,380",
"Assets": "134,152",
"Expenses": "150,335",
"Revenues": "154,015",
"Stockholders Equity": "88,772",
"Net Income": "2,522",
"Comprehensive Net Income": "1,631",
"BaseVar": "243,411",
"ECR before LimitedLiability": "137%",
"Economic Capital Ratio": "193%"
}
}
},
"top_rated": true,
"trend": 10.0,
"value": 1.9296501011339187,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000787253.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000787253.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000787253.svg"
},
{
"company_id": "0001321834",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001321834.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001321834.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001321834.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001321834_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001321834_main_keyfigs.svg",
"name": "Q C Technologies INC",
"rank": 11,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001321834.svg",
"report_text": "The relative strengths and weaknesses of Q C Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Q C Technologies INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 92% points.The greatest weakness of Q C Technologies INC is the variable Other Revenues, reducing the Economic Capital Ratio by 45% points.
The company's Economic Capital Ratio, given in the ranking table, is 180%, being 40% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001321834_2024_Q_C_Technologies_INC.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "17.8",
"Liabilities": "53.0",
"Stockholders Equity": "126",
"ECR before LimitedLiability": "141",
"Liabilities, Current": "29.3",
"Other Liabilities": "12.1",
"Assets, Current": "40.4",
"Assets": "41.6",
"Other Assets": "-6.74",
"Assets, Non-Current": "11.7",
"Property, Plant and Equipment, Net": "-3.37",
"Other Expenses": "4.87",
"Expenses": "16.5",
"Revenues": "-7.84",
"Net Income": "10.5",
"Research and Development": "4.74",
"General and Administrative Expense": "7.01",
"Other Revenues": "-7.84",
"Other Net Income": "1.70",
"Comprehensive Net Income": "10.6",
"Economic Capital Ratio": "91.5"
},
"2018": {
"Liabilities, Non-Current": "3.04",
"Liabilities": "6.50",
"Stockholders Equity": "6.83",
"ECR before LimitedLiability": "-39.9",
"Other Liabilities": "1.70",
"Liabilities, Current": "0.849",
"Property, Plant and Equipment, Net": "-14.8",
"Assets": "-0.886",
"Other Assets": "-0.794",
"Assets, Current": "18.6",
"Goodwill": "-2.18",
"Assets, Non-Current": "1.03",
"Other Expenses": "-0.883",
"Expenses": "-62.3",
"Revenues": "-22.9",
"Net Income": "-86.1",
"General and Administrative Expense": "-55.0",
"Other Revenues": "-22.9",
"Comprehensive Net Income": "-85.7",
"Other Net Income": "2.01",
"Economic Capital Ratio": "-60.4"
},
"2019": {
"Liabilities, Non-Current": "18.9",
"Liabilities": "35.0",
"Stockholders Equity": "97.2",
"ECR before LimitedLiability": "89.8",
"Other Liabilities": "12.4",
"Liabilities, Current": "5.64",
"Assets, Non-Current": "-2.67",
"Assets": "43.4",
"Goodwill": "-5.94",
"Property, Plant and Equipment, Net": "-8.03",
"Assets, Current": "112",
"Research and Development": "4.93",
"Expenses": "2.62",
"Revenues": "-18.0",
"Net Income": "-12.7",
"Other Expenses": "5.92",
"General and Administrative Expense": "-8.20",
"Other Revenues": "-18.0",
"Other Net Income": "2.59",
"Comprehensive Net Income": "-12.5",
"Economic Capital Ratio": "60.4"
},
"2020": {
"Liabilities, Current": "21.4",
"Liabilities": "47.5",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "94.8",
"Liabilities, Non-Current": "24.4",
"Other Liabilities": "5.25",
"Goodwill": "-6.09",
"Assets": "51.2",
"Assets, Current": "125",
"Assets, Non-Current": "-4.95",
"Property, Plant and Equipment, Net": "-7.71",
"Other Expenses": "6.20",
"Expenses": "5.27",
"Revenues": "-30.9",
"Net Income": "-40.1",
"Research and Development": "-21.1",
"General and Administrative Expense": "20.1",
"Other Revenues": "-30.9",
"Comprehensive Net Income": "-40.1",
"Other Net Income": "-14.0",
"Economic Capital Ratio": "57.0"
},
"2021": {
"Liabilities, Non-Current": "18.8",
"Liabilities": "22.9",
"Stockholders Equity": "30.3",
"ECR before LimitedLiability": "-51.2",
"Liabilities, Current": "19.2",
"Other Liabilities": "10.6",
"Assets": "17.9",
"Assets, Non-Current": "42.3",
"Other Assets": "-58.5",
"Goodwill": "25.2",
"Property, Plant and Equipment, Net": "-28.5",
"Other Expenses": "-78.8",
"Expenses": "-86.6",
"Revenues": "-54.6",
"Net Income": "-136",
"Research and Development": "-30.0",
"General and Administrative Expense": "18.6",
"Other Revenues": "-54.6",
"Comprehensive Net Income": "-136",
"Other Net Income": "-6.62",
"Economic Capital Ratio": "-55.6"
},
"2022": {
"Liabilities, Non-Current": "24.9",
"Liabilities": "40.8",
"Stockholders Equity": "48.0",
"ECR before LimitedLiability": "-13.1",
"Other Liabilities": "9.27",
"Liabilities, Current": "8.08",
"Other Assets": "-56.2",
"Assets": "44.1",
"Assets, Current": "-10.3",
"Property, Plant and Equipment, Net": "-19.9",
"Assets, Non-Current": "87.7",
"Goodwill": "58.1",
"General and Administrative Expense": "7.67",
"Expenses": "-44.5",
"Revenues": "-42.4",
"Net Income": "-80.1",
"Research and Development": "-55.7",
"Other Expenses": "6.31",
"Other Revenues": "-42.4",
"Comprehensive Net Income": "-79.7",
"Economic Capital Ratio": "-23.6"
},
"2023": {
"Liabilities, Non-Current": "31.5",
"Liabilities": "58.0",
"Stockholders Equity": "32.3",
"ECR before LimitedLiability": "54.9",
"Other Liabilities": "10.1",
"Liabilities, Current": "19.9",
"Other Assets": "-33.2",
"Assets": "-7.80",
"Property, Plant and Equipment, Net": "-15.3",
"Goodwill": "43.7",
"Assets, Current": "-8.55",
"Assets, Non-Current": "72.9",
"Expenses": "-24.7",
"Revenues": "-45.2",
"Net Income": "5.90",
"Research and Development": "-38.1",
"General and Administrative Expense": "19.9",
"Other Revenues": "-45.2",
"Other Net Income": "91.7",
"Comprehensive Net Income": "5.77",
"Economic Capital Ratio": "39.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001321834_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "13,060",
"Assets, Non-Current": "3,591",
"General and Administrative Expense": "5,086",
"Goodwill": "2,176",
"Liabilities, Current": "1,844",
"Liabilities, Non-Current": "0",
"Other Assets": "-2,378",
"Other Compr. Net Income": "0",
"Other Expenses": "1,613",
"Other Liabilities": "0",
"Other Net Income": "77",
"Other Revenues": "4,427",
"Property, Plant and Equipment, Net": "201",
"Research and Development": "916"
},
"output_variables": {
"Liabilities": "1,844",
"Assets": "16,651",
"Expenses": "7,616",
"Revenues": "4,427",
"Stockholders Equity": "14,807",
"Net Income": "-3,111",
"Comprehensive Net Income": "-3,111",
"BaseVar": "15,307",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "225%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,670",
"Assets, Non-Current": "1,137",
"General and Administrative Expense": "8,987",
"Goodwill": "243",
"Liabilities, Current": "1,974",
"Liabilities, Non-Current": "0",
"Other Assets": "-327",
"Other Compr. Net Income": "0",
"Other Expenses": "1,676",
"Other Liabilities": "0",
"Other Net Income": "789",
"Other Revenues": "1,666",
"Property, Plant and Equipment, Net": "83",
"Research and Development": "1,063"
},
"output_variables": {
"Liabilities": "1,974",
"Assets": "7,807",
"Expenses": "11,726",
"Revenues": "1,666",
"Stockholders Equity": "5,834",
"Net Income": "-9,272",
"Comprehensive Net Income": "-9,272",
"BaseVar": "11,980",
"ECR before LimitedLiability": "-26%",
"Economic Capital Ratio": "83%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "10,311",
"Assets, Non-Current": "574",
"General and Administrative Expense": "5,065",
"Goodwill": "170",
"Liabilities, Current": "1,530",
"Liabilities, Non-Current": "0",
"Other Assets": "-204",
"Other Compr. Net Income": "44",
"Other Expenses": "181",
"Other Liabilities": "0",
"Other Net Income": "-58",
"Other Revenues": "1,577",
"Property, Plant and Equipment, Net": "34",
"Research and Development": "277"
},
"output_variables": {
"Liabilities": "1,530",
"Assets": "10,885",
"Expenses": "5,523",
"Revenues": "1,577",
"Stockholders Equity": "9,355",
"Net Income": "-4,004",
"Comprehensive Net Income": "-3,982",
"BaseVar": "9,808",
"ECR before LimitedLiability": "142%",
"Economic Capital Ratio": "196%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "36,843",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,322",
"Goodwill": "0",
"Liabilities, Current": "2,263",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-5,295",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "7,964"
},
"output_variables": {
"Liabilities": "2,263",
"Assets": "36,843",
"Expenses": "12,286",
"Revenues": "0",
"Stockholders Equity": "34,579",
"Net Income": "-17,581",
"Comprehensive Net Income": "-17,581",
"BaseVar": "28,343",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "203%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "12,665",
"Assets, Non-Current": "12,148",
"General and Administrative Expense": "6,420",
"Goodwill": "10,499",
"Liabilities, Current": "1,040",
"Liabilities, Non-Current": "126",
"Other Assets": "-10,499",
"Other Compr. Net Income": "0",
"Other Expenses": "15,645",
"Other Liabilities": "0",
"Other Net Income": "-1,079",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "6,745"
},
"output_variables": {
"Liabilities": "1,166",
"Assets": "24,813",
"Expenses": "28,810",
"Revenues": "0",
"Stockholders Equity": "23,647",
"Net Income": "-29,889",
"Comprehensive Net Income": "-29,889",
"BaseVar": "27,934",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "103%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "5,402",
"Assets, Non-Current": "12,138",
"General and Administrative Expense": "5,520",
"Goodwill": "10,499",
"Liabilities, Current": "2,769",
"Liabilities, Non-Current": "76",
"Other Assets": "-10,499",
"Other Compr. Net Income": "0",
"Other Expenses": "695",
"Other Liabilities": "0",
"Other Net Income": "85",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "9,067"
},
"output_variables": {
"Liabilities": "2,845",
"Assets": "17,540",
"Expenses": "15,283",
"Revenues": "0",
"Stockholders Equity": "14,695",
"Net Income": "-15,197",
"Comprehensive Net Income": "-15,197",
"BaseVar": "17,877",
"ECR before LimitedLiability": "48%",
"Economic Capital Ratio": "129%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "5,816",
"Assets, Non-Current": "12,046",
"General and Administrative Expense": "5,443",
"Goodwill": "10,499",
"Liabilities, Current": "4,988",
"Liabilities, Non-Current": "101",
"Other Assets": "-10,499",
"Other Compr. Net Income": "0",
"Other Expenses": "3,812",
"Other Liabilities": "0",
"Other Net Income": "13,123",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "7,868"
},
"output_variables": {
"Liabilities": "5,089",
"Assets": "17,862",
"Expenses": "17,123",
"Revenues": "0",
"Stockholders Equity": "12,774",
"Net Income": "-4,000",
"Comprehensive Net Income": "-4,000",
"BaseVar": "26,599",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "180%"
}
}
},
"top_rated": true,
"trend": 24.0,
"value": 1.7986484434834997,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001321834.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001321834.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001321834.svg"
},
{
"company_id": "0001731348",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001731348.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001731348.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001731348.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001731348_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001731348_main_keyfigs.svg",
"name": "Tilray Brands Inc",
"rank": 12,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001731348.svg",
"report_text": "The relative strengths and weaknesses of Tilray Brands Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Tilray Brands Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 95% points.The greatest weakness of Tilray Brands Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 22% points.
The company's Economic Capital Ratio, given in the ranking table, is 180%, being 40% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001731348_2024_Tilray_Brands_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "12.2",
"Liabilities": "-68.6",
"Stockholders Equity": "-7.05",
"ECR before LimitedLiability": "-4.71",
"Other Liabilities": "-124",
"Liabilities, Current": "22.2",
"Assets": "34.9",
"Other Assets": "3.20",
"Assets, Current": "39.7",
"Goodwill": "-10.2",
"Assets, Non-Current": "-7.84",
"Other Expenses": "6.64",
"Expenses": "34.3",
"Revenues": "-25.1",
"Net Income": "14.5",
"Research and Development": "9.20",
"General and Administrative Expense": "29.2",
"Other Revenues": "-25.1",
"Comprehensive Net Income": "14.7",
"Other Net Income": "-2.27",
"Economic Capital Ratio": "-25.2"
},
"2019": {
"Liabilities, Non-Current": "13.4",
"Liabilities": "-54.2",
"Stockholders Equity": "-11.7",
"ECR before LimitedLiability": "10.8",
"Other Liabilities": "-93.3",
"Liabilities, Current": "15.4",
"Assets, Non-Current": "-8.91",
"Assets": "32.6",
"Goodwill": "33.4",
"Property, Plant and Equipment, Net": "7.73",
"Other Assets": "5.38",
"Assets, Current": "-12.6",
"Research and Development": "8.02",
"Expenses": "32.7",
"Revenues": "-18.0",
"Net Income": "18.3",
"Other Expenses": "-4.72",
"General and Administrative Expense": "32.6",
"Other Revenues": "-18.0",
"Comprehensive Net Income": "18.7",
"Economic Capital Ratio": "-18.7"
},
"2020": {
"Liabilities, Current": "15.9",
"Liabilities": "10.0",
"Stockholders Equity": "52.5",
"ECR before LimitedLiability": "92.7",
"Liabilities, Non-Current": "-11.5",
"Other Liabilities": "4.58",
"Goodwill": "26.6",
"Assets": "26.3",
"Assets, Current": "-2.80",
"Assets, Non-Current": "12.2",
"Property, Plant and Equipment, Net": "-7.75",
"Other Expenses": "1.46",
"Expenses": "15.7",
"Revenues": "-5.52",
"Net Income": "13.6",
"Research and Development": "5.61",
"General and Administrative Expense": "8.58",
"Other Revenues": "-5.52",
"Comprehensive Net Income": "13.5",
"Other Net Income": "3.46",
"Economic Capital Ratio": "54.9"
},
"2021": {
"Liabilities, Non-Current": "-13.0",
"Liabilities": "-3.91",
"Assets": "34.6",
"Stockholders Equity": "54.1",
"ECR before LimitedLiability": "49.5",
"Liabilities, Current": "4.23",
"Other Liabilities": "4.12",
"Assets, Current": "-10.1",
"Assets, Non-Current": "-4.36",
"Goodwill": "84.7",
"Other Expenses": "5.02",
"Expenses": "29.0",
"Revenues": "-15.6",
"Net Income": "9.86",
"Research and Development": "6.31",
"General and Administrative Expense": "17.4",
"Other Revenues": "-15.6",
"Comprehensive Net Income": "10.9",
"Other Net Income": "-3.30",
"Other Compr. Net Income": "1.05",
"Economic Capital Ratio": "45.2"
},
"2022": {
"Liabilities, Non-Current": "21.0",
"Liabilities": "20.8",
"Assets": "32.2",
"Stockholders Equity": "75.5",
"ECR before LimitedLiability": "73.8",
"Other Liabilities": "-17.6",
"Liabilities, Current": "15.1",
"Assets, Current": "-7.63",
"Assets, Non-Current": "-4.32",
"Goodwill": "71.3",
"General and Administrative Expense": "17.6",
"Expenses": "20.7",
"Revenues": "-16.1",
"Net Income": "9.47",
"Research and Development": "6.50",
"Other Expenses": "-3.42",
"Other Revenues": "-16.1",
"Other Net Income": "4.58",
"Comprehensive Net Income": "7.53",
"Other Compr. Net Income": "-1.96",
"Economic Capital Ratio": "63.3"
},
"2023": {
"Liabilities, Non-Current": "21.8",
"Liabilities": "30.0",
"Stockholders Equity": "80.7",
"ECR before LimitedLiability": "54.7",
"Other Liabilities": "-12.5",
"Liabilities, Current": "20.2",
"Assets": "38.1",
"Property, Plant and Equipment, Net": "-3.20",
"Goodwill": "95.2",
"Assets, Current": "-7.58",
"Assets, Non-Current": "-9.11",
"Other Expenses": "-22.1",
"Expenses": "-1.38",
"Revenues": "-13.9",
"Net Income": "-17.4",
"Research and Development": "4.89",
"General and Administrative Expense": "16.6",
"Other Revenues": "-13.9",
"Other Net Income": "-2.15",
"Comprehensive Net Income": "-17.9",
"Economic Capital Ratio": "39.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001731348_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "554,302",
"Assets, Non-Current": "0",
"General and Administrative Expense": "75,528",
"Goodwill": "4,486",
"Liabilities, Current": "25,937",
"Liabilities, Non-Current": "0",
"Other Assets": "17,665",
"Other Compr. Net Income": "-103",
"Other Expenses": "16,537",
"Other Liabilities": "433,077",
"Other Net Income": "-14,524",
"Other Revenues": "43,130",
"Property, Plant and Equipment, Net": "80,214",
"Research and Development": "4,264"
},
"output_variables": {
"Liabilities": "459,014",
"Assets": "656,667",
"Expenses": "96,329",
"Revenues": "43,130",
"Stockholders Equity": "197,653",
"Net Income": "-67,723",
"Comprehensive Net Income": "-67,774",
"BaseVar": "634,884",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "119%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "259,027",
"Assets, Non-Current": "28,962",
"General and Administrative Expense": "143,052",
"Goodwill": "392,079",
"Liabilities, Current": "92,427",
"Liabilities, Non-Current": "15,341",
"Other Assets": "32,045",
"Other Compr. Net Income": "5,153",
"Other Expenses": "115,642",
"Other Liabilities": "503,291",
"Other Net Income": "-32,421",
"Other Revenues": "166,979",
"Property, Plant and Equipment, Net": "184,217",
"Research and Development": "6,558"
},
"output_variables": {
"Liabilities": "611,059",
"Assets": "896,330",
"Expenses": "265,252",
"Revenues": "166,979",
"Stockholders Equity": "285,271",
"Net Income": "-130,694",
"Comprehensive Net Income": "-128,118",
"BaseVar": "988,597",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "117%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "581,627",
"Assets, Non-Current": "426,062",
"General and Administrative Expense": "422,037",
"Goodwill": "710,648",
"Liabilities, Current": "168,341",
"Liabilities, Non-Current": "290,433",
"Other Assets": "19,595",
"Other Compr. Net Income": "-8,041",
"Other Expenses": "77,030",
"Other Liabilities": "4,227",
"Other Net Income": "-5,176",
"Other Revenues": "405,326",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "1,916"
},
"output_variables": {
"Liabilities": "463,001",
"Assets": "1,737,932",
"Expenses": "500,983",
"Revenues": "405,326",
"Stockholders Equity": "1,274,931",
"Net Income": "-100,833",
"Comprehensive Net Income": "-104,854",
"BaseVar": "1,560,230",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "201%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "883,609",
"Assets, Non-Current": "26,552",
"General and Administrative Expense": "528,054",
"Goodwill": "4,438,712",
"Liabilities, Current": "667,086",
"Liabilities, Non-Current": "839,017",
"Other Assets": "25,791",
"Other Compr. Net Income": "121,418",
"Other Expenses": "107,400",
"Other Liabilities": "53,946",
"Other Net Income": "-212,815",
"Other Revenues": "513,085",
"Property, Plant and Equipment, Net": "650,698",
"Research and Development": "830"
},
"output_variables": {
"Liabilities": "1,560,049",
"Assets": "6,025,362",
"Expenses": "636,284",
"Revenues": "513,085",
"Stockholders Equity": "4,465,313",
"Net Income": "-336,014",
"Comprehensive Net Income": "-275,305",
"BaseVar": "4,534,506",
"ECR before LimitedLiability": "154%",
"Economic Capital Ratio": "204%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "803,503",
"Assets, Non-Current": "18,262",
"General and Administrative Expense": "709,282",
"Goodwill": "3,919,180",
"Liabilities, Current": "476,980",
"Liabilities, Non-Current": "191",
"Other Assets": "121,250",
"Other Compr. Net Income": "-216,101",
"Other Expenses": "521,431",
"Other Liabilities": "531,157",
"Other Net Income": "169,727",
"Other Revenues": "628,372",
"Property, Plant and Equipment, Net": "587,499",
"Research and Development": "1,518"
},
"output_variables": {
"Liabilities": "1,008,328",
"Assets": "5,449,694",
"Expenses": "1,232,231",
"Revenues": "628,372",
"Stockholders Equity": "4,441,366",
"Net Income": "-434,132",
"Comprehensive Net Income": "-542,182",
"BaseVar": "4,352,226",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "216%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "773,029",
"Assets, Non-Current": "10,739",
"General and Administrative Expense": "680,163",
"Goodwill": "2,982,628",
"Liabilities, Current": "600,343",
"Liabilities, Non-Current": "215",
"Other Assets": "111,196",
"Other Compr. Net Income": "-35,502",
"Other Expenses": "1,308,783",
"Other Liabilities": "376,758",
"Other Net Income": "-80,496",
"Other Revenues": "627,124",
"Property, Plant and Equipment, Net": "429,667",
"Research and Development": "682"
},
"output_variables": {
"Liabilities": "977,316",
"Assets": "4,307,259",
"Expenses": "1,989,628",
"Revenues": "627,124",
"Stockholders Equity": "3,329,943",
"Net Income": "-1,443,000",
"Comprehensive Net Income": "-1,460,751",
"BaseVar": "4,008,662",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "180%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.7968179397008952,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001731348.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001731348.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001731348.svg"
},
{
"company_id": "0000874716",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000874716.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000874716.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000874716.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000874716_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000874716_main_keyfigs.svg",
"name": "Idexx Laboratories INC DE",
"rank": 13,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000874716.svg",
"report_text": "The relative strengths and weaknesses of Idexx Laboratories INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Idexx Laboratories INC DE compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 59% points.The greatest weakness of Idexx Laboratories INC DE is the variable Other Assets, reducing the Economic Capital Ratio by 21% points.
The company's Economic Capital Ratio, given in the ranking table, is 178%, being 38% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000874716_2024_Idexx_Laboratories_INC_DE.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "4.39",
"Liabilities": "21.9",
"Stockholders Equity": "-14.3",
"ECR before LimitedLiability": "23.6",
"Liabilities, Current": "-18.4",
"Liabilities, Non-Current": "32.6",
"Assets": "-11.3",
"Property, Plant and Equipment, Net": "0.217",
"Assets, Current": "-8.67",
"Assets, Non-Current": "28.2",
"Other Assets": "-18.8",
"Other Expenses": "21.1",
"Expenses": "-8.82",
"Revenues": "28.5",
"Net Income": "23.0",
"General and Administrative Expense": "-32.3",
"Research and Development": "1.98",
"Other Revenues": "28.5",
"Other Net Income": "3.49",
"Comprehensive Net Income": "23.1",
"Economic Capital Ratio": "25.6"
},
"2011": {
"Liabilities, Current": "-10.1",
"Liabilities": "9.33",
"Stockholders Equity": "-4.45",
"ECR before LimitedLiability": "88.9",
"Liabilities, Non-Current": "4.54",
"Other Liabilities": "14.3",
"Assets": "-5.93",
"Assets, Non-Current": "45.2",
"Other Assets": "-23.7",
"Goodwill": "5.99",
"Assets, Current": "-11.7",
"General and Administrative Expense": "-12.4",
"Expenses": "17.7",
"Revenues": "45.9",
"Net Income": "58.1",
"Research and Development": "9.32",
"Other Expenses": "21.3",
"Other Revenues": "45.9",
"Comprehensive Net Income": "58.1",
"Other Net Income": "-7.26",
"Economic Capital Ratio": "26.9"
},
"2012": {
"Liabilities, Current": "-16.6",
"Liabilities": "13.2",
"Stockholders Equity": "-4.10",
"ECR before LimitedLiability": "64.6",
"Liabilities, Non-Current": "4.25",
"Other Liabilities": "23.5",
"Assets, Current": "-9.87",
"Assets": "-6.33",
"Other Assets": "-21.8",
"Assets, Non-Current": "39.4",
"Property, Plant and Equipment, Net": "3.65",
"Goodwill": "2.84",
"Other Expenses": "24.4",
"Expenses": "17.1",
"Revenues": "43.6",
"Net Income": "63.1",
"Research and Development": "10.4",
"General and Administrative Expense": "-17.2",
"Other Revenues": "43.6",
"Comprehensive Net Income": "63.2",
"Economic Capital Ratio": "32.1"
},
"2013": {
"Liabilities, Current": "-9.09",
"Liabilities": "-3.70",
"Stockholders Equity": "-20.6",
"ECR before LimitedLiability": "47.9",
"Other Liabilities": "16.4",
"Liabilities, Non-Current": "-11.9",
"Assets": "-11.0",
"Assets, Non-Current": "48.7",
"Property, Plant and Equipment, Net": "6.04",
"Other Assets": "-28.2",
"Assets, Current": "-11.7",
"General and Administrative Expense": "-16.4",
"Expenses": "18.6",
"Revenues": "44.8",
"Net Income": "63.5",
"Research and Development": "8.33",
"Other Expenses": "28.2",
"Other Revenues": "44.8",
"Other Net Income": "-3.22",
"Comprehensive Net Income": "63.2",
"Economic Capital Ratio": "7.79"
},
"2014": {
"Liabilities, Non-Current": "-25.6",
"Liabilities": "-26.1",
"Stockholders Equity": "-39.5",
"ECR before LimitedLiability": "24.4",
"Liabilities, Current": "-14.6",
"Other Liabilities": "13.5",
"Assets, Current": "-16.9",
"Assets": "-16.4",
"Goodwill": "-4.01",
"Other Assets": "-35.5",
"Assets, Non-Current": "26.5",
"Property, Plant and Equipment, Net": "6.26",
"Other Expenses": "23.5",
"Expenses": "24.1",
"Revenues": "24.2",
"Net Income": "28.5",
"Research and Development": "12.8",
"General and Administrative Expense": "-3.18",
"Other Revenues": "24.2",
"Comprehensive Net Income": "28.4",
"Economic Capital Ratio": "-25.0"
},
"2015": {
"Other Liabilities": "4.32",
"Liabilities": "-34.1",
"Stockholders Equity": "-63.1",
"Liabilities, Current": "-12.6",
"Liabilities, Non-Current": "-42.3",
"Assets, Current": "-20.3",
"Assets": "-32.5",
"Other Assets": "-46.4",
"Goodwill": "-8.19",
"Assets, Non-Current": "10.1",
"Property, Plant and Equipment, Net": "3.92",
"Research and Development": "3.97",
"Expenses": "4.98",
"Revenues": "6.60",
"Net Income": "12.0",
"General and Administrative Expense": "-15.1",
"Other Expenses": "5.64",
"Other Revenues": "6.60",
"ECR before LimitedLiability": "-1.40",
"Comprehensive Net Income": "11.8",
"Economic Capital Ratio": "-47.3"
},
"2016": {
"Liabilities, Non-Current": "-39.4",
"Liabilities": "-47.8",
"Stockholders Equity": "-84.4",
"Liabilities, Current": "-18.5",
"Other Liabilities": "4.65",
"Property, Plant and Equipment, Net": "-4.73",
"Assets": "-43.0",
"Other Assets": "-38.0",
"Assets, Non-Current": "10.2",
"Assets, Current": "-33.4",
"Goodwill": "-9.97",
"Research and Development": "4.84",
"Expenses": "5.34",
"Revenues": "7.23",
"Net Income": "11.0",
"General and Administrative Expense": "-23.8",
"Other Expenses": "6.20",
"Other Revenues": "7.23",
"ECR before LimitedLiability": "-37.4",
"Comprehensive Net Income": "11.0",
"Economic Capital Ratio": "-57.3"
},
"2017": {
"Other Liabilities": "10.9",
"Liabilities": "-39.4",
"Stockholders Equity": "-76.4",
"Liabilities, Current": "-18.6",
"Liabilities, Non-Current": "-35.1",
"Assets, Non-Current": "14.5",
"Assets": "-40.0",
"Other Assets": "-35.4",
"Assets, Current": "-20.2",
"Goodwill": "-12.6",
"Property, Plant and Equipment, Net": "-13.8",
"Research and Development": "10.9",
"Expenses": "10.9",
"Revenues": "13.4",
"Net Income": "15.1",
"Other Expenses": "11.2",
"General and Administrative Expense": "-20.7",
"Other Revenues": "13.4",
"ECR before LimitedLiability": "-36.4",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "-57.9"
},
"2018": {
"Liabilities, Non-Current": "-45.8",
"Liabilities": "-37.4",
"Stockholders Equity": "-87.6",
"ECR before LimitedLiability": "-16.2",
"Other Liabilities": "17.4",
"Liabilities, Current": "-10.6",
"Property, Plant and Equipment, Net": "-2.65",
"Assets": "-46.7",
"Other Assets": "-38.6",
"Assets, Current": "-38.7",
"Goodwill": "-7.42",
"Assets, Non-Current": "25.5",
"Other Expenses": "13.0",
"Expenses": "15.9",
"Revenues": "25.7",
"Net Income": "28.7",
"Research and Development": "14.2",
"General and Administrative Expense": "-10.8",
"Other Revenues": "25.7",
"Comprehensive Net Income": "28.7",
"Economic Capital Ratio": "-36.7"
},
"2019": {
"Liabilities, Non-Current": "-46.6",
"Liabilities": "-26.9",
"Stockholders Equity": "-72.7",
"ECR before LimitedLiability": "13.8",
"Other Liabilities": "20.0",
"Liabilities, Current": "-3.05",
"Assets, Non-Current": "37.1",
"Assets": "-38.8",
"Goodwill": "-7.55",
"Property, Plant and Equipment, Net": "0.630",
"Other Assets": "-35.2",
"Assets, Current": "-33.2",
"Research and Development": "8.25",
"Expenses": "17.3",
"Revenues": "36.8",
"Net Income": "40.4",
"Other Expenses": "8.60",
"Other Revenues": "36.8",
"Other Net Income": "6.06",
"Comprehensive Net Income": "40.4",
"Economic Capital Ratio": "-15.6"
},
"2020": {
"Liabilities, Current": "16.4",
"Liabilities": "-8.44",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "40.1",
"Liabilities, Non-Current": "-36.0",
"Other Liabilities": "8.34",
"Goodwill": "-7.30",
"Assets": "-31.3",
"Other Assets": "-25.6",
"Assets, Current": "-24.2",
"Assets, Non-Current": "44.8",
"Property, Plant and Equipment, Net": "-3.39",
"Other Revenues": "56.6",
"Revenues": "56.6",
"Net Income": "63.6",
"Comprehensive Net Income": "63.6",
"General and Administrative Expense": "-10.4",
"Other Expenses": "6.71",
"Other Net Income": "6.90",
"Research and Development": "4.97",
"Economic Capital Ratio": "2.32"
},
"2021": {
"Liabilities, Non-Current": "-28.5",
"Liabilities": "-10.3",
"Stockholders Equity": "-79.7",
"Economic Capital Ratio": "-4.81",
"Liabilities, Current": "4.93",
"Other Liabilities": "11.7",
"Assets, Current": "-30.2",
"Assets": "-37.5",
"Assets, Non-Current": "47.9",
"Other Assets": "-26.3",
"Goodwill": "-9.36",
"Property, Plant and Equipment, Net": "-2.92",
"Other Expenses": "8.78",
"Expenses": "0.672",
"Revenues": "69.1",
"Net Income": "69.4",
"Research and Development": "8.46",
"General and Administrative Expense": "-15.8",
"Other Revenues": "69.1",
"Comprehensive Net Income": "69.4",
"Other Net Income": "0.867"
},
"2022": {
"Liabilities, Non-Current": "-15.2",
"Liabilities": "-13.8",
"Stockholders Equity": "-68.3",
"ECR before LimitedLiability": "-2.57",
"Other Liabilities": "12.1",
"Liabilities, Current": "-11.2",
"Other Assets": "-29.2",
"Assets": "-36.3",
"Assets, Current": "-25.3",
"Property, Plant and Equipment, Net": "-4.47",
"Assets, Non-Current": "52.9",
"Goodwill": "-11.8",
"General and Administrative Expense": "-7.47",
"Expenses": "4.50",
"Revenues": "54.7",
"Net Income": "54.9",
"Research and Development": "4.77",
"Other Expenses": "7.46",
"Other Revenues": "54.7",
"Comprehensive Net Income": "54.9",
"Economic Capital Ratio": "-13.1"
},
"2023": {
"Liabilities, Non-Current": "-8.84",
"Liabilities": "27.3",
"Stockholders Equity": "-16.7",
"ECR before LimitedLiability": "52.8",
"Other Liabilities": "10.4",
"Liabilities, Current": "25.5",
"Other Assets": "-20.8",
"Assets": "-17.8",
"Property, Plant and Equipment, Net": "-3.19",
"Goodwill": "-8.69",
"Assets, Current": "-4.28",
"Assets, Non-Current": "29.0",
"Other Expenses": "9.83",
"Expenses": "-1.02",
"Revenues": "59.3",
"Net Income": "57.8",
"Research and Development": "2.26",
"General and Administrative Expense": "-12.8",
"Other Revenues": "59.3",
"Comprehensive Net Income": "57.8",
"Economic Capital Ratio": "37.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000874716_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "460,591",
"Assets, Non-Current": "436,553",
"General and Administrative Expense": "830,914",
"Goodwill": "204,864",
"Liabilities, Current": "285,112",
"Liabilities, Non-Current": "37,751",
"Other Assets": "-406,589",
"Other Compr. Net Income": "0",
"Other Expenses": "63,224",
"Other Liabilities": "0",
"Other Net Income": "663",
"Other Revenues": "1,103,392",
"Property, Plant and Equipment, Net": "201,725",
"Research and Development": "68,597"
},
"output_variables": {
"Liabilities": "322,863",
"Assets": "897,144",
"Expenses": "962,735",
"Revenues": "1,103,392",
"Stockholders Equity": "574,281",
"Net Income": "141,320",
"Comprehensive Net Income": "141,320",
"BaseVar": "1,643,398",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "203%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "524,227",
"Assets, Non-Current": "506,587",
"General and Administrative Expense": "906,422",
"Goodwill": "241,819",
"Liabilities, Current": "436,879",
"Liabilities, Non-Current": "54,342",
"Other Assets": "-458,596",
"Other Compr. Net Income": "0",
"Other Expenses": "76,215",
"Other Liabilities": "0",
"Other Net Income": "1,744",
"Other Revenues": "1,218,689",
"Property, Plant and Equipment, Net": "216,777",
"Research and Development": "76,042"
},
"output_variables": {
"Liabilities": "491,221",
"Assets": "1,030,814",
"Expenses": "1,058,679",
"Revenues": "1,218,689",
"Stockholders Equity": "539,593",
"Net Income": "161,754",
"Comprehensive Net Income": "161,754",
"BaseVar": "1,900,574",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "180%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "569,537",
"Assets, Non-Current": "534,065",
"General and Administrative Expense": "948,761",
"Goodwill": "237,827",
"Liabilities, Current": "406,333",
"Liabilities, Non-Current": "61,012",
"Other Assets": "-483,004",
"Other Compr. Net Income": "491",
"Other Expenses": "86,178",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,295,240",
"Property, Plant and Equipment, Net": "245,177",
"Research and Development": "82,014"
},
"output_variables": {
"Liabilities": "467,345",
"Assets": "1,103,602",
"Expenses": "1,116,953",
"Revenues": "1,295,240",
"Stockholders Equity": "636,257",
"Net Income": "178,287",
"Comprehensive Net Income": "178,532",
"BaseVar": "1,991,816",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "191%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "652,706",
"Assets, Non-Current": "577,810",
"General and Administrative Expense": "1,022,293",
"Goodwill": "239,365",
"Liabilities, Current": "478,353",
"Liabilities, Non-Current": "233,949",
"Other Assets": "-520,579",
"Other Compr. Net Income": "-2,326",
"Other Expenses": "80,853",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,378,943",
"Property, Plant and Equipment, Net": "281,214",
"Research and Development": "88,003"
},
"output_variables": {
"Liabilities": "712,302",
"Assets": "1,230,516",
"Expenses": "1,191,149",
"Revenues": "1,378,943",
"Stockholders Equity": "518,214",
"Net Income": "187,794",
"Comprehensive Net Income": "186,631",
"BaseVar": "2,257,618",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "162%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "759,398",
"Assets, Non-Current": "624,813",
"General and Administrative Expense": "1,127,289",
"Goodwill": "249,572",
"Liabilities, Current": "820,906",
"Liabilities, Non-Current": "445,716",
"Other Assets": "-553,159",
"Other Compr. Net Income": "-21,738",
"Other Expenses": "80,033",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,487,536",
"Property, Plant and Equipment, Net": "303,587",
"Research and Development": "98,263"
},
"output_variables": {
"Liabilities": "1,266,622",
"Assets": "1,384,211",
"Expenses": "1,305,585",
"Revenues": "1,487,536",
"Stockholders Equity": "117,589",
"Net Income": "181,951",
"Comprehensive Net Income": "171,082",
"BaseVar": "2,732,846",
"ECR before LimitedLiability": "25%",
"Economic Capital Ratio": "109%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "821,634",
"Assets, Non-Current": "653,359",
"General and Administrative Expense": "1,194,087",
"Goodwill": "234,843",
"Liabilities, Current": "856,761",
"Liabilities, Non-Current": "702,227",
"Other Assets": "-567,869",
"Other Compr. Net Income": "-34,251",
"Other Expenses": "118,457",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,604,360",
"Property, Plant and Equipment, Net": "333,026",
"Research and Development": "99,681"
},
"output_variables": {
"Liabilities": "1,558,988",
"Assets": "1,474,993",
"Expenses": "1,412,225",
"Revenues": "1,604,360",
"Stockholders Equity": "-83,995",
"Net Income": "192,135",
"Comprehensive Net Income": "175,010",
"BaseVar": "3,042,408",
"ECR before LimitedLiability": "4.0%",
"Economic Capital Ratio": "89%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "845,584",
"Assets, Non-Current": "685,120",
"General and Administrative Expense": "1,324,062",
"Goodwill": "224,383",
"Liabilities, Current": "934,568",
"Liabilities, Non-Current": "704,349",
"Other Assets": "-581,805",
"Other Compr. Net Income": "-797",
"Other Expenses": "131,841",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,779,079",
"Property, Plant and Equipment, Net": "357,422",
"Research and Development": "101,122"
},
"output_variables": {
"Liabilities": "1,638,917",
"Assets": "1,530,704",
"Expenses": "1,557,025",
"Revenues": "1,779,079",
"Stockholders Equity": "-108,213",
"Net Income": "222,054",
"Comprehensive Net Income": "221,656",
"BaseVar": "3,253,261",
"ECR before LimitedLiability": "4.6%",
"Economic Capital Ratio": "89%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "971,985",
"Assets, Non-Current": "741,431",
"General and Administrative Expense": "1,446,848",
"Goodwill": "243,719",
"Liabilities, Current": "1,004,567",
"Liabilities, Non-Current": "762,691",
"Other Assets": "-622,815",
"Other Compr. Net Income": "6,458",
"Other Expenses": "155,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,974,312",
"Property, Plant and Equipment, Net": "379,096",
"Research and Development": "109,182"
},
"output_variables": {
"Liabilities": "1,767,258",
"Assets": "1,713,416",
"Expenses": "1,711,043",
"Revenues": "1,974,312",
"Stockholders Equity": "-53,842",
"Net Income": "263,269",
"Comprehensive Net Income": "266,498",
"BaseVar": "3,586,244",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "95%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "654,172",
"Assets, Non-Current": "883,177",
"General and Administrative Expense": "1,604,044",
"Goodwill": "256,314",
"Liabilities, Current": "799,711",
"Liabilities, Non-Current": "776,138",
"Other Assets": "-693,584",
"Other Compr. Net Income": "-5,337",
"Other Expenses": "115,439",
"Other Liabilities": "-29,267",
"Other Net Income": "0",
"Other Revenues": "2,214,393",
"Property, Plant and Equipment, Net": "437,270",
"Research and Development": "117,863"
},
"output_variables": {
"Liabilities": "1,546,582",
"Assets": "1,537,349",
"Expenses": "1,837,346",
"Revenues": "2,214,393",
"Stockholders Equity": "-9,233",
"Net Income": "377,047",
"Comprehensive Net Income": "374,378",
"BaseVar": "3,570,504",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "107%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "679,639",
"Assets, Non-Current": "1,152,836",
"General and Administrative Expense": "1,720,869",
"Goodwill": "298,192",
"Liabilities, Current": "758,361",
"Liabilities, Non-Current": "929,313",
"Other Assets": "-832,037",
"Other Compr. Net Income": "-4,463",
"Other Expenses": "125,481",
"Other Liabilities": "-33,024",
"Other Net Income": "0",
"Other Revenues": "2,407,335",
"Property, Plant and Equipment, Net": "533,845",
"Research and Development": "133,193"
},
"output_variables": {
"Liabilities": "1,654,650",
"Assets": "1,832,475",
"Expenses": "1,979,543",
"Revenues": "2,407,335",
"Stockholders Equity": "177,825",
"Net Income": "427,792",
"Comprehensive Net Income": "425,560",
"BaseVar": "3,939,233",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "120%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,062,738",
"Assets, Non-Current": "1,231,823",
"General and Administrative Expense": "1,870,882",
"Goodwill": "295,890",
"Liabilities, Current": "594,468",
"Liabilities, Non-Current": "1,079,005",
"Other Assets": "-851,057",
"Other Compr. Net Income": "-7,788",
"Other Expenses": "112,979",
"Other Liabilities": "-11,707",
"Other Net Income": "0",
"Other Revenues": "2,707,241",
"Property, Plant and Equipment, Net": "555,167",
"Research and Development": "141,249"
},
"output_variables": {
"Liabilities": "1,661,766",
"Assets": "2,294,561",
"Expenses": "2,125,110",
"Revenues": "2,707,241",
"Stockholders Equity": "632,795",
"Net Income": "582,131",
"Comprehensive Net Income": "578,237",
"BaseVar": "4,398,233",
"ECR before LimitedLiability": "73%",
"Economic Capital Ratio": "148%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "955,655",
"Assets, Non-Current": "1,481,548",
"General and Administrative Expense": "2,122,323",
"Goodwill": "458,380",
"Liabilities, Current": "772,514",
"Liabilities, Non-Current": "983,632",
"Other Assets": "-1,046,047",
"Other Compr. Net Income": "132",
"Other Expenses": "187,618",
"Other Liabilities": "-8,935",
"Other Net Income": "0",
"Other Revenues": "3,215,794",
"Property, Plant and Equipment, Net": "587,667",
"Research and Development": "161,009"
},
"output_variables": {
"Liabilities": "1,747,211",
"Assets": "2,437,203",
"Expenses": "2,470,950",
"Revenues": "3,215,794",
"Stockholders Equity": "689,992",
"Net Income": "744,844",
"Comprehensive Net Income": "744,910",
"BaseVar": "4,935,645",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "1,101,477",
"Assets, Non-Current": "1,645,288",
"General and Administrative Expense": "2,213,739",
"Goodwill": "459,467",
"Liabilities, Current": "1,243,953",
"Liabilities, Non-Current": "902,225",
"Other Assets": "-1,108,941",
"Other Compr. Net Income": "-24,312",
"Other Expenses": "220,741",
"Other Liabilities": "-8,150",
"Other Net Income": "0",
"Other Revenues": "3,368,389",
"Property, Plant and Equipment, Net": "649,474",
"Research and Development": "254,820"
},
"output_variables": {
"Liabilities": "2,138,028",
"Assets": "2,746,765",
"Expenses": "2,689,300",
"Revenues": "3,368,389",
"Stockholders Equity": "608,737",
"Net Income": "679,089",
"Comprehensive Net Income": "666,933",
"BaseVar": "5,483,397",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "139%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "1,495,254",
"Assets, Non-Current": "1,764,671",
"General and Administrative Expense": "2,372,874",
"Goodwill": "450,461",
"Liabilities, Current": "958,782",
"Liabilities, Non-Current": "823,848",
"Other Assets": "-1,152,638",
"Other Compr. Net Income": "6,590",
"Other Expenses": "257,715",
"Other Liabilities": "-7,235",
"Other Net Income": "0",
"Other Revenues": "3,666,582",
"Property, Plant and Equipment, Net": "702,177",
"Research and Development": "190,951"
},
"output_variables": {
"Liabilities": "1,775,395",
"Assets": "3,259,925",
"Expenses": "2,821,540",
"Revenues": "3,666,582",
"Stockholders Equity": "1,484,530",
"Net Income": "845,042",
"Comprehensive Net Income": "848,337",
"BaseVar": "5,765,016",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "178%"
}
}
},
"top_rated": false,
"trend": 20.0,
"value": 1.7772408993251647,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000874716.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000874716.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000874716.svg"
},
{
"company_id": "0001906324",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001906324.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001906324.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001906324_main_keyfigs.svg",
"name": "Quidelortho Corp",
"rank": 14,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001906324.svg",
"report_text": "The relative strengths and weaknesses of Quidelortho Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quidelortho Corp compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 61% points.The greatest weakness of Quidelortho Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 36% points.
The company's Economic Capital Ratio, given in the ranking table, is 177%, being 37% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001906324_2024_Quidelortho_Corp.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities, Non-Current": "16.9",
"Liabilities": "47.5",
"Assets": "3.14",
"Stockholders Equity": "46.4",
"ECR before LimitedLiability": "113",
"Other Liabilities": "13.3",
"Liabilities, Current": "23.8",
"Assets, Current": "5.18",
"Property, Plant and Equipment, Net": "-0.597",
"Assets, Non-Current": "-1.20",
"General and Administrative Expense": "36.7",
"Expenses": "22.3",
"Revenues": "37.6",
"Net Income": "59.7",
"Research and Development": "5.44",
"Other Expenses": "-21.8",
"Other Revenues": "37.6",
"Other Net Income": "1.43",
"Comprehensive Net Income": "60.1",
"Other Compr. Net Income": "0.443",
"Economic Capital Ratio": "103"
},
"2023": {
"Liabilities, Non-Current": "-36.1",
"Liabilities": "2.40",
"Stockholders Equity": "31.5",
"ECR before LimitedLiability": "52.0",
"Other Liabilities": "6.59",
"Liabilities, Current": "26.6",
"Other Assets": "-0.867",
"Assets": "20.1",
"Goodwill": "60.7",
"Assets, Current": "-11.0",
"Assets, Non-Current": "-6.78",
"Other Expenses": "-9.51",
"Expenses": "17.8",
"Revenues": "3.69",
"Net Income": "19.6",
"Research and Development": "2.09",
"General and Administrative Expense": "26.0",
"Other Revenues": "3.69",
"Other Net Income": "-1.98",
"Comprehensive Net Income": "19.8",
"Economic Capital Ratio": "36.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001906324_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "1,440,300",
"Assets, Non-Current": "185,100",
"General and Administrative Expense": "239,600",
"Goodwill": "435,700",
"Liabilities, Current": "323,500",
"Liabilities, Non-Current": "177,100",
"Other Assets": "20,100",
"Other Compr. Net Income": "800",
"Other Expenses": "653,400",
"Other Liabilities": "400",
"Other Net Income": "-5,700",
"Other Revenues": "1,698,600",
"Property, Plant and Equipment, Net": "349,200",
"Research and Development": "95,700"
},
"output_variables": {
"Liabilities": "501,000",
"Assets": "2,430,400",
"Expenses": "988,700",
"Revenues": "1,698,600",
"Stockholders Equity": "1,929,400",
"Net Income": "704,200",
"Comprehensive Net Income": "704,600",
"BaseVar": "2,812,600",
"ECR before LimitedLiability": "228%",
"Economic Capital Ratio": "255%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "1,310,500",
"Assets, Non-Current": "356,600",
"General and Administrative Expense": "763,200",
"Goodwill": "5,426,300",
"Liabilities, Current": "1,026,000",
"Liabilities, Non-Current": "2,531,200",
"Other Assets": "25,900",
"Other Compr. Net Income": "37,600",
"Other Expenses": "1,829,700",
"Other Liabilities": "0",
"Other Net Income": "-168,200",
"Other Revenues": "2,997,800",
"Property, Plant and Equipment, Net": "1,443,800",
"Research and Development": "246,800"
},
"output_variables": {
"Liabilities": "3,557,200",
"Assets": "8,563,100",
"Expenses": "2,839,700",
"Revenues": "2,997,800",
"Stockholders Equity": "5,005,900",
"Net Income": "-10,100",
"Comprehensive Net Income": "8,700",
"BaseVar": "9,081,800",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "177%"
}
}
},
"top_rated": false,
"trend": -10.0,
"value": 1.7693207723622204,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001906324.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001906324.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001906324.svg"
},
{
"company_id": "0000899923",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000899923.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000899923.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000899923.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000899923_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000899923_main_keyfigs.svg",
"name": "Myriad Genetics INC",
"rank": 15,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000899923.svg",
"report_text": "The relative strengths and weaknesses of Myriad Genetics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Myriad Genetics INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Myriad Genetics INC is the variable Expenses, reducing the Economic Capital Ratio by 19% points.
The company's Economic Capital Ratio, given in the ranking table, is 173%, being 33% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000899923_2024_Myriad_Genetics_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "-1.22",
"Liabilities": "69.0",
"Stockholders Equity": "98.4",
"ECR before LimitedLiability": "125",
"Liabilities, Current": "33.4",
"Liabilities, Non-Current": "45.6",
"Goodwill": "1.45",
"Assets": "-6.03",
"Property, Plant and Equipment, Net": "1.03",
"Assets, Current": "-9.25",
"Assets, Non-Current": "-0.952",
"Other Expenses": "27.3",
"Expenses": "28.0",
"Revenues": "14.8",
"Net Income": "44.5",
"General and Administrative Expense": "-1.98",
"Research and Development": "2.70",
"Other Revenues": "14.8",
"Other Net Income": "3.09",
"Comprehensive Net Income": "44.6",
"Economic Capital Ratio": "127"
},
"2011": {
"Liabilities, Current": "53.8",
"Liabilities": "73.2",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "194",
"Liabilities, Non-Current": "17.8",
"Other Liabilities": "13.0",
"Property, Plant and Equipment, Net": "-0.276",
"Assets": "2.26",
"Assets, Non-Current": "0.356",
"Other Assets": "0.209",
"Assets, Current": "1.57",
"General and Administrative Expense": "13.9",
"Expenses": "33.8",
"Revenues": "32.3",
"Net Income": "57.1",
"Research and Development": "8.82",
"Other Expenses": "12.1",
"Other Revenues": "32.3",
"Comprehensive Net Income": "57.0",
"Other Net Income": "-7.41",
"Economic Capital Ratio": "132"
},
"2012": {
"Liabilities, Current": "40.6",
"Liabilities": "71.1",
"Stockholders Equity": "92.7",
"ECR before LimitedLiability": "156",
"Liabilities, Non-Current": "18.7",
"Other Liabilities": "25.6",
"Assets, Current": "1.44",
"Assets": "2.80",
"Other Assets": "0.671",
"Assets, Non-Current": "0.981",
"Property, Plant and Equipment, Net": "-0.534",
"Other Expenses": "13.6",
"Expenses": "30.8",
"Revenues": "33.4",
"Net Income": "61.8",
"Research and Development": "8.65",
"General and Administrative Expense": "9.42",
"Other Revenues": "33.4",
"Other Net Income": "0.252",
"Comprehensive Net Income": "61.8",
"Economic Capital Ratio": "123"
},
"2013": {
"Liabilities, Current": "45.4",
"Liabilities": "76.5",
"Stockholders Equity": "89.4",
"ECR before LimitedLiability": "165",
"Other Liabilities": "19.5",
"Liabilities, Non-Current": "27.4",
"Goodwill": "-0.348",
"Assets": "2.83",
"Assets, Non-Current": "1.89",
"Property, Plant and Equipment, Net": "-0.650",
"Assets, Current": "1.55",
"General and Administrative Expense": "5.17",
"Expenses": "26.5",
"Revenues": "42.5",
"Net Income": "64.2",
"Research and Development": "5.90",
"Other Expenses": "16.0",
"Other Revenues": "42.5",
"Other Net Income": "-2.50",
"Comprehensive Net Income": "64.1",
"Economic Capital Ratio": "125"
},
"2014": {
"Liabilities, Non-Current": "32.7",
"Liabilities": "94.2",
"Stockholders Equity": "96.2",
"ECR before LimitedLiability": "187",
"Liabilities, Current": "67.1",
"Other Liabilities": "13.5",
"Assets, Current": "-1.70",
"Assets": "3.40",
"Goodwill": "6.64",
"Assets, Non-Current": "1.03",
"Property, Plant and Equipment, Net": "-1.19",
"Other Expenses": "9.45",
"Expenses": "23.0",
"Revenues": "55.3",
"Net Income": "77.9",
"Research and Development": "8.34",
"General and Administrative Expense": "5.68",
"Other Revenues": "55.3",
"Other Net Income": "2.50",
"Comprehensive Net Income": "77.9",
"Economic Capital Ratio": "138"
},
"2015": {
"Other Liabilities": "17.3",
"Liabilities": "95.5",
"Stockholders Equity": "83.7",
"ECR before LimitedLiability": "163",
"Liabilities, Current": "62.6",
"Liabilities, Non-Current": "34.8",
"Assets, Current": "-4.10",
"Assets": "2.29",
"Other Assets": "-2.17",
"Goodwill": "13.5",
"Property, Plant and Equipment, Net": "-1.32",
"Research and Development": "2.10",
"Expenses": "5.30",
"Revenues": "57.3",
"Net Income": "63.4",
"General and Administrative Expense": "-25.5",
"Other Expenses": "26.8",
"Other Revenues": "57.3",
"Comprehensive Net Income": "63.4",
"Other Net Income": "1.38",
"Economic Capital Ratio": "118"
},
"2016": {
"Liabilities, Non-Current": "31.9",
"Liabilities": "74.0",
"Stockholders Equity": "63.3",
"ECR before LimitedLiability": "127",
"Liabilities, Current": "55.4",
"Other Liabilities": "-5.54",
"Property, Plant and Equipment, Net": "-2.96",
"Assets": "2.23",
"Assets, Non-Current": "1.62",
"Assets, Current": "-5.24",
"Goodwill": "13.7",
"Research and Development": "8.61",
"Expenses": "12.5",
"Revenues": "46.8",
"Net Income": "56.2",
"General and Administrative Expense": "-22.6",
"Other Expenses": "24.9",
"Other Revenues": "46.8",
"Comprehensive Net Income": "56.3",
"Other Net Income": "-2.23",
"Economic Capital Ratio": "107"
},
"2017": {
"Other Liabilities": "-25.5",
"Liabilities": "20.3",
"Stockholders Equity": "29.6",
"ECR before LimitedLiability": "56.5",
"Liabilities, Current": "19.3",
"Liabilities, Non-Current": "23.0",
"Assets, Non-Current": "-0.654",
"Assets": "8.04",
"Assets, Current": "-13.3",
"Goodwill": "62.8",
"Property, Plant and Equipment, Net": "-10.7",
"Research and Development": "7.74",
"Expenses": "12.6",
"Revenues": "21.8",
"Net Income": "29.9",
"Other Expenses": "5.65",
"General and Administrative Expense": "-0.828",
"Other Revenues": "21.8",
"Comprehensive Net Income": "29.8",
"Other Net Income": "-4.93",
"Economic Capital Ratio": "34.9"
},
"2018": {
"Liabilities, Non-Current": "24.6",
"Liabilities": "46.4",
"Stockholders Equity": "61.9",
"ECR before LimitedLiability": "119",
"Other Liabilities": "-10.4",
"Liabilities, Current": "33.9",
"Property, Plant and Equipment, Net": "-4.09",
"Assets": "9.11",
"Assets, Current": "-5.48",
"Goodwill": "36.4",
"Assets, Non-Current": "-2.05",
"Other Expenses": "2.38",
"Expenses": "19.5",
"Revenues": "27.6",
"Net Income": "46.1",
"Research and Development": "6.41",
"General and Administrative Expense": "10.9",
"Other Revenues": "27.6",
"Comprehensive Net Income": "46.4",
"Other Compr. Net Income": "0.343",
"Economic Capital Ratio": "98.4"
},
"2019": {
"Liabilities, Non-Current": "21.9",
"Liabilities": "19.3",
"Stockholders Equity": "37.1",
"ECR before LimitedLiability": "92.8",
"Other Liabilities": "-24.1",
"Liabilities, Current": "18.0",
"Assets, Non-Current": "-5.00",
"Assets": "12.1",
"Goodwill": "71.6",
"Property, Plant and Equipment, Net": "-7.16",
"Assets, Current": "-11.7",
"Research and Development": "3.56",
"Expenses": "16.9",
"Revenues": "14.9",
"Net Income": "35.7",
"Other Expenses": "-3.69",
"General and Administrative Expense": "17.0",
"Other Revenues": "14.9",
"Other Net Income": "3.22",
"Comprehensive Net Income": "35.7",
"Economic Capital Ratio": "63.4"
},
"2021": {
"Liabilities, Non-Current": "16.3",
"Liabilities": "28.4",
"Stockholders Equity": "13.3",
"ECR before LimitedLiability": "50.2",
"Liabilities, Current": "8.06",
"Other Liabilities": "5.56",
"Assets, Current": "-10.2",
"Assets": "-2.79",
"Assets, Non-Current": "-1.13",
"Other Assets": "0.647",
"Goodwill": "23.6",
"Property, Plant and Equipment, Net": "-7.85",
"Other Revenues": "13.5",
"Revenues": "13.5",
"Net Income": "24.3",
"Other Expenses": "-6.68",
"Comprehensive Net Income": "24.2",
"Research and Development": "4.15",
"Other Net Income": "11.2",
"General and Administrative Expense": "2.06",
"Economic Capital Ratio": "45.8"
},
"2022": {
"Liabilities, Non-Current": "4.57",
"Liabilities": "33.2",
"Stockholders Equity": "29.8",
"ECR before LimitedLiability": "56.5",
"Other Liabilities": "5.93",
"Liabilities, Current": "24.1",
"Assets": "2.53",
"Assets, Current": "-13.2",
"Property, Plant and Equipment, Net": "-6.71",
"Assets, Non-Current": "1.03",
"Goodwill": "35.4",
"General and Administrative Expense": "2.05",
"Expenses": "-1.83",
"Revenues": "17.4",
"Net Income": "17.2",
"Research and Development": "2.07",
"Other Expenses": "-5.95",
"Other Revenues": "17.4",
"Other Net Income": "1.59",
"Comprehensive Net Income": "17.4",
"Economic Capital Ratio": "46.0"
},
"2023": {
"Liabilities, Non-Current": "1.81",
"Liabilities": "47.7",
"Stockholders Equity": "30.2",
"ECR before LimitedLiability": "48.1",
"Other Liabilities": "4.39",
"Liabilities, Current": "42.3",
"Other Assets": "-1.66",
"Assets": "-5.07",
"Property, Plant and Equipment, Net": "-8.63",
"Goodwill": "42.0",
"Assets, Current": "-11.5",
"Assets, Non-Current": "-9.19",
"Other Expenses": "-15.6",
"Expenses": "-19.5",
"Revenues": "25.8",
"Net Income": "4.13",
"Research and Development": "-0.955",
"General and Administrative Expense": "-3.08",
"Other Revenues": "25.8",
"Comprehensive Net Income": "4.25",
"Economic Capital Ratio": "32.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000899923_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "473,976",
"Assets, Non-Current": "85,154",
"General and Administrative Expense": "205,700",
"Goodwill": "2,052",
"Liabilities, Current": "27,466",
"Liabilities, Non-Current": "0",
"Other Assets": "9,404",
"Other Compr. Net Income": "0",
"Other Expenses": "-11,469",
"Other Liabilities": "8,800",
"Other Net Income": "0",
"Other Revenues": "368,407",
"Property, Plant and Equipment, Net": "23,261",
"Research and Development": "21,873"
},
"output_variables": {
"Liabilities": "36,266",
"Assets": "593,847",
"Expenses": "216,104",
"Revenues": "368,407",
"Stockholders Equity": "557,581",
"Net Income": "152,303",
"Comprehensive Net Income": "152,303",
"BaseVar": "607,312",
"ECR before LimitedLiability": "291%",
"Economic Capital Ratio": "304%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "418,261",
"Assets, Non-Current": "70,857",
"General and Administrative Expense": "215,478",
"Goodwill": "72,766",
"Liabilities, Current": "34,387",
"Liabilities, Non-Current": "0",
"Other Assets": "25,863",
"Other Compr. Net Income": "0",
"Other Expenses": "60,018",
"Other Liabilities": "9,648",
"Other Net Income": "0",
"Other Revenues": "403,957",
"Property, Plant and Equipment, Net": "23,080",
"Research and Development": "27,751"
},
"output_variables": {
"Liabilities": "44,035",
"Assets": "610,827",
"Expenses": "303,247",
"Revenues": "403,957",
"Stockholders Equity": "566,792",
"Net Income": "100,710",
"Comprehensive Net Income": "100,710",
"BaseVar": "681,033",
"ECR before LimitedLiability": "268%",
"Economic Capital Ratio": "285%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "422,492",
"Assets, Non-Current": "113,692",
"General and Administrative Expense": "259,835",
"Goodwill": "72,572",
"Liabilities, Current": "44,967",
"Liabilities, Non-Current": "0",
"Other Assets": "57,648",
"Other Compr. Net Income": "-313",
"Other Expenses": "85,596",
"Other Liabilities": "10,008",
"Other Net Income": "4,222",
"Other Revenues": "496,005",
"Property, Plant and Equipment, Net": "24,231",
"Research and Development": "42,645"
},
"output_variables": {
"Liabilities": "54,975",
"Assets": "690,635",
"Expenses": "388,076",
"Revenues": "496,005",
"Stockholders Equity": "635,660",
"Net Income": "112,151",
"Comprehensive Net Income": "111,994",
"BaseVar": "817,113",
"ECR before LimitedLiability": "264%",
"Economic Capital Ratio": "282%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "483,992",
"Assets, Non-Current": "171,748",
"General and Administrative Expense": "316,215",
"Goodwill": "70,180",
"Liabilities, Current": "64,509",
"Liabilities, Non-Current": "0",
"Other Assets": "50,299",
"Other Compr. Net Income": "-262",
"Other Expenses": "101,379",
"Other Liabilities": "10,718",
"Other Net Income": "5,274",
"Other Revenues": "613,165",
"Property, Plant and Equipment, Net": "27,602",
"Research and Development": "53,706"
},
"output_variables": {
"Liabilities": "75,227",
"Assets": "803,821",
"Expenses": "471,300",
"Revenues": "613,165",
"Stockholders Equity": "728,594",
"Net Income": "147,139",
"Comprehensive Net Income": "147,008",
"BaseVar": "984,524",
"ECR before LimitedLiability": "261%",
"Economic Capital Ratio": "279%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "322,400",
"Assets, Non-Current": "89,100",
"General and Administrative Expense": "423,200",
"Goodwill": "374,500",
"Liabilities, Current": "80,600",
"Liabilities, Non-Current": "0",
"Other Assets": "3,200",
"Other Compr. Net Income": "-1,100",
"Other Expenses": "114,700",
"Other Liabilities": "24,200",
"Other Net Income": "3,400",
"Other Revenues": "778,200",
"Property, Plant and Equipment, Net": "34,600",
"Research and Development": "67,500"
},
"output_variables": {
"Liabilities": "104,800",
"Assets": "823,800",
"Expenses": "605,400",
"Revenues": "778,200",
"Stockholders Equity": "719,000",
"Net Income": "176,200",
"Comprehensive Net Income": "175,650",
"BaseVar": "1,158,350",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "271%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "283,600",
"Assets, Non-Current": "45,600",
"General and Administrative Expense": "498,800",
"Goodwill": "369,800",
"Liabilities, Current": "68,700",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-5,500",
"Other Expenses": "69,300",
"Other Liabilities": "35,400",
"Other Net Income": "700",
"Other Revenues": "723,100",
"Property, Plant and Equipment, Net": "67,200",
"Research and Development": "75,500"
},
"output_variables": {
"Liabilities": "104,100",
"Assets": "766,200",
"Expenses": "643,600",
"Revenues": "723,100",
"Stockholders Equity": "662,100",
"Net Income": "80,200",
"Comprehensive Net Income": "77,450",
"BaseVar": "1,121,600",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "253%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "314,500",
"Assets, Non-Current": "84,900",
"General and Administrative Expense": "491,900",
"Goodwill": "422,800",
"Liabilities, Current": "72,300",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,500",
"Other Expenses": "68,100",
"Other Liabilities": "60,100",
"Other Net Income": "2,100",
"Other Revenues": "753,800",
"Property, Plant and Equipment, Net": "58,300",
"Research and Development": "70,600"
},
"output_variables": {
"Liabilities": "132,400",
"Assets": "880,500",
"Expenses": "630,600",
"Revenues": "753,800",
"Stockholders Equity": "748,100",
"Net Income": "125,300",
"Comprehensive Net Income": "124,050",
"BaseVar": "1,200,950",
"ECR before LimitedLiability": "227%",
"Economic Capital Ratio": "254%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "301,700",
"Assets, Non-Current": "48,500",
"General and Administrative Expense": "476,400",
"Goodwill": "807,600",
"Liabilities, Current": "217,500",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "4,200",
"Other Expenses": "191,000",
"Other Liabilities": "223,400",
"Other Net Income": "-7,800",
"Other Revenues": "769,900",
"Property, Plant and Equipment, Net": "51,100",
"Research and Development": "74,400"
},
"output_variables": {
"Liabilities": "440,900",
"Assets": "1,208,900",
"Expenses": "741,800",
"Revenues": "769,900",
"Stockholders Equity": "768,000",
"Net Income": "20,300",
"Comprehensive Net Income": "22,400",
"BaseVar": "1,586,750",
"ECR before LimitedLiability": "130%",
"Economic Capital Ratio": "188%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "327,600",
"Assets, Non-Current": "30,700",
"General and Administrative Expense": "435,000",
"Goodwill": "773,800",
"Liabilities, Current": "102,200",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "1,700",
"Other Expenses": "103,000",
"Other Liabilities": "107,000",
"Other Net Income": "-1,800",
"Other Revenues": "743,700",
"Property, Plant and Equipment, Net": "43,200",
"Research and Development": "70,800"
},
"output_variables": {
"Liabilities": "209,200",
"Assets": "1,175,300",
"Expenses": "608,800",
"Revenues": "743,700",
"Stockholders Equity": "966,100",
"Net Income": "133,100",
"Comprehensive Net Income": "133,950",
"BaseVar": "1,370,250",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "242%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "348,600",
"Assets, Non-Current": "54,900",
"General and Administrative Expense": "555,500",
"Goodwill": "1,101,900",
"Liabilities, Current": "200,400",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1,100",
"Other Expenses": "197,700",
"Other Liabilities": "273,400",
"Other Net Income": "-7,600",
"Other Revenues": "851,100",
"Property, Plant and Equipment, Net": "57,300",
"Research and Development": "85,900"
},
"output_variables": {
"Liabilities": "473,800",
"Assets": "1,562,700",
"Expenses": "839,100",
"Revenues": "851,100",
"Stockholders Equity": "1,088,900",
"Net Income": "4,400",
"Comprehensive Net Income": "3,850",
"BaseVar": "1,867,700",
"ECR before LimitedLiability": "147%",
"Economic Capital Ratio": "199%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "484,800",
"Assets, Non-Current": "149,100",
"General and Administrative Expense": "537,800",
"Goodwill": "643,300",
"Liabilities, Current": "240,100",
"Liabilities, Non-Current": "84,900",
"Other Assets": "0",
"Other Compr. Net Income": "-2,800",
"Other Expenses": "231,500",
"Other Liabilities": "27,900",
"Other Net Income": "133,400",
"Other Revenues": "690,600",
"Property, Plant and Equipment, Net": "43,500",
"Research and Development": "81,900"
},
"output_variables": {
"Liabilities": "352,900",
"Assets": "1,320,700",
"Expenses": "851,200",
"Revenues": "690,600",
"Stockholders Equity": "967,800",
"Net Income": "-27,200",
"Comprehensive Net Income": "-28,600",
"BaseVar": "1,675,800",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "205%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "274,600",
"Assets, Non-Current": "174,200",
"General and Administrative Expense": "514,700",
"Goodwill": "666,500",
"Liabilities, Current": "140,700",
"Liabilities, Non-Current": "145,400",
"Other Assets": "0",
"Other Compr. Net Income": "-3,800",
"Other Expenses": "190,300",
"Other Liabilities": "26,800",
"Other Net Income": "0",
"Other Revenues": "678,400",
"Property, Plant and Equipment, Net": "83,400",
"Research and Development": "85,400"
},
"output_variables": {
"Liabilities": "312,900",
"Assets": "1,198,700",
"Expenses": "790,400",
"Revenues": "678,400",
"Stockholders Equity": "885,800",
"Net Income": "-112,000",
"Comprehensive Net Income": "-113,900",
"BaseVar": "1,492,100",
"ECR before LimitedLiability": "145%",
"Economic Capital Ratio": "198%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "313,600",
"Assets, Non-Current": "77,000",
"General and Administrative Expense": "572,900",
"Goodwill": "636,900",
"Liabilities, Current": "155,900",
"Liabilities, Non-Current": "177,200",
"Other Assets": "0",
"Other Compr. Net Income": "5,200",
"Other Expenses": "350,100",
"Other Liabilities": "30,200",
"Other Net Income": "-4,800",
"Other Revenues": "753,200",
"Property, Plant and Equipment, Net": "119,000",
"Research and Development": "88,700"
},
"output_variables": {
"Liabilities": "363,300",
"Assets": "1,146,500",
"Expenses": "1,011,700",
"Revenues": "753,200",
"Stockholders Equity": "783,200",
"Net Income": "-263,300",
"Comprehensive Net Income": "-260,700",
"BaseVar": "1,642,350",
"ECR before LimitedLiability": "108%",
"Economic Capital Ratio": "173%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 1.730314435982968,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000899923.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000899923.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000899923.svg"
},
{
"company_id": "0000073290",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000073290.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000073290.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000073290.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000073290_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000073290_main_keyfigs.svg",
"name": "Biomerica INC",
"rank": 16,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000073290.svg",
"report_text": "The relative strengths and weaknesses of Biomerica INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biomerica INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 87% points.The greatest weakness of Biomerica INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 170%, being 30% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000073290_2024_Biomerica_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "42.9",
"Liabilities": "81.9",
"Stockholders Equity": "59.8",
"ECR before LimitedLiability": "137",
"Liabilities, Non-Current": "22.0",
"Other Liabilities": "35.3",
"Other Expenses": "36.8",
"Expenses": "7.40",
"Net Income": "63.2",
"Research and Development": "13.7",
"General and Administrative Expense": "-48.4",
"Other Revenues": "55.0",
"Revenues": "55.0",
"Assets, Current": "5.42",
"Other Assets": "0.942",
"Assets, Non-Current": "-1.18",
"Property, Plant and Equipment, Net": "-1.04",
"Goodwill": "-2.57",
"Other Net Income": "1.82",
"Comprehensive Net Income": "63.3",
"Economic Capital Ratio": "104"
},
"2013": {
"Liabilities, Current": "54.1",
"Liabilities": "90.9",
"Stockholders Equity": "73.5",
"ECR before LimitedLiability": "153",
"Other Liabilities": "27.2",
"Liabilities, Non-Current": "31.3",
"Goodwill": "-2.31",
"Assets": "1.05",
"Assets, Non-Current": "-0.902",
"Property, Plant and Equipment, Net": "-0.566",
"Assets, Current": "6.44",
"General and Administrative Expense": "-48.7",
"Expenses": "4.65",
"Revenues": "59.0",
"Net Income": "59.7",
"Research and Development": "8.57",
"Other Expenses": "39.4",
"Other Revenues": "59.0",
"Other Net Income": "-3.92",
"Comprehensive Net Income": "59.5",
"Economic Capital Ratio": "113"
},
"2014": {
"Liabilities, Non-Current": "29.6",
"Liabilities": "94.7",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "168",
"Liabilities, Current": "63.5",
"Other Liabilities": "20.4",
"Assets, Current": "11.8",
"Assets": "8.34",
"Goodwill": "-2.72",
"Other Assets": "3.02",
"Assets, Non-Current": "-1.31",
"Other Expenses": "30.1",
"Expenses": "6.39",
"Revenues": "38.8",
"Net Income": "46.7",
"Research and Development": "6.29",
"General and Administrative Expense": "-32.7",
"Other Revenues": "38.8",
"Other Net Income": "2.25",
"Comprehensive Net Income": "46.8",
"Economic Capital Ratio": "119"
},
"2015": {
"Other Liabilities": "28.5",
"Liabilities": "101",
"Stockholders Equity": "101",
"ECR before LimitedLiability": "160",
"Liabilities, Current": "60.9",
"Liabilities, Non-Current": "33.9",
"Assets, Current": "9.81",
"Assets": "4.76",
"Other Assets": "2.92",
"Goodwill": "-3.21",
"Property, Plant and Equipment, Net": "-1.78",
"Research and Development": "-1.47",
"Expenses": "-4.61",
"Revenues": "46.4",
"Net Income": "43.8",
"General and Administrative Expense": "-52.1",
"Other Expenses": "43.0",
"Other Revenues": "46.4",
"Comprehensive Net Income": "44.2",
"Other Net Income": "1.76",
"Economic Capital Ratio": "114"
},
"2016": {
"Liabilities, Non-Current": "33.0",
"Liabilities": "94.8",
"Stockholders Equity": "64.8",
"ECR before LimitedLiability": "95.5",
"Liabilities, Current": "59.7",
"Other Liabilities": "15.6",
"Property, Plant and Equipment, Net": "-6.92",
"Assets": "-4.06",
"Assets, Non-Current": "-2.31",
"Assets, Current": "13.3",
"Goodwill": "-6.54",
"Research and Development": "4.44",
"Expenses": "-28.1",
"Revenues": "43.9",
"Net Income": "15.0",
"General and Administrative Expense": "-61.2",
"Other Expenses": "24.6",
"Other Revenues": "43.9",
"Comprehensive Net Income": "15.3",
"Other Net Income": "-2.19",
"Economic Capital Ratio": "75.5"
},
"2017": {
"Other Liabilities": "23.3",
"Liabilities": "109",
"Stockholders Equity": "51.9",
"ECR before LimitedLiability": "95.4",
"Liabilities, Current": "63.6",
"Liabilities, Non-Current": "41.1",
"Assets, Non-Current": "-2.47",
"Assets": "-10.1",
"Assets, Current": "11.8",
"Goodwill": "-8.27",
"Property, Plant and Equipment, Net": "-10.0",
"Research and Development": "-3.93",
"Expenses": "-41.9",
"Revenues": "70.8",
"Net Income": "24.6",
"Other Expenses": "35.6",
"General and Administrative Expense": "-80.3",
"Other Revenues": "70.8",
"Comprehensive Net Income": "24.0",
"Other Net Income": "-6.42",
"Economic Capital Ratio": "73.8"
},
"2018": {
"Liabilities, Non-Current": "31.3",
"Liabilities": "78.8",
"Stockholders Equity": "26.9",
"ECR before LimitedLiability": "75.2",
"Other Liabilities": "19.4",
"Liabilities, Current": "36.4",
"Property, Plant and Equipment, Net": "-10.8",
"Assets": "-14.1",
"Other Assets": "2.34",
"Assets, Current": "15.0",
"Goodwill": "-10.3",
"Assets, Non-Current": "-7.00",
"Other Expenses": "18.2",
"Expenses": "-33.8",
"Revenues": "54.3",
"Net Income": "19.1",
"Research and Development": "-10.2",
"General and Administrative Expense": "-42.0",
"Other Revenues": "54.3",
"Comprehensive Net Income": "19.4",
"Economic Capital Ratio": "54.7"
},
"2019": {
"Liabilities, Non-Current": "34.0",
"Liabilities": "71.0",
"Stockholders Equity": "13.5",
"ECR before LimitedLiability": "57.0",
"Other Liabilities": "22.3",
"Liabilities, Current": "19.6",
"Assets, Non-Current": "-14.1",
"Assets": "-23.6",
"Goodwill": "-16.1",
"Property, Plant and Equipment, Net": "-15.7",
"Assets, Current": "23.6",
"Research and Development": "-20.0",
"Expenses": "-40.0",
"Revenues": "47.5",
"Net Income": "8.40",
"Other Expenses": "15.9",
"General and Administrative Expense": "-35.1",
"Other Revenues": "47.5",
"Other Net Income": "7.58",
"Comprehensive Net Income": "8.39",
"Economic Capital Ratio": "27.5"
},
"2020": {
"Liabilities, Current": "26.3",
"Liabilities": "40.9",
"Stockholders Equity": "59.7",
"ECR before LimitedLiability": "106",
"Liabilities, Non-Current": "10.8",
"Other Liabilities": "6.70",
"Goodwill": "-5.95",
"Assets": "13.2",
"Assets, Current": "37.7",
"Assets, Non-Current": "0.818",
"Property, Plant and Equipment, Net": "-7.35",
"Other Expenses": "7.60",
"Expenses": "-1.71",
"Revenues": "6.01",
"Net Income": "9.52",
"Research and Development": "-5.25",
"General and Administrative Expense": "-4.13",
"Other Revenues": "6.01",
"Comprehensive Net Income": "9.59",
"Other Net Income": "5.22",
"Economic Capital Ratio": "67.8"
},
"2021": {
"Liabilities, Non-Current": "13.3",
"Liabilities": "54.6",
"Stockholders Equity": "0.850",
"ECR before LimitedLiability": "-7.01",
"Liabilities, Current": "32.0",
"Other Liabilities": "12.0",
"Assets, Current": "15.0",
"Assets": "-26.3",
"Other Assets": "3.44",
"Goodwill": "-21.7",
"Property, Plant and Equipment, Net": "-19.3",
"Other Expenses": "17.3",
"Expenses": "-53.1",
"Revenues": "17.0",
"Net Income": "-37.4",
"Research and Development": "-7.57",
"General and Administrative Expense": "-60.9",
"Other Revenues": "17.0",
"Comprehensive Net Income": "-37.4",
"Other Net Income": "1.66",
"Economic Capital Ratio": "-11.4"
},
"2022": {
"Liabilities, Non-Current": "37.6",
"Liabilities": "80.7",
"Stockholders Equity": "-49.3",
"ECR before LimitedLiability": "22.5",
"Other Liabilities": "19.9",
"Liabilities, Current": "55.8",
"Assets": "-50.8",
"Assets, Current": "-8.83",
"Property, Plant and Equipment, Net": "-25.7",
"Assets, Non-Current": "-12.2",
"Goodwill": "-27.4",
"General and Administrative Expense": "-109",
"Expenses": "-82.4",
"Revenues": "82.7",
"Net Income": "13.3",
"Research and Development": "2.61",
"Other Expenses": "23.6",
"Other Revenues": "82.7",
"Other Net Income": "3.71",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "12.0"
},
"2023": {
"Liabilities, Non-Current": "18.1",
"Liabilities": "60.3",
"Stockholders Equity": "74.3",
"ECR before LimitedLiability": "45.3",
"Other Liabilities": "8.95",
"Liabilities, Current": "36.6",
"Assets": "10.4",
"Property, Plant and Equipment, Net": "-14.2",
"Goodwill": "-15.1",
"Assets, Current": "87.4",
"Assets, Non-Current": "-7.33",
"Other Expenses": "15.2",
"Expenses": "-31.8",
"Revenues": "1.20",
"Net Income": "-29.8",
"Research and Development": "-5.94",
"General and Administrative Expense": "-40.2",
"Other Revenues": "1.20",
"Other Net Income": "0.943",
"Comprehensive Net Income": "-30.1",
"Economic Capital Ratio": "30.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000073290_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "4,487",
"Assets, Non-Current": "79",
"General and Administrative Expense": "5,229",
"Goodwill": "195",
"Liabilities, Current": "592",
"Liabilities, Non-Current": "0",
"Other Assets": "226",
"Other Compr. Net Income": "-1.6",
"Other Expenses": "65",
"Other Liabilities": "0",
"Other Net Income": "108",
"Other Revenues": "6,081",
"Property, Plant and Equipment, Net": "585",
"Research and Development": "347"
},
"output_variables": {
"Liabilities": "592",
"Assets": "5,571",
"Expenses": "5,641",
"Revenues": "6,081",
"Stockholders Equity": "4,979",
"Net Income": "548",
"Comprehensive Net Income": "548",
"BaseVar": "8,998",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "263%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "5,253",
"Assets, Non-Current": "71",
"General and Administrative Expense": "5,500",
"Goodwill": "165",
"Liabilities, Current": "560",
"Liabilities, Non-Current": "0",
"Other Assets": "250",
"Other Compr. Net Income": "-3.0",
"Other Expenses": "-12",
"Other Liabilities": "0",
"Other Net Income": "10",
"Other Revenues": "6,473",
"Property, Plant and Equipment, Net": "655",
"Research and Development": "459"
},
"output_variables": {
"Liabilities": "560",
"Assets": "6,395",
"Expenses": "5,946",
"Revenues": "6,473",
"Stockholders Equity": "5,835",
"Net Income": "537",
"Comprehensive Net Income": "535",
"BaseVar": "9,694",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "268%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "4,913",
"Assets, Non-Current": "36",
"General and Administrative Expense": "4,977",
"Goodwill": "382",
"Liabilities, Current": "556",
"Liabilities, Non-Current": "0",
"Other Assets": "524",
"Other Compr. Net Income": "-1.1",
"Other Expenses": "-211",
"Other Liabilities": "0",
"Other Net Income": "20",
"Other Revenues": "5,120",
"Property, Plant and Equipment, Net": "614",
"Research and Development": "590"
},
"output_variables": {
"Liabilities": "556",
"Assets": "6,470",
"Expenses": "5,356",
"Revenues": "5,120",
"Stockholders Equity": "5,914",
"Net Income": "-216",
"Comprehensive Net Income": "-216",
"BaseVar": "8,762",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "252%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "4,392",
"Assets, Non-Current": "57",
"General and Administrative Expense": "4,899",
"Goodwill": "321",
"Liabilities, Current": "524",
"Liabilities, Non-Current": "0",
"Other Assets": "909",
"Other Compr. Net Income": "-2.1",
"Other Expenses": "-315",
"Other Liabilities": "0",
"Other Net Income": "24",
"Other Revenues": "4,962",
"Property, Plant and Equipment, Net": "445",
"Research and Development": "734"
},
"output_variables": {
"Liabilities": "524",
"Assets": "6,124",
"Expenses": "5,318",
"Revenues": "4,962",
"Stockholders Equity": "5,601",
"Net Income": "-331",
"Comprehensive Net Income": "-332",
"BaseVar": "8,477",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "249%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "4,835",
"Assets, Non-Current": "56",
"General and Administrative Expense": "5,186",
"Goodwill": "249",
"Liabilities, Current": "506",
"Liabilities, Non-Current": "0",
"Other Assets": "206",
"Other Compr. Net Income": "-1.3",
"Other Expenses": "704",
"Other Liabilities": "0",
"Other Net Income": "31",
"Other Revenues": "5,140",
"Property, Plant and Equipment, Net": "381",
"Research and Development": "780"
},
"output_variables": {
"Liabilities": "506",
"Assets": "5,727",
"Expenses": "6,671",
"Revenues": "5,140",
"Stockholders Equity": "5,220",
"Net Income": "-1,500",
"Comprehensive Net Income": "-1,500",
"BaseVar": "9,038",
"ECR before LimitedLiability": "181%",
"Economic Capital Ratio": "222%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "4,210",
"Assets, Non-Current": "95",
"General and Administrative Expense": "5,616",
"Goodwill": "174",
"Liabilities, Current": "529",
"Liabilities, Non-Current": "0",
"Other Assets": "206",
"Other Compr. Net Income": "-2.2",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "46",
"Other Revenues": "5,792",
"Property, Plant and Equipment, Net": "332",
"Research and Development": "1,131"
},
"output_variables": {
"Liabilities": "529",
"Assets": "5,018",
"Expenses": "6,746",
"Revenues": "5,792",
"Stockholders Equity": "4,489",
"Net Income": "-909",
"Comprehensive Net Income": "-910",
"BaseVar": "9,067",
"ECR before LimitedLiability": "189%",
"Economic Capital Ratio": "227%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,484",
"Assets, Non-Current": "113",
"General and Administrative Expense": "5,648",
"Goodwill": "99",
"Liabilities, Current": "897",
"Liabilities, Non-Current": "0",
"Other Assets": "175",
"Other Compr. Net Income": "-10",
"Other Expenses": "32",
"Other Liabilities": "0",
"Other Net Income": "48",
"Other Revenues": "5,564",
"Property, Plant and Equipment, Net": "351",
"Research and Development": "1,398"
},
"output_variables": {
"Liabilities": "897",
"Assets": "5,223",
"Expenses": "7,078",
"Revenues": "5,564",
"Stockholders Equity": "4,326",
"Net Income": "-1,466",
"Comprehensive Net Income": "-1,471",
"BaseVar": "9,410",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "198%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,495",
"Assets, Non-Current": "127",
"General and Administrative Expense": "5,934",
"Goodwill": "107",
"Liabilities, Current": "1,264",
"Liabilities, Non-Current": "0",
"Other Assets": "165",
"Other Compr. Net Income": "-10",
"Other Expenses": "24",
"Other Liabilities": "0",
"Other Net Income": "44",
"Other Revenues": "5,201",
"Property, Plant and Equipment, Net": "351",
"Research and Development": "1,679"
},
"output_variables": {
"Liabilities": "1,264",
"Assets": "5,245",
"Expenses": "7,638",
"Revenues": "5,201",
"Stockholders Equity": "3,981",
"Net Income": "-2,393",
"Comprehensive Net Income": "-2,398",
"BaseVar": "9,701",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "163%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "14,767",
"Assets, Non-Current": "1,880",
"General and Administrative Expense": "7,185",
"Goodwill": "169",
"Liabilities, Current": "1,477",
"Liabilities, Non-Current": "1,570",
"Other Assets": "165",
"Other Compr. Net Income": "-3.3",
"Other Expenses": "7.4",
"Other Liabilities": "0",
"Other Net Income": "71",
"Other Revenues": "6,693",
"Property, Plant and Equipment, Net": "279",
"Research and Development": "1,910"
},
"output_variables": {
"Liabilities": "3,047",
"Assets": "17,260",
"Expenses": "9,103",
"Revenues": "6,693",
"Stockholders Equity": "14,213",
"Net Income": "-2,339",
"Comprehensive Net Income": "-2,341",
"BaseVar": "18,088",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "214%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "9,231",
"Assets, Non-Current": "1,817",
"General and Administrative Expense": "12,504",
"Goodwill": "295",
"Liabilities, Current": "1,300",
"Liabilities, Non-Current": "1,292",
"Other Assets": "165",
"Other Compr. Net Income": "-8.1",
"Other Expenses": "13",
"Other Liabilities": "0",
"Other Net Income": "66",
"Other Revenues": "7,199",
"Property, Plant and Equipment, Net": "311",
"Research and Development": "2,194"
},
"output_variables": {
"Liabilities": "2,592",
"Assets": "11,819",
"Expenses": "14,712",
"Revenues": "7,199",
"Stockholders Equity": "9,227",
"Net Income": "-7,446",
"Comprehensive Net Income": "-7,450",
"BaseVar": "18,198",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "147%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "9,427",
"Assets, Non-Current": "1,398",
"General and Administrative Expense": "21,593",
"Goodwill": "170",
"Liabilities, Current": "2,011",
"Liabilities, Non-Current": "1,038",
"Other Assets": "165",
"Other Compr. Net Income": "-26",
"Other Expenses": "24",
"Other Liabilities": "0",
"Other Net Income": "27",
"Other Revenues": "18,871",
"Property, Plant and Equipment, Net": "214",
"Research and Development": "1,812"
},
"output_variables": {
"Liabilities": "3,049",
"Assets": "11,374",
"Expenses": "23,429",
"Revenues": "18,871",
"Stockholders Equity": "8,325",
"Net Income": "-4,531",
"Comprehensive Net Income": "-4,544",
"BaseVar": "28,388",
"ECR before LimitedLiability": "95%",
"Economic Capital Ratio": "164%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "12,797",
"Assets, Non-Current": "1,114",
"General and Administrative Expense": "10,978",
"Goodwill": "165",
"Liabilities, Current": "1,945",
"Liabilities, Non-Current": "785",
"Other Assets": "165",
"Other Compr. Net Income": "-36",
"Other Expenses": "51",
"Other Liabilities": "0",
"Other Net Income": "134",
"Other Revenues": "5,339",
"Property, Plant and Equipment, Net": "213",
"Research and Development": "1,584"
},
"output_variables": {
"Liabilities": "2,730",
"Assets": "14,454",
"Expenses": "12,613",
"Revenues": "5,339",
"Stockholders Equity": "11,724",
"Net Income": "-7,140",
"Comprehensive Net Income": "-7,158",
"BaseVar": "17,653",
"ECR before LimitedLiability": "104%",
"Economic Capital Ratio": "170%"
}
}
},
"top_rated": false,
"trend": 10.0,
"value": 1.702910493186967,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000073290.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000073290.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000073290.svg"
},
{
"company_id": "0001374328",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001374328.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001374328.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001374328.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001374328_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001374328_main_keyfigs.svg",
"name": "Fitlife Brands INC",
"rank": 17,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001374328.svg",
"report_text": "The relative strengths and weaknesses of Fitlife Brands INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Fitlife Brands INC compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 59% points.The greatest weakness of Fitlife Brands INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 21% points.
The company's Economic Capital Ratio, given in the ranking table, is 168%, being 28% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001374328_2024_Fitlife_Brands_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "53.4",
"Liabilities": "95.2",
"Stockholders Equity": "-40.7",
"ECR before LimitedLiability": "108",
"Liabilities, Non-Current": "25.7",
"Other Liabilities": "27.0",
"Property, Plant and Equipment, Net": "-14.6",
"Assets": "-33.5",
"Assets, Non-Current": "-6.95",
"Goodwill": "2.56",
"Assets, Current": "-23.4",
"General and Administrative Expense": "53.1",
"Expenses": "-37.8",
"Revenues": "118",
"Net Income": "86.8",
"Research and Development": "30.1",
"Other Expenses": "-133",
"Other Revenues": "118",
"Comprehensive Net Income": "86.7",
"Other Net Income": "-11.4",
"Economic Capital Ratio": "45.6"
},
"2012": {
"Liabilities, Current": "46.1",
"Liabilities": "100",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "113",
"Liabilities, Non-Current": "29.3",
"Other Liabilities": "46.3",
"Assets, Current": "-8.09",
"Assets": "-18.3",
"Assets, Non-Current": "-4.12",
"Property, Plant and Equipment, Net": "-8.41",
"Goodwill": "-3.90",
"Other Expenses": "-134",
"Expenses": "-26.0",
"Revenues": "142",
"Net Income": "109",
"Research and Development": "31.9",
"General and Administrative Expense": "53.0",
"Other Revenues": "142",
"Other Net Income": "-1.19",
"Comprehensive Net Income": "109",
"Economic Capital Ratio": "80.5"
},
"2013": {
"Liabilities, Current": "39.7",
"Liabilities": "58.8",
"Stockholders Equity": "-47.1",
"ECR before LimitedLiability": "64.9",
"Other Liabilities": "26.2",
"Liabilities, Non-Current": "-5.15",
"Goodwill": "-11.0",
"Assets": "-35.1",
"Assets, Non-Current": "-7.12",
"Property, Plant and Equipment, Net": "-14.7",
"Assets, Current": "-11.0",
"General and Administrative Expense": "37.3",
"Expenses": "-18.4",
"Revenues": "96.8",
"Net Income": "93.1",
"Research and Development": "23.4",
"Other Expenses": "-76.7",
"Other Revenues": "96.8",
"Other Net Income": "-4.97",
"Comprehensive Net Income": "92.9",
"Economic Capital Ratio": "24.8"
},
"2014": {
"Liabilities, Non-Current": "10.1",
"Liabilities": "102",
"Stockholders Equity": "16.6",
"ECR before LimitedLiability": "126",
"Liabilities, Current": "76.5",
"Other Liabilities": "24.9",
"Assets, Current": "-1.12",
"Assets": "-20.0",
"Goodwill": "-8.50",
"Assets, Non-Current": "-4.51",
"Property, Plant and Equipment, Net": "-10.2",
"Other Expenses": "-102",
"Expenses": "-14.1",
"Revenues": "121",
"Net Income": "104",
"Research and Development": "25.9",
"General and Administrative Expense": "51.9",
"Other Revenues": "121",
"Other Net Income": "2.57",
"Comprehensive Net Income": "105",
"Economic Capital Ratio": "76.9"
},
"2015": {
"Other Liabilities": "22.1",
"Liabilities": "46.0",
"Stockholders Equity": "21.1",
"ECR before LimitedLiability": "79.3",
"Liabilities, Current": "8.24",
"Liabilities, Non-Current": "17.9",
"Assets, Current": "-6.68",
"Assets": "-9.20",
"Other Assets": "-3.37",
"Goodwill": "20.5",
"Assets, Non-Current": "-3.91",
"Property, Plant and Equipment, Net": "-11.0",
"Research and Development": "13.9",
"Expenses": "-2.00",
"Revenues": "49.7",
"Net Income": "48.7",
"General and Administrative Expense": "15.1",
"Other Expenses": "-29.2",
"Other Revenues": "49.7",
"Comprehensive Net Income": "49.2",
"Economic Capital Ratio": "33.4"
},
"2016": {
"Liabilities, Non-Current": "32.0",
"Liabilities": "79.6",
"Stockholders Equity": "-11.8",
"ECR before LimitedLiability": "71.4",
"Liabilities, Current": "39.0",
"Other Liabilities": "16.9",
"Property, Plant and Equipment, Net": "-14.8",
"Assets": "-25.1",
"Assets, Non-Current": "-4.52",
"Assets, Current": "-20.4",
"Goodwill": "12.9",
"Research and Development": "25.1",
"Expenses": "-23.7",
"Revenues": "98.1",
"Net Income": "62.6",
"General and Administrative Expense": "5.69",
"Other Expenses": "-55.9",
"Other Revenues": "98.1",
"Comprehensive Net Income": "63.1",
"Other Net Income": "-3.31",
"Economic Capital Ratio": "51.5"
},
"2017": {
"Other Liabilities": "4.91",
"Liabilities": "12.6",
"Stockholders Equity": "-70.6",
"ECR before LimitedLiability": "-74.7",
"Liabilities, Current": "1.21",
"Liabilities, Non-Current": "8.51",
"Assets, Non-Current": "-10.4",
"Assets": "-90.1",
"Assets, Current": "-25.4",
"Goodwill": "-22.9",
"Property, Plant and Equipment, Net": "-26.0",
"Research and Development": "16.5",
"Expenses": "-63.5",
"Revenues": "39.6",
"Net Income": "-16.9",
"Other Expenses": "-111",
"General and Administrative Expense": "4.46",
"Other Revenues": "39.6",
"Comprehensive Net Income": "-17.2",
"Other Net Income": "-5.70",
"Economic Capital Ratio": "-96.2"
},
"2018": {
"Liabilities, Non-Current": "45.3",
"Liabilities": "67.8",
"Stockholders Equity": "-111",
"ECR before LimitedLiability": "28.8",
"Other Liabilities": "28.0",
"Liabilities, Current": "15.2",
"Property, Plant and Equipment, Net": "-30.3",
"Assets": "-64.6",
"Assets, Current": "-30.8",
"Goodwill": "-23.9",
"Assets, Non-Current": "-19.5",
"Other Expenses": "32.4",
"Expenses": "-55.0",
"Revenues": "94.0",
"Net Income": "71.4",
"Research and Development": "36.2",
"General and Administrative Expense": "-115",
"Other Revenues": "94.0",
"Comprehensive Net Income": "71.6",
"Other Net Income": "-2.18",
"Economic Capital Ratio": "8.33"
},
"2019": {
"Liabilities, Non-Current": "50.0",
"Liabilities": "109",
"Stockholders Equity": "-110",
"ECR before LimitedLiability": "99.0",
"Other Liabilities": "36.9",
"Liabilities, Current": "37.9",
"Assets, Non-Current": "-13.8",
"Assets": "-40.8",
"Goodwill": "-15.5",
"Property, Plant and Equipment, Net": "-18.6",
"Assets, Current": "-17.2",
"Research and Development": "24.6",
"Expenses": "-50.7",
"Revenues": "137",
"Net Income": "124",
"Other Expenses": "23.7",
"General and Administrative Expense": "-109",
"Other Revenues": "137",
"Other Net Income": "11.7",
"Comprehensive Net Income": "124",
"Economic Capital Ratio": "69.6"
},
"2020": {
"Liabilities, Current": "21.0",
"Liabilities": "66.7",
"Stockholders Equity": "0.256",
"ECR before LimitedLiability": "151",
"Liabilities, Non-Current": "49.4",
"Other Liabilities": "4.95",
"Goodwill": "-3.59",
"Assets": "-5.67",
"Other Assets": "7.35",
"Assets, Non-Current": "-2.91",
"Property, Plant and Equipment, Net": "-4.68",
"Other Expenses": "40.6",
"Expenses": "4.73",
"Revenues": "80.7",
"Net Income": "92.8",
"Research and Development": "11.7",
"General and Administrative Expense": "-53.8",
"Other Revenues": "80.7",
"Comprehensive Net Income": "92.9",
"Other Net Income": "8.18",
"Economic Capital Ratio": "113"
},
"2022": {
"Liabilities, Non-Current": "46.4",
"Liabilities": "84.8",
"Stockholders Equity": "22.2",
"ECR before LimitedLiability": "110",
"Other Liabilities": "18.6",
"Liabilities, Current": "37.3",
"Assets": "-6.49",
"Assets, Current": "12.2",
"Property, Plant and Equipment, Net": "-5.94",
"Assets, Non-Current": "-4.47",
"Goodwill": "-5.92",
"General and Administrative Expense": "-40.8",
"Expenses": "-14.7",
"Revenues": "69.3",
"Net Income": "58.9",
"Research and Development": "14.4",
"Other Expenses": "9.29",
"Other Revenues": "69.3",
"Other Net Income": "3.04",
"Comprehensive Net Income": "59.4",
"Economic Capital Ratio": "99.9"
},
"2023": {
"Liabilities, Non-Current": "-16.4",
"Liabilities": "26.4",
"Stockholders Equity": "-9.00",
"ECR before LimitedLiability": "43.4",
"Other Liabilities": "9.57",
"Liabilities, Current": "31.8",
"Assets": "-15.7",
"Property, Plant and Equipment, Net": "-16.4",
"Goodwill": "59.2",
"Assets, Current": "-15.3",
"Assets, Non-Current": "-14.5",
"Other Expenses": "10.9",
"Expenses": "-4.01",
"Revenues": "47.1",
"Net Income": "40.9",
"Research and Development": "7.40",
"General and Administrative Expense": "-21.4",
"Other Revenues": "47.1",
"Other Net Income": "-1.06",
"Comprehensive Net Income": "40.5",
"Economic Capital Ratio": "28.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001374328_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "3,296",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,675",
"Goodwill": "1,477",
"Liabilities, Current": "1,616",
"Liabilities, Non-Current": "0",
"Other Assets": "6.8",
"Other Compr. Net Income": "0",
"Other Expenses": "8,207",
"Other Liabilities": "0",
"Other Net Income": "118",
"Other Revenues": "12,092",
"Property, Plant and Equipment, Net": "43",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,616",
"Assets": "4,823",
"Expenses": "11,883",
"Revenues": "12,092",
"Stockholders Equity": "3,206",
"Net Income": "327",
"Comprehensive Net Income": "327",
"BaseVar": "15,266",
"ECR before LimitedLiability": "147%",
"Economic Capital Ratio": "199%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "6,397",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,400",
"Goodwill": "1,257",
"Liabilities, Current": "1,870",
"Liabilities, Non-Current": "0",
"Other Assets": "3.0",
"Other Compr. Net Income": "0",
"Other Expenses": "11,812",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "18,093",
"Property, Plant and Equipment, Net": "19",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,870",
"Assets": "7,676",
"Expenses": "16,212",
"Revenues": "18,093",
"Stockholders Equity": "5,805",
"Net Income": "1,881",
"Comprehensive Net Income": "1,881",
"BaseVar": "21,925",
"ECR before LimitedLiability": "206%",
"Economic Capital Ratio": "239%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "8,134",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,516",
"Goodwill": "1,037",
"Liabilities, Current": "2,475",
"Liabilities, Non-Current": "1,947",
"Other Assets": "53",
"Other Compr. Net Income": "0",
"Other Expenses": "12,781",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "19,684",
"Property, Plant and Equipment, Net": "6.0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,422",
"Assets": "9,230",
"Expenses": "18,296",
"Revenues": "19,684",
"Stockholders Equity": "4,809",
"Net Income": "1,388",
"Comprehensive Net Income": "1,388",
"BaseVar": "25,816",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "179%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "9,060",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,015",
"Goodwill": "1,037",
"Liabilities, Current": "1,950",
"Liabilities, Non-Current": "1,440",
"Other Assets": "3.0",
"Other Compr. Net Income": "0",
"Other Expenses": "13,094",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "19,960",
"Property, Plant and Equipment, Net": "3.1",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,390",
"Assets": "10,104",
"Expenses": "18,108",
"Revenues": "19,960",
"Stockholders Equity": "6,714",
"Net Income": "1,852",
"Comprehensive Net Income": "1,852",
"BaseVar": "25,781",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "210%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "9,536",
"Assets, Non-Current": "0",
"General and Administrative Expense": "7,068",
"Goodwill": "6,930",
"Liabilities, Current": "6,533",
"Liabilities, Non-Current": "914",
"Other Assets": "866",
"Other Compr. Net Income": "0",
"Other Expenses": "11,953",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "17,931",
"Property, Plant and Equipment, Net": "227",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,448",
"Assets": "17,558",
"Expenses": "19,021",
"Revenues": "17,931",
"Stockholders Equity": "10,111",
"Net Income": "-1,090",
"Comprehensive Net Income": "-1,090",
"BaseVar": "30,979",
"ECR before LimitedLiability": "102%",
"Economic Capital Ratio": "169%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "8,126",
"Assets, Non-Current": "0",
"General and Administrative Expense": "9,121",
"Goodwill": "6,508",
"Liabilities, Current": "4,644",
"Liabilities, Non-Current": "369",
"Other Assets": "742",
"Other Compr. Net Income": "0",
"Other Expenses": "15,721",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "25,314",
"Property, Plant and Equipment, Net": "171",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,013",
"Assets": "15,546",
"Expenses": "24,841",
"Revenues": "25,314",
"Stockholders Equity": "10,533",
"Net Income": "472",
"Comprehensive Net Income": "472",
"BaseVar": "35,357",
"ECR before LimitedLiability": "145%",
"Economic Capital Ratio": "198%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "6,320",
"Assets, Non-Current": "0",
"General and Administrative Expense": "7,705",
"Goodwill": "225",
"Liabilities, Current": "5,951",
"Liabilities, Non-Current": "0",
"Other Assets": "22",
"Other Compr. Net Income": "0",
"Other Expenses": "19,736",
"Other Liabilities": "0",
"Other Net Income": "-120",
"Other Revenues": "17,799",
"Property, Plant and Equipment, Net": "295",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,951",
"Assets": "6,862",
"Expenses": "27,441",
"Revenues": "17,799",
"Stockholders Equity": "912",
"Net Income": "-9,762",
"Comprehensive Net Income": "-9,762",
"BaseVar": "29,087",
"ECR before LimitedLiability": "-133%",
"Economic Capital Ratio": "57%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,438",
"Assets, Non-Current": "0",
"General and Administrative Expense": "16,355",
"Goodwill": "225",
"Liabilities, Current": "3,548",
"Liabilities, Non-Current": "0",
"Other Assets": "10",
"Other Compr. Net Income": "0",
"Other Expenses": "80",
"Other Liabilities": "0",
"Other Net Income": "-133",
"Other Revenues": "17,077",
"Property, Plant and Equipment, Net": "189",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,548",
"Assets": "5,862",
"Expenses": "16,435",
"Revenues": "17,077",
"Stockholders Equity": "2,314",
"Net Income": "509",
"Comprehensive Net Income": "509",
"BaseVar": "21,528",
"ECR before LimitedLiability": "78%",
"Economic Capital Ratio": "152%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "5,701",
"Assets, Non-Current": "254",
"General and Administrative Expense": "16,864",
"Goodwill": "225",
"Liabilities, Current": "2,776",
"Liabilities, Non-Current": "208",
"Other Assets": "10",
"Other Compr. Net Income": "0",
"Other Expenses": "59",
"Other Liabilities": "0",
"Other Net Income": "124",
"Other Revenues": "19,497",
"Property, Plant and Equipment, Net": "136",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,984",
"Assets": "6,326",
"Expenses": "16,923",
"Revenues": "19,497",
"Stockholders Equity": "3,342",
"Net Income": "2,698",
"Comprehensive Net Income": "2,698",
"BaseVar": "22,927",
"ECR before LimitedLiability": "156%",
"Economic Capital Ratio": "205%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "11,873",
"Assets, Non-Current": "208",
"General and Administrative Expense": "17,502",
"Goodwill": "225",
"Liabilities, Current": "4,129",
"Liabilities, Non-Current": "158",
"Other Assets": "4,370",
"Other Compr. Net Income": "0",
"Other Expenses": "-4,408",
"Other Liabilities": "453",
"Other Net Income": "64",
"Other Revenues": "21,744",
"Property, Plant and Equipment, Net": "98",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,740",
"Assets": "16,774",
"Expenses": "13,094",
"Revenues": "21,744",
"Stockholders Equity": "12,034",
"Net Income": "8,714",
"Comprehensive Net Income": "8,714",
"BaseVar": "28,208",
"ECR before LimitedLiability": "234%",
"Economic Capital Ratio": "259%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "23,203",
"Assets, Non-Current": "103",
"General and Administrative Expense": "23,036",
"Goodwill": "508",
"Liabilities, Current": "4,270",
"Liabilities, Non-Current": "49",
"Other Assets": "1,847",
"Other Compr. Net Income": "0",
"Other Expenses": "1,459",
"Other Liabilities": "0",
"Other Net Income": "121",
"Other Revenues": "28,803",
"Property, Plant and Equipment, Net": "46",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,319",
"Assets": "25,707",
"Expenses": "24,495",
"Revenues": "28,803",
"Stockholders Equity": "21,388",
"Net Income": "4,429",
"Comprehensive Net Income": "4,429",
"BaseVar": "41,722",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "252%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "14,693",
"Assets, Non-Current": "121",
"General and Administrative Expense": "43,429",
"Goodwill": "39,603",
"Liabilities, Current": "12,750",
"Liabilities, Non-Current": "15,560",
"Other Assets": "792",
"Other Compr. Net Income": "-292",
"Other Expenses": "3,428",
"Other Liabilities": "0",
"Other Net Income": "-547",
"Other Revenues": "52,700",
"Property, Plant and Equipment, Net": "137",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "28,310",
"Assets": "55,346",
"Expenses": "46,857",
"Revenues": "52,700",
"Stockholders Equity": "27,036",
"Net Income": "5,296",
"Comprehensive Net Income": "5,150",
"BaseVar": "92,026",
"ECR before LimitedLiability": "101%",
"Economic Capital Ratio": "168%"
}
}
},
"top_rated": false,
"trend": -12.0,
"value": 1.6836819299612964,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001374328.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001374328.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001374328.svg"
},
{
"company_id": "0001504678",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001504678.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001504678.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001504678.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001504678_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001504678_main_keyfigs.svg",
"name": "Loop Industries Inc",
"rank": 18,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001504678.svg",
"report_text": "The relative strengths and weaknesses of Loop Industries Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Loop Industries Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 86% points.The greatest weakness of Loop Industries Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 167%, being 27% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001504678_2024_Loop_Industries_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Liabilities, Current": "0.417",
"Liabilities": "0.401",
"Stockholders Equity": "-29.8",
"ECR before LimitedLiability": "-114",
"Other Liabilities": "-0.156",
"Liabilities, Non-Current": "-0.185",
"Goodwill": "-2.10",
"Assets": "-35.3",
"Assets, Non-Current": "-0.489",
"Property, Plant and Equipment, Net": "-1.61",
"Other Assets": "-0.257",
"Assets, Current": "-8.40",
"General and Administrative Expense": "-0.521",
"Expenses": "-7.67",
"Revenues": "-2.38",
"Net Income": "-27.7",
"Research and Development": "0.170",
"Other Expenses": "-6.03",
"Other Revenues": "-2.38",
"Comprehensive Net Income": "-27.8",
"Economic Capital Ratio": "-154"
},
"2016": {
"Liabilities, Non-Current": "3.22",
"Liabilities": "0.449",
"Stockholders Equity": "5.79",
"ECR before LimitedLiability": "-46.6",
"Liabilities, Current": "-3.39",
"Other Liabilities": "1.39",
"Property, Plant and Equipment, Net": "37.5",
"Assets": "6.80",
"Assets, Non-Current": "-1.52",
"Assets, Current": "-4.60",
"Goodwill": "0.450",
"Research and Development": "-3.48",
"Expenses": "-6.44",
"Revenues": "-15.4",
"Net Income": "-62.6",
"General and Administrative Expense": "-4.60",
"Other Expenses": "4.41",
"Other Revenues": "-15.4",
"Comprehensive Net Income": "-62.3",
"Other Net Income": "-0.460",
"Economic Capital Ratio": "-66.6"
},
"2021": {
"Liabilities, Non-Current": "17.3",
"Liabilities": "19.4",
"Stockholders Equity": "31.3",
"ECR before LimitedLiability": "-39.2",
"Liabilities, Current": "-6.22",
"Other Liabilities": "8.23",
"Assets, Current": "43.2",
"Assets": "28.1",
"Assets, Non-Current": "-11.6",
"Other Assets": "1.48",
"Goodwill": "-20.8",
"Property, Plant and Equipment, Net": "-9.88",
"Other Expenses": "-6.89",
"Expenses": "-40.0",
"Revenues": "-41.6",
"Net Income": "-75.4",
"Research and Development": "-44.2",
"General and Administrative Expense": "12.5",
"Other Revenues": "-41.6",
"Comprehensive Net Income": "-74.9",
"Economic Capital Ratio": "-43.5"
},
"2023": {
"Liabilities, Non-Current": "14.3",
"Liabilities": "69.1",
"Stockholders Equity": "77.6",
"ECR before LimitedLiability": "42.5",
"Other Liabilities": "9.49",
"Liabilities, Current": "48.8",
"Assets": "6.19",
"Property, Plant and Equipment, Net": "-11.7",
"Goodwill": "-15.0",
"Assets, Current": "86.0",
"Assets, Non-Current": "-14.7",
"Other Expenses": "14.6",
"Expenses": "-38.4",
"Revenues": "-42.8",
"Net Income": "-35.1",
"Research and Development": "-42.0",
"General and Administrative Expense": "-10.1",
"Other Revenues": "-42.8",
"Other Net Income": "53.9",
"Comprehensive Net Income": "-36.7",
"Economic Capital Ratio": "27.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001504678_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "2.1",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6.5",
"Goodwill": "0",
"Liabilities, Current": "7.7",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "9.9",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7.7",
"Assets": "2.1",
"Expenses": "16",
"Revenues": "0",
"Stockholders Equity": "-5.6",
"Net Income": "-16",
"Comprehensive Net Income": "-16",
"BaseVar": "13",
"ECR before LimitedLiability": "-489%",
"Economic Capital Ratio": "0.42%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "712",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,748",
"Goodwill": "372",
"Liabilities, Current": "1,065",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "5.9",
"Other Expenses": "287",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "1,399",
"Research and Development": "802"
},
"output_variables": {
"Liabilities": "1,065",
"Assets": "2,483",
"Expenses": "2,836",
"Revenues": "0",
"Stockholders Equity": "1,417",
"Net Income": "-2,836",
"Comprehensive Net Income": "-2,833",
"BaseVar": "3,195",
"ECR before LimitedLiability": "-50%",
"Economic Capital Ratio": "80%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "37,596",
"Assets, Non-Current": "1,500",
"General and Administrative Expense": "11,540",
"Goodwill": "795",
"Liabilities, Current": "9,063",
"Liabilities, Non-Current": "1,516",
"Other Assets": "0",
"Other Compr. Net Income": "382",
"Other Expenses": "6,118",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,513",
"Research and Development": "18,687"
},
"output_variables": {
"Liabilities": "10,579",
"Assets": "43,404",
"Expenses": "36,345",
"Revenues": "0",
"Stockholders Equity": "32,825",
"Net Income": "-36,345",
"Comprehensive Net Income": "-36,154",
"BaseVar": "45,355",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "36,424",
"Assets, Non-Current": "0",
"General and Administrative Expense": "20,429",
"Goodwill": "1,210",
"Liabilities, Current": "3,584",
"Liabilities, Non-Current": "3,240",
"Other Assets": "381",
"Other Compr. Net Income": "-1,045",
"Other Expenses": "739",
"Other Liabilities": "0",
"Other Net Income": "16,367",
"Other Revenues": "41",
"Property, Plant and Equipment, Net": "2,545",
"Research and Development": "17,346"
},
"output_variables": {
"Liabilities": "6,824",
"Assets": "40,560",
"Expenses": "38,514",
"Revenues": "41",
"Stockholders Equity": "33,736",
"Net Income": "-22,106",
"Comprehensive Net Income": "-22,628",
"BaseVar": "51,676",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "167%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.674636080907613,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001504678.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001504678.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001504678.svg"
},
{
"company_id": "0001880319",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001880319.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001880319.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001880319_main_keyfigs.svg",
"name": "Perimeter Solutions Inc",
"rank": 19,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001880319.svg",
"report_text": "The relative strengths and weaknesses of Perimeter Solutions Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Perimeter Solutions Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 88% points.The greatest weakness of Perimeter Solutions Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 37% points.
The company's Economic Capital Ratio, given in the ranking table, is 164%, being 24% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001880319_2024_Perimeter_Solutions_Inc.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities, Non-Current": "-32.4",
"Liabilities": "-42.4",
"Stockholders Equity": "10.1",
"ECR before LimitedLiability": "16.7",
"Other Liabilities": "-13.2",
"Liabilities, Current": "4.62",
"Assets": "36.0",
"Assets, Current": "-15.7",
"Property, Plant and Equipment, Net": "-8.50",
"Assets, Non-Current": "-7.06",
"Goodwill": "82.9",
"General and Administrative Expense": "20.2",
"Expenses": "37.6",
"Revenues": "-13.1",
"Net Income": "22.0",
"Research and Development": "6.28",
"Other Expenses": "9.26",
"Other Revenues": "-13.1",
"Other Net Income": "-0.219",
"Comprehensive Net Income": "21.9",
"Economic Capital Ratio": "6.23"
},
"2023": {
"Liabilities, Non-Current": "-37.1",
"Liabilities": "-27.4",
"Stockholders Equity": "27.6",
"ECR before LimitedLiability": "39.1",
"Other Liabilities": "-7.79",
"Liabilities, Current": "15.4",
"Assets": "42.1",
"Property, Plant and Equipment, Net": "-8.14",
"Goodwill": "88.2",
"Assets, Current": "-11.3",
"Assets, Non-Current": "-8.16",
"Other Expenses": "9.79",
"Expenses": "33.1",
"Revenues": "-11.0",
"Net Income": "19.0",
"Research and Development": "3.96",
"General and Administrative Expense": "18.0",
"Other Revenues": "-11.0",
"Other Net Income": "-1.41",
"Comprehensive Net Income": "19.0",
"Economic Capital Ratio": "24.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001880319_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "308,522",
"Assets, Non-Current": "20,348",
"General and Administrative Expense": "292,172",
"Goodwill": "2,068,900",
"Liabilities, Current": "352,424",
"Liabilities, Non-Current": "690,086",
"Other Assets": "0",
"Other Compr. Net Income": "-18,336",
"Other Expenses": "-56,263",
"Other Liabilities": "275,206",
"Other Net Income": "-32,838",
"Other Revenues": "360,505",
"Property, Plant and Equipment, Net": "58,846",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,317,716",
"Assets": "2,456,616",
"Expenses": "235,909",
"Revenues": "360,505",
"Stockholders Equity": "1,138,900",
"Net Income": "91,758",
"Comprehensive Net Income": "82,590",
"BaseVar": "2,210,960",
"ECR before LimitedLiability": "87%",
"Economic Capital Ratio": "159%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "251,014",
"Assets, Non-Current": "17,656",
"General and Administrative Expense": "240,326",
"Goodwill": "1,981,286",
"Liabilities, Current": "308,505",
"Liabilities, Non-Current": "683,595",
"Other Assets": "6,064",
"Other Compr. Net Income": "5,761",
"Other Expenses": "-18,571",
"Other Liabilities": "171,027",
"Other Net Income": "-32,867",
"Other Revenues": "322,108",
"Property, Plant and Equipment, Net": "59,402",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,163,127",
"Assets": "2,315,422",
"Expenses": "221,755",
"Revenues": "322,108",
"Stockholders Equity": "1,152,295",
"Net Income": "67,486",
"Comprehensive Net Income": "70,366",
"BaseVar": "2,030,520",
"ECR before LimitedLiability": "95%",
"Economic Capital Ratio": "164%"
}
}
},
"top_rated": false,
"trend": 10.0,
"value": 1.6411512494913274,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001880319.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001880319.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001880319.svg"
},
{
"company_id": "0000811641",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000811641.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000811641.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000811641.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000811641_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000811641_main_keyfigs.svg",
"name": "Immucell CORP DE",
"rank": 20,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000811641.svg",
"report_text": "The relative strengths and weaknesses of Immucell CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Immucell CORP DE compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 71% points.The greatest weakness of Immucell CORP DE is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 161%, being 21% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000811641_2024_Immucell_CORP_DE.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "35.7",
"Liabilities": "30.0",
"Stockholders Equity": "78.7",
"ECR before LimitedLiability": "133",
"Liabilities, Non-Current": "11.4",
"Other Liabilities": "-21.1",
"Property, Plant and Equipment, Net": "7.45",
"Assets": "26.7",
"Assets, Non-Current": "-1.95",
"Other Assets": "6.85",
"Goodwill": "-4.32",
"Assets, Current": "15.6",
"General and Administrative Expense": "30.8",
"Expenses": "23.8",
"Revenues": "5.42",
"Net Income": "23.1",
"Research and Development": "-6.31",
"Other Revenues": "5.42",
"Comprehensive Net Income": "23.1",
"Other Net Income": "-6.15",
"Economic Capital Ratio": "70.7"
},
"2012": {
"Liabilities, Current": "26.9",
"Liabilities": "30.9",
"Stockholders Equity": "75.1",
"ECR before LimitedLiability": "107",
"Liabilities, Non-Current": "12.2",
"Other Liabilities": "-7.99",
"Assets, Current": "15.0",
"Assets": "21.8",
"Other Assets": "5.55",
"Assets, Non-Current": "-1.68",
"Property, Plant and Equipment, Net": "5.68",
"Goodwill": "-4.29",
"Other Expenses": "-3.33",
"Expenses": "25.9",
"Revenues": "6.62",
"Net Income": "31.9",
"Research and Development": "3.13",
"General and Administrative Expense": "26.1",
"Other Revenues": "6.62",
"Comprehensive Net Income": "31.9",
"Economic Capital Ratio": "74.4"
},
"2013": {
"Liabilities, Current": "36.6",
"Liabilities": "47.1",
"Stockholders Equity": "80.5",
"ECR before LimitedLiability": "126",
"Other Liabilities": "-6.91",
"Liabilities, Non-Current": "19.7",
"Goodwill": "-4.23",
"Assets": "16.4",
"Assets, Non-Current": "-1.64",
"Property, Plant and Equipment, Net": "6.13",
"Other Assets": "3.48",
"Assets, Current": "12.4",
"General and Administrative Expense": "25.6",
"Expenses": "20.4",
"Revenues": "17.0",
"Net Income": "34.3",
"Other Expenses": "-4.65",
"Other Revenues": "17.0",
"Other Net Income": "-2.68",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "85.4"
},
"2014": {
"Liabilities, Non-Current": "6.58",
"Liabilities": "67.0",
"Stockholders Equity": "92.2",
"ECR before LimitedLiability": "147",
"Liabilities, Current": "50.9",
"Other Liabilities": "16.2",
"Assets, Current": "1.73",
"Assets": "14.8",
"Goodwill": "-5.84",
"Other Assets": "8.55",
"Assets, Non-Current": "-1.91",
"Property, Plant and Equipment, Net": "13.8",
"Other Expenses": "-10.9",
"Expenses": "14.3",
"Revenues": "26.4",
"Net Income": "41.8",
"Research and Development": "-7.90",
"General and Administrative Expense": "32.2",
"Other Revenues": "26.4",
"Comprehensive Net Income": "41.9",
"Economic Capital Ratio": "97.7"
},
"2015": {
"Other Liabilities": "19.8",
"Liabilities": "46.8",
"Stockholders Equity": "60.7",
"ECR before LimitedLiability": "124",
"Liabilities, Current": "48.9",
"Liabilities, Non-Current": "-27.0",
"Assets, Current": "4.49",
"Assets": "11.1",
"Goodwill": "-6.99",
"Assets, Non-Current": "-1.71",
"Property, Plant and Equipment, Net": "18.9",
"Research and Development": "1.79",
"Expenses": "16.9",
"Revenues": "29.9",
"Net Income": "48.4",
"General and Administrative Expense": "21.6",
"Other Expenses": "-6.51",
"Other Revenues": "29.9",
"Comprehensive Net Income": "48.7",
"Other Net Income": "0.915",
"Economic Capital Ratio": "78.3"
},
"2016": {
"Liabilities, Non-Current": "-9.49",
"Liabilities": "31.1",
"Stockholders Equity": "72.8",
"ECR before LimitedLiability": "98.4",
"Liabilities, Current": "30.8",
"Other Liabilities": "9.12",
"Property, Plant and Equipment, Net": "17.4",
"Assets": "22.6",
"Assets, Non-Current": "-1.48",
"Assets, Current": "10.3",
"Goodwill": "-4.38",
"Research and Development": "6.30",
"Expenses": "24.2",
"Revenues": "6.02",
"Net Income": "28.5",
"General and Administrative Expense": "15.9",
"Other Expenses": "2.15",
"Other Revenues": "6.02",
"Comprehensive Net Income": "28.8",
"Other Net Income": "-1.61",
"Economic Capital Ratio": "78.4"
},
"2017": {
"Other Liabilities": "9.79",
"Liabilities": "7.22",
"Stockholders Equity": "55.6",
"ECR before LimitedLiability": "64.9",
"Liabilities, Current": "28.4",
"Liabilities, Non-Current": "-38.9",
"Assets, Non-Current": "-2.32",
"Assets": "31.4",
"Other Assets": "0.900",
"Assets, Current": "-7.63",
"Goodwill": "-6.60",
"Property, Plant and Equipment, Net": "82.2",
"Research and Development": "4.37",
"Expenses": "24.0",
"Revenues": "-0.236",
"Net Income": "20.4",
"Other Expenses": "0.864",
"General and Administrative Expense": "18.6",
"Other Revenues": "-0.236",
"Comprehensive Net Income": "20.2",
"Other Net Income": "-3.27",
"Economic Capital Ratio": "43.3"
},
"2018": {
"Liabilities, Non-Current": "-39.5",
"Liabilities": "-0.508",
"Stockholders Equity": "41.6",
"ECR before LimitedLiability": "62.0",
"Other Liabilities": "9.84",
"Liabilities, Current": "22.6",
"Property, Plant and Equipment, Net": "101",
"Assets": "28.3",
"Assets, Current": "-12.7",
"Goodwill": "-6.74",
"Assets, Non-Current": "-5.12",
"Other Expenses": "9.14",
"Expenses": "20.9",
"Revenues": "-1.56",
"Net Income": "19.2",
"Research and Development": "-0.554",
"General and Administrative Expense": "12.0",
"Other Revenues": "-1.56",
"Comprehensive Net Income": "19.5",
"Other Compr. Net Income": "0.238",
"Economic Capital Ratio": "41.5"
},
"2019": {
"Liabilities, Non-Current": "-23.5",
"Liabilities": "17.8",
"Stockholders Equity": "57.9",
"ECR before LimitedLiability": "101",
"Other Liabilities": "12.9",
"Liabilities, Current": "24.6",
"Assets, Non-Current": "-5.53",
"Assets": "24.3",
"Goodwill": "-5.90",
"Property, Plant and Equipment, Net": "56.3",
"Assets, Current": "-1.28",
"Research and Development": "-2.11",
"Expenses": "21.0",
"Revenues": "2.33",
"Net Income": "26.6",
"Other Expenses": "6.97",
"General and Administrative Expense": "16.1",
"Other Revenues": "2.33",
"Other Net Income": "3.23",
"Comprehensive Net Income": "26.6",
"Economic Capital Ratio": "71.1"
},
"2020": {
"Liabilities, Current": "28.8",
"Liabilities": "13.8",
"Stockholders Equity": "36.2",
"ECR before LimitedLiability": "89.2",
"Liabilities, Non-Current": "-25.0",
"Other Liabilities": "5.75",
"Goodwill": "-6.94",
"Assets": "14.3",
"Assets, Current": "-8.50",
"Assets, Non-Current": "-4.06",
"Property, Plant and Equipment, Net": "59.0",
"Other Expenses": "6.97",
"Expenses": "10.2",
"Revenues": "4.55",
"Net Income": "20.1",
"Research and Development": "-4.40",
"General and Administrative Expense": "7.58",
"Other Revenues": "4.55",
"Comprehensive Net Income": "20.2",
"Other Net Income": "5.19",
"Economic Capital Ratio": "51.4"
},
"2021": {
"Liabilities, Non-Current": "-22.3",
"Liabilities": "16.0",
"Stockholders Equity": "27.9",
"ECR before LimitedLiability": "52.2",
"Liabilities, Current": "26.1",
"Other Liabilities": "8.53",
"Assets, Current": "-5.74",
"Assets": "7.94",
"Assets, Non-Current": "-4.81",
"Other Assets": "0.530",
"Goodwill": "-8.60",
"Property, Plant and Equipment, Net": "44.3",
"Other Expenses": "9.68",
"Expenses": "11.6",
"Revenues": "10.6",
"Net Income": "22.0",
"Research and Development": "-0.824",
"General and Administrative Expense": "2.70",
"Other Revenues": "10.6",
"Comprehensive Net Income": "22.0",
"Economic Capital Ratio": "47.9"
},
"2022": {
"Liabilities, Non-Current": "-28.7",
"Liabilities": "11.3",
"Stockholders Equity": "28.9",
"ECR before LimitedLiability": "47.5",
"Other Liabilities": "8.78",
"Liabilities, Current": "26.7",
"Assets": "11.8",
"Assets, Current": "-6.42",
"Property, Plant and Equipment, Net": "57.7",
"Assets, Non-Current": "-4.39",
"Goodwill": "-10.5",
"General and Administrative Expense": "3.31",
"Expenses": "10.5",
"Revenues": "5.93",
"Net Income": "17.5",
"Research and Development": "-1.95",
"Other Expenses": "9.09",
"Other Revenues": "5.93",
"Other Net Income": "0.939",
"Comprehensive Net Income": "17.9",
"Economic Capital Ratio": "37.0"
},
"2023": {
"Liabilities, Non-Current": "-39.9",
"Liabilities": "8.44",
"Stockholders Equity": "25.0",
"ECR before LimitedLiability": "36.4",
"Other Liabilities": "7.21",
"Liabilities, Current": "35.4",
"Other Assets": "-1.33",
"Assets": "13.0",
"Property, Plant and Equipment, Net": "71.2",
"Goodwill": "-14.3",
"Assets, Current": "-24.7",
"Assets, Non-Current": "24.4",
"Other Expenses": "13.0",
"Expenses": "3.97",
"Revenues": "5.26",
"Net Income": "9.14",
"Research and Development": "-4.38",
"General and Administrative Expense": "-4.24",
"Other Revenues": "5.26",
"Comprehensive Net Income": "9.04",
"Economic Capital Ratio": "21.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000811641_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "7,151",
"Assets, Non-Current": "19",
"General and Administrative Expense": "1,726",
"Goodwill": "0",
"Liabilities, Current": "635",
"Liabilities, Non-Current": "0",
"Other Assets": "1,306",
"Other Compr. Net Income": "0",
"Other Expenses": "2,010",
"Other Liabilities": "1,336",
"Other Net Income": "-64",
"Other Revenues": "5,111",
"Property, Plant and Equipment, Net": "2,515",
"Research and Development": "1,720"
},
"output_variables": {
"Liabilities": "1,971",
"Assets": "10,991",
"Expenses": "5,457",
"Revenues": "5,111",
"Stockholders Equity": "9,020",
"Net Income": "-410",
"Comprehensive Net Income": "-410",
"BaseVar": "11,797",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "224%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,363",
"Assets, Non-Current": "64",
"General and Administrative Expense": "1,892",
"Goodwill": "0",
"Liabilities, Current": "666",
"Liabilities, Non-Current": "0",
"Other Assets": "1,246",
"Other Compr. Net Income": "0",
"Other Expenses": "2,491",
"Other Liabilities": "1,170",
"Other Net Income": "0",
"Other Revenues": "5,390",
"Property, Plant and Equipment, Net": "2,358",
"Research and Development": "918"
},
"output_variables": {
"Liabilities": "1,836",
"Assets": "11,030",
"Expenses": "5,300",
"Revenues": "5,390",
"Stockholders Equity": "9,195",
"Net Income": "90",
"Comprehensive Net Income": "90",
"BaseVar": "11,778",
"ECR before LimitedLiability": "197%",
"Economic Capital Ratio": "233%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "7,268",
"Assets, Non-Current": "14",
"General and Administrative Expense": "1,926",
"Goodwill": "0",
"Liabilities, Current": "636",
"Liabilities, Non-Current": "0",
"Other Assets": "1,155",
"Other Compr. Net Income": "0",
"Other Expenses": "2,810",
"Other Liabilities": "929",
"Other Net Income": "0",
"Other Revenues": "6,007",
"Property, Plant and Equipment, Net": "2,525",
"Research and Development": "1,154"
},
"output_variables": {
"Liabilities": "1,565",
"Assets": "10,961",
"Expenses": "5,890",
"Revenues": "6,007",
"Stockholders Equity": "9,396",
"Net Income": "117",
"Comprehensive Net Income": "117",
"BaseVar": "12,211",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "240%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "5,469",
"Assets, Non-Current": "19",
"General and Administrative Expense": "2,476",
"Goodwill": "0",
"Liabilities, Current": "1,009",
"Liabilities, Non-Current": "785",
"Other Assets": "1,726",
"Other Compr. Net Income": "-3.5",
"Other Expenses": "3,109",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,597",
"Property, Plant and Equipment, Net": "3,838",
"Research and Development": "2,179"
},
"output_variables": {
"Liabilities": "1,793",
"Assets": "11,052",
"Expenses": "7,764",
"Revenues": "7,597",
"Stockholders Equity": "9,258",
"Net Income": "-167",
"Comprehensive Net Income": "-169",
"BaseVar": "14,105",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "7,873",
"Assets, Non-Current": "50",
"General and Administrative Expense": "2,893",
"Goodwill": "0",
"Liabilities, Current": "818",
"Liabilities, Non-Current": "3,169",
"Other Assets": "959",
"Other Compr. Net Income": "-27",
"Other Expenses": "4,887",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,229",
"Property, Plant and Equipment, Net": "5,719",
"Research and Development": "1,235"
},
"output_variables": {
"Liabilities": "3,987",
"Assets": "14,601",
"Expenses": "9,015",
"Revenues": "10,229",
"Stockholders Equity": "10,614",
"Net Income": "1,213",
"Comprehensive Net Income": "1,200",
"BaseVar": "18,929",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "214%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "14,348",
"Assets, Non-Current": "34",
"General and Administrative Expense": "3,286",
"Goodwill": "267",
"Liabilities, Current": "2,059",
"Liabilities, Non-Current": "2,916",
"Other Assets": "201",
"Other Compr. Net Income": "26",
"Other Expenses": "4,505",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "9,544",
"Property, Plant and Equipment, Net": "9,846",
"Research and Development": "1,244"
},
"output_variables": {
"Liabilities": "4,975",
"Assets": "24,697",
"Expenses": "9,036",
"Revenues": "9,544",
"Stockholders Equity": "19,722",
"Net Income": "508",
"Comprehensive Net Income": "522",
"BaseVar": "24,139",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "225%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "7,507",
"Assets, Non-Current": "0.92",
"General and Administrative Expense": "3,418",
"Goodwill": "248",
"Liabilities, Current": "2,064",
"Liabilities, Non-Current": "8,640",
"Other Assets": "473",
"Other Compr. Net Income": "23",
"Other Expenses": "5,135",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,431",
"Property, Plant and Equipment, Net": "26,070",
"Research and Development": "2,047"
},
"output_variables": {
"Liabilities": "10,704",
"Assets": "34,299",
"Expenses": "10,599",
"Revenues": "10,431",
"Stockholders Equity": "23,595",
"Net Income": "-168",
"Comprehensive Net Income": "-157",
"BaseVar": "33,028",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "197%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,421",
"Assets, Non-Current": "13",
"General and Administrative Expense": "9,616",
"Goodwill": "229",
"Liabilities, Current": "2,565",
"Liabilities, Non-Current": "8,421",
"Other Assets": "40",
"Other Compr. Net Income": "31",
"Other Expenses": "175",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,986",
"Property, Plant and Equipment, Net": "26,028",
"Research and Development": "3,517"
},
"output_variables": {
"Liabilities": "10,986",
"Assets": "32,731",
"Expenses": "13,308",
"Revenues": "10,986",
"Stockholders Equity": "21,744",
"Net Income": "-2,322",
"Comprehensive Net Income": "-2,306",
"BaseVar": "34,021",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "185%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,189",
"Assets, Non-Current": "27",
"General and Administrative Expense": "10,989",
"Goodwill": "210",
"Liabilities, Current": "2,495",
"Liabilities, Non-Current": "7,205",
"Other Assets": "0",
"Other Compr. Net Income": "-74",
"Other Expenses": "342",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "13,723",
"Property, Plant and Equipment, Net": "25,266",
"Research and Development": "3,688"
},
"output_variables": {
"Liabilities": "9,701",
"Assets": "38,692",
"Expenses": "15,018",
"Revenues": "13,723",
"Stockholders Equity": "28,991",
"Net Income": "-1,296",
"Comprehensive Net Income": "-1,333",
"BaseVar": "38,604",
"ECR before LimitedLiability": "159%",
"Economic Capital Ratio": "207%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "12,157",
"Assets, Non-Current": "1,247",
"General and Administrative Expense": "12,368",
"Goodwill": "191",
"Liabilities, Current": "2,211",
"Liabilities, Non-Current": "9,872",
"Other Assets": "0",
"Other Compr. Net Income": "44",
"Other Expenses": "-10",
"Other Liabilities": "0",
"Other Net Income": "348",
"Other Revenues": "15,342",
"Property, Plant and Equipment, Net": "26,755",
"Research and Development": "4,355"
},
"output_variables": {
"Liabilities": "12,083",
"Assets": "40,350",
"Expenses": "16,712",
"Revenues": "15,342",
"Stockholders Equity": "28,266",
"Net Income": "-1,022",
"Comprehensive Net Income": "-1,000",
"BaseVar": "42,440",
"ECR before LimitedLiability": "144%",
"Economic Capital Ratio": "197%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "16,265",
"Assets, Non-Current": "1,135",
"General and Administrative Expense": "14,817",
"Goodwill": "172",
"Liabilities, Current": "2,534",
"Liabilities, Non-Current": "9,354",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "9.2",
"Other Liabilities": "0",
"Other Net Income": "-327",
"Other Revenues": "19,243",
"Property, Plant and Equipment, Net": "26,894",
"Research and Development": "4,169"
},
"output_variables": {
"Liabilities": "11,889",
"Assets": "44,466",
"Expenses": "18,995",
"Revenues": "19,243",
"Stockholders Equity": "32,577",
"Net Income": "-78",
"Comprehensive Net Income": "-78",
"BaseVar": "47,459",
"ECR before LimitedLiability": "158%",
"Economic Capital Ratio": "207%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "13,995",
"Assets, Non-Current": "2,271",
"General and Administrative Expense": "16,373",
"Goodwill": "153",
"Liabilities, Current": "3,072",
"Liabilities, Non-Current": "11,409",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7.7",
"Other Liabilities": "0",
"Other Net Income": "-187",
"Other Revenues": "18,568",
"Property, Plant and Equipment, Net": "28,442",
"Research and Development": "4,494"
},
"output_variables": {
"Liabilities": "14,481",
"Assets": "44,861",
"Expenses": "20,875",
"Revenues": "18,568",
"Stockholders Equity": "30,380",
"Net Income": "-2,494",
"Comprehensive Net Income": "-2,494",
"BaseVar": "49,485",
"ECR before LimitedLiability": "132%",
"Economic Capital Ratio": "189%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "16,041",
"General and Administrative Expense": "18,825",
"Goodwill": "134",
"Liabilities, Current": "4,197",
"Liabilities, Non-Current": "14,618",
"Other Assets": "58",
"Other Compr. Net Income": "0",
"Other Expenses": "4.6",
"Other Liabilities": "0",
"Other Net Income": "-22",
"Other Revenues": "17,472",
"Property, Plant and Equipment, Net": "27,576",
"Research and Development": "4,395"
},
"output_variables": {
"Liabilities": "18,815",
"Assets": "43,808",
"Expenses": "23,224",
"Revenues": "17,472",
"Stockholders Equity": "24,993",
"Net Income": "-5,775",
"Comprehensive Net Income": "-5,775",
"BaseVar": "51,671",
"ECR before LimitedLiability": "91%",
"Economic Capital Ratio": "161%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 1.6134079571310314,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000811641.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000811641.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000811641.svg"
},
{
"company_id": "0001307954",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001307954.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001307954.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001307954.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001307954_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001307954_main_keyfigs.svg",
"name": "Huntsman CORP",
"rank": 21,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001307954.svg",
"report_text": "The relative strengths and weaknesses of Huntsman CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Huntsman CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Huntsman CORP is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 26% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 20% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001307954_2024_Huntsman_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "-2.03",
"Liabilities": "-45.4",
"Stockholders Equity": "-67.7",
"ECR before LimitedLiability": "-63.6",
"Liabilities, Current": "2.22",
"Liabilities, Non-Current": "-45.6",
"Goodwill": "-21.9",
"Assets": "-28.8",
"Property, Plant and Equipment, Net": "24.7",
"Assets, Current": "-25.7",
"Assets, Non-Current": "-6.92",
"Other Assets": "7.77",
"Other Revenues": "5.95",
"Revenues": "5.95",
"Net Income": "8.75",
"Comprehensive Net Income": "8.76",
"Research and Development": "8.63",
"Other Net Income": "2.35",
"Other Expenses": "-53.9",
"General and Administrative Expense": "32.3",
"Economic Capital Ratio": "-61.6"
},
"2011": {
"Liabilities, Current": "30.9",
"Liabilities": "-25.6",
"Stockholders Equity": "-54.5",
"ECR before LimitedLiability": "24.0",
"Liabilities, Non-Current": "-77.2",
"Other Liabilities": "9.20",
"Property, Plant and Equipment, Net": "30.9",
"Assets": "-28.2",
"Other Assets": "3.25",
"Goodwill": "-16.8",
"Assets, Current": "-33.8",
"General and Administrative Expense": "36.1",
"Expenses": "18.4",
"Revenues": "31.4",
"Net Income": "32.1",
"Research and Development": "19.3",
"Other Expenses": "-66.2",
"Other Revenues": "31.4",
"Comprehensive Net Income": "31.9",
"Other Net Income": "-9.30",
"Economic Capital Ratio": "-38.0"
},
"2012": {
"Liabilities, Current": "13.8",
"Liabilities": "-31.2",
"Stockholders Equity": "-59.2",
"ECR before LimitedLiability": "-7.55",
"Liabilities, Non-Current": "-71.2",
"Other Liabilities": "19.2",
"Assets, Current": "-31.5",
"Assets": "-28.6",
"Other Assets": "2.75",
"Property, Plant and Equipment, Net": "31.2",
"Goodwill": "-18.5",
"Other Expenses": "-56.5",
"Expenses": "23.9",
"Revenues": "33.9",
"Net Income": "35.4",
"Research and Development": "20.7",
"General and Administrative Expense": "36.9",
"Other Revenues": "33.9",
"Other Net Income": "-4.05",
"Comprehensive Net Income": "35.2",
"Economic Capital Ratio": "-40.0"
},
"2013": {
"Liabilities, Current": "21.5",
"Liabilities": "-21.0",
"Stockholders Equity": "-52.4",
"ECR before LimitedLiability": "6.12",
"Other Liabilities": "12.2",
"Liabilities, Non-Current": "-60.4",
"Goodwill": "-18.7",
"Assets": "-28.2",
"Property, Plant and Equipment, Net": "33.3",
"Other Assets": "-2.40",
"Assets, Current": "-30.0",
"General and Administrative Expense": "37.9",
"Expenses": "16.6",
"Revenues": "36.1",
"Net Income": "36.8",
"Research and Development": "17.1",
"Other Expenses": "-54.6",
"Other Revenues": "36.1",
"Other Net Income": "-6.37",
"Comprehensive Net Income": "36.9",
"Economic Capital Ratio": "-34.0"
},
"2014": {
"Liabilities, Non-Current": "-71.6",
"Liabilities": "-13.1",
"Stockholders Equity": "-30.3",
"ECR before LimitedLiability": "26.7",
"Liabilities, Current": "26.5",
"Other Liabilities": "9.73",
"Assets, Current": "-25.2",
"Assets": "-16.6",
"Goodwill": "-20.4",
"Other Assets": "5.65",
"Property, Plant and Equipment, Net": "26.3",
"Other Expenses": "-52.5",
"Expenses": "26.2",
"Revenues": "26.4",
"Net Income": "29.2",
"Research and Development": "19.3",
"General and Administrative Expense": "30.4",
"Other Revenues": "26.4",
"Comprehensive Net Income": "28.9",
"Other Compr. Net Income": "-2.12",
"Economic Capital Ratio": "-22.7"
},
"2018": {
"Property, Plant and Equipment, Net": "13.3",
"Assets": "-28.2",
"Liabilities, Non-Current": "-43.5",
"Stockholders Equity": "-45.1",
"ECR before LimitedLiability": "17.4",
"Other Assets": "4.42",
"Assets, Current": "-29.2",
"Goodwill": "-12.5",
"Other Expenses": "16.1",
"Expenses": "10.1",
"Revenues": "53.8",
"Net Income": "56.2",
"Research and Development": "17.4",
"General and Administrative Expense": "-21.3",
"Other Revenues": "53.8",
"Other Liabilities": "15.2",
"Liabilities, Current": "21.9",
"Comprehensive Net Income": "56.1",
"Other Net Income": "-2.76",
"Other Compr. Net Income": "-2.64",
"Economic Capital Ratio": "-3.04"
},
"2019": {
"Liabilities, Non-Current": "-45.7",
"Liabilities": "-19.0",
"Stockholders Equity": "-30.6",
"ECR before LimitedLiability": "34.9",
"Other Liabilities": "15.1",
"Liabilities, Current": "8.16",
"Assets": "-12.2",
"Goodwill": "-11.0",
"Property, Plant and Equipment, Net": "7.38",
"Other Assets": "4.94",
"Assets, Current": "-12.3",
"Research and Development": "10.2",
"Expenses": "19.7",
"Revenues": "27.5",
"Net Income": "56.8",
"Other Expenses": "12.4",
"General and Administrative Expense": "-3.15",
"Other Revenues": "27.5",
"Other Net Income": "5.80",
"Comprehensive Net Income": "56.8",
"Economic Capital Ratio": "5.48"
},
"2020": {
"Liabilities, Current": "6.12",
"Liabilities": "-9.32",
"Stockholders Equity": "-25.8",
"ECR before LimitedLiability": "51.6",
"Liabilities, Non-Current": "-22.9",
"Other Liabilities": "6.44",
"Goodwill": "-4.59",
"Assets": "-12.1",
"Other Assets": "2.73",
"Assets, Current": "-16.1",
"Property, Plant and Equipment, Net": "6.04",
"Other Expenses": "11.2",
"Expenses": "7.95",
"Revenues": "20.3",
"Net Income": "43.9",
"Research and Development": "7.07",
"General and Administrative Expense": "-9.91",
"Other Revenues": "20.3",
"Comprehensive Net Income": "43.9",
"Other Net Income": "13.0",
"Economic Capital Ratio": "13.8"
},
"2021": {
"Liabilities, Non-Current": "-16.9",
"Liabilities": "3.08",
"Stockholders Equity": "-42.2",
"ECR before LimitedLiability": "16.0",
"Liabilities, Current": "8.61",
"Other Liabilities": "10.3",
"Assets, Current": "-19.5",
"Assets": "-22.4",
"Assets, Non-Current": "-0.410",
"Other Assets": "2.84",
"Goodwill": "-9.55",
"Property, Plant and Equipment, Net": "3.81",
"Other Revenues": "38.0",
"Revenues": "38.0",
"Net Income": "44.8",
"Other Expenses": "11.7",
"Comprehensive Net Income": "45.3",
"Research and Development": "10.9",
"Other Net Income": "5.86",
"General and Administrative Expense": "-21.7",
"Economic Capital Ratio": "11.7"
},
"2022": {
"Liabilities, Non-Current": "-17.4",
"Liabilities": "10.1",
"Stockholders Equity": "-33.2",
"ECR before LimitedLiability": "19.4",
"Other Liabilities": "11.5",
"Liabilities, Current": "14.9",
"Other Assets": "1.29",
"Assets": "-22.6",
"Assets, Current": "-18.2",
"Property, Plant and Equipment, Net": "3.77",
"Goodwill": "-10.4",
"General and Administrative Expense": "-22.7",
"Expenses": "-2.65",
"Revenues": "43.2",
"Net Income": "42.9",
"Research and Development": "10.6",
"Other Expenses": "10.8",
"Other Revenues": "43.2",
"Other Net Income": "2.41",
"Comprehensive Net Income": "42.6",
"Economic Capital Ratio": "8.92"
},
"2023": {
"Liabilities, Non-Current": "-25.5",
"Liabilities": "21.7",
"Stockholders Equity": "-8.17",
"ECR before LimitedLiability": "35.0",
"Other Liabilities": "9.25",
"Liabilities, Current": "35.2",
"Assets": "-14.8",
"Property, Plant and Equipment, Net": "8.35",
"Goodwill": "-8.69",
"Assets, Current": "-12.2",
"Assets, Non-Current": "-1.02",
"Other Expenses": "15.8",
"Expenses": "-5.76",
"Revenues": "37.9",
"Net Income": "32.9",
"Research and Development": "5.83",
"General and Administrative Expense": "-25.7",
"Other Revenues": "37.9",
"Other Net Income": "1.59",
"Comprehensive Net Income": "32.6",
"Economic Capital Ratio": "19.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001307954_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "4,008,000",
"Assets, Non-Current": "729,000",
"General and Administrative Expense": "861,000",
"Goodwill": "199,000",
"Liabilities, Current": "2,053,000",
"Liabilities, Non-Current": "4,493,000",
"Other Assets": "173,000",
"Other Compr. Net Income": "-15,000",
"Other Expenses": "8,086,000",
"Other Liabilities": "318,000",
"Other Net Income": "-122,000",
"Other Revenues": "9,252,000",
"Property, Plant and Equipment, Net": "3,605,000",
"Research and Development": "151,000"
},
"output_variables": {
"Liabilities": "6,864,000",
"Assets": "8,714,000",
"Expenses": "9,098,000",
"Revenues": "9,252,000",
"Stockholders Equity": "1,850,000",
"Net Income": "32,000",
"Comprehensive Net Income": "24,500",
"BaseVar": "17,032,500",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "3,946,000",
"Assets, Non-Current": "684,000",
"General and Administrative Expense": "921,000",
"Goodwill": "205,000",
"Liabilities, Current": "1,826,000",
"Liabilities, Non-Current": "4,742,000",
"Other Assets": "200,000",
"Other Compr. Net Income": "-269,000",
"Other Expenses": "9,886,000",
"Other Liabilities": "313,000",
"Other Net Income": "4,000",
"Other Revenues": "11,223,000",
"Property, Plant and Equipment, Net": "3,622,000",
"Research and Development": "166,000"
},
"output_variables": {
"Liabilities": "6,881,000",
"Assets": "8,657,000",
"Expenses": "10,973,000",
"Revenues": "11,223,000",
"Stockholders Equity": "1,776,000",
"Net Income": "254,000",
"Comprehensive Net Income": "119,500",
"BaseVar": "19,003,500",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4,119,000",
"Assets, Non-Current": "604,000",
"General and Administrative Expense": "951,000",
"Goodwill": "185,000",
"Liabilities, Current": "2,181,000",
"Liabilities, Non-Current": "4,575,000",
"Other Assets": "231,000",
"Other Compr. Net Income": "-195,000",
"Other Expenses": "9,408,000",
"Other Liabilities": "232,000",
"Other Net Income": "-303,000",
"Other Revenues": "11,187,000",
"Property, Plant and Equipment, Net": "3,745,000",
"Research and Development": "152,000"
},
"output_variables": {
"Liabilities": "6,988,000",
"Assets": "8,884,000",
"Expenses": "10,511,000",
"Revenues": "11,187,000",
"Stockholders Equity": "1,896,000",
"Net Income": "373,000",
"Comprehensive Net Income": "275,500",
"BaseVar": "19,034,000",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "118%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "4,159,000",
"Assets, Non-Current": "743,000",
"General and Administrative Expense": "942,000",
"Goodwill": "218,000",
"Liabilities, Current": "2,159,000",
"Liabilities, Non-Current": "4,581,000",
"Other Assets": "244,000",
"Other Compr. Net Income": "146,000",
"Other Expenses": "9,612,000",
"Other Liabilities": "319,000",
"Other Net Income": "-236,000",
"Other Revenues": "11,079,000",
"Property, Plant and Equipment, Net": "3,824,000",
"Research and Development": "140,000"
},
"output_variables": {
"Liabilities": "7,059,000",
"Assets": "9,188,000",
"Expenses": "10,694,000",
"Revenues": "11,079,000",
"Stockholders Equity": "2,129,000",
"Net Income": "149,000",
"Comprehensive Net Income": "222,000",
"BaseVar": "19,201,000",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "121%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "5,039,000",
"Assets, Non-Current": "888,000",
"General and Administrative Expense": "974,000",
"Goodwill": "217,000",
"Liabilities, Current": "2,332,000",
"Liabilities, Non-Current": "6,380,000",
"Other Assets": "435,000",
"Other Compr. Net Income": "-498,000",
"Other Expenses": "9,864,000",
"Other Liabilities": "339,000",
"Other Net Income": "-237,000",
"Other Revenues": "11,578,000",
"Property, Plant and Equipment, Net": "4,423,000",
"Research and Development": "158,000"
},
"output_variables": {
"Liabilities": "9,051,000",
"Assets": "11,002,000",
"Expenses": "10,996,000",
"Revenues": "11,578,000",
"Stockholders Equity": "1,951,000",
"Net Income": "345,000",
"Comprehensive Net Income": "96,000",
"BaseVar": "21,681,000",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "111%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "2,958,000",
"Assets, Non-Current": "1,079,000",
"General and Administrative Expense": "8,184,000",
"Goodwill": "494,000",
"Liabilities, Current": "1,907,000",
"Liabilities, Non-Current": "3,297,000",
"Other Assets": "358,000",
"Other Compr. Net Income": "-506,000",
"Other Expenses": "164,000",
"Other Liabilities": "0",
"Other Net Income": "-229,000",
"Other Revenues": "9,379,000",
"Property, Plant and Equipment, Net": "3,064,000",
"Research and Development": "152,000"
},
"output_variables": {
"Liabilities": "5,204,000",
"Assets": "7,953,000",
"Expenses": "8,500,000",
"Revenues": "9,379,000",
"Stockholders Equity": "2,749,000",
"Net Income": "650,000",
"Comprehensive Net Income": "397,000",
"BaseVar": "15,885,500",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "3,755,000",
"Assets, Non-Current": "1,383,000",
"General and Administrative Expense": "6,201,000",
"Goodwill": "473,000",
"Liabilities, Current": "2,037,000",
"Liabilities, Non-Current": "3,459,000",
"Other Assets": "326,000",
"Other Compr. Net Income": "-67,000",
"Other Expenses": "-48,000",
"Other Liabilities": "0",
"Other Net Income": "91,000",
"Other Revenues": "6,797,000",
"Property, Plant and Equipment, Net": "2,383,000",
"Research and Development": "137,000"
},
"output_variables": {
"Liabilities": "5,496,000",
"Assets": "8,320,000",
"Expenses": "6,290,000",
"Revenues": "6,797,000",
"Stockholders Equity": "2,824,000",
"Net Income": "598,000",
"Comprehensive Net Income": "564,500",
"BaseVar": "13,530,500",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "141%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,568,000",
"Assets, Non-Current": "1,366,000",
"General and Administrative Expense": "5,693,000",
"Goodwill": "986,000",
"Liabilities, Current": "2,191,000",
"Liabilities, Non-Current": "2,849,000",
"Other Assets": "288,000",
"Other Compr. Net Income": "-16,000",
"Other Expenses": "-197,000",
"Other Liabilities": "0",
"Other Net Income": "679,000",
"Other Revenues": "6,018,000",
"Property, Plant and Equipment, Net": "2,505,000",
"Research and Development": "135,000"
},
"output_variables": {
"Liabilities": "5,040,000",
"Assets": "8,713,000",
"Expenses": "5,631,000",
"Revenues": "6,018,000",
"Stockholders Equity": "3,673,000",
"Net Income": "1,066,000",
"Comprehensive Net Income": "1,058,000",
"BaseVar": "13,048,500",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "160%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,928,000",
"Assets, Non-Current": "1,563,000",
"General and Administrative Expense": "7,529,000",
"Goodwill": "1,119,000",
"Liabilities, Current": "2,212,000",
"Liabilities, Non-Current": "2,621,000",
"Other Assets": "206,000",
"Other Compr. Net Income": "84,000",
"Other Expenses": "188,000",
"Other Liabilities": "0",
"Other Net Income": "518,000",
"Other Revenues": "8,453,000",
"Property, Plant and Equipment, Net": "2,576,000",
"Research and Development": "150,000"
},
"output_variables": {
"Liabilities": "4,833,000",
"Assets": "9,392,000",
"Expenses": "7,867,000",
"Revenues": "8,453,000",
"Stockholders Equity": "4,559,000",
"Net Income": "1,104,000",
"Comprehensive Net Income": "1,146,000",
"BaseVar": "15,573,500",
"ECR before LimitedLiability": "104%",
"Economic Capital Ratio": "170%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "3,145,000",
"Assets, Non-Current": "1,485,000",
"General and Administrative Expense": "7,188,000",
"Goodwill": "1,066,000",
"Liabilities, Current": "1,951,000",
"Liabilities, Non-Current": "2,429,000",
"Other Assets": "147,000",
"Other Compr. Net Income": "-128,000",
"Other Expenses": "224,000",
"Other Liabilities": "0",
"Other Net Income": "37,000",
"Other Revenues": "8,023,000",
"Property, Plant and Equipment, Net": "2,377,000",
"Research and Development": "125,000"
},
"output_variables": {
"Liabilities": "4,380,000",
"Assets": "8,220,000",
"Expenses": "7,537,000",
"Revenues": "8,023,000",
"Stockholders Equity": "3,840,000",
"Net Income": "523,000",
"Comprehensive Net Income": "459,000",
"BaseVar": "14,162,500",
"ECR before LimitedLiability": "91%",
"Economic Capital Ratio": "161%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "2,314,000",
"Assets, Non-Current": "1,415,000",
"General and Administrative Expense": "5,894,000",
"Goodwill": "1,031,000",
"Liabilities, Current": "1,415,000",
"Liabilities, Non-Current": "2,355,000",
"Other Assets": "112,000",
"Other Compr. Net Income": "-29,000",
"Other Expenses": "82,000",
"Other Liabilities": "0",
"Other Net Income": "133,000",
"Other Revenues": "6,111,000",
"Property, Plant and Equipment, Net": "2,376,000",
"Research and Development": "115,000"
},
"output_variables": {
"Liabilities": "3,770,000",
"Assets": "7,248,000",
"Expenses": "6,091,000",
"Revenues": "6,111,000",
"Stockholders Equity": "3,478,000",
"Net Income": "153,000",
"Comprehensive Net Income": "138,500",
"BaseVar": "11,691,000",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": 6.0,
"value": 1.5997392219884028,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001307954.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001307954.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001307954.svg"
},
{
"company_id": "0000768408",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000768408.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000768408.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000768408.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000768408_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000768408_main_keyfigs.svg",
"name": "Cyanotech CORP",
"rank": 22,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000768408.svg",
"report_text": "The relative strengths and weaknesses of Cyanotech CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cyanotech CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Cyanotech CORP is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 32% points.
The company's Economic Capital Ratio, given in the ranking table, is 159%, being 19% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000768408_2024_Cyanotech_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "44.2",
"Liabilities": "64.9",
"Stockholders Equity": "41.4",
"ECR before LimitedLiability": "146",
"Liabilities, Non-Current": "9.21",
"Other Liabilities": "19.9",
"General and Administrative Expense": "39.9",
"Expenses": "8.05",
"Net Income": "58.1",
"Research and Development": "16.6",
"Other Expenses": "-54.2",
"Other Revenues": "59.5",
"Revenues": "59.5",
"Property, Plant and Equipment, Net": "7.85",
"Assets, Non-Current": "-1.81",
"Other Assets": "1.74",
"Goodwill": "-5.37",
"Assets, Current": "-1.96",
"Comprehensive Net Income": "58.0",
"Other Net Income": "-9.70",
"Economic Capital Ratio": "84.2"
},
"2012": {
"Liabilities, Current": "27.7",
"Liabilities": "65.1",
"Stockholders Equity": "30.6",
"ECR before LimitedLiability": "119",
"Liabilities, Non-Current": "15.4",
"Other Liabilities": "32.9",
"Assets, Current": "-2.73",
"Assets": "-3.23",
"Other Assets": "2.44",
"Assets, Non-Current": "-1.64",
"Property, Plant and Equipment, Net": "5.43",
"Goodwill": "-5.30",
"Other Expenses": "-52.3",
"Expenses": "10.3",
"Revenues": "63.6",
"Net Income": "72.5",
"Research and Development": "19.4",
"General and Administrative Expense": "37.4",
"Other Revenues": "63.6",
"Comprehensive Net Income": "72.6",
"Economic Capital Ratio": "87.0"
},
"2013": {
"Liabilities, Current": "36.1",
"Liabilities": "35.1",
"Stockholders Equity": "29.5",
"ECR before LimitedLiability": "102",
"Other Liabilities": "18.2",
"Liabilities, Non-Current": "-22.9",
"Goodwill": "-7.31",
"Assets": "1.96",
"Property, Plant and Equipment, Net": "10.5",
"Other Assets": "12.4",
"Assets, Current": "-7.17",
"General and Administrative Expense": "25.2",
"Expenses": "16.7",
"Revenues": "41.5",
"Net Income": "55.5",
"Research and Development": "13.0",
"Other Expenses": "-22.2",
"Other Revenues": "41.5",
"Other Net Income": "-3.50",
"Comprehensive Net Income": "55.4",
"Economic Capital Ratio": "61.8"
},
"2014": {
"Liabilities, Non-Current": "-12.0",
"Liabilities": "51.7",
"Stockholders Equity": "50.3",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "47.8",
"Other Liabilities": "15.6",
"Assets, Current": "-9.36",
"Assets": "4.25",
"Goodwill": "-10.3",
"Other Assets": "4.38",
"Assets, Non-Current": "-1.65",
"Property, Plant and Equipment, Net": "33.6",
"Other Expenses": "-33.6",
"Expenses": "8.85",
"Revenues": "37.9",
"Net Income": "49.3",
"Research and Development": "15.1",
"General and Administrative Expense": "27.8",
"Other Revenues": "37.9",
"Comprehensive Net Income": "49.4",
"Economic Capital Ratio": "61.7"
},
"2015": {
"Other Liabilities": "24.3",
"Liabilities": "68.2",
"Stockholders Equity": "39.3",
"ECR before LimitedLiability": "109",
"Liabilities, Current": "50.4",
"Liabilities, Non-Current": "-3.00",
"Assets, Current": "-13.1",
"Assets": "-6.51",
"Other Assets": "1.58",
"Goodwill": "-10.8",
"Assets, Non-Current": "-1.31",
"Property, Plant and Equipment, Net": "27.8",
"Research and Development": "12.2",
"Expenses": "-3.97",
"Revenues": "57.9",
"Net Income": "54.2",
"General and Administrative Expense": "11.1",
"Other Expenses": "-27.4",
"Other Revenues": "57.9",
"Comprehensive Net Income": "54.7",
"Economic Capital Ratio": "62.7"
},
"2016": {
"Liabilities, Non-Current": "26.8",
"Liabilities": "34.1",
"Stockholders Equity": "-4.68",
"ECR before LimitedLiability": "34.1",
"Liabilities, Current": "35.7",
"Other Liabilities": "-32.1",
"Property, Plant and Equipment, Net": "45.6",
"Assets": "-17.8",
"Assets, Non-Current": "-3.28",
"Assets, Current": "-24.3",
"Goodwill": "-15.4",
"Research and Development": "18.5",
"Expenses": "-7.23",
"Revenues": "45.1",
"Net Income": "32.2",
"General and Administrative Expense": "13.0",
"Other Expenses": "-35.8",
"Other Revenues": "45.1",
"Comprehensive Net Income": "32.5",
"Other Net Income": "-3.54",
"Economic Capital Ratio": "14.2"
},
"2017": {
"Other Liabilities": "-25.7",
"Liabilities": "39.4",
"Stockholders Equity": "-2.55",
"ECR before LimitedLiability": "38.2",
"Liabilities, Current": "32.6",
"Liabilities, Non-Current": "30.0",
"Assets, Non-Current": "-4.88",
"Assets": "-17.2",
"Assets, Current": "-16.6",
"Goodwill": "-15.5",
"Property, Plant and Equipment, Net": "29.5",
"Research and Development": "17.6",
"Expenses": "-8.16",
"Revenues": "55.9",
"Net Income": "36.4",
"Other Expenses": "31.0",
"General and Administrative Expense": "-52.5",
"Other Revenues": "55.9",
"Comprehensive Net Income": "35.9",
"Other Net Income": "-7.68",
"Economic Capital Ratio": "16.7"
},
"2018": {
"Liabilities, Non-Current": "26.5",
"Liabilities": "34.4",
"Stockholders Equity": "-7.31",
"ECR before LimitedLiability": "61.6",
"Other Liabilities": "-22.5",
"Liabilities, Current": "28.0",
"Property, Plant and Equipment, Net": "26.9",
"Assets": "-15.0",
"Assets, Current": "-14.2",
"Goodwill": "-11.6",
"Assets, Non-Current": "-7.83",
"Other Expenses": "16.9",
"Expenses": "-2.32",
"Revenues": "55.9",
"Net Income": "51.0",
"Research and Development": "15.7",
"General and Administrative Expense": "-33.9",
"Other Revenues": "55.9",
"Comprehensive Net Income": "51.4",
"Other Net Income": "-1.66",
"Economic Capital Ratio": "41.1"
},
"2019": {
"Liabilities, Non-Current": "-1.24",
"Liabilities": "19.6",
"Stockholders Equity": "-21.5",
"ECR before LimitedLiability": "43.9",
"Other Liabilities": "18.5",
"Liabilities, Current": "2.35",
"Assets, Non-Current": "-14.8",
"Assets": "-22.3",
"Goodwill": "-17.0",
"Property, Plant and Equipment, Net": "32.8",
"Assets, Current": "-14.8",
"Research and Development": "11.0",
"Expenses": "-6.43",
"Revenues": "45.5",
"Net Income": "44.4",
"Other Expenses": "12.1",
"General and Administrative Expense": "-27.4",
"Other Revenues": "45.5",
"Other Net Income": "5.70",
"Comprehensive Net Income": "44.5",
"Economic Capital Ratio": "14.4"
},
"2020": {
"Liabilities, Current": "22.9",
"Liabilities": "18.4",
"Stockholders Equity": "-30.5",
"ECR before LimitedLiability": "54.4",
"Liabilities, Non-Current": "-13.2",
"Other Liabilities": "7.88",
"Goodwill": "-14.7",
"Assets": "-23.8",
"Assets, Current": "-19.4",
"Assets, Non-Current": "-2.73",
"Property, Plant and Equipment, Net": "15.2",
"Other Expenses": "8.95",
"Expenses": "-12.7",
"Revenues": "46.8",
"Net Income": "39.2",
"Research and Development": "8.50",
"General and Administrative Expense": "-28.9",
"Other Revenues": "46.8",
"Comprehensive Net Income": "39.3",
"Other Net Income": "6.79",
"Economic Capital Ratio": "16.6"
},
"2021": {
"Liabilities, Non-Current": "-10.9",
"Liabilities": "22.6",
"Stockholders Equity": "-44.7",
"ECR before LimitedLiability": "19.2",
"Liabilities, Current": "21.3",
"Other Liabilities": "11.7",
"Assets, Current": "-19.1",
"Assets": "-27.7",
"Assets, Non-Current": "-5.11",
"Goodwill": "-17.8",
"Property, Plant and Equipment, Net": "13.0",
"Other Expenses": "13.5",
"Expenses": "-14.3",
"Revenues": "51.1",
"Net Income": "39.7",
"Research and Development": "12.0",
"General and Administrative Expense": "-38.4",
"Other Revenues": "51.1",
"Comprehensive Net Income": "39.7",
"Other Net Income": "5.15",
"Economic Capital Ratio": "14.9"
},
"2022": {
"Liabilities, Non-Current": "-7.32",
"Liabilities": "39.0",
"Stockholders Equity": "-20.6",
"ECR before LimitedLiability": "45.9",
"Other Liabilities": "13.3",
"Liabilities, Current": "33.4",
"Assets": "-20.5",
"Assets, Current": "-9.54",
"Property, Plant and Equipment, Net": "8.76",
"Assets, Non-Current": "-4.28",
"Goodwill": "-15.7",
"General and Administrative Expense": "-35.8",
"Expenses": "-11.6",
"Revenues": "57.1",
"Net Income": "44.2",
"Research and Development": "10.4",
"Other Expenses": "14.0",
"Other Revenues": "57.1",
"Other Net Income": "0.923",
"Comprehensive Net Income": "44.8",
"Economic Capital Ratio": "35.4"
},
"2023": {
"Liabilities, Non-Current": "0.180",
"Liabilities": "31.0",
"Stockholders Equity": "3.16",
"ECR before LimitedLiability": "34.2",
"Other Liabilities": "9.39",
"Liabilities, Current": "22.0",
"Other Assets": "-1.92",
"Assets": "-12.9",
"Property, Plant and Equipment, Net": "16.1",
"Goodwill": "-18.6",
"Assets, Current": "-0.713",
"Assets, Non-Current": "-3.30",
"Other Expenses": "15.4",
"Expenses": "-13.7",
"Revenues": "34.3",
"Net Income": "18.4",
"Research and Development": "4.87",
"General and Administrative Expense": "-32.1",
"Other Revenues": "34.3",
"Comprehensive Net Income": "18.3",
"Economic Capital Ratio": "19.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000768408_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "8,481",
"Assets, Non-Current": "287",
"General and Administrative Expense": "4,808",
"Goodwill": "0",
"Liabilities, Current": "2,196",
"Liabilities, Non-Current": "553",
"Other Assets": "535",
"Other Compr. Net Income": "0",
"Other Expenses": "9,941",
"Other Liabilities": "0",
"Other Net Income": "-66",
"Other Revenues": "16,827",
"Property, Plant and Equipment, Net": "4,557",
"Research and Development": "282"
},
"output_variables": {
"Liabilities": "2,749",
"Assets": "13,860",
"Expenses": "15,031",
"Revenues": "16,827",
"Stockholders Equity": "11,111",
"Net Income": "1,730",
"Comprehensive Net Income": "1,730",
"BaseVar": "24,266",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "238%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "11,419",
"Assets, Non-Current": "478",
"General and Administrative Expense": "6,494",
"Goodwill": "0",
"Liabilities, Current": "3,361",
"Liabilities, Non-Current": "400",
"Other Assets": "1,307",
"Other Compr. Net Income": "0",
"Other Expenses": "14,135",
"Other Liabilities": "12",
"Other Net Income": "-50",
"Other Revenues": "24,631",
"Property, Plant and Equipment, Net": "5,834",
"Research and Development": "320"
},
"output_variables": {
"Liabilities": "3,773",
"Assets": "19,038",
"Expenses": "20,949",
"Revenues": "24,631",
"Stockholders Equity": "15,265",
"Net Income": "3,632",
"Comprehensive Net Income": "3,632",
"BaseVar": "34,220",
"ECR before LimitedLiability": "215%",
"Economic Capital Ratio": "245%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "12,191",
"Assets, Non-Current": "772",
"General and Administrative Expense": "8,355",
"Goodwill": "0",
"Liabilities, Current": "2,885",
"Liabilities, Non-Current": "5,454",
"Other Assets": "6,789",
"Other Compr. Net Income": "0",
"Other Expenses": "14,648",
"Other Liabilities": "21",
"Other Net Income": "-111",
"Other Revenues": "27,581",
"Property, Plant and Equipment, Net": "8,835",
"Research and Development": "258"
},
"output_variables": {
"Liabilities": "8,360",
"Assets": "28,587",
"Expenses": "23,261",
"Revenues": "27,581",
"Stockholders Equity": "20,227",
"Net Income": "4,209",
"Comprehensive Net Income": "4,209",
"BaseVar": "43,950",
"ECR before LimitedLiability": "173%",
"Economic Capital Ratio": "216%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "12,584",
"Assets, Non-Current": "902",
"General and Administrative Expense": "10,884",
"Goodwill": "0",
"Liabilities, Current": "4,155",
"Liabilities, Non-Current": "5,263",
"Other Assets": "1,737",
"Other Compr. Net Income": "0",
"Other Expenses": "17,127",
"Other Liabilities": "8.0",
"Other Net Income": "-118",
"Other Revenues": "28,178",
"Property, Plant and Equipment, Net": "14,754",
"Research and Development": "469"
},
"output_variables": {
"Liabilities": "9,426",
"Assets": "29,977",
"Expenses": "28,480",
"Revenues": "28,178",
"Stockholders Equity": "20,551",
"Net Income": "-420",
"Comprehensive Net Income": "-420",
"BaseVar": "48,090",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "195%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "11,794",
"Assets, Non-Current": "846",
"General and Administrative Expense": "13,531",
"Goodwill": "0",
"Liabilities, Current": "4,315",
"Liabilities, Non-Current": "5,109",
"Other Assets": "3,521",
"Other Compr. Net Income": "0",
"Other Expenses": "19,692",
"Other Liabilities": "8.0",
"Other Net Income": "-93",
"Other Revenues": "33,809",
"Property, Plant and Equipment, Net": "14,754",
"Research and Development": "517"
},
"output_variables": {
"Liabilities": "9,432",
"Assets": "30,915",
"Expenses": "33,740",
"Revenues": "33,809",
"Stockholders Equity": "21,483",
"Net Income": "-24",
"Comprehensive Net Income": "-24",
"BaseVar": "53,994",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "199%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "12,655",
"Assets, Non-Current": "696",
"General and Administrative Expense": "12,018",
"Goodwill": "0",
"Liabilities, Current": "6,121",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "23,302",
"Other Liabilities": "7,198",
"Other Net Income": "-282",
"Other Revenues": "31,840",
"Property, Plant and Equipment, Net": "17,796",
"Research and Development": "633"
},
"output_variables": {
"Liabilities": "13,319",
"Assets": "31,147",
"Expenses": "35,953",
"Revenues": "31,840",
"Stockholders Equity": "17,828",
"Net Income": "-4,395",
"Comprehensive Net Income": "-4,395",
"BaseVar": "56,270",
"ECR before LimitedLiability": "90%",
"Economic Capital Ratio": "161%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "12,236",
"Assets, Non-Current": "213",
"General and Administrative Expense": "32,131",
"Goodwill": "0",
"Liabilities, Current": "6,032",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5.0",
"Other Liabilities": "6,522",
"Other Net Income": "-528",
"Other Revenues": "32,042",
"Property, Plant and Equipment, Net": "16,712",
"Research and Development": "593"
},
"output_variables": {
"Liabilities": "12,554",
"Assets": "29,161",
"Expenses": "32,729",
"Revenues": "32,042",
"Stockholders Equity": "16,607",
"Net Income": "-1,215",
"Comprehensive Net Income": "-1,215",
"BaseVar": "53,507",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,617",
"Assets, Non-Current": "291",
"General and Administrative Expense": "32,138",
"Goodwill": "0",
"Liabilities, Current": "5,707",
"Liabilities, Non-Current": "0",
"Other Assets": "65",
"Other Compr. Net Income": "0",
"Other Expenses": "-110",
"Other Liabilities": "5,893",
"Other Net Income": "-499",
"Other Revenues": "34,115",
"Property, Plant and Equipment, Net": "15,734",
"Research and Development": "563"
},
"output_variables": {
"Liabilities": "11,600",
"Assets": "29,707",
"Expenses": "32,591",
"Revenues": "34,115",
"Stockholders Equity": "18,107",
"Net Income": "1,025",
"Comprehensive Net Income": "1,025",
"BaseVar": "54,256",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "185%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "14,592",
"Assets, Non-Current": "282",
"General and Administrative Expense": "32,276",
"Goodwill": "0",
"Liabilities, Current": "9,488",
"Liabilities, Non-Current": "5,229",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "599",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "30,202",
"Property, Plant and Equipment, Net": "14,752",
"Research and Development": "923"
},
"output_variables": {
"Liabilities": "14,717",
"Assets": "29,626",
"Expenses": "33,798",
"Revenues": "30,202",
"Stockholders Equity": "14,909",
"Net Income": "-3,596",
"Comprehensive Net Income": "-3,596",
"BaseVar": "54,172",
"ECR before LimitedLiability": "76%",
"Economic Capital Ratio": "150%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "14,728",
"Assets, Non-Current": "4,017",
"General and Administrative Expense": "30,238",
"Goodwill": "0",
"Liabilities, Current": "6,359",
"Liabilities, Non-Current": "9,582",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "666",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "31,899",
"Property, Plant and Equipment, Net": "13,042",
"Research and Development": "608"
},
"output_variables": {
"Liabilities": "15,941",
"Assets": "31,787",
"Expenses": "31,512",
"Revenues": "31,899",
"Stockholders Equity": "15,846",
"Net Income": "387",
"Comprehensive Net Income": "387",
"BaseVar": "55,570",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "163%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "15,106",
"Assets, Non-Current": "3,637",
"General and Administrative Expense": "31,622",
"Goodwill": "0",
"Liabilities, Current": "5,808",
"Liabilities, Non-Current": "8,030",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "553",
"Other Liabilities": "0",
"Other Net Income": "1,389",
"Other Revenues": "32,345",
"Property, Plant and Equipment, Net": "12,136",
"Research and Development": "639"
},
"output_variables": {
"Liabilities": "13,838",
"Assets": "30,879",
"Expenses": "32,814",
"Revenues": "32,345",
"Stockholders Equity": "17,041",
"Net Income": "920",
"Comprehensive Net Income": "920",
"BaseVar": "55,632",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "174%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "16,264",
"Assets, Non-Current": "3,896",
"General and Administrative Expense": "32,682",
"Goodwill": "0",
"Liabilities, Current": "4,821",
"Liabilities, Non-Current": "7,737",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "28",
"Other Liabilities": "0",
"Other Net Income": "-392",
"Other Revenues": "35,968",
"Property, Plant and Equipment, Net": "11,885",
"Research and Development": "712"
},
"output_variables": {
"Liabilities": "12,558",
"Assets": "32,045",
"Expenses": "33,422",
"Revenues": "35,968",
"Stockholders Equity": "19,487",
"Net Income": "2,154",
"Comprehensive Net Income": "2,154",
"BaseVar": "57,192",
"ECR before LimitedLiability": "129%",
"Economic Capital Ratio": "188%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "13,496",
"Assets, Non-Current": "4,866",
"General and Administrative Expense": "25,328",
"Goodwill": "0",
"Liabilities, Current": "8,103",
"Liabilities, Non-Current": "5,278",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "520",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "23,178",
"Property, Plant and Equipment, Net": "11,366",
"Research and Development": "770"
},
"output_variables": {
"Liabilities": "13,381",
"Assets": "29,728",
"Expenses": "26,618",
"Revenues": "23,178",
"Stockholders Equity": "16,347",
"Net Income": "-3,440",
"Comprehensive Net Income": "-3,440",
"BaseVar": "46,452",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "159%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 1.5920697837582094,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000768408.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000768408.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000768408.svg"
},
{
"company_id": "0001386570",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001386570.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001386570.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001386570.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001386570_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001386570_main_keyfigs.svg",
"name": "Niagen Bioscience Inc",
"rank": 23,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001386570.svg",
"report_text": "The relative strengths and weaknesses of Niagen Bioscience Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Niagen Bioscience Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 73% points.The greatest weakness of Niagen Bioscience Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 70% points.
The company's Economic Capital Ratio, given in the ranking table, is 156%, being 16% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001386570_2024_Niagen_Bioscience_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities": "7.56",
"Stockholders Equity": "-10.8",
"ECR before LimitedLiability": "-18.3",
"Liabilities, Non-Current": "3.72",
"Other Liabilities": "3.91",
"Property, Plant and Equipment, Net": "-3.30",
"Assets": "-28.5",
"Assets, Non-Current": "-4.22",
"Other Assets": "-0.678",
"Goodwill": "-8.77",
"Assets, Current": "-9.16",
"General and Administrative Expense": "-102",
"Expenses": "-30.9",
"Revenues": "9.52",
"Net Income": "-15.5",
"Research and Development": "9.81",
"Other Expenses": "17.7",
"Other Revenues": "9.52",
"Comprehensive Net Income": "-15.6",
"Other Net Income": "-3.94",
"Economic Capital Ratio": "-80.3"
},
"2012": {
"Liabilities, Current": "-3.43",
"Liabilities": "6.79",
"Stockholders Equity": "-12.2",
"ECR before LimitedLiability": "-53.5",
"Liabilities, Non-Current": "3.82",
"Other Liabilities": "6.34",
"Assets, Current": "-7.18",
"Assets": "-34.0",
"Other Assets": "-1.13",
"Assets, Non-Current": "-4.98",
"Property, Plant and Equipment, Net": "-7.24",
"Goodwill": "-10.0",
"Other Expenses": "20.9",
"Expenses": "-31.1",
"Revenues": "7.55",
"Net Income": "-12.2",
"Research and Development": "11.0",
"General and Administrative Expense": "-110",
"Other Revenues": "7.55",
"Comprehensive Net Income": "-12.2",
"Economic Capital Ratio": "-86.0"
},
"2013": {
"Liabilities, Current": "10.9",
"Liabilities": "55.5",
"Stockholders Equity": "4.29",
"ECR before LimitedLiability": "29.8",
"Other Liabilities": "21.9",
"Liabilities, Non-Current": "25.6",
"Goodwill": "-18.8",
"Assets": "-26.0",
"Assets, Non-Current": "23.1",
"Property, Plant and Equipment, Net": "-6.61",
"Other Assets": "-7.78",
"Assets, Current": "-13.1",
"General and Administrative Expense": "-93.8",
"Expenses": "-35.4",
"Revenues": "50.9",
"Net Income": "2.23",
"Research and Development": "22.2",
"Other Expenses": "51.8",
"Other Revenues": "50.9",
"Other Net Income": "-5.03",
"Economic Capital Ratio": "-10.4"
},
"2019": {
"Liabilities, Non-Current": "3.11",
"Liabilities": "5.04",
"Stockholders Equity": "-43.1",
"Other Liabilities": "0.438",
"Liabilities, Current": "0.496",
"Assets, Non-Current": "-17.8",
"Assets": "-61.2",
"Goodwill": "-22.7",
"Property, Plant and Equipment, Net": "-21.4",
"Other Assets": "0.138",
"Research and Development": "0.572",
"Expenses": "-56.7",
"Revenues": "7.32",
"Net Income": "-5.67",
"Other Expenses": "2.12",
"General and Administrative Expense": "-79.9",
"Other Revenues": "7.32",
"ECR before LimitedLiability": "-22.2",
"Other Net Income": "0.425",
"Comprehensive Net Income": "-5.51",
"Economic Capital Ratio": "-51.6"
},
"2020": {
"Liabilities, Current": "8.43",
"Liabilities": "11.5",
"Stockholders Equity": "-92.5",
"ECR before LimitedLiability": "-15.1",
"Liabilities, Non-Current": "11.1",
"Other Liabilities": "-8.49",
"Goodwill": "-34.5",
"Assets": "-83.2",
"Assets, Current": "-33.4",
"Assets, Non-Current": "-25.9",
"Property, Plant and Equipment, Net": "-37.6",
"Other Expenses": "8.72",
"Expenses": "-81.6",
"Revenues": "20.4",
"Net Income": "3.13",
"Research and Development": "7.70",
"General and Administrative Expense": "-101",
"Other Revenues": "20.4",
"Comprehensive Net Income": "3.35",
"Other Net Income": "8.45",
"Economic Capital Ratio": "-52.9"
},
"2021": {
"Liabilities, Non-Current": "29.4",
"Liabilities": "36.2",
"Stockholders Equity": "-72.4",
"ECR before LimitedLiability": "-33.7",
"Liabilities, Current": "11.4",
"Assets, Current": "-11.2",
"Assets": "-60.2",
"Assets, Non-Current": "-16.2",
"Other Assets": "2.46",
"Goodwill": "-33.0",
"Property, Plant and Equipment, Net": "-26.8",
"Other Expenses": "23.1",
"Expenses": "-58.3",
"Revenues": "37.9",
"Net Income": "-5.28",
"Research and Development": "12.7",
"General and Administrative Expense": "-84.8",
"Other Revenues": "37.9",
"Comprehensive Net Income": "-5.29",
"Other Net Income": "1.25",
"Economic Capital Ratio": "-38.1"
},
"2022": {
"Liabilities, Non-Current": "33.2",
"Liabilities": "51.3",
"Stockholders Equity": "-58.3",
"ECR before LimitedLiability": "-5.91",
"Other Liabilities": "3.08",
"Liabilities, Current": "17.3",
"Assets": "-52.5",
"Assets, Current": "2.85",
"Property, Plant and Equipment, Net": "-25.5",
"Assets, Non-Current": "-16.6",
"Goodwill": "-30.1",
"General and Administrative Expense": "-73.6",
"Expenses": "-50.2",
"Revenues": "52.5",
"Net Income": "18.1",
"Research and Development": "8.44",
"Other Expenses": "21.1",
"Other Revenues": "52.5",
"Other Net Income": "7.35",
"Comprehensive Net Income": "18.9",
"Economic Capital Ratio": "-16.4"
},
"2023": {
"Liabilities, Non-Current": "36.4",
"Liabilities": "71.4",
"Stockholders Equity": "-33.7",
"ECR before LimitedLiability": "31.1",
"Other Liabilities": "3.19",
"Liabilities, Current": "36.3",
"Other Assets": "-2.87",
"Assets": "-42.5",
"Property, Plant and Equipment, Net": "-22.8",
"Goodwill": "-25.4",
"Assets, Current": "25.1",
"Assets, Non-Current": "-19.2",
"Other Expenses": "25.9",
"Expenses": "-46.2",
"Revenues": "73.0",
"Net Income": "37.0",
"Research and Development": "2.00",
"General and Administrative Expense": "-70.3",
"Other Revenues": "73.0",
"Comprehensive Net Income": "36.8",
"Economic Capital Ratio": "15.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001386570_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "4,953",
"Assets, Non-Current": "144",
"General and Administrative Expense": "15,977",
"Goodwill": "100",
"Liabilities, Current": "3,343",
"Liabilities, Non-Current": "0",
"Other Assets": "-100",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-31",
"Other Revenues": "8,113",
"Property, Plant and Equipment, Net": "1,172",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,343",
"Assets": "6,270",
"Expenses": "15,977",
"Revenues": "8,113",
"Stockholders Equity": "2,927",
"Net Income": "-7,895",
"Comprehensive Net Income": "-7,895",
"BaseVar": "16,867",
"ECR before LimitedLiability": "-81%",
"Economic Capital Ratio": "73%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,927",
"Assets, Non-Current": "171",
"General and Administrative Expense": "23,247",
"Goodwill": "136",
"Liabilities, Current": "4,763",
"Liabilities, Non-Current": "0",
"Other Assets": "-136",
"Other Compr. Net Income": "0",
"Other Expenses": "-29",
"Other Liabilities": "0",
"Other Net Income": "-23",
"Other Revenues": "11,610",
"Property, Plant and Equipment, Net": "936",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,763",
"Assets": "9,035",
"Expenses": "23,218",
"Revenues": "11,610",
"Stockholders Equity": "4,272",
"Net Income": "-11,630",
"Comprehensive Net Income": "-11,630",
"BaseVar": "24,324",
"ECR before LimitedLiability": "-84%",
"Economic Capital Ratio": "72%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "5,791",
"Assets, Non-Current": "2,133",
"General and Administrative Expense": "14,502",
"Goodwill": "202",
"Liabilities, Current": "2,838",
"Liabilities, Non-Current": "0",
"Other Assets": "-202",
"Other Compr. Net Income": "0",
"Other Expenses": "45",
"Other Liabilities": "0",
"Other Net Income": "-33",
"Other Revenues": "10,161",
"Property, Plant and Equipment, Net": "1,063",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,838",
"Assets": "8,987",
"Expenses": "14,547",
"Revenues": "10,161",
"Stockholders Equity": "6,149",
"Net Income": "-4,420",
"Comprehensive Net Income": "-4,420",
"BaseVar": "18,283",
"ECR before LimitedLiability": "68%",
"Economic Capital Ratio": "144%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "33,518",
"Assets, Non-Current": "1,653",
"General and Administrative Expense": "73,046",
"Goodwill": "1,311",
"Liabilities, Current": "15,063",
"Liabilities, Non-Current": "848",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "125",
"Other Liabilities": "3,891",
"Other Net Income": "-847",
"Other Revenues": "46,291",
"Property, Plant and Equipment, Net": "3,765",
"Research and Development": "4,420"
},
"output_variables": {
"Liabilities": "19,802",
"Assets": "40,247",
"Expenses": "77,591",
"Revenues": "46,291",
"Stockholders Equity": "20,445",
"Net Income": "-32,147",
"Comprehensive Net Income": "-32,147",
"BaseVar": "92,389",
"ECR before LimitedLiability": "-14%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "32,219",
"Assets, Non-Current": "1,851",
"General and Administrative Expense": "75,379",
"Goodwill": "1,082",
"Liabilities, Current": "16,476",
"Liabilities, Non-Current": "997",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "4,461",
"Other Net Income": "-71",
"Other Revenues": "59,257",
"Property, Plant and Equipment, Net": "3,206",
"Research and Development": "3,732"
},
"output_variables": {
"Liabilities": "21,934",
"Assets": "38,358",
"Expenses": "79,111",
"Revenues": "59,257",
"Stockholders Equity": "16,424",
"Net Income": "-19,925",
"Comprehensive Net Income": "-19,925",
"BaseVar": "99,366",
"ECR before LimitedLiability": "8.5%",
"Economic Capital Ratio": "93%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "48,905",
"Assets, Non-Current": "5,075",
"General and Administrative Expense": "90,690",
"Goodwill": "857",
"Liabilities, Current": "17,613",
"Liabilities, Non-Current": "4,154",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "55",
"Other Liabilities": "4,346",
"Other Net Income": "0",
"Other Revenues": "67,449",
"Property, Plant and Equipment, Net": "3,003",
"Research and Development": "3,832"
},
"output_variables": {
"Liabilities": "26,113",
"Assets": "57,840",
"Expenses": "94,577",
"Revenues": "67,449",
"Stockholders Equity": "31,727",
"Net Income": "-27,128",
"Comprehensive Net Income": "-27,128",
"BaseVar": "122,990",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "121%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "46,567",
"Assets, Non-Current": "4,020",
"General and Administrative Expense": "85,852",
"Goodwill": "671",
"Liabilities, Current": "17,869",
"Liabilities, Non-Current": "3,539",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "3,977",
"Other Net Income": "2,088",
"Other Revenues": "72,050",
"Property, Plant and Equipment, Net": "2,799",
"Research and Development": "4,826"
},
"output_variables": {
"Liabilities": "25,385",
"Assets": "54,057",
"Expenses": "90,678",
"Revenues": "72,050",
"Stockholders Equity": "28,672",
"Net Income": "-16,540",
"Comprehensive Net Income": "-16,540",
"BaseVar": "122,129",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "136%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "49,534",
"Assets, Non-Current": "2,783",
"General and Administrative Expense": "84,211",
"Goodwill": "510",
"Liabilities, Current": "20,622",
"Liabilities, Non-Current": "2,563",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "3,323",
"Other Net Income": "661",
"Other Revenues": "83,570",
"Property, Plant and Equipment, Net": "2,137",
"Research and Development": "4,958"
},
"output_variables": {
"Liabilities": "26,508",
"Assets": "54,964",
"Expenses": "89,169",
"Revenues": "83,570",
"Stockholders Equity": "28,456",
"Net Income": "-4,938",
"Comprehensive Net Income": "-4,938",
"BaseVar": "127,436",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "156%"
}
}
},
"top_rated": false,
"trend": 11.0,
"value": 1.560392122721905,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001386570.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001386570.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001386570.svg"
},
{
"company_id": "0001522767",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001522767.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001522767.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001522767.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001522767_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001522767_main_keyfigs.svg",
"name": "Marimed INC",
"rank": 24,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001522767.svg",
"report_text": "The relative strengths and weaknesses of Marimed INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Marimed INC compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 39% points.The greatest weakness of Marimed INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 56% points.
The company's Economic Capital Ratio, given in the ranking table, is 146%, being 5.6% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001522767_2024_Marimed_INC.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "-19.6",
"Liabilities": "-49.8",
"ECR before LimitedLiability": "13.6",
"Liabilities, Current": "-44.0",
"Liabilities, Non-Current": "14.0",
"Assets, Non-Current": "-1.95",
"Assets": "37.0",
"Other Assets": "1.70",
"Assets, Current": "-17.2",
"Goodwill": "-10.7",
"Property, Plant and Equipment, Net": "66.9",
"Research and Development": "10.5",
"Expenses": "44.2",
"Net Income": "32.5",
"Other Expenses": "5.96",
"General and Administrative Expense": "25.3",
"Other Revenues": "-12.6",
"Revenues": "-12.6",
"Comprehensive Net Income": "32.3",
"Other Net Income": "3.21",
"Economic Capital Ratio": "-7.96"
},
"2018": {
"Liabilities, Non-Current": "14.3",
"Liabilities": "3.94",
"Stockholders Equity": "64.9",
"ECR before LimitedLiability": "89.6",
"Other Liabilities": "-23.2",
"Liabilities, Current": "9.68",
"Property, Plant and Equipment, Net": "21.9",
"Assets": "35.2",
"Other Assets": "32.4",
"Assets, Current": "-6.79",
"Goodwill": "-4.43",
"Other Expenses": "4.51",
"Expenses": "30.8",
"Revenues": "-15.4",
"Net Income": "25.6",
"Research and Development": "8.77",
"General and Administrative Expense": "17.4",
"Other Revenues": "-15.4",
"Comprehensive Net Income": "25.7",
"Other Net Income": "10.0",
"Economic Capital Ratio": "69.1"
},
"2019": {
"Liabilities, Non-Current": "3.17",
"Liabilities": "-2.98",
"Stockholders Equity": "-24.5",
"ECR before LimitedLiability": "-46.8",
"Other Liabilities": "-1.91",
"Liabilities, Current": "-4.66",
"Assets, Non-Current": "-8.47",
"Assets": "-23.9",
"Goodwill": "-12.8",
"Property, Plant and Equipment, Net": "32.5",
"Other Assets": "4.61",
"Assets, Current": "-24.6",
"Other Revenues": "-1.53",
"Revenues": "-1.53",
"Net Income": "-19.2",
"Research and Development": "6.33",
"Comprehensive Net Income": "-19.2",
"General and Administrative Expense": "16.1",
"Other Expenses": "-19.2",
"Other Net Income": "-17.6",
"Economic Capital Ratio": "-76.2"
},
"2020": {
"Liabilities, Current": "-2.25",
"Liabilities": "-28.9",
"Stockholders Equity": "-40.8",
"ECR before LimitedLiability": "23.5",
"Liabilities, Non-Current": "19.9",
"Other Liabilities": "-49.8",
"Goodwill": "-13.5",
"Assets": "-15.3",
"Other Assets": "2.98",
"Assets, Current": "-29.5",
"Assets, Non-Current": "-6.74",
"Property, Plant and Equipment, Net": "47.2",
"Expenses": "23.4",
"Revenues": "18.8",
"Net Income": "36.2",
"Research and Development": "9.02",
"General and Administrative Expense": "15.8",
"Other Revenues": "18.8",
"Comprehensive Net Income": "36.3",
"Other Net Income": "-6.67",
"Economic Capital Ratio": "-14.4"
},
"2023": {
"Liabilities, Non-Current": "22.4",
"Liabilities": "14.7",
"Stockholders Equity": "-10.1",
"ECR before LimitedLiability": "20.7",
"Other Liabilities": "-55.5",
"Liabilities, Current": "39.2",
"Assets": "-14.6",
"Property, Plant and Equipment, Net": "27.7",
"Goodwill": "-8.95",
"Assets, Current": "-17.4",
"Assets, Non-Current": "-8.27",
"Other Expenses": "-2.90",
"Expenses": "2.65",
"Revenues": "31.4",
"Net Income": "22.2",
"Research and Development": "7.53",
"General and Administrative Expense": "-1.84",
"Other Revenues": "31.4",
"Other Net Income": "-10.5",
"Comprehensive Net Income": "22.1",
"Economic Capital Ratio": "5.59"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001522767_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "5,089",
"Assets, Non-Current": "580",
"General and Administrative Expense": "1,439",
"Goodwill": "0",
"Liabilities, Current": "15,422",
"Liabilities, Non-Current": "240",
"Other Assets": "579",
"Other Compr. Net Income": "0",
"Other Expenses": "3,423",
"Other Liabilities": "5,532",
"Other Net Income": "2,235",
"Other Revenues": "6,068",
"Property, Plant and Equipment, Net": "25,955",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "21,195",
"Assets": "32,202",
"Expenses": "4,862",
"Revenues": "6,068",
"Stockholders Equity": "11,007",
"Net Income": "3,441",
"Comprehensive Net Income": "3,441",
"BaseVar": "33,281",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "15,709",
"Assets, Non-Current": "83",
"General and Administrative Expense": "14,244",
"Goodwill": "185",
"Liabilities, Current": "9,889",
"Liabilities, Non-Current": "338",
"Other Assets": "32,884",
"Other Compr. Net Income": "0",
"Other Expenses": "2,964",
"Other Liabilities": "10,969",
"Other Net Income": "7,953",
"Other Revenues": "11,852",
"Property, Plant and Equipment, Net": "34,100",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "21,196",
"Assets": "82,961",
"Expenses": "17,208",
"Revenues": "11,852",
"Stockholders Equity": "61,764",
"Net Income": "2,597",
"Comprehensive Net Income": "2,597",
"BaseVar": "70,585",
"ECR before LimitedLiability": "167%",
"Economic Capital Ratio": "213%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "7,377",
"Assets, Non-Current": "5,963",
"General and Administrative Expense": "35,789",
"Goodwill": "2,364",
"Liabilities, Current": "36,720",
"Liabilities, Non-Current": "5,500",
"Other Assets": "3,075",
"Other Compr. Net Income": "0",
"Other Expenses": "51,414",
"Other Liabilities": "13,023",
"Other Net Income": "-40,283",
"Other Revenues": "45,605",
"Property, Plant and Equipment, Net": "42,792",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "55,244",
"Assets": "61,572",
"Expenses": "87,203",
"Revenues": "45,605",
"Stockholders Equity": "6,328",
"Net Income": "-81,881",
"Comprehensive Net Income": "-81,881",
"BaseVar": "144,953",
"ECR before LimitedLiability": "-125%",
"Economic Capital Ratio": "60%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "21,043",
"Assets, Non-Current": "5,328",
"General and Administrative Expense": "29,470",
"Goodwill": "2,229",
"Liabilities, Current": "23,227",
"Liabilities, Non-Current": "4,922",
"Other Assets": "2,209",
"Other Compr. Net Income": "0",
"Other Expenses": "8,962",
"Other Liabilities": "25,471",
"Other Net Income": "-10,034",
"Other Revenues": "50,895",
"Property, Plant and Equipment, Net": "45,637",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "53,620",
"Assets": "76,445",
"Expenses": "38,432",
"Revenues": "50,895",
"Stockholders Equity": "22,825",
"Net Income": "2,429",
"Comprehensive Net Income": "2,429",
"BaseVar": "114,713",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "51,432",
"Assets, Non-Current": "22,253",
"General and Administrative Expense": "104,811",
"Goodwill": "29,005",
"Liabilities, Current": "30,862",
"Liabilities, Non-Current": "8,555",
"Other Assets": "4,330",
"Other Compr. Net Income": "0",
"Other Expenses": "38,813",
"Other Liabilities": "67,792",
"Other Net Income": "-20,981",
"Other Revenues": "148,598",
"Property, Plant and Equipment, Net": "89,103",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "107,209",
"Assets": "196,123",
"Expenses": "143,624",
"Revenues": "148,598",
"Stockholders Equity": "88,914",
"Net Income": "-16,007",
"Comprehensive Net Income": "-16,007",
"BaseVar": "308,268",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.4571542196249332,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001522767.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001522767.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001522767.svg"
},
{
"company_id": "0001708035",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001708035.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001708035.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001708035.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001708035_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001708035_main_keyfigs.svg",
"name": "Ecovyst Inc",
"rank": 25,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001708035.svg",
"report_text": "The relative strengths and weaknesses of Ecovyst Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ecovyst Inc compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 27% points.The greatest weakness of Ecovyst Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 66% points.
The company's Economic Capital Ratio, given in the ranking table, is 146%, being 5.5% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001708035_2024_Ecovyst_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "9.19",
"Liabilities": "-37.3",
"ECR before LimitedLiability": "9.85",
"Liabilities, Current": "21.9",
"Liabilities, Non-Current": "-79.3",
"Assets, Non-Current": "8.57",
"Assets": "26.7",
"Assets, Current": "-23.3",
"Goodwill": "47.0",
"Property, Plant and Equipment, Net": "9.83",
"Research and Development": "12.1",
"Expenses": "35.2",
"Net Income": "26.2",
"Other Expenses": "-8.19",
"General and Administrative Expense": "31.2",
"Other Revenues": "-3.05",
"Revenues": "-3.05",
"Comprehensive Net Income": "26.6",
"Other Compr. Net Income": "0.353",
"Other Net Income": "-4.72",
"Economic Capital Ratio": "-11.7"
},
"2018": {
"Liabilities, Non-Current": "-80.9",
"Liabilities": "-41.6",
"Stockholders Equity": "-5.97",
"ECR before LimitedLiability": "19.8",
"Other Liabilities": "9.26",
"Liabilities, Current": "19.2",
"Property, Plant and Equipment, Net": "13.6",
"Assets": "22.6",
"Assets, Current": "-25.1",
"Goodwill": "47.5",
"Assets, Non-Current": "5.14",
"Other Expenses": "6.75",
"Expenses": "34.4",
"Revenues": "-2.65",
"Net Income": "31.8",
"Research and Development": "11.4",
"General and Administrative Expense": "14.6",
"Other Revenues": "-2.65",
"Comprehensive Net Income": "31.4",
"Other Net Income": "0.385",
"Economic Capital Ratio": "-0.700"
},
"2019": {
"Liabilities, Non-Current": "-71.3",
"Liabilities": "-35.1",
"Stockholders Equity": "-1.31",
"ECR before LimitedLiability": "42.5",
"Other Liabilities": "3.07",
"Liabilities, Current": "23.8",
"Assets, Non-Current": "3.03",
"Assets": "21.3",
"Goodwill": "41.8",
"Property, Plant and Equipment, Net": "12.8",
"Assets, Current": "-22.2",
"Research and Development": "8.47",
"Expenses": "33.6",
"Revenues": "-2.25",
"Net Income": "36.1",
"Other Expenses": "4.19",
"General and Administrative Expense": "19.5",
"Other Revenues": "-2.25",
"Other Net Income": "4.42",
"Comprehensive Net Income": "36.4",
"Economic Capital Ratio": "13.0"
},
"2020": {
"Liabilities, Current": "18.1",
"Liabilities": "-32.0",
"Stockholders Equity": "-14.3",
"ECR before LimitedLiability": "27.7",
"Liabilities, Non-Current": "-60.4",
"Other Liabilities": "5.16",
"Goodwill": "35.4",
"Assets": "8.82",
"Assets, Current": "-30.4",
"Assets, Non-Current": "7.02",
"Property, Plant and Equipment, Net": "16.2",
"Other Expenses": "-2.54",
"Expenses": "18.8",
"Revenues": "-3.37",
"Net Income": "16.9",
"Research and Development": "7.44",
"General and Administrative Expense": "13.6",
"Other Revenues": "-3.37",
"Comprehensive Net Income": "16.8",
"Other Net Income": "1.70",
"Economic Capital Ratio": "-10.1"
},
"2021": {
"Liabilities, Non-Current": "-63.6",
"Liabilities": "-42.5",
"Stockholders Equity": "-26.1",
"ECR before LimitedLiability": "-19.0",
"Liabilities, Current": "9.78",
"Other Liabilities": "6.95",
"Assets, Current": "-29.7",
"Assets": "4.27",
"Assets, Non-Current": "16.3",
"Goodwill": "12.7",
"Property, Plant and Equipment, Net": "18.5",
"Other Expenses": "6.45",
"Expenses": "29.1",
"Revenues": "-4.42",
"Net Income": "16.5",
"Research and Development": "9.50",
"General and Administrative Expense": "11.9",
"Other Revenues": "-4.42",
"Comprehensive Net Income": "17.0",
"Other Net Income": "-6.77",
"Economic Capital Ratio": "-23.3"
},
"2022": {
"Liabilities, Non-Current": "-62.8",
"Liabilities": "-33.5",
"Stockholders Equity": "-19.9",
"ECR before LimitedLiability": "2.90",
"Other Liabilities": "8.01",
"Liabilities, Current": "15.2",
"Assets": "3.42",
"Assets, Current": "-24.7",
"Property, Plant and Equipment, Net": "14.4",
"Assets, Non-Current": "14.7",
"Goodwill": "9.59",
"General and Administrative Expense": "8.56",
"Expenses": "23.0",
"Revenues": "3.20",
"Net Income": "30.0",
"Research and Development": "8.81",
"Other Expenses": "4.82",
"Other Revenues": "3.20",
"Other Net Income": "3.05",
"Comprehensive Net Income": "30.7",
"Economic Capital Ratio": "-7.60"
},
"2023": {
"Liabilities, Non-Current": "-66.1",
"Liabilities": "-23.4",
"Stockholders Equity": "-1.94",
"ECR before LimitedLiability": "20.7",
"Other Liabilities": "6.46",
"Liabilities, Current": "27.3",
"Other Assets": "-1.53",
"Assets": "13.3",
"Property, Plant and Equipment, Net": "15.1",
"Goodwill": "10.5",
"Assets, Current": "-17.7",
"Assets, Non-Current": "12.5",
"Other Expenses": "8.14",
"Expenses": "21.6",
"Revenues": "2.68",
"Net Income": "26.2",
"Research and Development": "5.40",
"General and Administrative Expense": "7.39",
"Other Revenues": "2.68",
"Comprehensive Net Income": "25.9",
"Economic Capital Ratio": "5.50"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001708035_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "548,968",
"Assets, Non-Current": "544,003",
"General and Administrative Expense": "145,107",
"Goodwill": "2,092,100",
"Liabilities, Current": "477,745",
"Liabilities, Non-Current": "2,305,791",
"Other Assets": "0",
"Other Compr. Net Income": "57,062",
"Other Expenses": "1,219,337",
"Other Liabilities": "0",
"Other Net Income": "-49,094",
"Other Revenues": "1,472,101",
"Property, Plant and Equipment, Net": "1,230,384",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,783,536",
"Assets": "4,415,455",
"Expenses": "1,364,444",
"Revenues": "1,472,101",
"Stockholders Equity": "1,631,919",
"Net Income": "58,563",
"Comprehensive Net Income": "87,094",
"BaseVar": "5,070,846",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "558,616",
"Assets, Non-Current": "576,465",
"General and Administrative Expense": "1,395,148",
"Goodwill": "1,983,365",
"Liabilities, Current": "451,735",
"Liabilities, Non-Current": "2,211,545",
"Other Assets": "0",
"Other Compr. Net Income": "-44,736",
"Other Expenses": "172,168",
"Other Liabilities": "0",
"Other Net Income": "18,783",
"Other Revenues": "1,608,154",
"Property, Plant and Equipment, Net": "1,208,979",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,663,280",
"Assets": "4,327,425",
"Expenses": "1,567,316",
"Revenues": "1,608,154",
"Stockholders Equity": "1,664,145",
"Net Income": "59,621",
"Comprehensive Net Income": "37,253",
"BaseVar": "5,114,847",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "143%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "568,591",
"Assets, Non-Current": "629,294",
"General and Administrative Expense": "1,343,430",
"Goodwill": "1,936,190",
"Liabilities, Current": "269,468",
"Liabilities, Non-Current": "2,048,022",
"Other Assets": "0",
"Other Compr. Net Income": "21,111",
"Other Expenses": "188,064",
"Other Liabilities": "218,037",
"Other Net Income": "44,732",
"Other Revenues": "1,567,072",
"Property, Plant and Equipment, Net": "1,186,770",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,535,527",
"Assets": "4,320,845",
"Expenses": "1,531,494",
"Revenues": "1,567,072",
"Stockholders Equity": "1,785,318",
"Net Income": "80,310",
"Comprehensive Net Income": "90,866",
"BaseVar": "5,010,390",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "149%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "428,140",
"Assets, Non-Current": "542,405",
"General and Administrative Expense": "959,301",
"Goodwill": "1,244,041",
"Liabilities, Current": "377,239",
"Liabilities, Non-Current": "1,543,403",
"Other Assets": "0",
"Other Compr. Net Income": "-11,559",
"Other Expenses": "329,843",
"Other Liabilities": "0",
"Other Net Income": "-99,923",
"Other Revenues": "1,107,363",
"Property, Plant and Equipment, Net": "983,235",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,920,642",
"Assets": "3,197,821",
"Expenses": "1,289,144",
"Revenues": "1,107,363",
"Stockholders Equity": "1,277,179",
"Net Income": "-281,704",
"Comprehensive Net Income": "-287,484",
"BaseVar": "3,813,226",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "136%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "291,669",
"Assets, Non-Current": "491,563",
"General and Administrative Expense": "532,321",
"Goodwill": "551,756",
"Liabilities, Current": "271,830",
"Liabilities, Non-Current": "918,652",
"Other Assets": "0",
"Other Compr. Net Income": "18,986",
"Other Expenses": "73,410",
"Other Liabilities": "0",
"Other Net Income": "-145,086",
"Other Revenues": "611,201",
"Property, Plant and Equipment, Net": "596,231",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,190,482",
"Assets": "1,931,219",
"Expenses": "605,731",
"Revenues": "611,201",
"Stockholders Equity": "740,737",
"Net Income": "-139,616",
"Comprehensive Net Income": "-130,123",
"BaseVar": "2,251,352",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "135%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "267,704",
"Assets, Non-Current": "498,865",
"General and Administrative Expense": "680,863",
"Goodwill": "533,095",
"Liabilities, Current": "265,587",
"Liabilities, Non-Current": "911,737",
"Other Assets": "0",
"Other Compr. Net Income": "11,784",
"Other Expenses": "97,068",
"Other Liabilities": "0",
"Other Net Income": "31,469",
"Other Revenues": "820,159",
"Property, Plant and Equipment, Net": "584,889",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,177,324",
"Assets": "1,884,553",
"Expenses": "777,931",
"Revenues": "820,159",
"Stockholders Equity": "707,229",
"Net Income": "73,697",
"Comprehensive Net Income": "79,589",
"BaseVar": "2,351,610",
"ECR before LimitedLiability": "68%",
"Economic Capital Ratio": "145%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "245,987",
"Assets, Non-Current": "493,840",
"General and Administrative Expense": "572,368",
"Goodwill": "521,020",
"Liabilities, Current": "234,872",
"Liabilities, Non-Current": "897,415",
"Other Assets": "0",
"Other Compr. Net Income": "-6,950",
"Other Expenses": "77,615",
"Other Liabilities": "0",
"Other Net Income": "30,019",
"Other Revenues": "691,118",
"Property, Plant and Equipment, Net": "576,904",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,132,287",
"Assets": "1,837,751",
"Expenses": "649,983",
"Revenues": "691,118",
"Stockholders Equity": "705,464",
"Net Income": "71,154",
"Comprehensive Net Income": "67,679",
"BaseVar": "2,174,054",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
}
},
"top_rated": false,
"trend": 6.0,
"value": 1.4562202907113462,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001708035.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001708035.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001708035.svg"
},
{
"company_id": "0001754195",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001754195.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001754195.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001754195.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001754195_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001754195_main_keyfigs.svg",
"name": "Trulieve Cannabis Corp",
"rank": 26,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001754195.svg",
"report_text": "The relative strengths and weaknesses of Trulieve Cannabis Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Trulieve Cannabis Corp compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Trulieve Cannabis Corp is the variable Other Liabilities, reducing the Economic Capital Ratio by 57% points.
The company's Economic Capital Ratio, given in the ranking table, is 145%, being 5.0% points above the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001754195_2024_Trulieve_Cannabis_Corp.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "12.9",
"Liabilities": "-12.7",
"Stockholders Equity": "20.1",
"ECR before LimitedLiability": "31.4",
"Liabilities, Current": "8.03",
"Other Liabilities": "-38.5",
"Assets, Current": "-15.9",
"Assets": "18.1",
"Assets, Non-Current": "-3.90",
"Other Assets": "2.28",
"Goodwill": "44.0",
"Property, Plant and Equipment, Net": "7.58",
"Other Expenses": "2.47",
"Expenses": "22.3",
"Revenues": "-2.13",
"Net Income": "19.5",
"Research and Development": "7.55",
"General and Administrative Expense": "11.9",
"Other Revenues": "-2.13",
"Comprehensive Net Income": "19.5",
"Economic Capital Ratio": "27.1"
},
"2022": {
"Liabilities, Non-Current": "16.0",
"Liabilities": "-8.86",
"Stockholders Equity": "11.9",
"ECR before LimitedLiability": "24.6",
"Other Liabilities": "-45.8",
"Liabilities, Current": "15.0",
"Other Assets": "2.13",
"Assets": "13.1",
"Assets, Current": "-17.3",
"Property, Plant and Equipment, Net": "6.85",
"Assets, Non-Current": "-6.67",
"Goodwill": "45.4",
"General and Administrative Expense": "10.5",
"Expenses": "17.6",
"Revenues": "0.473",
"Net Income": "15.8",
"Research and Development": "8.14",
"Other Expenses": "-1.32",
"Other Revenues": "0.473",
"Other Net Income": "-2.20",
"Comprehensive Net Income": "16.1",
"Economic Capital Ratio": "14.1"
},
"2023": {
"Liabilities, Non-Current": "18.4",
"Liabilities": "3.94",
"Stockholders Equity": "13.7",
"ECR before LimitedLiability": "20.1",
"Other Liabilities": "-57.0",
"Liabilities, Current": "34.1",
"Assets": "8.06",
"Property, Plant and Equipment, Net": "6.93",
"Goodwill": "47.9",
"Assets, Current": "-17.6",
"Assets, Non-Current": "-11.6",
"Other Expenses": "-7.78",
"Expenses": "5.73",
"Revenues": "4.72",
"Net Income": "4.18",
"Research and Development": "6.25",
"General and Administrative Expense": "7.54",
"Other Revenues": "4.72",
"Other Net Income": "-6.11",
"Comprehensive Net Income": "4.07",
"Economic Capital Ratio": "4.99"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001754195_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "524,420",
"Assets, Non-Current": "144,285",
"General and Administrative Expense": "687,972",
"Goodwill": "1,883,340",
"Liabilities, Current": "420,247",
"Liabilities, Non-Current": "130,530",
"Other Assets": "78,911",
"Other Compr. Net Income": "0",
"Other Expenses": "199,528",
"Other Liabilities": "712,722",
"Other Net Income": "-33,440",
"Other Revenues": "938,385",
"Property, Plant and Equipment, Net": "779,916",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,263,499",
"Assets": "3,410,872",
"Expenses": "887,500",
"Revenues": "938,385",
"Stockholders Equity": "2,147,373",
"Net Income": "17,445",
"Comprehensive Net Income": "17,445",
"BaseVar": "3,266,848",
"ECR before LimitedLiability": "127%",
"Economic Capital Ratio": "186%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "592,952",
"Assets, Non-Current": "116,095",
"General and Administrative Expense": "1,012,487",
"Goodwill": "1,804,141",
"Liabilities, Current": "433,840",
"Liabilities, Non-Current": "128,571",
"Other Assets": "88,913",
"Other Compr. Net Income": "0",
"Other Expenses": "356,738",
"Other Liabilities": "908,933",
"Other Net Income": "-123,314",
"Other Revenues": "1,239,812",
"Property, Plant and Equipment, Net": "796,947",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,471,344",
"Assets": "3,399,048",
"Expenses": "1,369,225",
"Revenues": "1,239,812",
"Stockholders Equity": "1,927,704",
"Net Income": "-252,727",
"Comprehensive Net Income": "-252,727",
"BaseVar": "3,801,372",
"ECR before LimitedLiability": "98%",
"Economic Capital Ratio": "166%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "477,348",
"Assets, Non-Current": "106,289",
"General and Administrative Expense": "926,727",
"Goodwill": "1,401,096",
"Liabilities, Current": "321,813",
"Liabilities, Non-Current": "99,321",
"Other Assets": "67,970",
"Other Compr. Net Income": "0",
"Other Expenses": "575,437",
"Other Liabilities": "899,308",
"Other Net Income": "-160,165",
"Other Revenues": "1,129,193",
"Property, Plant and Equipment, Net": "676,352",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,320,442",
"Assets": "2,729,055",
"Expenses": "1,502,164",
"Revenues": "1,129,193",
"Stockholders Equity": "1,408,613",
"Net Income": "-533,136",
"Comprehensive Net Income": "-533,136",
"BaseVar": "3,420,510",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.4511650472382258,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001754195.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001754195.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001754195.svg"
},
{
"company_id": "0000074303",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000074303.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000074303.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000074303.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000074303_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000074303_main_keyfigs.svg",
"name": "OLIN Corp",
"rank": 27,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000074303.svg",
"report_text": "The relative strengths and weaknesses of OLIN Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of OLIN Corp compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 40% points.The greatest weakness of OLIN Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 133%, being 6.7% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000074303_2024_OLIN_Corp.pdf",
"shrinked_graph_json": {
"2010": {
"Liabilities": "-32.8",
"Stockholders Equity": "-28.9",
"ECR before LimitedLiability": "-30.5",
"Liabilities, Current": "1.73",
"Liabilities, Non-Current": "-36.2",
"Goodwill": "-4.33",
"Assets": "-4.43",
"Property, Plant and Equipment, Net": "15.0",
"Assets, Current": "-12.7",
"Assets, Non-Current": "-7.23",
"Other Assets": "9.43",
"Other Expenses": "21.0",
"Expenses": "8.06",
"Revenues": "-3.03",
"Net Income": "9.56",
"General and Administrative Expense": "-19.2",
"Research and Development": "8.02",
"Other Revenues": "-3.03",
"Other Net Income": "4.53",
"Comprehensive Net Income": "9.63",
"Economic Capital Ratio": "-28.5"
},
"2011": {
"Liabilities, Current": "25.7",
"Liabilities": "-22.1",
"Stockholders Equity": "-11.3",
"ECR before LimitedLiability": "63.0",
"Liabilities, Non-Current": "-61.5",
"Other Liabilities": "5.23",
"Property, Plant and Equipment, Net": "22.8",
"Assets": "3.43",
"Assets, Non-Current": "-2.36",
"Other Assets": "2.89",
"Goodwill": "11.7",
"Assets, Current": "-21.4",
"General and Administrative Expense": "-4.85",
"Expenses": "28.8",
"Revenues": "16.3",
"Net Income": "47.9",
"Research and Development": "14.7",
"Other Expenses": "18.4",
"Other Revenues": "16.3",
"Comprehensive Net Income": "47.8",
"Economic Capital Ratio": "0.966"
},
"2012": {
"Liabilities, Current": "15.1",
"Liabilities": "-34.4",
"Stockholders Equity": "-22.1",
"ECR before LimitedLiability": "16.0",
"Liabilities, Non-Current": "-69.6",
"Other Liabilities": "12.2",
"Assets, Current": "-26.2",
"Assets": "2.32",
"Assets, Non-Current": "1.50",
"Property, Plant and Equipment, Net": "27.3",
"Goodwill": "12.7",
"Other Expenses": "25.4",
"Expenses": "33.0",
"Revenues": "14.0",
"Net Income": "48.4",
"Research and Development": "16.2",
"General and Administrative Expense": "-8.75",
"Other Revenues": "14.0",
"Comprehensive Net Income": "46.8",
"Other Compr. Net Income": "-1.24",
"Economic Capital Ratio": "-16.5"
},
"2013": {
"Liabilities, Current": "25.1",
"Liabilities": "-16.8",
"Stockholders Equity": "-18.2",
"ECR before LimitedLiability": "35.3",
"Other Liabilities": "8.23",
"Liabilities, Non-Current": "-57.4",
"Goodwill": "9.75",
"Assets": "-4.23",
"Property, Plant and Equipment, Net": "23.4",
"Other Assets": "-2.99",
"Assets, Current": "-24.2",
"General and Administrative Expense": "-18.6",
"Expenses": "22.4",
"Revenues": "28.7",
"Net Income": "50.6",
"Research and Development": "14.3",
"Other Expenses": "28.6",
"Other Revenues": "28.7",
"Other Net Income": "-2.96",
"Comprehensive Net Income": "50.6",
"Economic Capital Ratio": "-4.82"
},
"2014": {
"Liabilities, Non-Current": "-58.3",
"Liabilities": "-1.31",
"Stockholders Equity": "3.36",
"ECR before LimitedLiability": "56.9",
"Liabilities, Current": "41.5",
"Other Liabilities": "6.72",
"Assets, Current": "-23.7",
"Assets": "3.47",
"Goodwill": "10.7",
"Assets, Non-Current": "1.43",
"Property, Plant and Equipment, Net": "25.0",
"Other Expenses": "18.1",
"Expenses": "25.8",
"Revenues": "24.3",
"Net Income": "55.5",
"Research and Development": "16.9",
"General and Administrative Expense": "-9.17",
"Other Revenues": "24.3",
"Other Net Income": "1.76",
"Comprehensive Net Income": "53.8",
"Economic Capital Ratio": "7.51"
},
"2015": {
"Other Liabilities": "-5.10",
"Liabilities": "-44.7",
"Stockholders Equity": "-3.52",
"ECR before LimitedLiability": "31.4",
"Liabilities, Current": "23.6",
"Liabilities, Non-Current": "-68.3",
"Assets, Current": "-21.1",
"Assets": "35.6",
"Other Assets": "-5.63",
"Goodwill": "23.8",
"Assets, Non-Current": "2.30",
"Property, Plant and Equipment, Net": "37.0",
"Research and Development": "9.38",
"Expenses": "36.8",
"Revenues": "-6.46",
"Net Income": "35.9",
"General and Administrative Expense": "8.62",
"Other Expenses": "22.4",
"Other Revenues": "-6.46",
"Comprehensive Net Income": "35.9",
"Economic Capital Ratio": "-14.5"
},
"2016": {
"Liabilities, Non-Current": "-66.8",
"Liabilities": "-35.4",
"Stockholders Equity": "-31.1",
"ECR before LimitedLiability": "-5.23",
"Liabilities, Current": "34.1",
"Other Liabilities": "-9.56",
"Property, Plant and Equipment, Net": "32.8",
"Assets": "-3.37",
"Assets, Non-Current": "2.84",
"Assets, Current": "-37.5",
"Goodwill": "19.8",
"Research and Development": "16.9",
"Expenses": "27.1",
"Revenues": "12.2",
"Net Income": "36.8",
"General and Administrative Expense": "-16.2",
"Other Expenses": "27.8",
"Other Revenues": "12.2",
"Comprehensive Net Income": "36.8",
"Other Net Income": "-2.11",
"Economic Capital Ratio": "-25.2"
},
"2017": {
"Other Liabilities": "11.6",
"Liabilities": "-25.3",
"Stockholders Equity": "-23.1",
"ECR before LimitedLiability": "0.975",
"Liabilities, Current": "25.2",
"Liabilities, Non-Current": "-71.0",
"Assets, Non-Current": "8.31",
"Assets": "-3.08",
"Assets, Current": "-29.2",
"Goodwill": "12.8",
"Property, Plant and Equipment, Net": "16.8",
"Research and Development": "16.0",
"Expenses": "21.7",
"Revenues": "19.9",
"Net Income": "38.0",
"Other Expenses": "25.3",
"General and Administrative Expense": "-17.9",
"Other Revenues": "19.9",
"Comprehensive Net Income": "37.7",
"Other Net Income": "-4.78",
"Economic Capital Ratio": "-20.6"
},
"2018": {
"Liabilities, Non-Current": "-66.1",
"Liabilities": "-27.7",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "8.83",
"Other Liabilities": "12.2",
"Liabilities, Current": "19.3",
"Property, Plant and Equipment, Net": "21.7",
"Assets": "-10.3",
"Assets, Current": "-33.4",
"Goodwill": "15.5",
"Assets, Non-Current": "1.48",
"Other Expenses": "8.51",
"Expenses": "19.2",
"Revenues": "23.2",
"Net Income": "44.5",
"Research and Development": "15.8",
"General and Administrative Expense": "-5.21",
"Other Revenues": "23.2",
"Comprehensive Net Income": "44.4",
"Other Compr. Net Income": "-0.146",
"Economic Capital Ratio": "-11.6"
},
"2019": {
"Liabilities, Non-Current": "-74.5",
"Liabilities": "-35.7",
"Stockholders Equity": "-37.2",
"ECR before LimitedLiability": "15.6",
"Other Liabilities": "13.9",
"Liabilities, Current": "17.3",
"Assets, Non-Current": "1.82",
"Assets": "-8.76",
"Goodwill": "13.7",
"Property, Plant and Equipment, Net": "20.7",
"Assets, Current": "-32.8",
"Research and Development": "11.8",
"Expenses": "24.9",
"Revenues": "15.4",
"Net Income": "37.6",
"Other Expenses": "8.45",
"General and Administrative Expense": "3.85",
"Other Revenues": "15.4",
"Other Net Income": "4.91",
"Comprehensive Net Income": "37.6",
"Economic Capital Ratio": "-13.9"
},
"2020": {
"Liabilities, Current": "13.9",
"Liabilities": "-37.9",
"Stockholders Equity": "-65.7",
"ECR before LimitedLiability": "-9.61",
"Liabilities, Non-Current": "-67.4",
"Other Liabilities": "6.52",
"Goodwill": "4.16",
"Assets": "-32.1",
"Assets, Current": "-47.5",
"Assets, Non-Current": "4.92",
"Property, Plant and Equipment, Net": "13.9",
"Expenses": "0.482",
"Net Income": "14.1",
"Research and Development": "10.9",
"General and Administrative Expense": "-9.58",
"Other Revenues": "13.9",
"Revenues": "13.9",
"Other Compr. Net Income": "0.832",
"Comprehensive Net Income": "14.1",
"Other Net Income": "7.13",
"Economic Capital Ratio": "-47.4"
},
"2021": {
"Liabilities, Non-Current": "-36.8",
"Liabilities": "-16.3",
"Stockholders Equity": "-67.8",
"ECR before LimitedLiability": "-8.60",
"Liabilities, Current": "8.03",
"Other Liabilities": "10.3",
"Assets, Current": "-35.1",
"Assets": "-33.6",
"Assets, Non-Current": "-1.15",
"Other Assets": "2.51",
"Goodwill": "-6.53",
"Property, Plant and Equipment, Net": "9.17",
"Other Expenses": "8.45",
"Expenses": "2.48",
"Revenues": "48.4",
"Net Income": "52.6",
"Research and Development": "13.7",
"General and Administrative Expense": "-18.4",
"Other Revenues": "48.4",
"Comprehensive Net Income": "53.9",
"Economic Capital Ratio": "-12.9"
},
"2022": {
"Liabilities, Non-Current": "-34.2",
"Liabilities": "-3.10",
"Stockholders Equity": "-57.5",
"ECR before LimitedLiability": "4.81",
"Other Liabilities": "11.9",
"Liabilities, Current": "16.6",
"Assets": "-32.7",
"Assets, Current": "-30.5",
"Property, Plant and Equipment, Net": "5.42",
"Assets, Non-Current": "-1.84",
"Goodwill": "-7.35",
"General and Administrative Expense": "-21.4",
"Expenses": "-0.807",
"Revenues": "56.1",
"Net Income": "57.8",
"Research and Development": "13.1",
"Other Expenses": "9.04",
"Other Revenues": "56.1",
"Other Net Income": "2.17",
"Comprehensive Net Income": "58.5",
"Economic Capital Ratio": "-5.68"
},
"2023": {
"Liabilities, Non-Current": "-41.6",
"Liabilities": "-1.99",
"Stockholders Equity": "-34.2",
"ECR before LimitedLiability": "8.48",
"Other Liabilities": "8.95",
"Liabilities, Current": "26.8",
"Other Assets": "-1.23",
"Assets": "-23.2",
"Property, Plant and Equipment, Net": "7.97",
"Goodwill": "-5.00",
"Assets, Current": "-21.7",
"Assets, Non-Current": "-3.11",
"Other Expenses": "13.5",
"Expenses": "-0.452",
"Revenues": "40.2",
"Net Income": "39.5",
"Research and Development": "7.89",
"General and Administrative Expense": "-20.3",
"Other Revenues": "40.2",
"Comprehensive Net Income": "39.4",
"Economic Capital Ratio": "-6.67"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000074303_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "882,800",
"Assets, Non-Current": "72,300",
"General and Administrative Expense": "1,484,300",
"Goodwill": "300,300",
"Liabilities, Current": "391,000",
"Liabilities, Non-Current": "803,900",
"Other Assets": "118,300",
"Other Compr. Net Income": "0",
"Other Expenses": "71,700",
"Other Liabilities": "23,500",
"Other Net Income": "34,900",
"Other Revenues": "1,585,900",
"Property, Plant and Equipment, Net": "675,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,218,400",
"Assets": "2,048,700",
"Expenses": "1,556,000",
"Revenues": "1,585,900",
"Stockholders Equity": "830,300",
"Net Income": "64,800",
"Comprehensive Net Income": "64,800",
"BaseVar": "3,221,950",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "149%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "780,300",
"Assets, Non-Current": "85,600",
"General and Administrative Expense": "1,735,300",
"Goodwill": "627,400",
"Liabilities, Current": "399,100",
"Liabilities, Non-Current": "965,100",
"Other Assets": "70,900",
"Other Compr. Net Income": "0",
"Other Expenses": "178,800",
"Other Liabilities": "99,600",
"Other Net Income": "185,900",
"Other Revenues": "1,969,900",
"Property, Plant and Equipment, Net": "885,400",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,463,800",
"Assets": "2,449,600",
"Expenses": "1,914,100",
"Revenues": "1,969,900",
"Stockholders Equity": "985,800",
"Net Income": "241,700",
"Comprehensive Net Income": "241,700",
"BaseVar": "3,991,650",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "749,100",
"Assets, Non-Current": "224,100",
"General and Administrative Expense": "1,916,600",
"Goodwill": "747,100",
"Liabilities, Current": "434,000",
"Liabilities, Non-Current": "1,234,900",
"Other Assets": "23,100",
"Other Compr. Net Income": "-77,100",
"Other Expenses": "118,800",
"Other Liabilities": "110,400",
"Other Net Income": "-7,300",
"Other Revenues": "2,192,300",
"Property, Plant and Equipment, Net": "1,034,300",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,779,300",
"Assets": "2,777,700",
"Expenses": "2,035,400",
"Revenues": "2,192,300",
"Stockholders Equity": "998,400",
"Net Income": "149,600",
"Comprehensive Net Income": "111,050",
"BaseVar": "4,434,550",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "839,900",
"Assets, Non-Current": "213,100",
"General and Administrative Expense": "2,223,700",
"Goodwill": "747,100",
"Liabilities, Current": "407,500",
"Liabilities, Non-Current": "1,176,600",
"Other Assets": "14,900",
"Other Compr. Net Income": "6,200",
"Other Expenses": "115,500",
"Other Liabilities": "117,600",
"Other Net Income": "2,100",
"Other Revenues": "2,515,700",
"Property, Plant and Equipment, Net": "987,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,701,700",
"Assets": "2,802,800",
"Expenses": "2,339,200",
"Revenues": "2,515,700",
"Stockholders Equity": "1,101,100",
"Net Income": "178,600",
"Comprehensive Net Income": "181,700",
"BaseVar": "4,683,850",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "150%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "816,100",
"Assets, Non-Current": "191,400",
"General and Administrative Expense": "2,023,600",
"Goodwill": "747,100",
"Liabilities, Current": "377,700",
"Liabilities, Non-Current": "1,200,000",
"Other Assets": "12,500",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "176,100",
"Other Liabilities": "107,100",
"Other Net Income": "3,800",
"Other Revenues": "2,242,700",
"Property, Plant and Equipment, Net": "931,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,684,800",
"Assets": "2,698,100",
"Expenses": "2,199,700",
"Revenues": "2,242,700",
"Stockholders Equity": "1,013,300",
"Net Income": "46,800",
"Comprehensive Net Income": "7,800",
"BaseVar": "4,453,550",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "141%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,933,400",
"Assets, Non-Current": "487,500",
"General and Administrative Expense": "2,673,300",
"Goodwill": "2,851,600",
"Liabilities, Current": "1,147,700",
"Liabilities, Non-Current": "4,660,100",
"Other Assets": "95,900",
"Other Compr. Net Income": "-49,400",
"Other Expenses": "305,800",
"Other Liabilities": "1,095,200",
"Other Net Income": "3,000",
"Other Revenues": "2,900,100",
"Property, Plant and Equipment, Net": "3,953,400",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,903,000",
"Assets": "9,321,800",
"Expenses": "2,979,100",
"Revenues": "2,900,100",
"Stockholders Equity": "2,418,800",
"Net Income": "-76,000",
"Comprehensive Net Income": "-100,700",
"BaseVar": "11,078,200",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "121%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "1,546,200",
"Assets, Non-Current": "644,400",
"General and Administrative Expense": "5,246,900",
"Goodwill": "2,747,600",
"Liabilities, Current": "922,600",
"Liabilities, Non-Current": "4,534,500",
"Other Assets": "119,500",
"Other Compr. Net Income": "-17,500",
"Other Expenses": "400,600",
"Other Liabilities": "1,032,500",
"Other Net Income": "5,100",
"Other Revenues": "5,561,200",
"Property, Plant and Equipment, Net": "3,704,900",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,489,600",
"Assets": "8,762,600",
"Expenses": "5,647,500",
"Revenues": "5,561,200",
"Stockholders Equity": "2,273,000",
"Net Income": "-81,200",
"Comprehensive Net Income": "-89,950",
"BaseVar": "13,241,750",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "121%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,699,200",
"Assets, Non-Current": "1,208,400",
"General and Administrative Expense": "5,890,300",
"Goodwill": "2,698,500",
"Liabilities, Current": "1,465,500",
"Liabilities, Non-Current": "4,999,100",
"Other Assets": "36,400",
"Other Compr. Net Income": "25,400",
"Other Expenses": "-14,900",
"Other Liabilities": "0",
"Other Net Income": "3,600",
"Other Revenues": "6,271,700",
"Property, Plant and Equipment, Net": "3,575,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,464,600",
"Assets": "9,218,300",
"Expenses": "5,875,400",
"Revenues": "6,271,700",
"Stockholders Equity": "2,753,700",
"Net Income": "399,900",
"Comprehensive Net Income": "412,600",
"BaseVar": "13,929,500",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "133%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,707,400",
"Assets, Non-Current": "1,150,400",
"General and Administrative Expense": "6,252,700",
"Goodwill": "2,631,200",
"Liabilities, Current": "1,637,200",
"Liabilities, Non-Current": "4,528,000",
"Other Assets": "26,300",
"Other Compr. Net Income": "-80,500",
"Other Expenses": "562,700",
"Other Liabilities": "0",
"Other Net Income": "3,600",
"Other Revenues": "6,952,500",
"Property, Plant and Equipment, Net": "3,482,100",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,165,200",
"Assets": "8,997,400",
"Expenses": "6,815,400",
"Revenues": "6,952,500",
"Stockholders Equity": "2,832,200",
"Net Income": "140,700",
"Comprehensive Net Income": "100,450",
"BaseVar": "14,507,300",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,714,000",
"Assets, Non-Current": "1,546,900",
"General and Administrative Expense": "5,856,100",
"Goodwill": "2,567,800",
"Liabilities, Current": "1,536,700",
"Liabilities, Non-Current": "5,233,600",
"Other Assets": "35,300",
"Other Compr. Net Income": "-152,400",
"Other Expenses": "294,100",
"Other Liabilities": "0",
"Other Net Income": "17,300",
"Other Revenues": "6,121,600",
"Property, Plant and Equipment, Net": "3,323,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,770,300",
"Assets": "9,187,800",
"Expenses": "6,150,200",
"Revenues": "6,121,600",
"Stockholders Equity": "2,417,500",
"Net Income": "-11,300",
"Comprehensive Net Income": "-87,500",
"BaseVar": "14,199,800",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "122%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,717,100",
"Assets, Non-Current": "1,552,000",
"General and Administrative Expense": "5,796,600",
"Goodwill": "1,819,600",
"Liabilities, Current": "1,642,100",
"Liabilities, Non-Current": "5,178,000",
"Other Assets": "11,200",
"Other Compr. Net Income": "113,500",
"Other Expenses": "932,500",
"Other Liabilities": "0",
"Other Net Income": "500",
"Other Revenues": "5,758,700",
"Property, Plant and Equipment, Net": "3,171,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,820,100",
"Assets": "8,270,900",
"Expenses": "6,729,100",
"Revenues": "5,758,700",
"Stockholders Equity": "1,450,800",
"Net Income": "-969,900",
"Comprehensive Net Income": "-913,150",
"BaseVar": "13,846,400",
"ECR before LimitedLiability": "14%",
"Economic Capital Ratio": "98%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,248,300",
"Assets, Non-Current": "1,504,200",
"General and Administrative Expense": "7,033,300",
"Goodwill": "1,752,300",
"Liabilities, Current": "2,241,000",
"Liabilities, Non-Current": "3,624,500",
"Other Assets": "99,300",
"Other Compr. Net Income": "201,900",
"Other Expenses": "582,200",
"Other Liabilities": "0",
"Other Net Income": "200",
"Other Revenues": "8,912,000",
"Property, Plant and Equipment, Net": "2,913,600",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,865,500",
"Assets": "8,517,700",
"Expenses": "7,615,500",
"Revenues": "8,912,000",
"Stockholders Equity": "2,652,200",
"Net Income": "1,296,700",
"Comprehensive Net Income": "1,397,650",
"BaseVar": "15,556,400",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "2,156,400",
"Assets, Non-Current": "1,458,500",
"General and Administrative Expense": "7,588,200",
"Goodwill": "1,694,700",
"Liabilities, Current": "2,068,700",
"Liabilities, Non-Current": "3,431,900",
"Other Assets": "60,500",
"Other Compr. Net Income": "-7,900",
"Other Expenses": "479,600",
"Other Liabilities": "0",
"Other Net Income": "2,200",
"Other Revenues": "9,392,500",
"Property, Plant and Equipment, Net": "2,674,100",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,500,600",
"Assets": "8,044,200",
"Expenses": "8,067,800",
"Revenues": "9,392,500",
"Stockholders Equity": "2,543,600",
"Net Income": "1,326,900",
"Comprehensive Net Income": "1,322,950",
"BaseVar": "15,507,600",
"ECR before LimitedLiability": "71%",
"Economic Capital Ratio": "147%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "1,973,200",
"Assets, Non-Current": "1,463,200",
"General and Administrative Expense": "6,074,200",
"Goodwill": "1,669,800",
"Liabilities, Current": "2,004,400",
"Liabilities, Non-Current": "3,440,500",
"Other Assets": "87,400",
"Other Compr. Net Income": "7,800",
"Other Expenses": "354,000",
"Other Liabilities": "0",
"Other Net Income": "4,300",
"Other Revenues": "6,875,900",
"Property, Plant and Equipment, Net": "2,519,600",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,444,900",
"Assets": "7,713,200",
"Expenses": "6,428,200",
"Revenues": "6,875,900",
"Stockholders Equity": "2,268,300",
"Net Income": "452,000",
"Comprehensive Net Income": "455,900",
"BaseVar": "13,237,150",
"ECR before LimitedLiability": "54%",
"Economic Capital Ratio": "133%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 1.334510870212867,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000074303.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000074303.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000074303.svg"
},
{
"company_id": "0001653477",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001653477.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001653477.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001653477.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001653477_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001653477_main_keyfigs.svg",
"name": "Ingevity Corp",
"rank": 28,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001653477.svg",
"report_text": "The relative strengths and weaknesses of Ingevity Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ingevity Corp compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 33% points.The greatest weakness of Ingevity Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 72% points.
The company's Economic Capital Ratio, given in the ranking table, is 120%, being 20% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001653477_2024_Ingevity_Corp.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-68.7",
"Liabilities": "-22.5",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "-14.4",
"Liabilities, Current": "27.8",
"Property, Plant and Equipment, Net": "27.7",
"Assets": "-33.1",
"Other Assets": "11.1",
"Assets, Non-Current": "-4.47",
"Assets, Current": "-40.4",
"Goodwill": "-19.7",
"Research and Development": "22.2",
"Expenses": "15.2",
"Revenues": "28.0",
"Net Income": "29.2",
"General and Administrative Expense": "28.1",
"Other Expenses": "-43.4",
"Other Revenues": "28.0",
"Comprehensive Net Income": "29.1",
"Other Net Income": "-2.29",
"Economic Capital Ratio": "-34.4"
},
"2017": {
"Other Liabilities": "13.9",
"Liabilities": "-6.60",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "10.8",
"Liabilities, Current": "27.6",
"Liabilities, Non-Current": "-54.9",
"Assets": "-19.5",
"Other Assets": "8.10",
"Assets, Current": "-20.4",
"Goodwill": "-16.5",
"Property, Plant and Equipment, Net": "19.1",
"Research and Development": "16.5",
"Expenses": "13.2",
"Revenues": "47.1",
"Net Income": "56.4",
"Other Expenses": "-38.4",
"General and Administrative Expense": "42.3",
"Other Revenues": "47.1",
"Comprehensive Net Income": "55.2",
"Other Net Income": "-5.38",
"Economic Capital Ratio": "-10.7"
},
"2018": {
"Liabilities, Non-Current": "-77.8",
"Liabilities": "-33.1",
"Stockholders Equity": "-40.7",
"ECR before LimitedLiability": "11.3",
"Other Liabilities": "12.2",
"Liabilities, Current": "22.4",
"Property, Plant and Equipment, Net": "20.8",
"Assets": "-13.2",
"Other Assets": "5.75",
"Assets, Current": "-25.2",
"Goodwill": "2.63",
"Assets, Non-Current": "-8.41",
"Other Expenses": "8.57",
"Expenses": "25.2",
"Revenues": "29.3",
"Net Income": "50.1",
"Research and Development": "14.1",
"General and Administrative Expense": "1.73",
"Other Revenues": "29.3",
"Comprehensive Net Income": "50.0",
"Economic Capital Ratio": "-9.18"
},
"2019": {
"Liabilities, Non-Current": "-83.7",
"Liabilities": "-43.7",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "22.7",
"Other Liabilities": "12.9",
"Liabilities, Current": "17.3",
"Research and Development": "9.63",
"Expenses": "33.2",
"Net Income": "44.6",
"Other Expenses": "4.69",
"General and Administrative Expense": "17.4",
"Other Revenues": "11.8",
"Revenues": "11.8",
"Assets, Non-Current": "-9.30",
"Goodwill": "29.9",
"Property, Plant and Equipment, Net": "13.9",
"Other Assets": "4.86",
"Assets, Current": "-26.2",
"Other Net Income": "4.77",
"Comprehensive Net Income": "44.6",
"Economic Capital Ratio": "-6.78"
},
"2020": {
"Liabilities, Current": "17.2",
"Liabilities": "-41.7",
"Stockholders Equity": "-35.7",
"ECR before LimitedLiability": "24.4",
"Liabilities, Non-Current": "-70.7",
"Other Liabilities": "5.43",
"Goodwill": "24.6",
"Assets": "-4.67",
"Other Assets": "3.60",
"Assets, Current": "-25.2",
"Assets, Non-Current": "-7.74",
"Property, Plant and Equipment, Net": "11.7",
"Expenses": "21.1",
"Revenues": "8.68",
"Net Income": "37.1",
"Research and Development": "7.01",
"General and Administrative Expense": "10.0",
"Other Revenues": "8.68",
"Comprehensive Net Income": "37.4",
"Other Net Income": "5.58",
"Economic Capital Ratio": "-13.4"
},
"2021": {
"Liabilities, Non-Current": "-72.8",
"Liabilities": "-45.7",
"Stockholders Equity": "-50.9",
"ECR before LimitedLiability": "-25.2",
"Liabilities, Current": "13.2",
"Other Liabilities": "7.88",
"Assets, Current": "-27.4",
"Assets": "-15.1",
"Assets, Non-Current": "-8.06",
"Other Assets": "5.03",
"Goodwill": "11.7",
"Property, Plant and Equipment, Net": "11.6",
"Other Expenses": "7.50",
"Expenses": "22.5",
"Revenues": "12.6",
"Net Income": "33.8",
"Research and Development": "10.0",
"General and Administrative Expense": "4.27",
"Other Revenues": "12.6",
"Comprehensive Net Income": "34.0",
"Economic Capital Ratio": "-29.5"
},
"2022": {
"Liabilities, Non-Current": "-74.7",
"Liabilities": "-39.4",
"Stockholders Equity": "-43.7",
"ECR before LimitedLiability": "-13.7",
"Other Liabilities": "8.84",
"Liabilities, Current": "18.9",
"Other Assets": "7.78",
"Assets": "-12.5",
"Assets, Current": "-25.4",
"Property, Plant and Equipment, Net": "9.60",
"Assets, Non-Current": "-9.99",
"Goodwill": "13.5",
"General and Administrative Expense": "4.99",
"Expenses": "21.6",
"Revenues": "13.8",
"Net Income": "39.2",
"Research and Development": "9.29",
"Other Expenses": "6.61",
"Other Revenues": "13.8",
"Comprehensive Net Income": "38.4",
"Economic Capital Ratio": "-24.2"
},
"2023": {
"Liabilities, Non-Current": "-71.9",
"Liabilities": "-22.3",
"Stockholders Equity": "-34.1",
"ECR before LimitedLiability": "-5.29",
"Other Liabilities": "7.84",
"Liabilities, Current": "32.8",
"Other Assets": "6.26",
"Assets": "-13.9",
"Property, Plant and Equipment, Net": "7.76",
"Goodwill": "11.5",
"Assets, Current": "-19.9",
"Assets, Non-Current": "-14.5",
"Other Expenses": "6.35",
"Expenses": "9.14",
"Revenues": "20.0",
"Net Income": "29.8",
"Research and Development": "6.04",
"General and Administrative Expense": "-3.23",
"Other Revenues": "20.0",
"Comprehensive Net Income": "30.1",
"Economic Capital Ratio": "-20.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001653477_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "295,200",
"Assets, Non-Current": "22,000",
"General and Administrative Expense": "114,000",
"Goodwill": "19,700",
"Liabilities, Current": "136,900",
"Liabilities, Non-Current": "491,500",
"Other Assets": "73,100",
"Other Compr. Net Income": "-11,700",
"Other Expenses": "754,500",
"Other Liabilities": "69,800",
"Other Net Income": "4,600",
"Other Revenues": "908,300",
"Property, Plant and Equipment, Net": "422,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "698,200",
"Assets": "832,800",
"Expenses": "868,500",
"Revenues": "908,300",
"Stockholders Equity": "134,600",
"Net Income": "44,400",
"Comprehensive Net Income": "38,550",
"BaseVar": "1,662,050",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "112%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "368,700",
"Assets, Non-Current": "30,400",
"General and Administrative Expense": "106,400",
"Goodwill": "17,300",
"Liabilities, Current": "194,500",
"Liabilities, Non-Current": "457,200",
"Other Assets": "74,700",
"Other Compr. Net Income": "-11,100",
"Other Expenses": "702,800",
"Other Liabilities": "0",
"Other Net Income": "1,800",
"Other Revenues": "972,400",
"Property, Plant and Equipment, Net": "438,500",
"Research and Development": "19,800"
},
"output_variables": {
"Liabilities": "651,700",
"Assets": "929,600",
"Expenses": "829,000",
"Revenues": "972,400",
"Stockholders Equity": "277,900",
"Net Income": "145,200",
"Comprehensive Net Income": "139,650",
"BaseVar": "1,697,800",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "143%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "422,700",
"Assets, Non-Current": "38,300",
"General and Administrative Expense": "849,200",
"Goodwill": "256,300",
"Liabilities, Current": "220,200",
"Liabilities, Non-Current": "756,300",
"Other Assets": "74,100",
"Other Compr. Net Income": "-18,700",
"Other Expenses": "83,500",
"Other Liabilities": "0",
"Other Net Income": "2,400",
"Other Revenues": "1,133,600",
"Property, Plant and Equipment, Net": "523,800",
"Research and Development": "21,500"
},
"output_variables": {
"Liabilities": "976,500",
"Assets": "1,315,200",
"Expenses": "954,200",
"Revenues": "1,133,600",
"Stockholders Equity": "338,700",
"Net Income": "181,800",
"Comprehensive Net Income": "172,450",
"BaseVar": "2,200,300",
"ECR before LimitedLiability": "56%",
"Economic Capital Ratio": "135%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "463,200",
"Assets, Non-Current": "103,600",
"General and Administrative Expense": "974,000",
"Goodwill": "832,600",
"Liabilities, Current": "315,800",
"Liabilities, Non-Current": "1,295,100",
"Other Assets": "77,600",
"Other Compr. Net Income": "12,700",
"Other Expenses": "127,500",
"Other Liabilities": "0",
"Other Net Income": "12,000",
"Other Revenues": "1,292,900",
"Property, Plant and Equipment, Net": "664,700",
"Research and Development": "19,700"
},
"output_variables": {
"Liabilities": "1,610,900",
"Assets": "2,141,700",
"Expenses": "1,121,200",
"Revenues": "1,292,900",
"Stockholders Equity": "530,800",
"Net Income": "183,700",
"Comprehensive Net Income": "190,050",
"BaseVar": "3,095,700",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "628,700",
"Assets, Non-Current": "101,900",
"General and Administrative Expense": "900,000",
"Goodwill": "818,600",
"Liabilities, Current": "340,400",
"Liabilities, Non-Current": "1,352,000",
"Other Assets": "81,700",
"Other Compr. Net Income": "9,700",
"Other Expenses": "121,100",
"Other Liabilities": "0",
"Other Net Income": "9,000",
"Other Revenues": "1,216,100",
"Property, Plant and Equipment, Net": "703,600",
"Research and Development": "22,600"
},
"output_variables": {
"Liabilities": "1,692,400",
"Assets": "2,334,500",
"Expenses": "1,043,700",
"Revenues": "1,216,100",
"Stockholders Equity": "642,100",
"Net Income": "181,400",
"Comprehensive Net Income": "186,250",
"BaseVar": "3,152,700",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "724,900",
"Assets, Non-Current": "161,900",
"General and Administrative Expense": "1,058,000",
"Goodwill": "779,600",
"Liabilities, Current": "383,500",
"Liabilities, Non-Current": "1,411,700",
"Other Assets": "82,900",
"Other Compr. Net Income": "8,400",
"Other Expenses": "113,200",
"Other Liabilities": "0",
"Other Net Income": "-75,900",
"Other Revenues": "1,391,500",
"Property, Plant and Equipment, Net": "719,700",
"Research and Development": "26,300"
},
"output_variables": {
"Liabilities": "1,795,200",
"Assets": "2,469,000",
"Expenses": "1,197,500",
"Revenues": "1,391,500",
"Stockholders Equity": "673,800",
"Net Income": "118,100",
"Comprehensive Net Income": "122,300",
"BaseVar": "3,468,750",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "679,000",
"Assets, Non-Current": "142,100",
"General and Administrative Expense": "1,297,000",
"Goodwill": "923,300",
"Liabilities, Current": "410,000",
"Liabilities, Non-Current": "1,628,200",
"Other Assets": "193,500",
"Other Compr. Net Income": "-59,900",
"Other Expenses": "138,600",
"Other Liabilities": "0",
"Other Net Income": "9,200",
"Other Revenues": "1,668,300",
"Property, Plant and Equipment, Net": "798,600",
"Research and Development": "30,300"
},
"output_variables": {
"Liabilities": "2,038,200",
"Assets": "2,736,500",
"Expenses": "1,465,900",
"Revenues": "1,668,300",
"Stockholders Equity": "698,300",
"Net Income": "211,600",
"Comprehensive Net Income": "181,650",
"BaseVar": "3,989,000",
"ECR before LimitedLiability": "48%",
"Economic Capital Ratio": "128%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "658,600",
"Assets, Non-Current": "149,000",
"General and Administrative Expense": "1,403,900",
"Goodwill": "863,600",
"Liabilities, Current": "433,800",
"Liabilities, Non-Current": "1,558,100",
"Other Assets": "189,900",
"Other Compr. Net Income": "20,100",
"Other Expenses": "262,400",
"Other Liabilities": "0",
"Other Net Income": "600",
"Other Revenues": "1,692,100",
"Property, Plant and Equipment, Net": "762,200",
"Research and Development": "31,800"
},
"output_variables": {
"Liabilities": "1,991,900",
"Assets": "2,623,300",
"Expenses": "1,698,100",
"Revenues": "1,692,100",
"Stockholders Equity": "631,400",
"Net Income": "-5,400",
"Comprehensive Net Income": "4,650",
"BaseVar": "4,013,050",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "120%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 1.1968617436188986,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001653477.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001653477.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001653477.svg"
},
{
"company_id": "0001775194",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001775194.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001775194.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001775194_main_keyfigs.svg",
"name": "Upexi INC",
"rank": 29,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001775194.svg",
"report_text": "The relative strengths and weaknesses of Upexi INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Upexi INC compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Upexi INC is the variable Other Expenses, reducing the Economic Capital Ratio by 22% points.
The company's Economic Capital Ratio, given in the ranking table, is 119%, being 22% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001775194_2024_Upexi_INC.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "34.2",
"Liabilities": "52.5",
"Stockholders Equity": "3.62",
"ECR before LimitedLiability": "62.6",
"Liabilities, Current": "10.5",
"Other Liabilities": "12.8",
"Assets, Current": "0.776",
"Assets": "-10.9",
"Assets, Non-Current": "-6.80",
"Other Assets": "3.66",
"Goodwill": "-3.81",
"Property, Plant and Equipment, Net": "-5.12",
"Other Expenses": "2.59",
"Expenses": "-13.6",
"Revenues": "45.8",
"Net Income": "31.8",
"Research and Development": "13.0",
"General and Administrative Expense": "-30.1",
"Other Revenues": "45.8",
"Comprehensive Net Income": "31.8",
"Economic Capital Ratio": "58.3"
},
"2022": {
"Liabilities, Non-Current": "-10.3",
"Liabilities": "4.59",
"Stockholders Equity": "7.80",
"ECR before LimitedLiability": "22.7",
"Other Liabilities": "9.17",
"Liabilities, Current": "5.30",
"Other Assets": "21.8",
"Assets": "2.85",
"Assets, Current": "-9.20",
"Property, Plant and Equipment, Net": "-2.45",
"Assets, Non-Current": "-9.16",
"Goodwill": "8.14",
"Expenses": "2.57",
"Revenues": "7.41",
"Net Income": "11.9",
"Research and Development": "9.38",
"Other Expenses": "-5.45",
"Other Revenues": "7.41",
"Other Net Income": "1.76",
"Comprehensive Net Income": "12.3",
"Economic Capital Ratio": "12.2"
},
"2023": {
"Liabilities, Non-Current": "-6.99",
"Liabilities": "7.85",
"Stockholders Equity": "-10.8",
"ECR before LimitedLiability": "-6.45",
"Other Liabilities": "8.71",
"Liabilities, Current": "5.99",
"Other Assets": "34.7",
"Assets": "-14.1",
"Property, Plant and Equipment, Net": "-20.3",
"Goodwill": "-9.87",
"Assets, Non-Current": "-20.9",
"Other Expenses": "-21.6",
"Expenses": "-8.96",
"Revenues": "14.6",
"Net Income": "-3.31",
"Research and Development": "8.12",
"General and Administrative Expense": "5.71",
"Other Revenues": "14.6",
"Other Net Income": "-8.14",
"Comprehensive Net Income": "-3.44",
"Economic Capital Ratio": "-21.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001775194_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "18,293",
"Assets, Non-Current": "467",
"General and Administrative Expense": "21,027",
"Goodwill": "4,259",
"Liabilities, Current": "5,819",
"Liabilities, Non-Current": "217",
"Other Assets": "1,404",
"Other Compr. Net Income": "0",
"Other Expenses": "2,924",
"Other Liabilities": "0",
"Other Net Income": "-269",
"Other Revenues": "24,095",
"Property, Plant and Equipment, Net": "2,832",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,037",
"Assets": "27,255",
"Expenses": "23,951",
"Revenues": "24,095",
"Stockholders Equity": "21,218",
"Net Income": "-125",
"Comprehensive Net Income": "-125",
"BaseVar": "40,803",
"ECR before LimitedLiability": "174%",
"Economic Capital Ratio": "217%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "17,062",
"Assets, Non-Current": "920",
"General and Administrative Expense": "22,454",
"Goodwill": "13,400",
"Liabilities, Current": "10,128",
"Liabilities, Non-Current": "9,577",
"Other Assets": "9,770",
"Other Compr. Net Income": "0",
"Other Expenses": "7,619",
"Other Liabilities": "0",
"Other Net Income": "101",
"Other Revenues": "23,065",
"Property, Plant and Equipment, Net": "7,339",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "19,704",
"Assets": "48,491",
"Expenses": "30,073",
"Revenues": "23,065",
"Stockholders Equity": "28,787",
"Net Income": "-6,906",
"Comprehensive Net Income": "-6,906",
"BaseVar": "60,717",
"ECR before LimitedLiability": "95%",
"Economic Capital Ratio": "165%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "30,013",
"Assets, Non-Current": "487",
"General and Administrative Expense": "28,365",
"Goodwill": "9,811",
"Liabilities, Current": "22,392",
"Liabilities, Non-Current": "13,573",
"Other Assets": "20,659",
"Other Compr. Net Income": "0",
"Other Expenses": "23,407",
"Other Liabilities": "0",
"Other Net Income": "-4,676",
"Other Revenues": "36,442",
"Property, Plant and Equipment, Net": "2,831",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "35,965",
"Assets": "63,801",
"Expenses": "51,772",
"Revenues": "36,442",
"Stockholders Equity": "27,837",
"Net Income": "-20,006",
"Comprehensive Net Income": "-20,006",
"BaseVar": "96,328",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "119%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 1.1852523283795051,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001775194.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001775194.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001775194.svg"
},
{
"company_id": "0001056358",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001056358.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001056358.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001056358.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001056358_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001056358_main_keyfigs.svg",
"name": "Mannatech INC",
"rank": 30,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001056358.svg",
"report_text": "The relative strengths and weaknesses of Mannatech INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Mannatech INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 79% points.The greatest weakness of Mannatech INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 127% points.
The company's Economic Capital Ratio, given in the ranking table, is 115%, being 25% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001056358_2024_Mannatech_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "-3.85",
"Liabilities": "-9.05",
"Stockholders Equity": "-140",
"ECR before LimitedLiability": "-70.0",
"Other Liabilities": "-5.76",
"Property, Plant and Equipment, Net": "-17.3",
"Assets": "-58.1",
"Other Assets": "9.04",
"Assets, Current": "-42.8",
"Assets, Non-Current": "-13.3",
"Goodwill": "-14.0",
"General and Administrative Expense": "3.92",
"Expenses": "-62.6",
"Revenues": "34.1",
"Net Income": "-34.3",
"Other Expenses": "-72.3",
"Research and Development": "7.47",
"Other Revenues": "34.1",
"Comprehensive Net Income": "-34.2",
"Other Net Income": "1.13",
"Economic Capital Ratio": "-70.7"
},
"2010": {
"Liabilities": "65.1",
"Stockholders Equity": "-124",
"ECR before LimitedLiability": "-29.4",
"Liabilities, Current": "11.6",
"Liabilities, Non-Current": "59.2",
"Goodwill": "-32.3",
"Assets": "-66.0",
"Property, Plant and Equipment, Net": "-17.8",
"Assets, Current": "-42.4",
"Assets, Non-Current": "-19.2",
"Other Assets": "15.5",
"Other Expenses": "-110",
"Expenses": "-90.9",
"Revenues": "69.9",
"Net Income": "2.46",
"General and Administrative Expense": "0.961",
"Research and Development": "20.1",
"Other Revenues": "69.9",
"Other Net Income": "7.69",
"Comprehensive Net Income": "2.63",
"Economic Capital Ratio": "-27.4"
},
"2011": {
"Liabilities, Current": "21.5",
"Liabilities": "26.5",
"Stockholders Equity": "-120",
"ECR before LimitedLiability": "12.3",
"Liabilities, Non-Current": "15.7",
"Other Liabilities": "19.3",
"Property, Plant and Equipment, Net": "-28.7",
"Assets": "-95.4",
"Assets, Non-Current": "-15.7",
"Goodwill": "-40.1",
"Assets, Current": "-73.9",
"General and Administrative Expense": "19.8",
"Expenses": "-80.7",
"Revenues": "66.1",
"Net Income": "25.7",
"Research and Development": "21.0",
"Other Expenses": "-141",
"Other Revenues": "66.1",
"Comprehensive Net Income": "25.8",
"Other Net Income": "-23.1",
"Economic Capital Ratio": "-49.7"
},
"2012": {
"Liabilities, Current": "31.4",
"Liabilities": "63.0",
"Stockholders Equity": "-131",
"ECR before LimitedLiability": "19.9",
"Liabilities, Non-Current": "23.7",
"Other Liabilities": "47.8",
"Assets, Current": "-53.5",
"Assets": "-73.2",
"Other Assets": "8.93",
"Assets, Non-Current": "-10.5",
"Property, Plant and Equipment, Net": "-24.7",
"Goodwill": "-31.3",
"Other Expenses": "-119",
"Expenses": "-64.4",
"Revenues": "99.2",
"Net Income": "69.9",
"Research and Development": "49.9",
"General and Administrative Expense": "15.8",
"Other Revenues": "99.2",
"Comprehensive Net Income": "69.9",
"Economic Capital Ratio": "-12.6"
},
"2013": {
"Liabilities, Current": "28.6",
"Liabilities": "69.1",
"Stockholders Equity": "-101",
"ECR before LimitedLiability": "38.7",
"Other Liabilities": "33.1",
"Liabilities, Non-Current": "34.3",
"Goodwill": "-27.6",
"Assets": "-63.4",
"Assets, Non-Current": "-7.35",
"Property, Plant and Equipment, Net": "-20.9",
"Assets, Current": "-41.2",
"General and Administrative Expense": "12.7",
"Expenses": "-49.9",
"Revenues": "98.1",
"Net Income": "73.4",
"Research and Development": "35.2",
"Other Expenses": "-90.9",
"Other Revenues": "98.1",
"Other Net Income": "-10.2",
"Comprehensive Net Income": "73.4",
"Economic Capital Ratio": "-1.46"
},
"2014": {
"Liabilities, Non-Current": "37.3",
"Liabilities": "82.2",
"Stockholders Equity": "-34.5",
"ECR before LimitedLiability": "81.1",
"Liabilities, Current": "60.6",
"Other Liabilities": "26.3",
"Assets, Current": "-31.3",
"Assets": "-49.0",
"Goodwill": "-24.3",
"Other Assets": "22.4",
"Assets, Non-Current": "-5.37",
"Property, Plant and Equipment, Net": "-20.0",
"Other Expenses": "-92.9",
"Expenses": "-34.1",
"Revenues": "99.1",
"Net Income": "85.9",
"Research and Development": "36.0",
"General and Administrative Expense": "28.8",
"Other Revenues": "99.1",
"Comprehensive Net Income": "86.0",
"Economic Capital Ratio": "31.6"
},
"2015": {
"Other Liabilities": "35.8",
"Liabilities": "98.1",
"Stockholders Equity": "-29.5",
"ECR before LimitedLiability": "91.3",
"Liabilities, Current": "64.6",
"Liabilities, Non-Current": "43.2",
"Assets, Current": "-24.4",
"Assets": "-44.4",
"Other Assets": "3.61",
"Goodwill": "-20.6",
"Property, Plant and Equipment, Net": "-17.7",
"Research and Development": "25.2",
"Expenses": "-45.3",
"Revenues": "113",
"Net Income": "97.9",
"General and Administrative Expense": "3.64",
"Other Expenses": "-74.5",
"Other Revenues": "113",
"Comprehensive Net Income": "98.1",
"Other Net Income": "-3.27",
"Economic Capital Ratio": "45.4"
},
"2016": {
"Liabilities, Non-Current": "42.8",
"Liabilities": "85.7",
"Stockholders Equity": "-69.9",
"ECR before LimitedLiability": "43.2",
"Liabilities, Current": "51.0",
"Other Liabilities": "19.2",
"Property, Plant and Equipment, Net": "-25.7",
"Assets": "-52.3",
"Other Assets": "23.1",
"Assets, Current": "-34.8",
"Goodwill": "-22.5",
"Research and Development": "36.7",
"Expenses": "-51.3",
"Revenues": "99.8",
"Net Income": "85.2",
"General and Administrative Expense": "-10.3",
"Other Expenses": "-74.8",
"Other Revenues": "99.8",
"Comprehensive Net Income": "85.3",
"Other Net Income": "-6.72",
"Economic Capital Ratio": "23.2"
},
"2017": {
"Other Liabilities": "26.0",
"Liabilities": "82.7",
"Stockholders Equity": "-57.8",
"ECR before LimitedLiability": "35.1",
"Liabilities, Current": "35.7",
"Liabilities, Non-Current": "45.2",
"Assets, Non-Current": "-5.22",
"Assets": "-50.3",
"Other Assets": "21.4",
"Assets, Current": "-24.1",
"Goodwill": "-24.0",
"Property, Plant and Equipment, Net": "-30.2",
"Research and Development": "33.8",
"Expenses": "-53.8",
"Revenues": "94.1",
"Net Income": "70.2",
"Other Expenses": "-82.6",
"Other Revenues": "94.1",
"Comprehensive Net Income": "72.7",
"Other Net Income": "-9.87",
"Economic Capital Ratio": "13.5"
},
"2018": {
"Liabilities, Non-Current": "40.3",
"Liabilities": "55.4",
"Stockholders Equity": "-109",
"ECR before LimitedLiability": "15.3",
"Other Liabilities": "25.9",
"Liabilities, Current": "24.7",
"Property, Plant and Equipment, Net": "-36.3",
"Assets": "-71.9",
"Other Assets": "34.2",
"Assets, Current": "-46.7",
"Goodwill": "-29.7",
"Assets, Non-Current": "-17.7",
"Other Expenses": "-124",
"Expenses": "-63.7",
"Revenues": "82.2",
"Net Income": "57.7",
"Research and Development": "38.7",
"General and Administrative Expense": "36.9",
"Other Revenues": "82.2",
"Comprehensive Net Income": "57.6",
"Economic Capital Ratio": "-5.21"
},
"2019": {
"Liabilities, Non-Current": "32.4",
"Liabilities": "70.3",
"Stockholders Equity": "-90.3",
"ECR before LimitedLiability": "48.3",
"Other Liabilities": "29.6",
"Liabilities, Current": "22.1",
"Assets, Non-Current": "-13.5",
"Assets": "-58.8",
"Goodwill": "-25.2",
"Property, Plant and Equipment, Net": "-29.1",
"Other Assets": "23.4",
"Assets, Current": "-33.9",
"Research and Development": "24.4",
"Expenses": "-45.5",
"Revenues": "86.7",
"Net Income": "73.7",
"Other Expenses": "-106",
"General and Administrative Expense": "45.5",
"Other Revenues": "86.7",
"Comprehensive Net Income": "73.6",
"Economic Capital Ratio": "18.8"
},
"2020": {
"Liabilities, Current": "17.2",
"Liabilities": "69.7",
"Stockholders Equity": "-108",
"ECR before LimitedLiability": "46.2",
"Liabilities, Non-Current": "44.6",
"Other Liabilities": "12.7",
"Goodwill": "-24.4",
"Assets": "-61.0",
"Other Assets": "16.7",
"Assets, Current": "-38.8",
"Property, Plant and Equipment, Net": "-29.7",
"Other Expenses": "-90.7",
"Expenses": "-61.4",
"Revenues": "82.1",
"Net Income": "70.0",
"Research and Development": "18.2",
"General and Administrative Expense": "14.6",
"Other Revenues": "82.1",
"Comprehensive Net Income": "70.1",
"Other Net Income": "13.7",
"Economic Capital Ratio": "8.44"
},
"2021": {
"Liabilities, Non-Current": "45.4",
"Liabilities": "74.0",
"Stockholders Equity": "-164",
"ECR before LimitedLiability": "5.02",
"Liabilities, Current": "13.6",
"Other Liabilities": "19.7",
"Assets, Current": "-41.5",
"Assets": "-66.7",
"Assets, Non-Current": "-14.5",
"Other Assets": "14.9",
"Goodwill": "-31.6",
"Property, Plant and Equipment, Net": "-29.0",
"Other Expenses": "-98.5",
"Expenses": "-66.7",
"Revenues": "96.5",
"Net Income": "75.5",
"Research and Development": "26.3",
"General and Administrative Expense": "7.66",
"Other Revenues": "96.5",
"Comprehensive Net Income": "75.3",
"Other Compr. Net Income": "-2.14",
"Economic Capital Ratio": "0.682"
},
"2022": {
"Liabilities, Non-Current": "31.0",
"Liabilities": "34.1",
"Stockholders Equity": "-150",
"ECR before LimitedLiability": "-26.7",
"Other Liabilities": "22.5",
"Liabilities, Current": "15.2",
"Assets": "-92.0",
"Assets, Current": "-52.8",
"Property, Plant and Equipment, Net": "-40.7",
"Assets, Non-Current": "-22.7",
"Goodwill": "-47.6",
"General and Administrative Expense": "11.6",
"Expenses": "-83.0",
"Revenues": "65.2",
"Net Income": "34.5",
"Research and Development": "29.8",
"Other Expenses": "-113",
"Other Revenues": "65.2",
"Other Net Income": "4.59",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "-37.2"
},
"2023": {
"Liabilities, Non-Current": "31.5",
"Liabilities": "40.0",
"Stockholders Equity": "-127",
"ECR before LimitedLiability": "-9.73",
"Other Liabilities": "17.5",
"Liabilities, Current": "32.0",
"Assets": "-94.6",
"Property, Plant and Equipment, Net": "-43.4",
"Goodwill": "-50.6",
"Assets, Current": "-45.4",
"Assets, Non-Current": "-33.3",
"Other Expenses": "-78.7",
"Expenses": "-104",
"Revenues": "79.1",
"Net Income": "35.1",
"Research and Development": "20.7",
"General and Administrative Expense": "-48.3",
"Other Revenues": "79.1",
"Comprehensive Net Income": "34.9",
"Other Compr. Net Income": "-1.32",
"Economic Capital Ratio": "-24.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001056358_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "64,485",
"Assets, Non-Current": "2,503",
"General and Administrative Expense": "116,810",
"Goodwill": "0",
"Liabilities, Current": "42,679",
"Liabilities, Non-Current": "3,348",
"Other Assets": "8,170",
"Other Compr. Net Income": "0",
"Other Expenses": "191,782",
"Other Liabilities": "4,991",
"Other Net Income": "1,519",
"Other Revenues": "289,705",
"Property, Plant and Equipment, Net": "27,144",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "51,018",
"Assets": "102,302",
"Expenses": "308,592",
"Revenues": "289,705",
"Stockholders Equity": "51,284",
"Net Income": "-17,368",
"Comprehensive Net Income": "-17,368",
"BaseVar": "376,568",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "55,215",
"Assets, Non-Current": "3,054",
"General and Administrative Expense": "95,411",
"Goodwill": "0",
"Liabilities, Current": "32,240",
"Liabilities, Non-Current": "4,996",
"Other Assets": "4,705",
"Other Compr. Net Income": "0",
"Other Expenses": "143,734",
"Other Liabilities": "3,107",
"Other Net Income": "441",
"Other Revenues": "228,088",
"Property, Plant and Equipment, Net": "18,449",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "40,343",
"Assets": "81,423",
"Expenses": "239,145",
"Revenues": "228,088",
"Stockholders Equity": "41,080",
"Net Income": "-10,616",
"Comprehensive Net Income": "-10,616",
"BaseVar": "294,720",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "150%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "41,731",
"Assets, Non-Current": "2,815",
"General and Administrative Expense": "86,118",
"Goodwill": "0",
"Liabilities, Current": "29,876",
"Liabilities, Non-Current": "5,382",
"Other Assets": "4,158",
"Other Compr. Net Income": "881",
"Other Expenses": "134,241",
"Other Liabilities": "1,359",
"Other Net Income": "-989",
"Other Revenues": "200,689",
"Property, Plant and Equipment, Net": "9,566",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,617",
"Assets": "58,270",
"Expenses": "220,359",
"Revenues": "200,689",
"Stockholders Equity": "21,653",
"Net Income": "-20,659",
"Comprehensive Net Income": "-20,218",
"BaseVar": "258,902",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "35,302",
"Assets, Non-Current": "3,187",
"General and Administrative Expense": "71,817",
"Goodwill": "0",
"Liabilities, Current": "24,221",
"Liabilities, Non-Current": "2,178",
"Other Assets": "4,246",
"Other Compr. Net Income": "-250",
"Other Expenses": "103,698",
"Other Liabilities": "940",
"Other Net Income": "680",
"Other Revenues": "173,447",
"Property, Plant and Equipment, Net": "4,825",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "27,339",
"Assets": "47,560",
"Expenses": "175,515",
"Revenues": "173,447",
"Stockholders Equity": "20,221",
"Net Income": "-1,388",
"Comprehensive Net Income": "-1,513",
"BaseVar": "212,396",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "43,674",
"Assets, Non-Current": "3,591",
"General and Administrative Expense": "69,855",
"Goodwill": "0",
"Liabilities, Current": "30,058",
"Liabilities, Non-Current": "2,101",
"Other Assets": "5,557",
"Other Compr. Net Income": "-66",
"Other Expenses": "102,447",
"Other Liabilities": "450",
"Other Net Income": "-1,947",
"Other Revenues": "177,423",
"Property, Plant and Equipment, Net": "3,239",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "32,609",
"Assets": "56,061",
"Expenses": "172,302",
"Revenues": "177,423",
"Stockholders Equity": "23,452",
"Net Income": "3,174",
"Comprehensive Net Income": "3,141",
"BaseVar": "220,204",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "153%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "49,363",
"Assets, Non-Current": "3,567",
"General and Administrative Expense": "74,543",
"Goodwill": "0",
"Liabilities, Current": "33,008",
"Liabilities, Non-Current": "2,136",
"Other Assets": "14,468",
"Other Compr. Net Income": "634",
"Other Expenses": "106,121",
"Other Liabilities": "878",
"Other Net Income": "-2,921",
"Other Revenues": "190,081",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,022",
"Assets": "67,398",
"Expenses": "180,664",
"Revenues": "190,081",
"Stockholders Equity": "31,376",
"Net Income": "6,496",
"Comprehensive Net Income": "6,813",
"BaseVar": "238,860",
"ECR before LimitedLiability": "96%",
"Economic Capital Ratio": "165%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "49,885",
"Assets, Non-Current": "3,759",
"General and Administrative Expense": "68,560",
"Goodwill": "0",
"Liabilities, Current": "26,379",
"Liabilities, Non-Current": "1,994",
"Other Assets": "14,998",
"Other Compr. Net Income": "795",
"Other Expenses": "101,923",
"Other Liabilities": "1,705",
"Other Net Income": "-3,945",
"Other Revenues": "180,267",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "30,078",
"Assets": "68,642",
"Expenses": "170,483",
"Revenues": "180,267",
"Stockholders Equity": "38,564",
"Net Income": "5,839",
"Comprehensive Net Income": "6,236",
"BaseVar": "227,105",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "181%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "50,762",
"Assets, Non-Current": "4,013",
"General and Administrative Expense": "73,744",
"Goodwill": "0",
"Liabilities, Current": "29,981",
"Liabilities, Non-Current": "1,465",
"Other Assets": "16,413",
"Other Compr. Net Income": "1,148",
"Other Expenses": "105,493",
"Other Liabilities": "857",
"Other Net Income": "-1,653",
"Other Revenues": "180,304",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "32,303",
"Assets": "71,188",
"Expenses": "179,237",
"Revenues": "180,304",
"Stockholders Equity": "38,885",
"Net Income": "-586",
"Comprehensive Net Income": "-12",
"BaseVar": "232,916",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "56,248",
"Assets, Non-Current": "3,876",
"General and Administrative Expense": "71,137",
"Goodwill": "0",
"Liabilities, Current": "34,592",
"Liabilities, Non-Current": "1,300",
"Other Assets": "16,118",
"Other Compr. Net Income": "4,150",
"Other Expenses": "107,287",
"Other Liabilities": "109",
"Other Net Income": "-59",
"Other Revenues": "176,696",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,001",
"Assets": "76,242",
"Expenses": "178,424",
"Revenues": "176,696",
"Stockholders Equity": "40,241",
"Net Income": "-1,787",
"Comprehensive Net Income": "288",
"BaseVar": "235,786",
"ECR before LimitedLiability": "99%",
"Economic Capital Ratio": "167%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "42,387",
"Assets, Non-Current": "3,894",
"General and Administrative Expense": "68,632",
"Goodwill": "0",
"Liabilities, Current": "33,617",
"Liabilities, Non-Current": "2,302",
"Other Assets": "15,917",
"Other Compr. Net Income": "-1,647",
"Other Expenses": "109,391",
"Other Liabilities": "955",
"Other Net Income": "579",
"Other Revenues": "173,558",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,874",
"Assets": "62,198",
"Expenses": "178,023",
"Revenues": "173,558",
"Stockholders Equity": "25,324",
"Net Income": "-3,886",
"Comprehensive Net Income": "-4,710",
"BaseVar": "226,440",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "139%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "41,029",
"Assets, Non-Current": "9,600",
"General and Administrative Expense": "62,374",
"Goodwill": "0",
"Liabilities, Current": "28,895",
"Liabilities, Non-Current": "6,200",
"Other Assets": "12,294",
"Other Compr. Net Income": "-580",
"Other Expenses": "91,368",
"Other Liabilities": "553",
"Other Net Income": "-697",
"Other Revenues": "157,700",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "35,648",
"Assets": "62,923",
"Expenses": "153,742",
"Revenues": "157,700",
"Stockholders Equity": "27,275",
"Net Income": "3,261",
"Comprehensive Net Income": "2,971",
"BaseVar": "205,645",
"ECR before LimitedLiability": "82%",
"Economic Capital Ratio": "155%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "42,477",
"Assets, Non-Current": "11,977",
"General and Administrative Expense": "63,350",
"Goodwill": "0",
"Liabilities, Current": "31,990",
"Liabilities, Non-Current": "7,245",
"Other Assets": "10,882",
"Other Compr. Net Income": "1,393",
"Other Expenses": "83,030",
"Other Liabilities": "129",
"Other Net Income": "1,234",
"Other Revenues": "151,407",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "39,364",
"Assets": "65,336",
"Expenses": "146,380",
"Revenues": "151,407",
"Stockholders Equity": "25,972",
"Net Income": "6,261",
"Comprehensive Net Income": "6,958",
"BaseVar": "202,557",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "42,838",
"Assets, Non-Current": "9,220",
"General and Administrative Expense": "63,576",
"Goodwill": "0",
"Liabilities, Current": "30,101",
"Liabilities, Non-Current": "5,049",
"Other Assets": "7,567",
"Other Compr. Net Income": "-2,808",
"Other Expenses": "86,187",
"Other Liabilities": "63",
"Other Net Income": "-157",
"Other Revenues": "159,762",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "35,213",
"Assets": "59,625",
"Expenses": "149,763",
"Revenues": "159,762",
"Stockholders Equity": "24,412",
"Net Income": "9,842",
"Comprehensive Net Income": "8,438",
"BaseVar": "203,664",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "159%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "34,953",
"Assets, Non-Current": "8,439",
"General and Administrative Expense": "60,530",
"Goodwill": "0",
"Liabilities, Current": "29,838",
"Liabilities, Non-Current": "5,026",
"Other Assets": "1,977",
"Other Compr. Net Income": "-2,527",
"Other Expenses": "81,094",
"Other Liabilities": "88",
"Other Net Income": "-74",
"Other Revenues": "137,208",
"Property, Plant and Equipment, Net": "3,759",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "34,952",
"Assets": "49,128",
"Expenses": "141,624",
"Revenues": "137,208",
"Stockholders Equity": "14,176",
"Net Income": "-4,490",
"Comprehensive Net Income": "-5,754",
"BaseVar": "182,756",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "27,664",
"Assets, Non-Current": "7,066",
"General and Administrative Expense": "77,703",
"Goodwill": "0",
"Liabilities, Current": "25,780",
"Liabilities, Non-Current": "3,986",
"Other Assets": "2,329",
"Other Compr. Net Income": "-807",
"Other Expenses": "56,325",
"Other Liabilities": "956",
"Other Net Income": "-166",
"Other Revenues": "131,955",
"Property, Plant and Equipment, Net": "4,147",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "30,722",
"Assets": "41,206",
"Expenses": "134,028",
"Revenues": "131,955",
"Stockholders Equity": "10,484",
"Net Income": "-2,239",
"Comprehensive Net Income": "-2,642",
"BaseVar": "169,442",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
}
},
"top_rated": false,
"trend": 7.0,
"value": 1.1524417645570797,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001056358.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001056358.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001056358.svg"
},
{
"company_id": "0000880242",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000880242.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000880242.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000880242_main_keyfigs.svg",
"name": "Biolargo INC",
"rank": 31,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000880242.svg",
"report_text": "The relative strengths and weaknesses of Biolargo INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biolargo INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Biolargo INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 88% points.
The company's Economic Capital Ratio, given in the ranking table, is 110%, being 30% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000880242_2024_Biolargo_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "0.0281",
"Liabilities": "0.0282",
"Stockholders Equity": "-18.0",
"ECR before LimitedLiability": "-91.4",
"Liabilities, Non-Current": "0.0207",
"Other Liabilities": "-0.0211",
"Property, Plant and Equipment, Net": "-0.367",
"Assets": "-31.2",
"Assets, Non-Current": "-0.0710",
"Other Assets": "0.0122",
"Goodwill": "-0.309",
"Assets, Current": "-9.59",
"General and Administrative Expense": "-1.96",
"Expenses": "-2.51",
"Revenues": "-0.342",
"Net Income": "-15.3",
"Other Expenses": "-0.0388",
"Other Revenues": "-0.342",
"Comprehensive Net Income": "-15.3",
"Other Net Income": "-0.0124",
"Economic Capital Ratio": "-153"
},
"2013": {
"Liabilities, Current": "0",
"Liabilities": "0",
"Assets": "-31.8",
"Stockholders Equity": "-1.11",
"ECR before LimitedLiability": "-114",
"Other Liabilities": "0",
"Liabilities, Non-Current": "0",
"Goodwill": "-0.0215",
"Assets, Non-Current": "0",
"Property, Plant and Equipment, Net": "-0.0105",
"Other Assets": "0",
"Assets, Current": "-4.90",
"General and Administrative Expense": "-0.154",
"Expenses": "-1.47",
"Revenues": "0",
"Net Income": "-13.5",
"Research and Development": "0",
"Other Expenses": "0",
"Other Revenues": "0",
"Comprehensive Net Income": "-13.5",
"Economic Capital Ratio": "-155"
},
"2014": {
"Liabilities, Non-Current": "0",
"Liabilities": "0",
"ECR before LimitedLiability": "-84.1",
"Liabilities, Current": "0",
"Other Liabilities": "0",
"Assets, Current": "-1.26",
"Assets": "-19.4",
"Goodwill": "0",
"Other Assets": "0",
"Assets, Non-Current": "0",
"Property, Plant and Equipment, Net": "0",
"Other Expenses": "0",
"Expenses": "-1.18",
"Net Income": "-15.4",
"Research and Development": "0",
"General and Administrative Expense": "-0.143",
"Other Revenues": "0",
"Revenues": "0",
"Stockholders Equity": "0",
"Comprehensive Net Income": "-15.3",
"Economic Capital Ratio": "-134"
},
"2015": {
"Other Liabilities": "0.241",
"Liabilities": "0.577",
"Stockholders Equity": "3.62",
"ECR before LimitedLiability": "-71.6",
"Liabilities, Current": "0.384",
"Assets, Current": "14.6",
"Assets": "-29.7",
"Other Assets": "-9.41",
"Goodwill": "-20.6",
"Assets, Non-Current": "-4.02",
"Property, Plant and Equipment, Net": "-17.0",
"Research and Development": "-6.54",
"Expenses": "-42.9",
"Revenues": "-23.9",
"Net Income": "-94.3",
"General and Administrative Expense": "-52.1",
"Other Expenses": "9.62",
"Other Revenues": "-23.9",
"Comprehensive Net Income": "-93.7",
"Other Net Income": "-17.2",
"Economic Capital Ratio": "-117"
},
"2022": {
"Liabilities": "9.06",
"Stockholders Equity": "-67.7",
"ECR before LimitedLiability": "-62.4",
"Other Liabilities": "2.90",
"Liabilities, Current": "4.94",
"Other Assets": "3.55",
"Assets": "-71.8",
"Assets, Current": "-8.56",
"Property, Plant and Equipment, Net": "-6.68",
"Assets, Non-Current": "-2.21",
"Goodwill": "-18.2",
"General and Administrative Expense": "-73.4",
"Expenses": "-64.0",
"Revenues": "11.3",
"Net Income": "-15.8",
"Other Expenses": "4.91",
"Other Revenues": "11.3",
"Other Net Income": "2.22",
"Comprehensive Net Income": "-6.88",
"Other Compr. Net Income": "1.85",
"Economic Capital Ratio": "-72.9"
},
"2023": {
"Liabilities, Non-Current": "24.1",
"Liabilities": "30.7",
"Stockholders Equity": "-52.6",
"ECR before LimitedLiability": "-15.2",
"Other Liabilities": "15.6",
"Liabilities, Current": "26.6",
"Other Assets": "-5.06",
"Assets": "-72.0",
"Property, Plant and Equipment, Net": "-34.8",
"Goodwill": "-42.8",
"Assets, Non-Current": "-23.6",
"Other Expenses": "25.2",
"Expenses": "-81.3",
"Revenues": "34.4",
"Net Income": "-9.73",
"Research and Development": "-18.1",
"General and Administrative Expense": "-87.7",
"Other Revenues": "34.4",
"Comprehensive Net Income": "-2.68",
"Other Compr. Net Income": "7.37",
"Economic Capital Ratio": "-30.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000880242_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "202",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,165",
"Goodwill": "0",
"Liabilities, Current": "1,374",
"Liabilities, Non-Current": "390",
"Other Assets": "42",
"Other Compr. Net Income": "0",
"Other Expenses": "846",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "156",
"Property, Plant and Equipment, Net": "2.7",
"Research and Development": "99"
},
"output_variables": {
"Liabilities": "1,764",
"Assets": "246",
"Expenses": "4,111",
"Revenues": "156",
"Stockholders Equity": "-1,518",
"Net Income": "-3,954",
"Comprehensive Net Income": "-3,954",
"BaseVar": "3,139",
"ECR before LimitedLiability": "-600%",
"Economic Capital Ratio": "0.028%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "126",
"Assets, Non-Current": "41",
"General and Administrative Expense": "2,005",
"Goodwill": "0",
"Liabilities, Current": "732",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "322",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "168",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "742"
},
"output_variables": {
"Liabilities": "732",
"Assets": "167",
"Expenses": "3,069",
"Revenues": "168",
"Stockholders Equity": "-565",
"Net Income": "-2,901",
"Comprehensive Net Income": "-2,901",
"BaseVar": "2,068",
"ECR before LimitedLiability": "-817%",
"Economic Capital Ratio": "0.000030%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "231",
"Assets, Non-Current": "30",
"General and Administrative Expense": "2,793",
"Goodwill": "0",
"Liabilities, Current": "653",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "415",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "112",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "643"
},
"output_variables": {
"Liabilities": "653",
"Assets": "261",
"Expenses": "3,851",
"Revenues": "112",
"Stockholders Equity": "-392",
"Net Income": "-3,740",
"Comprehensive Net Income": "-3,740",
"BaseVar": "2,438",
"ECR before LimitedLiability": "-936%",
"Economic Capital Ratio": "0.00000029%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,891",
"Assets, Non-Current": "19",
"General and Administrative Expense": "3,552",
"Goodwill": "0",
"Liabilities, Current": "460",
"Liabilities, Non-Current": "309",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "73",
"Other Liabilities": "0",
"Other Net Income": "-896",
"Other Revenues": "128",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "685"
},
"output_variables": {
"Liabilities": "769",
"Assets": "1,910",
"Expenses": "4,309",
"Revenues": "128",
"Stockholders Equity": "1,141",
"Net Income": "-5,077",
"Comprehensive Net Income": "-5,077",
"BaseVar": "4,006",
"ECR before LimitedLiability": "-262%",
"Economic Capital Ratio": "18%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "3,153",
"Assets, Non-Current": "1,024",
"General and Administrative Expense": "9,758",
"Goodwill": "0",
"Liabilities, Current": "1,576",
"Liabilities, Non-Current": "1,271",
"Other Assets": "394",
"Other Compr. Net Income": "625",
"Other Expenses": "197",
"Other Liabilities": "0",
"Other Net Income": "258",
"Other Revenues": "5,884",
"Property, Plant and Equipment, Net": "287",
"Research and Development": "1,319"
},
"output_variables": {
"Liabilities": "2,847",
"Assets": "4,858",
"Expenses": "11,274",
"Revenues": "5,884",
"Stockholders Equity": "2,011",
"Net Income": "-5,132",
"Comprehensive Net Income": "-4,820",
"BaseVar": "12,873",
"ECR before LimitedLiability": "-54%",
"Economic Capital Ratio": "79%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "6,362",
"Assets, Non-Current": "1,181",
"General and Administrative Expense": "14,134",
"Goodwill": "0",
"Liabilities, Current": "2,710",
"Liabilities, Non-Current": "1,293",
"Other Assets": "0",
"Other Compr. Net Income": "1,016",
"Other Expenses": "394",
"Other Liabilities": "0",
"Other Net Income": "-68",
"Other Revenues": "12,230",
"Property, Plant and Equipment, Net": "662",
"Research and Development": "2,282"
},
"output_variables": {
"Liabilities": "4,003",
"Assets": "8,205",
"Expenses": "16,810",
"Revenues": "12,230",
"Stockholders Equity": "4,202",
"Net Income": "-4,648",
"Comprehensive Net Income": "-4,140",
"BaseVar": "21,166",
"ECR before LimitedLiability": "26%",
"Economic Capital Ratio": "110%"
}
}
},
"top_rated": false,
"trend": 13.0,
"value": 1.0980589940050514,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000880242.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000880242.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000880242.svg"
},
{
"company_id": "0001756390",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001756390.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001756390.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001756390.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001756390_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001756390_main_keyfigs.svg",
"name": "Ascend Wellness Holdings Inc",
"rank": 32,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001756390.svg",
"report_text": "The relative strengths and weaknesses of Ascend Wellness Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ascend Wellness Holdings Inc compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 17% points.The greatest weakness of Ascend Wellness Holdings Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 90% points.
The company's Economic Capital Ratio, given in the ranking table, is 101%, being 39% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001756390_2024_Ascend_Wellness_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "-75.0",
"Liabilities": "-49.9",
"Stockholders Equity": "-59.7",
"ECR before LimitedLiability": "-51.7",
"Liabilities, Current": "12.4",
"Other Liabilities": "8.00",
"Assets, Current": "-29.4",
"Assets": "-20.4",
"Assets, Non-Current": "3.24",
"Goodwill": "-9.80",
"Property, Plant and Equipment, Net": "18.1",
"Other Expenses": "1.74",
"Expenses": "18.1",
"Revenues": "1.95",
"Net Income": "12.4",
"Research and Development": "12.4",
"General and Administrative Expense": "4.91",
"Other Revenues": "1.95",
"Comprehensive Net Income": "12.4",
"Other Net Income": "-8.43",
"Economic Capital Ratio": "-56.1"
},
"2022": {
"Liabilities, Non-Current": "-82.5",
"Liabilities": "-52.6",
"Assets": "-11.9",
"Stockholders Equity": "-52.7",
"ECR before LimitedLiability": "-39.7",
"Other Liabilities": "8.44",
"Liabilities, Current": "15.2",
"Assets, Current": "-31.4",
"Property, Plant and Equipment, Net": "17.2",
"Goodwill": "12.3",
"General and Administrative Expense": "4.49",
"Expenses": "17.5",
"Revenues": "0.930",
"Net Income": "17.5",
"Research and Development": "10.9",
"Other Expenses": "6.50",
"Other Revenues": "0.930",
"Other Net Income": "-1.94",
"Comprehensive Net Income": "17.5",
"Other Compr. Net Income": "0.441",
"Economic Capital Ratio": "-50.2"
},
"2023": {
"Liabilities, Non-Current": "-90.3",
"Liabilities": "-36.4",
"Stockholders Equity": "-44.5",
"ECR before LimitedLiability": "-23.5",
"Other Liabilities": "7.49",
"Liabilities, Current": "17.4",
"Other Assets": "-2.62",
"Assets": "-14.3",
"Property, Plant and Equipment, Net": "9.21",
"Goodwill": "7.88",
"Assets, Current": "-22.2",
"Assets, Non-Current": "-3.44",
"Other Expenses": "13.1",
"Expenses": "13.1",
"Revenues": "12.4",
"Net Income": "16.9",
"Research and Development": "7.41",
"General and Administrative Expense": "-7.15",
"Other Revenues": "12.4",
"Comprehensive Net Income": "16.9",
"Economic Capital Ratio": "-38.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001756390_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "258,012",
"Assets, Non-Current": "123,530",
"General and Administrative Expense": "313,074",
"Goodwill": "102,238",
"Liabilities, Current": "118,818",
"Liabilities, Non-Current": "428,141",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "78,231",
"Other Liabilities": "0",
"Other Net Income": "-63,733",
"Other Revenues": "332,381",
"Property, Plant and Equipment, Net": "239,656",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "546,959",
"Assets": "723,436",
"Expenses": "391,305",
"Revenues": "332,381",
"Stockholders Equity": "176,477",
"Net Income": "-122,657",
"Comprehensive Net Income": "-122,657",
"BaseVar": "1,028,907",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "103%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "198,743",
"Assets, Non-Current": "128,094",
"General and Administrative Expense": "408,452",
"Goodwill": "265,463",
"Liabilities, Current": "144,556",
"Liabilities, Non-Current": "564,189",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "46,693",
"Other Liabilities": "0",
"Other Net Income": "-31,680",
"Other Revenues": "405,926",
"Property, Plant and Equipment, Net": "279,860",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "708,745",
"Assets": "872,160",
"Expenses": "455,145",
"Revenues": "405,926",
"Stockholders Equity": "163,415",
"Net Income": "-80,899",
"Comprehensive Net Income": "-80,899",
"BaseVar": "1,236,828",
"ECR before LimitedLiability": "18%",
"Economic Capital Ratio": "102%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "228,860",
"Assets, Non-Current": "153,618",
"General and Administrative Expense": "522,209",
"Goodwill": "268,990",
"Liabilities, Current": "128,431",
"Liabilities, Non-Current": "648,247",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "33,454",
"Other Liabilities": "0",
"Other Net Income": "-11,141",
"Other Revenues": "518,590",
"Property, Plant and Equipment, Net": "268,082",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "776,678",
"Assets": "919,550",
"Expenses": "555,663",
"Revenues": "518,590",
"Stockholders Equity": "142,872",
"Net Income": "-48,214",
"Comprehensive Net Income": "-48,214",
"BaseVar": "1,390,811",
"ECR before LimitedLiability": "17%",
"Economic Capital Ratio": "101%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 1.0145532440359726,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001756390.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001756390.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001756390.svg"
},
{
"company_id": "0001886799",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001886799.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001886799.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001886799_main_keyfigs.svg",
"name": "Bright Green Corp",
"rank": 33,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001886799.svg",
"report_text": "The relative strengths and weaknesses of Bright Green Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Bright Green Corp compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 93% points.The greatest weakness of Bright Green Corp is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 66% points.
The company's Economic Capital Ratio, given in the ranking table, is 100%, being 40% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001886799_2024_Bright_Green_Corp.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities": "-0.830",
"Stockholders Equity": "-2.89",
"ECR before LimitedLiability": "-65.8",
"Other Liabilities": "1.75",
"Liabilities, Current": "-2.33",
"Other Assets": "2.87",
"Assets": "-2.31",
"Assets, Current": "-22.4",
"Property, Plant and Equipment, Net": "60.3",
"Assets, Non-Current": "1.94",
"Goodwill": "-7.19",
"General and Administrative Expense": "-29.4",
"Expenses": "-8.59",
"Revenues": "-8.36",
"Net Income": "-58.9",
"Research and Development": "3.33",
"Other Expenses": "2.32",
"Other Revenues": "-8.36",
"Other Net Income": "0.338",
"Comprehensive Net Income": "-58.4",
"Economic Capital Ratio": "-76.3"
},
"2023": {
"Liabilities, Non-Current": "15.5",
"Liabilities": "11.5",
"Stockholders Equity": "18.2",
"ECR before LimitedLiability": "-24.9",
"Other Liabilities": "7.09",
"Liabilities, Current": "-17.7",
"Other Assets": "5.00",
"Assets": "17.3",
"Property, Plant and Equipment, Net": "92.6",
"Goodwill": "-24.7",
"Assets, Current": "-39.7",
"Assets, Non-Current": "-21.0",
"Other Expenses": "-20.2",
"Expenses": "-29.4",
"Revenues": "-39.3",
"Net Income": "-65.5",
"Research and Development": "7.05",
"General and Administrative Expense": "-16.6",
"Other Revenues": "-39.3",
"Comprehensive Net Income": "-65.6",
"Economic Capital Ratio": "-40.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001886799_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "492",
"Assets, Non-Current": "3,991",
"General and Administrative Expense": "26,609",
"Goodwill": "1.0",
"Liabilities, Current": "7,523",
"Liabilities, Non-Current": "3,686",
"Other Assets": "1,158",
"Other Compr. Net Income": "0",
"Other Expenses": "918",
"Other Liabilities": "0",
"Other Net Income": "-135",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "17,146",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "11,209",
"Assets": "22,788",
"Expenses": "27,527",
"Revenues": "0",
"Stockholders Equity": "11,579",
"Net Income": "-27,662",
"Comprehensive Net Income": "-27,662",
"BaseVar": "30,830",
"ECR before LimitedLiability": "-69%",
"Economic Capital Ratio": "76%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "268",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,253",
"Goodwill": "1.0",
"Liabilities, Current": "6,236",
"Liabilities, Non-Current": "202",
"Other Assets": "726",
"Other Compr. Net Income": "0",
"Other Expenses": "4,656",
"Other Liabilities": "0",
"Other Net Income": "-219",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "16,407",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,438",
"Assets": "17,403",
"Expenses": "12,909",
"Revenues": "0",
"Stockholders Equity": "10,965",
"Net Income": "-13,128",
"Comprehensive Net Income": "-13,128",
"BaseVar": "18,484",
"ECR before LimitedLiability": "16%",
"Economic Capital Ratio": "100%"
}
}
},
"top_rated": false,
"trend": 15.0,
"value": 1.0004608522219438,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001886799.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001886799.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001886799.svg"
},
{
"company_id": "0001642380",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001642380.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001642380.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001642380.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001642380_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001642380_main_keyfigs.svg",
"name": "Insight Molecular Diagnostics Inc",
"rank": 34,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001642380.svg",
"report_text": "The relative strengths and weaknesses of Insight Molecular Diagnostics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Insight Molecular Diagnostics Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 40% points.The greatest weakness of Insight Molecular Diagnostics Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 102% points.
The company's Economic Capital Ratio, given in the ranking table, is 96%, being 44% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001642380_2024_Insight_Molecular_Diagnostics_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "17.9",
"Liabilities": "9.68",
"Stockholders Equity": "25.8",
"ECR before LimitedLiability": "-19.9",
"Liabilities, Current": "-12.6",
"Other Liabilities": "3.72",
"Property, Plant and Equipment, Net": "-13.8",
"Assets": "25.7",
"Assets, Non-Current": "-5.78",
"Assets, Current": "40.2",
"Goodwill": "-7.54",
"Research and Development": "-35.5",
"Expenses": "-18.5",
"Revenues": "-44.9",
"Net Income": "-62.0",
"General and Administrative Expense": "-10.7",
"Other Expenses": "22.2",
"Other Revenues": "-44.9",
"Comprehensive Net Income": "-63.0",
"Other Net Income": "-2.40",
"Economic Capital Ratio": "-39.9"
},
"2017": {
"Liabilities": "1.32",
"Stockholders Equity": "-7.66",
"ECR before LimitedLiability": "-86.6",
"Liabilities, Current": "-1.41",
"Liabilities, Non-Current": "3.37",
"Assets, Non-Current": "-6.06",
"Assets": "-16.1",
"Other Assets": "1.08",
"Assets, Current": "20.5",
"Goodwill": "-12.1",
"Property, Plant and Equipment, Net": "-17.3",
"Research and Development": "-21.9",
"Expenses": "-33.2",
"Revenues": "-23.4",
"Net Income": "-64.5",
"Other Expenses": "11.8",
"General and Administrative Expense": "-26.1",
"Other Revenues": "-23.4",
"Comprehensive Net Income": "-66.3",
"Other Net Income": "-4.79",
"Economic Capital Ratio": "-108"
},
"2019": {
"Liabilities, Non-Current": "17.2",
"Liabilities": "15.2",
"Stockholders Equity": "70.3",
"ECR before LimitedLiability": "47.8",
"Other Liabilities": "-13.5",
"Liabilities, Current": "10.9",
"Assets, Non-Current": "27.1",
"Assets": "69.6",
"Goodwill": "-10.4",
"Property, Plant and Equipment, Net": "-12.2",
"Other Assets": "21.4",
"Assets, Current": "40.0",
"Research and Development": "-12.1",
"Expenses": "-3.78",
"Revenues": "-33.7",
"Net Income": "-34.7",
"Other Expenses": "8.23",
"Other Revenues": "-33.7",
"Other Net Income": "2.76",
"Comprehensive Net Income": "-34.6",
"Economic Capital Ratio": "18.3"
},
"2021": {
"Liabilities, Non-Current": "19.2",
"Liabilities": "-46.4",
"Stockholders Equity": "-18.4",
"ECR before LimitedLiability": "-50.7",
"Liabilities, Current": "15.5",
"Other Liabilities": "-91.6",
"Assets, Current": "-26.5",
"Assets": "19.2",
"Assets, Non-Current": "-14.4",
"Other Assets": "11.5",
"Goodwill": "37.9",
"Property, Plant and Equipment, Net": "-18.7",
"Other Expenses": "-4.82",
"Expenses": "8.82",
"Revenues": "-30.1",
"Net Income": "-21.3",
"General and Administrative Expense": "14.0",
"Other Revenues": "-30.1",
"Comprehensive Net Income": "-21.3",
"Other Net Income": "1.23",
"Economic Capital Ratio": "-55.0"
},
"2022": {
"Liabilities, Non-Current": "2.34",
"Liabilities": "-13.1",
"Stockholders Equity": "-0.971",
"Other Liabilities": "-62.6",
"Liabilities, Current": "1.70",
"Other Assets": "3.21",
"Assets": "2.07",
"ECR before LimitedLiability": "-58.2",
"Assets, Current": "-7.81",
"Property, Plant and Equipment, Net": "-5.96",
"Assets, Non-Current": "-0.996",
"Goodwill": "26.8",
"General and Administrative Expense": "2.94",
"Expenses": "8.99",
"Revenues": "-22.8",
"Net Income": "-35.8",
"Other Expenses": "3.65",
"Other Revenues": "-22.8",
"Other Net Income": "-40.9",
"Comprehensive Net Income": "-35.4",
"Economic Capital Ratio": "-68.7"
},
"2023": {
"Liabilities, Non-Current": "11.6",
"Liabilities": "-42.1",
"ECR before LimitedLiability": "-28.9",
"Other Liabilities": "-102",
"Liabilities, Current": "11.9",
"Other Assets": "11.5",
"Assets": "13.3",
"Property, Plant and Equipment, Net": "-20.4",
"Goodwill": "39.7",
"Assets, Current": "-21.4",
"Assets, Non-Current": "-17.1",
"Other Expenses": "9.30",
"Expenses": "11.5",
"Net Income": "-19.5",
"Research and Development": "-8.48",
"General and Administrative Expense": "11.5",
"Other Revenues": "-30.6",
"Revenues": "-30.6",
"Other Net Income": "-4.15",
"Comprehensive Net Income": "-19.6",
"Economic Capital Ratio": "-44.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001642380_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "12,696",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,463",
"Goodwill": "988",
"Liabilities, Current": "4,275",
"Liabilities, Non-Current": "0",
"Other Assets": "75",
"Other Compr. Net Income": "-304",
"Other Expenses": "0",
"Other Liabilities": "310",
"Other Net Income": "-28",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "688",
"Research and Development": "5,677"
},
"output_variables": {
"Liabilities": "4,585",
"Assets": "14,447",
"Expenses": "11,140",
"Revenues": "0",
"Stockholders Equity": "9,862",
"Net Income": "-11,168",
"Comprehensive Net Income": "-11,320",
"BaseVar": "15,252",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "107%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "8,528",
"Assets, Non-Current": "0",
"General and Administrative Expense": "11,675",
"Goodwill": "746",
"Liabilities, Current": "4,454",
"Liabilities, Non-Current": "0",
"Other Assets": "120",
"Other Compr. Net Income": "-234",
"Other Expenses": "0",
"Other Liabilities": "1,359",
"Other Net Income": "-526",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "822",
"Research and Development": "7,174"
},
"output_variables": {
"Liabilities": "5,813",
"Assets": "10,216",
"Expenses": "18,849",
"Revenues": "0",
"Stockholders Equity": "4,403",
"Net Income": "-19,375",
"Comprehensive Net Income": "-19,492",
"BaseVar": "17,819",
"ECR before LimitedLiability": "-168%",
"Economic Capital Ratio": "45%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "22,956",
"Assets, Non-Current": "10,964",
"General and Administrative Expense": "15,445",
"Goodwill": "0",
"Liabilities, Current": "4,440",
"Liabilities, Non-Current": "0",
"Other Assets": "5,939",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "4,581",
"Other Net Income": "-187",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "6,794"
},
"output_variables": {
"Liabilities": "9,021",
"Assets": "39,859",
"Expenses": "22,239",
"Revenues": "0",
"Stockholders Equity": "30,838",
"Net Income": "-22,426",
"Comprehensive Net Income": "-22,426",
"BaseVar": "35,653",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "39,143",
"Assets, Non-Current": "264",
"General and Administrative Expense": "37,688",
"Goodwill": "109,929",
"Liabilities, Current": "14,120",
"Liabilities, Non-Current": "0",
"Other Assets": "10,227",
"Other Compr. Net Income": "37",
"Other Expenses": "21,359",
"Other Liabilities": "80,226",
"Other Net Income": "854",
"Other Revenues": "7,727",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "13,631"
},
"output_variables": {
"Liabilities": "94,346",
"Assets": "159,563",
"Expenses": "72,678",
"Revenues": "7,727",
"Stockholders Equity": "65,217",
"Net Income": "-64,097",
"Comprehensive Net Income": "-64,078",
"BaseVar": "167,602",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "25,536",
"Assets, Non-Current": "371",
"General and Administrative Expense": "23,893",
"Goodwill": "61,633",
"Liabilities, Current": "12,106",
"Liabilities, Non-Current": "0",
"Other Assets": "12,551",
"Other Compr. Net Income": "2.0",
"Other Expenses": "-12,239",
"Other Liabilities": "48,391",
"Other Net Income": "-54,905",
"Other Revenues": "958",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "7,301"
},
"output_variables": {
"Liabilities": "60,497",
"Assets": "100,091",
"Expenses": "18,955",
"Revenues": "958",
"Stockholders Equity": "39,594",
"Net Income": "-72,902",
"Comprehensive Net Income": "-72,901",
"BaseVar": "117,704",
"ECR before LimitedLiability": "-23%",
"Economic Capital Ratio": "84%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "10,698",
"Assets, Non-Current": "463",
"General and Administrative Expense": "14,979",
"Goodwill": "56,595",
"Liabilities, Current": "7,194",
"Liabilities, Non-Current": "0",
"Other Assets": "7,136",
"Other Compr. Net Income": "10",
"Other Expenses": "2,366",
"Other Liabilities": "42,104",
"Other Net Income": "-2,645",
"Other Revenues": "1,503",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "9,294"
},
"output_variables": {
"Liabilities": "49,298",
"Assets": "74,892",
"Expenses": "26,639",
"Revenues": "1,503",
"Stockholders Equity": "25,594",
"Net Income": "-27,781",
"Comprehensive Net Income": "-27,776",
"BaseVar": "77,494",
"ECR before LimitedLiability": "12%",
"Economic Capital Ratio": "96%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 0.9610628564301593,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001642380.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001642380.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001642380.svg"
},
{
"company_id": "0001909747",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001909747.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001909747.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001909747_main_keyfigs.svg",
"name": "Jushi Holdings Inc",
"rank": 35,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001909747.svg",
"report_text": "The relative strengths and weaknesses of Jushi Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Jushi Holdings Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 30% points.The greatest weakness of Jushi Holdings Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 57% points.
The company's Economic Capital Ratio, given in the ranking table, is 84%, being 56% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001909747_2024_Jushi_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities, Non-Current": "-56.8",
"Liabilities": "-21.8",
"Stockholders Equity": "-60.2",
"Other Liabilities": "1.01",
"Liabilities, Current": "1.96",
"Other Assets": "-42.2",
"Assets": "-19.1",
"Assets, Current": "-35.0",
"Property, Plant and Equipment, Net": "1.84",
"Assets, Non-Current": "47.2",
"General and Administrative Expense": "-0.263",
"Expenses": "-0.686",
"Revenues": "-0.218",
"Net Income": "-0.252",
"Research and Development": "1.66",
"Other Expenses": "-1.26",
"Other Revenues": "-0.218",
"ECR before LimitedLiability": "-58.6",
"Other Net Income": "0.857",
"Comprehensive Net Income": "-0.201",
"Economic Capital Ratio": "-69.1"
},
"2023": {
"Liabilities, Non-Current": "-56.8",
"Liabilities": "-35.2",
"Stockholders Equity": "-55.7",
"Other Liabilities": "0.514",
"Liabilities, Current": "0.703",
"Other Assets": "-49.0",
"Assets": "-13.7",
"Property, Plant and Equipment, Net": "1.28",
"Goodwill": "0.151",
"Assets, Current": "-22.5",
"Assets, Non-Current": "30.2",
"Other Expenses": "0.692",
"Expenses": "1.25",
"Revenues": "0.717",
"Net Income": "1.55",
"Research and Development": "0.587",
"Other Revenues": "0.717",
"ECR before LimitedLiability": "-40.8",
"Other Net Income": "-0.321",
"Comprehensive Net Income": "1.54",
"Economic Capital Ratio": "-56.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001909747_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "70,051",
"Assets, Non-Current": "459,290",
"General and Administrative Expense": "344,972",
"Goodwill": "138,321",
"Liabilities, Current": "107,628",
"Liabilities, Non-Current": "375,822",
"Other Assets": "-316,076",
"Other Compr. Net Income": "0",
"Other Expenses": "168,093",
"Other Liabilities": "0",
"Other Net Income": "26,457",
"Other Revenues": "284,284",
"Property, Plant and Equipment, Net": "177,755",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "483,450",
"Assets": "529,341",
"Expenses": "513,065",
"Revenues": "284,284",
"Stockholders Equity": "45,891",
"Net Income": "-202,324",
"Comprehensive Net Income": "-202,324",
"BaseVar": "918,298",
"ECR before LimitedLiability": "-28%",
"Economic Capital Ratio": "83%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "81,635",
"Assets, Non-Current": "381,760",
"General and Administrative Expense": "263,689",
"Goodwill": "126,877",
"Liabilities, Current": "162,460",
"Liabilities, Non-Current": "308,554",
"Other Assets": "-286,145",
"Other Compr. Net Income": "0",
"Other Expenses": "40,380",
"Other Liabilities": "0",
"Other Net Income": "-30,478",
"Other Revenues": "269,445",
"Property, Plant and Equipment, Net": "159,268",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "471,014",
"Assets": "463,395",
"Expenses": "304,069",
"Revenues": "269,445",
"Stockholders Equity": "-7,619",
"Net Income": "-65,102",
"Comprehensive Net Income": "-65,102",
"BaseVar": "769,200",
"ECR before LimitedLiability": "-16%",
"Economic Capital Ratio": "84%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 0.8413822635829513,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001909747.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001909747.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001909747.svg"
},
{
"company_id": "0001134765",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001134765.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001134765.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001134765.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001134765_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001134765_main_keyfigs.svg",
"name": "Charlie s Holdings Inc",
"rank": 36,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001134765.svg",
"report_text": "The relative strengths and weaknesses of Charlie s Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Charlie s Holdings Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Charlie s Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 118% points.
The company's Economic Capital Ratio, given in the ranking table, is 82%, being 58% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001134765_2024_Charlie_s_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "0.0772",
"Liabilities": "0.0755",
"Stockholders Equity": "-37.6",
"ECR before LimitedLiability": "-91.4",
"Liabilities, Non-Current": "-0.0549",
"Other Liabilities": "-0.0251",
"Property, Plant and Equipment, Net": "-1.14",
"Assets": "-55.6",
"Assets, Non-Current": "-0.226",
"Other Assets": "0",
"Goodwill": "-0.885",
"Assets, Current": "-23.9",
"General and Administrative Expense": "-1.71",
"Expenses": "-0.811",
"Revenues": "-0.117",
"Net Income": "-11.9",
"Research and Development": "0.0474",
"Other Revenues": "-0.117",
"Comprehensive Net Income": "-11.9",
"Other Net Income": "-0.996",
"Economic Capital Ratio": "-153"
},
"2012": {
"Liabilities, Current": "-6.69",
"Liabilities": "-5.98",
"Stockholders Equity": "58.2",
"ECR before LimitedLiability": "17.6",
"Liabilities, Non-Current": "9.03",
"Other Liabilities": "-8.56",
"Assets, Current": "-21.0",
"Assets": "59.1",
"Other Assets": "39.8",
"Assets, Non-Current": "-5.07",
"Property, Plant and Equipment, Net": "-10.5",
"Goodwill": "62.2",
"Other Expenses": "9.56",
"Expenses": "9.06",
"Revenues": "-29.7",
"Net Income": "-24.1",
"Research and Development": "13.2",
"General and Administrative Expense": "-12.9",
"Other Revenues": "-29.7",
"Comprehensive Net Income": "-24.0",
"Economic Capital Ratio": "-14.8"
},
"2013": {
"Liabilities, Current": "-30.3",
"Liabilities": "-1.06",
"ECR before LimitedLiability": "-30.9",
"Other Liabilities": "1.40",
"Liabilities, Non-Current": "1.67",
"Goodwill": "7.73",
"Assets": "2.45",
"Assets, Non-Current": "-0.749",
"Property, Plant and Equipment, Net": "-1.12",
"Other Assets": "3.23",
"Assets, Current": "-0.669",
"General and Administrative Expense": "-0.797",
"Expenses": "-0.983",
"Net Income": "-32.8",
"Research and Development": "1.99",
"Other Expenses": "-1.11",
"Other Revenues": "-10.3",
"Revenues": "-10.3",
"Other Net Income": "-0.658",
"Comprehensive Net Income": "-32.9",
"Economic Capital Ratio": "-71.0"
},
"2014": {
"Liabilities, Non-Current": "4.06",
"Liabilities": "-4.97",
"Stockholders Equity": "-14.6",
"ECR before LimitedLiability": "-17.2",
"Liabilities, Current": "-12.6",
"Other Liabilities": "2.73",
"Assets, Current": "-14.7",
"Assets": "-11.6",
"Goodwill": "14.4",
"Other Assets": "12.1",
"Assets, Non-Current": "-4.01",
"Property, Plant and Equipment, Net": "-8.76",
"Other Expenses": "-6.80",
"Expenses": "-8.05",
"Revenues": "-5.19",
"Net Income": "-10.4",
"Research and Development": "7.15",
"General and Administrative Expense": "-7.63",
"Other Revenues": "-5.19",
"Comprehensive Net Income": "-10.4",
"Economic Capital Ratio": "-66.6"
},
"2015": {
"Other Liabilities": "3.47",
"Liabilities": "-2.30",
"Stockholders Equity": "-25.1",
"ECR before LimitedLiability": "-36.3",
"Liabilities, Current": "-13.2",
"Liabilities, Non-Current": "4.15",
"Assets, Current": "-21.7",
"Assets": "-25.4",
"Goodwill": "10.1",
"Assets, Non-Current": "-4.45",
"Property, Plant and Equipment, Net": "-13.2",
"Research and Development": "6.34",
"Expenses": "-15.3",
"Revenues": "-2.13",
"Net Income": "-20.5",
"General and Administrative Expense": "-14.5",
"Other Expenses": "-7.08",
"Other Revenues": "-2.13",
"Comprehensive Net Income": "-20.4",
"Other Net Income": "-4.35",
"Economic Capital Ratio": "-82.2"
},
"2016": {
"Liabilities, Non-Current": "4.13",
"Liabilities": "-10.1",
"Stockholders Equity": "-47.2",
"ECR before LimitedLiability": "-71.9",
"Liabilities, Current": "-20.1",
"Property, Plant and Equipment, Net": "-17.0",
"Assets": "-28.9",
"Other Assets": "5.47",
"Assets, Non-Current": "-5.15",
"Assets, Current": "-29.1",
"Goodwill": "25.6",
"Research and Development": "8.74",
"Expenses": "-12.8",
"Revenues": "-12.2",
"Net Income": "-10.8",
"General and Administrative Expense": "-22.5",
"Other Expenses": "3.80",
"Other Revenues": "-12.2",
"Comprehensive Net Income": "-10.7",
"Other Net Income": "14.7",
"Economic Capital Ratio": "-91.9"
},
"2017": {
"Other Liabilities": "-0.193",
"Liabilities": "-0.684",
"Stockholders Equity": "-61.6",
"ECR before LimitedLiability": "-113",
"Liabilities, Current": "-0.917",
"Liabilities, Non-Current": "0.275",
"Assets, Non-Current": "-5.88",
"Assets": "-57.7",
"Assets, Current": "-44.3",
"Goodwill": "7.62",
"Property, Plant and Equipment, Net": "-26.7",
"Research and Development": "5.30",
"Expenses": "-27.1",
"Revenues": "-7.69",
"Net Income": "-32.0",
"Other Expenses": "-15.0",
"General and Administrative Expense": "-17.4",
"Other Revenues": "-7.69",
"Comprehensive Net Income": "-32.2",
"Other Net Income": "3.51",
"Economic Capital Ratio": "-135"
},
"2018": {
"Liabilities, Non-Current": "0.226",
"Liabilities": "-1.47",
"Stockholders Equity": "-132",
"ECR before LimitedLiability": "-105",
"Liabilities, Current": "-3.22",
"Property, Plant and Equipment, Net": "-23.9",
"Assets": "-66.0",
"Other Assets": "-0.186",
"Assets, Current": "-56.6",
"Goodwill": "-0.850",
"Assets, Non-Current": "-12.5",
"Other Expenses": "5.03",
"Expenses": "-13.4",
"Revenues": "-16.5",
"Net Income": "0.768",
"Research and Development": "5.30",
"General and Administrative Expense": "-31.1",
"Other Revenues": "-16.5",
"Comprehensive Net Income": "0.876",
"Other Net Income": "14.8",
"Economic Capital Ratio": "-126"
},
"2019": {
"Liabilities, Non-Current": "5.92",
"Liabilities": "10.3",
"Stockholders Equity": "-140",
"ECR before LimitedLiability": "-27.5",
"Other Liabilities": "5.96",
"Liabilities, Current": "-1.38",
"Assets, Non-Current": "-3.96",
"Assets": "-99.6",
"Goodwill": "-15.1",
"Property, Plant and Equipment, Net": "-18.3",
"Assets, Current": "-50.5",
"Research and Development": "4.55",
"Expenses": "-52.6",
"Revenues": "39.9",
"Net Income": "23.2",
"Other Expenses": "2.89",
"General and Administrative Expense": "-78.5",
"Other Revenues": "39.9",
"Other Net Income": "15.6",
"Comprehensive Net Income": "23.3",
"Economic Capital Ratio": "-57.0"
},
"2020": {
"Liabilities, Current": "-13.5",
"Liabilities": "-4.78",
"Stockholders Equity": "-125",
"ECR before LimitedLiability": "-60.8",
"Liabilities, Non-Current": "3.76",
"Goodwill": "-21.6",
"Assets": "-75.2",
"Other Assets": "-4.27",
"Assets, Current": "-35.1",
"Assets, Non-Current": "-6.77",
"Property, Plant and Equipment, Net": "-23.8",
"Other Expenses": "6.82",
"Expenses": "-29.0",
"Revenues": "23.1",
"Net Income": "-3.29",
"Research and Development": "-5.56",
"General and Administrative Expense": "-29.9",
"Other Revenues": "23.1",
"Comprehensive Net Income": "-3.22",
"Other Net Income": "2.80",
"Economic Capital Ratio": "-98.6"
},
"2021": {
"Liabilities, Non-Current": "45.7",
"Liabilities": "60.4",
"Stockholders Equity": "-170",
"ECR before LimitedLiability": "25.9",
"Liabilities, Current": "-2.08",
"Other Liabilities": "18.9",
"Assets, Current": "-28.1",
"Assets": "-53.9",
"Assets, Non-Current": "-11.9",
"Other Assets": "-1.17",
"Goodwill": "-24.6",
"Property, Plant and Equipment, Net": "-20.7",
"Other Expenses": "-70.5",
"Expenses": "-47.1",
"Revenues": "98.0",
"Net Income": "97.0",
"Research and Development": "22.7",
"Other Revenues": "98.0",
"Comprehensive Net Income": "97.0",
"Other Net Income": "44.9",
"Economic Capital Ratio": "21.6"
},
"2022": {
"Liabilities, Non-Current": "15.8",
"Liabilities": "23.7",
"Stockholders Equity": "-209",
"ECR before LimitedLiability": "-45.6",
"Other Liabilities": "12.1",
"Liabilities, Current": "12.4",
"Assets": "-118",
"Assets, Current": "-73.4",
"Property, Plant and Equipment, Net": "-58.3",
"Assets, Non-Current": "-36.1",
"Goodwill": "-63.6",
"General and Administrative Expense": "11.7",
"Expenses": "-129",
"Revenues": "72.6",
"Net Income": "21.3",
"Research and Development": "12.0",
"Other Expenses": "-161",
"Other Revenues": "72.6",
"Other Net Income": "8.33",
"Comprehensive Net Income": "21.7",
"Economic Capital Ratio": "-56.1"
},
"2023": {
"Liabilities, Non-Current": "5.04",
"Liabilities": "12.1",
"Stockholders Equity": "-118",
"ECR before LimitedLiability": "-43.1",
"Other Liabilities": "2.46",
"Liabilities, Current": "3.82",
"Other Assets": "-1.45",
"Assets": "-97.2",
"Property, Plant and Equipment, Net": "-31.4",
"Goodwill": "-35.8",
"Assets, Current": "-5.64",
"Assets, Non-Current": "-15.5",
"Other Expenses": "-81.7",
"Expenses": "-75.8",
"Revenues": "47.2",
"Net Income": "7.82",
"Research and Development": "2.68",
"General and Administrative Expense": "-0.990",
"Other Revenues": "47.2",
"Comprehensive Net Income": "7.74",
"Economic Capital Ratio": "-58.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001134765_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "238",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,369",
"Goodwill": "19",
"Liabilities, Current": "1,869",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "718",
"Other Liabilities": "103",
"Other Net Income": "-1,126",
"Other Revenues": "1,267",
"Property, Plant and Equipment, Net": "9.7",
"Research and Development": "0.29"
},
"output_variables": {
"Liabilities": "1,972",
"Assets": "267",
"Expenses": "4,087",
"Revenues": "1,267",
"Stockholders Equity": "-1,705",
"Net Income": "-3,946",
"Comprehensive Net Income": "-3,946",
"BaseVar": "4,359",
"ECR before LimitedLiability": "-561%",
"Economic Capital Ratio": "0.077%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,237",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,273",
"Goodwill": "3,573",
"Liabilities, Current": "1,292",
"Liabilities, Non-Current": "0",
"Other Assets": "1,579",
"Other Compr. Net Income": "0",
"Other Expenses": "750",
"Other Liabilities": "772",
"Other Net Income": "-118",
"Other Revenues": "1,022",
"Property, Plant and Equipment, Net": "25",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,064",
"Assets": "6,415",
"Expenses": "4,023",
"Revenues": "1,022",
"Stockholders Equity": "4,351",
"Net Income": "-3,119",
"Comprehensive Net Income": "-3,119",
"BaseVar": "6,821",
"ECR before LimitedLiability": "67%",
"Economic Capital Ratio": "144%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "4,960",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,926",
"Goodwill": "3,523",
"Liabilities, Current": "5,438",
"Liabilities, Non-Current": "0",
"Other Assets": "1,486",
"Other Compr. Net Income": "0",
"Other Expenses": "4,448",
"Other Liabilities": "0",
"Other Net Income": "-391",
"Other Revenues": "2,649",
"Property, Plant and Equipment, Net": "8.4",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,438",
"Assets": "9,977",
"Expenses": "10,374",
"Revenues": "2,649",
"Stockholders Equity": "4,539",
"Net Income": "-8,115",
"Comprehensive Net Income": "-8,115",
"BaseVar": "14,415",
"ECR before LimitedLiability": "-25%",
"Economic Capital Ratio": "83%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "3,004",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,838",
"Goodwill": "3,475",
"Liabilities, Current": "7,755",
"Liabilities, Non-Current": "0",
"Other Assets": "1,352",
"Other Compr. Net Income": "0",
"Other Expenses": "4,402",
"Other Liabilities": "0",
"Other Net Income": "430",
"Other Revenues": "4,693",
"Property, Plant and Equipment, Net": "4.6",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,755",
"Assets": "7,835",
"Expenses": "13,240",
"Revenues": "4,693",
"Stockholders Equity": "80",
"Net Income": "-8,117",
"Comprehensive Net Income": "-8,117",
"BaseVar": "16,977",
"ECR before LimitedLiability": "-103%",
"Economic Capital Ratio": "67%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "3,855",
"Assets, Non-Current": "0",
"General and Administrative Expense": "10,549",
"Goodwill": "3,475",
"Liabilities, Current": "9,159",
"Liabilities, Non-Current": "0",
"Other Assets": "1,280",
"Other Compr. Net Income": "0",
"Other Expenses": "6,282",
"Other Liabilities": "0",
"Other Net Income": "-1,281",
"Other Revenues": "6,121",
"Property, Plant and Equipment, Net": "4.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,159",
"Assets": "8,614",
"Expenses": "16,831",
"Revenues": "6,121",
"Stockholders Equity": "-545",
"Net Income": "-11,991",
"Comprehensive Net Income": "-11,991",
"BaseVar": "21,003",
"ECR before LimitedLiability": "-143%",
"Economic Capital Ratio": "54%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "998",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,608",
"Goodwill": "3,475",
"Liabilities, Current": "7,161",
"Liabilities, Non-Current": "0",
"Other Assets": "460",
"Other Compr. Net Income": "0",
"Other Expenses": "2,254",
"Other Liabilities": "0",
"Other Net Income": "2,841",
"Other Revenues": "2,575",
"Property, Plant and Equipment, Net": "11",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,161",
"Assets": "4,943",
"Expenses": "10,862",
"Revenues": "2,575",
"Stockholders Equity": "-2,217",
"Net Income": "-5,446",
"Comprehensive Net Income": "-5,446",
"BaseVar": "14,191",
"ECR before LimitedLiability": "-140%",
"Economic Capital Ratio": "55%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,389",
"Assets, Non-Current": "0",
"General and Administrative Expense": "10,699",
"Goodwill": "3,475",
"Liabilities, Current": "8,206",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7,567",
"Other Liabilities": "2,050",
"Other Net Income": "1,996",
"Other Revenues": "3,823",
"Property, Plant and Equipment, Net": "5.9",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "10,256",
"Assets": "4,869",
"Expenses": "18,266",
"Revenues": "3,823",
"Stockholders Equity": "-5,386",
"Net Income": "-12,447",
"Comprehensive Net Income": "-12,447",
"BaseVar": "19,605",
"ECR before LimitedLiability": "-262%",
"Economic Capital Ratio": "18%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "53",
"Assets, Non-Current": "0",
"General and Administrative Expense": "12,638",
"Goodwill": "1,577",
"Liabilities, Current": "9,789",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "6,811",
"Other Revenues": "1,947",
"Property, Plant and Equipment, Net": "1.1",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,789",
"Assets": "1,631",
"Expenses": "12,638",
"Revenues": "1,947",
"Stockholders Equity": "-8,158",
"Net Income": "-3,879",
"Comprehensive Net Income": "-3,879",
"BaseVar": "16,408",
"ECR before LimitedLiability": "-264%",
"Economic Capital Ratio": "18%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "5,611",
"Assets, Non-Current": "2,237",
"General and Administrative Expense": "27,402",
"Goodwill": "0",
"Liabilities, Current": "7,177",
"Liabilities, Non-Current": "1,218",
"Other Assets": "-543",
"Other Compr. Net Income": "0",
"Other Expenses": "1,650",
"Other Liabilities": "0",
"Other Net Income": "3,618",
"Other Revenues": "22,740",
"Property, Plant and Equipment, Net": "543",
"Research and Development": "1,102"
},
"output_variables": {
"Liabilities": "8,395",
"Assets": "7,848",
"Expenses": "30,154",
"Revenues": "22,740",
"Stockholders Equity": "-547",
"Net Income": "-3,796",
"Comprehensive Net Income": "-3,796",
"BaseVar": "36,378",
"ECR before LimitedLiability": "-56%",
"Economic Capital Ratio": "79%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,723",
"Assets, Non-Current": "1,802",
"General and Administrative Expense": "20,084",
"Goodwill": "0",
"Liabilities, Current": "10,743",
"Liabilities, Non-Current": "1,778",
"Other Assets": "-531",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-417",
"Other Revenues": "16,692",
"Property, Plant and Equipment, Net": "531",
"Research and Development": "3,378"
},
"output_variables": {
"Liabilities": "12,521",
"Assets": "6,525",
"Expenses": "23,462",
"Revenues": "16,692",
"Stockholders Equity": "-5,996",
"Net Income": "-7,187",
"Comprehensive Net Income": "-7,187",
"BaseVar": "29,808",
"ECR before LimitedLiability": "-162%",
"Economic Capital Ratio": "47%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "7,994",
"Assets, Non-Current": "1,254",
"General and Administrative Expense": "10,484",
"Goodwill": "0",
"Liabilities, Current": "5,534",
"Liabilities, Non-Current": "583",
"Other Assets": "-431",
"Other Compr. Net Income": "0",
"Other Expenses": "10,765",
"Other Liabilities": "0",
"Other Net Income": "4,585",
"Other Revenues": "21,496",
"Property, Plant and Equipment, Net": "431",
"Research and Development": "24"
},
"output_variables": {
"Liabilities": "6,117",
"Assets": "9,248",
"Expenses": "21,273",
"Revenues": "21,496",
"Stockholders Equity": "3,131",
"Net Income": "4,808",
"Comprehensive Net Income": "4,808",
"BaseVar": "31,360",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "180%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "5,850",
"Assets, Non-Current": "1,211",
"General and Administrative Expense": "10,986",
"Goodwill": "0",
"Liabilities, Current": "4,783",
"Liabilities, Non-Current": "578",
"Other Assets": "-311",
"Other Compr. Net Income": "0",
"Other Expenses": "16,347",
"Other Liabilities": "0",
"Other Net Income": "121",
"Other Revenues": "26,424",
"Property, Plant and Equipment, Net": "311",
"Research and Development": "804"
},
"output_variables": {
"Liabilities": "5,361",
"Assets": "7,061",
"Expenses": "28,137",
"Revenues": "26,424",
"Stockholders Equity": "1,700",
"Net Income": "-1,592",
"Comprehensive Net Income": "-1,592",
"BaseVar": "33,552",
"ECR before LimitedLiability": "12%",
"Economic Capital Ratio": "96%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "5,086",
"Assets, Non-Current": "682",
"General and Administrative Expense": "8,077",
"Goodwill": "0",
"Liabilities, Current": "4,754",
"Liabilities, Non-Current": "1,121",
"Other Assets": "-157",
"Other Compr. Net Income": "0",
"Other Expenses": "10,206",
"Other Liabilities": "0",
"Other Net Income": "109",
"Other Revenues": "16,250",
"Property, Plant and Equipment, Net": "157",
"Research and Development": "169"
},
"output_variables": {
"Liabilities": "5,875",
"Assets": "5,768",
"Expenses": "18,452",
"Revenues": "16,250",
"Stockholders Equity": "-107",
"Net Income": "-2,093",
"Comprehensive Net Income": "-2,093",
"BaseVar": "23,227",
"ECR before LimitedLiability": "-38%",
"Economic Capital Ratio": "82%"
}
}
},
"top_rated": false,
"trend": 5.0,
"value": 0.8189034074060533,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001134765.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001134765.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001134765.svg"
},
{
"company_id": "0001586554",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001586554.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001586554.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001586554.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001586554_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001586554_main_keyfigs.svg",
"name": "Target Group Inc",
"rank": 37,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001586554.svg",
"report_text": "The relative strengths and weaknesses of Target Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Target Group Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 19% points.The greatest weakness of Target Group Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 66% points.
The company's Economic Capital Ratio, given in the ranking table, is 73%, being 67% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001586554_2024_Target_Group_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-0.514",
"Liabilities": "2.14",
"Stockholders Equity": "-68.5",
"ECR before LimitedLiability": "-124",
"Liabilities, Current": "2.32",
"Property, Plant and Equipment, Net": "-6.90",
"Assets": "-54.5",
"Other Assets": "-2.05",
"Assets, Non-Current": "0.513",
"Assets, Current": "-30.5",
"Goodwill": "-2.42",
"Research and Development": "0.575",
"Expenses": "-7.30",
"Revenues": "-5.81",
"Net Income": "-15.9",
"General and Administrative Expense": "1.65",
"Other Expenses": "-22.8",
"Other Revenues": "-5.81",
"Comprehensive Net Income": "-15.8",
"Other Net Income": "0.930",
"Economic Capital Ratio": "-144"
},
"2018": {
"Liabilities, Non-Current": "12.6",
"Liabilities": "-41.3",
"Stockholders Equity": "26.2",
"ECR before LimitedLiability": "8.36",
"Other Liabilities": "7.64",
"Liabilities, Current": "-66.6",
"Property, Plant and Equipment, Net": "-12.9",
"Assets": "48.1",
"Other Assets": "-42.9",
"Assets, Current": "-25.0",
"Goodwill": "49.9",
"Assets, Non-Current": "108",
"Other Expenses": "-9.27",
"Expenses": "40.1",
"Revenues": "-30.6",
"Comprehensive Net Income": "-6.29",
"Research and Development": "8.22",
"General and Administrative Expense": "41.8",
"Other Revenues": "-30.6",
"Other Net Income": "-9.70",
"Economic Capital Ratio": "-12.1"
},
"2019": {
"Liabilities": "-10.3",
"Stockholders Equity": "25.4",
"ECR before LimitedLiability": "2.93",
"Other Liabilities": "11.7",
"Liabilities, Current": "-25.0",
"Assets, Non-Current": "107",
"Assets": "27.2",
"Goodwill": "32.8",
"Property, Plant and Equipment, Net": "31.0",
"Other Assets": "-77.7",
"Assets, Current": "-41.7",
"Research and Development": "10.3",
"Expenses": "25.5",
"Revenues": "-40.4",
"Net Income": "-39.6",
"Other Expenses": "-21.6",
"General and Administrative Expense": "26.9",
"Other Revenues": "-40.4",
"Other Net Income": "-37.2",
"Comprehensive Net Income": "-41.2",
"Economic Capital Ratio": "-26.5"
},
"2020": {
"Liabilities, Current": "-2.25",
"Liabilities": "-29.3",
"Stockholders Equity": "-34.7",
"ECR before LimitedLiability": "-35.0",
"Liabilities, Non-Current": "-18.1",
"Other Liabilities": "0.835",
"Goodwill": "5.66",
"Assets": "-3.68",
"Other Assets": "-28.9",
"Assets, Current": "-11.3",
"Assets, Non-Current": "58.2",
"Property, Plant and Equipment, Net": "23.4",
"Expenses": "15.5",
"Revenues": "-8.37",
"Net Income": "-5.10",
"Research and Development": "2.09",
"General and Administrative Expense": "13.4",
"Other Revenues": "-8.37",
"Comprehensive Net Income": "-5.28",
"Other Net Income": "-7.15",
"Economic Capital Ratio": "-72.8"
},
"2021": {
"Liabilities, Non-Current": "-89.9",
"Liabilities": "-101",
"Stockholders Equity": "-68.4",
"Liabilities, Current": "-0.587",
"Other Liabilities": "0.402",
"Assets, Current": "-33.0",
"Assets": "0.110",
"ECR before LimitedLiability": "-70.5",
"Assets, Non-Current": "49.5",
"Other Assets": "-54.1",
"Goodwill": "1.31",
"Property, Plant and Equipment, Net": "9.79",
"Expenses": "6.93",
"Revenues": "-15.8",
"Net Income": "2.71",
"Research and Development": "0.766",
"General and Administrative Expense": "5.03",
"Other Revenues": "-15.8",
"Comprehensive Net Income": "2.74",
"Other Net Income": "1.10",
"Economic Capital Ratio": "-74.8"
},
"2022": {
"Liabilities, Non-Current": "-15.6",
"Liabilities": "-24.5",
"Stockholders Equity": "-53.0",
"ECR before LimitedLiability": "-81.7",
"Other Liabilities": "1.19",
"Liabilities, Current": "-11.8",
"Other Assets": "-21.6",
"Assets": "-13.0",
"Assets, Current": "-17.5",
"Property, Plant and Equipment, Net": "26.9",
"Assets, Non-Current": "39.5",
"Goodwill": "-9.37",
"General and Administrative Expense": "14.9",
"Expenses": "17.3",
"Revenues": "-12.0",
"Net Income": "-5.38",
"Research and Development": "2.97",
"Other Revenues": "-12.0",
"Other Net Income": "-9.05",
"Comprehensive Net Income": "-5.11",
"Economic Capital Ratio": "-92.2"
},
"2023": {
"Liabilities, Non-Current": "1.32",
"Liabilities": "-43.9",
"Stockholders Equity": "-63.5",
"ECR before LimitedLiability": "-51.7",
"Other Liabilities": "1.14",
"Liabilities, Current": "-65.5",
"Other Assets": "-11.1",
"Assets": "-8.56",
"Property, Plant and Equipment, Net": "15.0",
"Goodwill": "-6.67",
"Assets, Current": "-5.43",
"Assets, Non-Current": "19.2",
"Other Expenses": "-0.702",
"Expenses": "8.89",
"Revenues": "-2.23",
"Net Income": "6.36",
"Research and Development": "1.70",
"General and Administrative Expense": "7.75",
"Other Revenues": "-2.23",
"Comprehensive Net Income": "6.22",
"Economic Capital Ratio": "-66.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001586554_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "156",
"Assets, Non-Current": "138",
"General and Administrative Expense": "15",
"Goodwill": "138",
"Liabilities, Current": "2,114",
"Liabilities, Non-Current": "0",
"Other Assets": "-138",
"Other Compr. Net Income": "0",
"Other Expenses": "2,593",
"Other Liabilities": "0",
"Other Net Income": "371",
"Other Revenues": "5.9",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "114"
},
"output_variables": {
"Liabilities": "2,114",
"Assets": "294",
"Expenses": "2,721",
"Revenues": "5.9",
"Stockholders Equity": "-1,820",
"Net Income": "-2,345",
"Comprehensive Net Income": "-2,345",
"BaseVar": "2,753",
"ECR before LimitedLiability": "-402%",
"Economic Capital Ratio": "2.3%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "559",
"Assets, Non-Current": "6,222",
"General and Administrative Expense": "34",
"Goodwill": "3,594",
"Liabilities, Current": "3,437",
"Liabilities, Non-Current": "0",
"Other Assets": "-3,594",
"Other Compr. Net Income": "-56",
"Other Expenses": "1,155",
"Other Liabilities": "0",
"Other Net Income": "-620",
"Other Revenues": "0.26",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "92"
},
"output_variables": {
"Liabilities": "3,437",
"Assets": "6,781",
"Expenses": "1,281",
"Revenues": "0.26",
"Stockholders Equity": "3,344",
"Net Income": "-1,900",
"Comprehensive Net Income": "-1,928",
"BaseVar": "6,087",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "213",
"Assets, Non-Current": "16,252",
"General and Administrative Expense": "535",
"Goodwill": "8,148",
"Liabilities, Current": "5,135",
"Liabilities, Non-Current": "1,394",
"Other Assets": "-16,252",
"Other Compr. Net Income": "-503",
"Other Expenses": "4,155",
"Other Liabilities": "0",
"Other Net Income": "-5,678",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "8,104",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,529",
"Assets": "16,464",
"Expenses": "4,690",
"Revenues": "0",
"Stockholders Equity": "9,935",
"Net Income": "-10,368",
"Comprehensive Net Income": "-10,619",
"BaseVar": "16,932",
"ECR before LimitedLiability": "26%",
"Economic Capital Ratio": "109%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "755",
"Assets, Non-Current": "12,282",
"General and Administrative Expense": "161",
"Goodwill": "3,666",
"Liabilities, Current": "4,873",
"Liabilities, Non-Current": "11,684",
"Other Assets": "-11,460",
"Other Compr. Net Income": "-278",
"Other Expenses": "1,433",
"Other Liabilities": "0",
"Other Net Income": "-5,509",
"Other Revenues": "30",
"Property, Plant and Equipment, Net": "7,794",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,557",
"Assets": "13,037",
"Expenses": "1,594",
"Revenues": "30",
"Stockholders Equity": "-3,520",
"Net Income": "-7,074",
"Comprehensive Net Income": "-7,213",
"BaseVar": "18,503",
"ECR before LimitedLiability": "-81%",
"Economic Capital Ratio": "73%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "584",
"Assets, Non-Current": "12,479",
"General and Administrative Expense": "0",
"Goodwill": "3,682",
"Liabilities, Current": "4,043",
"Liabilities, Non-Current": "11,172",
"Other Assets": "-10,524",
"Other Compr. Net Income": "64",
"Other Expenses": "1,350",
"Other Liabilities": "0",
"Other Net Income": "1,623",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "6,842",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "15,215",
"Assets": "13,063",
"Expenses": "1,350",
"Revenues": "0",
"Stockholders Equity": "-2,152",
"Net Income": "273",
"Comprehensive Net Income": "305",
"BaseVar": "15,657",
"ECR before LimitedLiability": "-19%",
"Economic Capital Ratio": "84%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "910",
"Assets, Non-Current": "6,656",
"General and Administrative Expense": "0",
"Goodwill": "263",
"Liabilities, Current": "6,927",
"Liabilities, Non-Current": "7,198",
"Other Assets": "-5,817",
"Other Compr. Net Income": "112",
"Other Expenses": "1,240",
"Other Liabilities": "0",
"Other Net Income": "-3,281",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "5,554",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "14,125",
"Assets": "7,566",
"Expenses": "1,240",
"Revenues": "0",
"Stockholders Equity": "-6,560",
"Net Income": "-4,520",
"Comprehensive Net Income": "-4,464",
"BaseVar": "13,162",
"ECR before LimitedLiability": "-124%",
"Economic Capital Ratio": "60%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "3,094",
"Assets, Non-Current": "5,747",
"General and Administrative Expense": "2,065",
"Goodwill": "269",
"Liabilities, Current": "14,589",
"Liabilities, Non-Current": "1,224",
"Other Assets": "-5,700",
"Other Compr. Net Income": "-89",
"Other Expenses": "2,086",
"Other Liabilities": "0",
"Other Net Income": "108",
"Other Revenues": "3,720",
"Property, Plant and Equipment, Net": "5,430",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "15,814",
"Assets": "8,841",
"Expenses": "4,151",
"Revenues": "3,720",
"Stockholders Equity": "-6,973",
"Net Income": "-324",
"Comprehensive Net Income": "-368",
"BaseVar": "16,362",
"ECR before LimitedLiability": "-80%",
"Economic Capital Ratio": "73%"
}
}
},
"top_rated": false,
"trend": 13.0,
"value": 0.7328351379443498,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001586554.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001586554.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001586554.svg"
},
{
"company_id": "0001673431",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001673431.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001673431.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001673431_main_keyfigs.svg",
"name": "South East Asia Development Corp",
"rank": 38,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001673431.svg",
"report_text": "The relative strengths and weaknesses of South East Asia Development Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of South East Asia Development Corp compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 47% points.The greatest weakness of South East Asia Development Corp is the variable Stockholders Equity, reducing the Economic Capital Ratio by 132% points.
The company's Economic Capital Ratio, given in the ranking table, is 72%, being 68% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001673431_2024_South_East_Asia_Development_Corp.pdf",
"shrinked_graph_json": {
"2023": {
"Liabilities, Non-Current": "6.29",
"Liabilities": "-12.3",
"Stockholders Equity": "-132",
"ECR before LimitedLiability": "-52.7",
"Liabilities, Current": "-79.2",
"Other Assets": "36.3",
"Assets": "-55.3",
"Property, Plant and Equipment, Net": "-10.3",
"Goodwill": "-10.5",
"Assets, Current": "-17.2",
"Assets, Non-Current": "-9.51",
"Other Expenses": "-12.2",
"Expenses": "2.66",
"Revenues": "-11.7",
"Net Income": "30.2",
"Research and Development": "3.01",
"General and Administrative Expense": "23.6",
"Other Revenues": "-11.7",
"Other Net Income": "47.2",
"Comprehensive Net Income": "30.1",
"Economic Capital Ratio": "-67.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001673431_strength_weakness.svg",
"table_records": {
"2023": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "0",
"Goodwill": "0",
"Liabilities, Current": "323",
"Liabilities, Non-Current": "0",
"Other Assets": "110",
"Other Compr. Net Income": "0",
"Other Expenses": "214",
"Other Liabilities": "0",
"Other Net Income": "324",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "323",
"Assets": "110",
"Expenses": "214",
"Revenues": "0",
"Stockholders Equity": "-214",
"Net Income": "110",
"Comprehensive Net Income": "110",
"BaseVar": "486",
"ECR before LimitedLiability": "-84%",
"Economic Capital Ratio": "72%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.7228035010047306,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001673431.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001673431.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001673431.svg"
},
{
"company_id": "0001552189",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001552189.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001552189.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001552189.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001552189_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001552189_main_keyfigs.svg",
"name": "Panacea LIFE Sciences Holdings INC",
"rank": 39,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001552189.svg",
"report_text": "The relative strengths and weaknesses of Panacea LIFE Sciences Holdings INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Panacea LIFE Sciences Holdings INC compared to the market average is the variable General and Administrative Expense, increasing the Economic Capital Ratio by 9.1% points.The greatest weakness of Panacea LIFE Sciences Holdings INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 36% points.
The company's Economic Capital Ratio, given in the ranking table, is 71%, being 69% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001552189_2024_Panacea_LIFE_Sciences_Holdings_INC.pdf",
"shrinked_graph_json": {
"2015": {
"Other Liabilities": "-0.572",
"Liabilities": "1.11",
"Stockholders Equity": "-35.0",
"ECR before LimitedLiability": "-85.9",
"Liabilities, Current": "2.56",
"Liabilities, Non-Current": "-0.690",
"Assets, Current": "-10.7",
"Assets": "-45.8",
"Other Assets": "-3.55",
"Goodwill": "-7.83",
"Assets, Non-Current": "-1.73",
"Property, Plant and Equipment, Net": "-6.71",
"Research and Development": "-3.34",
"Expenses": "-22.1",
"Revenues": "-9.51",
"Net Income": "-39.5",
"Other Expenses": "-12.8",
"Other Revenues": "-9.51",
"Comprehensive Net Income": "-39.3",
"Other Net Income": "1.43",
"Economic Capital Ratio": "-132"
},
"2016": {
"Liabilities, Non-Current": "17.6",
"Liabilities": "12.3",
"Stockholders Equity": "34.4",
"ECR before LimitedLiability": "-11.1",
"Liabilities, Current": "-13.9",
"Other Liabilities": "7.92",
"Property, Plant and Equipment, Net": "-18.6",
"Assets": "33.9",
"Other Assets": "3.85",
"Assets, Non-Current": "-5.28",
"Assets, Current": "63.3",
"Goodwill": "-16.1",
"Research and Development": "-8.26",
"Expenses": "-18.3",
"Revenues": "-42.8",
"Net Income": "-59.8",
"General and Administrative Expense": "-8.96",
"Other Revenues": "-42.8",
"Comprehensive Net Income": "-59.6",
"Other Net Income": "-2.12",
"Economic Capital Ratio": "-31.1"
},
"2019": {
"Liabilities, Non-Current": "-1.79",
"Liabilities": "-3.91",
"Stockholders Equity": "-4.64",
"ECR before LimitedLiability": "-29.4",
"Other Liabilities": "2.48",
"Liabilities, Current": "-4.45",
"Research and Development": "3.14",
"Expenses": "-6.14",
"Net Income": "-20.2",
"Other Expenses": "-7.10",
"General and Administrative Expense": "-0.307",
"Other Revenues": "-7.40",
"Revenues": "-7.40",
"Assets, Non-Current": "4.31",
"Goodwill": "3.14",
"Property, Plant and Equipment, Net": "-4.95",
"Other Assets": "19.8",
"Assets, Current": "-7.11",
"Other Net Income": "3.29",
"Comprehensive Net Income": "-20.1",
"Economic Capital Ratio": "-58.9"
},
"2022": {
"Liabilities, Non-Current": "0.0813",
"Liabilities": "-38.4",
"Stockholders Equity": "-36.5",
"ECR before LimitedLiability": "-63.5",
"Other Liabilities": "-2.55",
"Liabilities, Current": "-16.4",
"Assets": "-1.83",
"Assets, Current": "-4.30",
"Property, Plant and Equipment, Net": "8.57",
"Assets, Non-Current": "0.762",
"Goodwill": "-2.70",
"General and Administrative Expense": "8.95",
"Expenses": "7.82",
"Revenues": "-5.10",
"Net Income": "-3.13",
"Research and Development": "2.08",
"Other Expenses": "-2.48",
"Other Revenues": "-5.10",
"Other Net Income": "-2.78",
"Comprehensive Net Income": "-3.07",
"Economic Capital Ratio": "-74.0"
},
"2023": {
"Liabilities, Non-Current": "-4.24",
"Liabilities": "-18.9",
"Stockholders Equity": "-35.6",
"ECR before LimitedLiability": "-53.6",
"Other Liabilities": "1.12",
"Liabilities, Current": "-12.7",
"Other Assets": "-0.858",
"Assets": "-6.00",
"Property, Plant and Equipment, Net": "5.63",
"Goodwill": "-2.97",
"Assets, Current": "-6.92",
"Other Expenses": "-2.60",
"Expenses": "7.96",
"Revenues": "-6.66",
"Net Income": "-3.18",
"Research and Development": "1.74",
"General and Administrative Expense": "9.12",
"Other Revenues": "-6.66",
"Other Net Income": "-2.99",
"Comprehensive Net Income": "-3.20",
"Economic Capital Ratio": "-68.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001552189_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "79",
"Assets, Non-Current": "0",
"General and Administrative Expense": "108",
"Goodwill": "4.1",
"Liabilities, Current": "178",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "204",
"Other Liabilities": "0",
"Other Net Income": "31",
"Other Revenues": "0.21",
"Property, Plant and Equipment, Net": "1.5",
"Research and Development": "77"
},
"output_variables": {
"Liabilities": "178",
"Assets": "85",
"Expenses": "389",
"Revenues": "0.21",
"Stockholders Equity": "-93",
"Net Income": "-358",
"Comprehensive Net Income": "-358",
"BaseVar": "342",
"ECR before LimitedLiability": "-369%",
"Economic Capital Ratio": "4.1%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,075",
"Assets, Non-Current": "0",
"General and Administrative Expense": "759",
"Goodwill": "0",
"Liabilities, Current": "625",
"Liabilities, Non-Current": "0",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "473",
"Other Liabilities": "0",
"Other Net Income": "-1.5",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "369"
},
"output_variables": {
"Liabilities": "625",
"Assets": "2,125",
"Expenses": "1,601",
"Revenues": "0",
"Stockholders Equity": "1,500",
"Net Income": "-1,603",
"Comprehensive Net Income": "-1,603",
"BaseVar": "2,176",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "116%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,429",
"Assets, Non-Current": "2,173",
"General and Administrative Expense": "6,267",
"Goodwill": "2,147",
"Liabilities, Current": "4,191",
"Liabilities, Non-Current": "1,927",
"Other Assets": "2,572",
"Other Compr. Net Income": "0",
"Other Expenses": "4,935",
"Other Liabilities": "0",
"Other Net Income": "654",
"Other Revenues": "346",
"Property, Plant and Equipment, Net": "477",
"Research and Development": "22"
},
"output_variables": {
"Liabilities": "6,117",
"Assets": "9,799",
"Expenses": "11,224",
"Revenues": "346",
"Stockholders Equity": "3,682",
"Net Income": "-10,225",
"Comprehensive Net Income": "-10,225",
"BaseVar": "14,070",
"ECR before LimitedLiability": "-65%",
"Economic Capital Ratio": "77%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "6,382",
"Assets, Non-Current": "3,242",
"General and Administrative Expense": "2,324",
"Goodwill": "2,189",
"Liabilities, Current": "15,074",
"Liabilities, Non-Current": "2,987",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,955",
"Other Liabilities": "3,573",
"Other Net Income": "-3,490",
"Other Revenues": "1,627",
"Property, Plant and Equipment, Net": "7,676",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "21,634",
"Assets": "19,489",
"Expenses": "7,279",
"Revenues": "1,627",
"Stockholders Equity": "-2,145",
"Net Income": "-9,143",
"Comprehensive Net Income": "-9,143",
"BaseVar": "26,760",
"ECR before LimitedLiability": "-59%",
"Economic Capital Ratio": "78%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "4,656",
"Assets, Non-Current": "3,865",
"General and Administrative Expense": "2,719",
"Goodwill": "3,014",
"Liabilities, Current": "19,448",
"Liabilities, Non-Current": "6,827",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,212",
"Other Liabilities": "0",
"Other Net Income": "-2,469",
"Other Revenues": "2,385",
"Property, Plant and Equipment, Net": "6,448",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "26,275",
"Assets": "17,983",
"Expenses": "7,931",
"Revenues": "2,385",
"Stockholders Equity": "-8,291",
"Net Income": "-8,015",
"Comprehensive Net Income": "-8,015",
"BaseVar": "28,522",
"ECR before LimitedLiability": "-88%",
"Economic Capital Ratio": "71%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 0.7137362341866021,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001552189.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001552189.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001552189.svg"
},
{
"company_id": "0001902700",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001902700.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001902700.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001902700_main_keyfigs.svg",
"name": "Pioneer Green Farms Inc",
"rank": 40,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001902700.svg",
"report_text": "The relative strengths and weaknesses of Pioneer Green Farms Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pioneer Green Farms Inc compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 19% points.The greatest weakness of Pioneer Green Farms Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 41% points.
The company's Economic Capital Ratio, given in the ranking table, is 55%, being 85% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001902700_2024_Pioneer_Green_Farms_Inc.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities, Non-Current": "-2.66",
"Liabilities": "-22.7",
"Stockholders Equity": "-31.6",
"ECR before LimitedLiability": "-86.6",
"Other Liabilities": "1.26",
"Liabilities, Current": "-20.8",
"Assets": "-16.8",
"Assets, Current": "-23.1",
"Property, Plant and Equipment, Net": "23.9",
"Assets, Non-Current": "7.27",
"Goodwill": "-13.0",
"General and Administrative Expense": "-4.62",
"Expenses": "-2.71",
"Revenues": "-14.5",
"Net Income": "-16.2",
"Research and Development": "3.50",
"Other Expenses": "-1.54",
"Other Revenues": "-14.5",
"Other Net Income": "0.585",
"Comprehensive Net Income": "-16.1",
"Economic Capital Ratio": "-97.1"
},
"2023": {
"Liabilities, Non-Current": "-2.20",
"Liabilities": "-26.4",
"Stockholders Equity": "-41.1",
"ECR before LimitedLiability": "-69.6",
"Other Liabilities": "0.949",
"Liabilities, Current": "-24.9",
"Other Assets": "-1.16",
"Assets": "-14.9",
"Property, Plant and Equipment, Net": "18.8",
"Goodwill": "-11.8",
"Assets, Current": "-18.4",
"Assets, Non-Current": "3.53",
"Other Expenses": "-10.5",
"Expenses": "4.68",
"Revenues": "-11.5",
"Net Income": "-7.23",
"Research and Development": "2.00",
"General and Administrative Expense": "13.5",
"Other Revenues": "-11.5",
"Comprehensive Net Income": "-7.27",
"Economic Capital Ratio": "-84.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001902700_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "32",
"Assets, Non-Current": "190",
"General and Administrative Expense": "500",
"Goodwill": "0",
"Liabilities, Current": "733",
"Liabilities, Non-Current": "210",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "124",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "390",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "943",
"Assets": "613",
"Expenses": "624",
"Revenues": "0",
"Stockholders Equity": "-331",
"Net Income": "-624",
"Comprehensive Net Income": "-624",
"BaseVar": "1,090",
"ECR before LimitedLiability": "-139%",
"Economic Capital Ratio": "55%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "26",
"Assets, Non-Current": "186",
"General and Administrative Expense": "5.5",
"Goodwill": "0",
"Liabilities, Current": "996",
"Liabilities, Non-Current": "209",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "407",
"Other Liabilities": "0",
"Other Net Income": "0.017",
"Other Revenues": "9.3",
"Property, Plant and Equipment, Net": "381",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,205",
"Assets": "593",
"Expenses": "413",
"Revenues": "9.3",
"Stockholders Equity": "-612",
"Net Income": "-403",
"Comprehensive Net Income": "-403",
"BaseVar": "1,110",
"ECR before LimitedLiability": "-138%",
"Economic Capital Ratio": "55%"
}
}
},
"top_rated": false,
"trend": 12.0,
"value": 0.5535720559637483,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001902700.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001902700.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001902700.svg"
},
{
"company_id": "0001870144",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001870144.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001870144.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001870144_main_keyfigs.svg",
"name": "Cardio Diagnostics Holdings Inc",
"rank": 41,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001870144.svg",
"report_text": "The relative strengths and weaknesses of Cardio Diagnostics Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cardio Diagnostics Holdings Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 17% points.The greatest weakness of Cardio Diagnostics Holdings Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 108% points.
The company's Economic Capital Ratio, given in the ranking table, is 53%, being 87% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001870144_2024_Cardio_Diagnostics_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2022": {
"Liabilities, Non-Current": "23.4",
"Liabilities": "8.69",
"Stockholders Equity": "29.2",
"ECR before LimitedLiability": "-28.8",
"Other Liabilities": "-61.0",
"Liabilities, Current": "28.5",
"Other Assets": "8.84",
"Assets": "28.8",
"Assets, Current": "62.3",
"Property, Plant and Equipment, Net": "-20.9",
"Assets, Non-Current": "-15.9",
"Goodwill": "-21.5",
"General and Administrative Expense": "-42.7",
"Expenses": "-27.4",
"Revenues": "-40.8",
"Net Income": "-62.7",
"Research and Development": "9.53",
"Other Expenses": "8.78",
"Other Revenues": "-40.8",
"Comprehensive Net Income": "-62.3",
"Economic Capital Ratio": "-39.3"
},
"2023": {
"Liabilities": "8.35",
"Stockholders Equity": "8.36",
"ECR before LimitedLiability": "-71.9",
"Other Liabilities": "1.73",
"Liabilities, Current": "6.31",
"Other Assets": "11.1",
"Assets": "-17.1",
"Property, Plant and Equipment, Net": "-10.7",
"Goodwill": "-20.4",
"Assets, Current": "16.8",
"Assets, Non-Current": "-7.77",
"Other Expenses": "8.57",
"Expenses": "-31.0",
"Revenues": "-21.7",
"Net Income": "-108",
"Research and Development": "2.26",
"General and Administrative Expense": "-45.0",
"Other Revenues": "-21.7",
"Other Net Income": "-12.7",
"Comprehensive Net Income": "-108",
"Economic Capital Ratio": "-87.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001870144_strength_weakness.svg",
"table_records": {
"2022": {
"input_variables": {
"Assets, Current": "5,886",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,493",
"Goodwill": "37",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "326",
"Other Compr. Net Income": "0",
"Other Expenses": "129",
"Other Liabilities": "1,948",
"Other Net Income": "0",
"Other Revenues": "0.95",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "40"
},
"output_variables": {
"Liabilities": "1,948",
"Assets": "6,249",
"Expenses": "4,662",
"Revenues": "0.95",
"Stockholders Equity": "4,302",
"Net Income": "-4,661",
"Comprehensive Net Income": "-4,661",
"BaseVar": "6,430",
"ECR before LimitedLiability": "30%",
"Economic Capital Ratio": "113%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "2,766",
"Assets, Non-Current": "575",
"General and Administrative Expense": "7,095",
"Goodwill": "21",
"Liabilities, Current": "841",
"Liabilities, Non-Current": "663",
"Other Assets": "528",
"Other Compr. Net Income": "0",
"Other Expenses": "19",
"Other Liabilities": "0",
"Other Net Income": "-1,134",
"Other Revenues": "17",
"Property, Plant and Equipment, Net": "572",
"Research and Development": "145"
},
"output_variables": {
"Liabilities": "1,504",
"Assets": "4,462",
"Expenses": "7,260",
"Revenues": "17",
"Stockholders Equity": "2,958",
"Net Income": "-8,377",
"Comprehensive Net Income": "-8,377",
"BaseVar": "7,189",
"ECR before LimitedLiability": "-145%",
"Economic Capital Ratio": "53%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 0.5305825723433873,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001870144.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001870144.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001870144.svg"
},
{
"company_id": "0000093314",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000093314.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000093314.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000093314.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000093314_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000093314_main_keyfigs.svg",
"name": "Volitionrx LTD",
"rank": 42,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000093314.svg",
"report_text": "The relative strengths and weaknesses of Volitionrx LTD are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Volitionrx LTD compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 16% points.The greatest weakness of Volitionrx LTD is the variable Stockholders Equity, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 52%, being 88% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000093314_2024_Volitionrx_LTD.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "-1.38",
"Liabilities": "-3.49",
"Stockholders Equity": "-12.6",
"ECR before LimitedLiability": "-79.6",
"Liabilities, Non-Current": "1.66",
"Other Liabilities": "-4.00",
"Assets, Current": "-25.6",
"Assets": "-7.11",
"Assets, Non-Current": "-6.42",
"Property, Plant and Equipment, Net": "-10.6",
"Goodwill": "40.5",
"Other Expenses": "-2.31",
"Expenses": "-27.4",
"Revenues": "-27.1",
"Net Income": "-45.5",
"Research and Development": "-36.7",
"General and Administrative Expense": "17.7",
"Other Revenues": "-27.1",
"Comprehensive Net Income": "-46.4",
"Other Compr. Net Income": "-0.333",
"Economic Capital Ratio": "-112"
},
"2013": {
"Goodwill": "24.7",
"Assets": "-24.4",
"Stockholders Equity": "-20.1",
"Other Liabilities": "-2.21",
"ECR before LimitedLiability": "-65.8",
"Assets, Non-Current": "-7.00",
"Property, Plant and Equipment, Net": "-12.6",
"Other Assets": "-4.27",
"Assets, Current": "-23.1",
"General and Administrative Expense": "20.8",
"Expenses": "-29.8",
"Revenues": "-28.1",
"Net Income": "-35.8",
"Research and Development": "-33.6",
"Other Expenses": "-14.7",
"Other Revenues": "-28.1",
"Liabilities, Current": "-1.64",
"Liabilities, Non-Current": "3.07",
"Other Net Income": "14.7",
"Comprehensive Net Income": "-35.8",
"Economic Capital Ratio": "-106"
},
"2014": {
"Liabilities, Non-Current": "0.713",
"Liabilities": "-0.453",
"Stockholders Equity": "-14.8",
"ECR before LimitedLiability": "-60.1",
"Liabilities, Current": "-1.44",
"Assets, Current": "-6.61",
"Assets": "-18.5",
"Other Assets": "0.401",
"Assets, Non-Current": "-5.21",
"Property, Plant and Equipment, Net": "-7.01",
"Other Expenses": "-4.16",
"Expenses": "-10.1",
"Revenues": "-25.0",
"Net Income": "-55.5",
"Research and Development": "-31.8",
"General and Administrative Expense": "15.2",
"Other Revenues": "-25.0",
"Other Net Income": "-20.4",
"Comprehensive Net Income": "-55.6",
"Other Compr. Net Income": "-0.142",
"Economic Capital Ratio": "-109"
},
"2015": {
"Liabilities": "13.4",
"Stockholders Equity": "30.8",
"ECR before LimitedLiability": "-25.2",
"Liabilities, Current": "8.27",
"Liabilities, Non-Current": "5.28",
"Assets, Current": "33.9",
"Assets": "2.13",
"Other Assets": "-6.99",
"Goodwill": "-6.83",
"Assets, Non-Current": "-3.96",
"Property, Plant and Equipment, Net": "-3.58",
"Research and Development": "-20.2",
"Expenses": "-51.8",
"Revenues": "-18.3",
"Net Income": "-105",
"General and Administrative Expense": "21.9",
"Other Expenses": "-19.7",
"Other Revenues": "-18.3",
"Comprehensive Net Income": "-105",
"Other Net Income": "3.80",
"Economic Capital Ratio": "-71.1"
},
"2016": {
"Liabilities, Non-Current": "11.9",
"Liabilities": "30.8",
"Stockholders Equity": "97.8",
"ECR before LimitedLiability": "55.2",
"Liabilities, Current": "22.6",
"Other Liabilities": "-3.05",
"Property, Plant and Equipment, Net": "-1.79",
"Assets": "72.0",
"Assets, Non-Current": "-2.38",
"Assets, Current": "98.0",
"Goodwill": "-5.53",
"Other Revenues": "-32.6",
"Revenues": "-32.6",
"Net Income": "-32.3",
"Research and Development": "-21.5",
"Comprehensive Net Income": "-32.4",
"Other Compr. Net Income": "-0.102",
"Other Net Income": "0.291",
"General and Administrative Expense": "24.9",
"Other Expenses": "-2.17",
"Economic Capital Ratio": "35.2"
},
"2017": {
"Other Liabilities": "-0.100",
"Liabilities": "1.58",
"Stockholders Equity": "9.40",
"Liabilities, Current": "1.41",
"Liabilities, Non-Current": "0.222",
"Assets, Non-Current": "-0.235",
"Assets": "6.25",
"Assets, Current": "14.9",
"Goodwill": "-9.48",
"Property, Plant and Equipment, Net": "0.599",
"Research and Development": "-55.1",
"Expenses": "-39.9",
"Revenues": "-42.2",
"Net Income": "-85.8",
"Other Expenses": "2.85",
"General and Administrative Expense": "-0.242",
"Other Revenues": "-42.2",
"ECR before LimitedLiability": "-47.4",
"Comprehensive Net Income": "-85.9",
"Other Net Income": "-0.117",
"Economic Capital Ratio": "-69.0"
},
"2018": {
"Liabilities, Non-Current": "-0.121",
"Liabilities": "0.888",
"Stockholders Equity": "7.63",
"Other Liabilities": "-0.0123",
"Liabilities, Current": "1.23",
"Property, Plant and Equipment, Net": "0.238",
"Assets": "6.29",
"Assets, Current": "21.0",
"Goodwill": "-8.40",
"Assets, Non-Current": "-6.70",
"Other Expenses": "1.07",
"Expenses": "-38.3",
"Revenues": "-46.0",
"Net Income": "-84.9",
"Research and Development": "-59.4",
"General and Administrative Expense": "0.612",
"Other Revenues": "-46.0",
"ECR before LimitedLiability": "-38.9",
"Comprehensive Net Income": "-83.6",
"Other Compr. Net Income": "0.0806",
"Economic Capital Ratio": "-59.3"
},
"2020": {
"Liabilities, Current": "-4.82",
"Liabilities": "2.23",
"Stockholders Equity": "11.2",
"Liabilities, Non-Current": "7.66",
"Other Liabilities": "-0.735",
"Goodwill": "-18.5",
"Assets": "11.1",
"ECR before LimitedLiability": "-13.0",
"Assets, Current": "18.1",
"Assets, Non-Current": "-14.8",
"Property, Plant and Equipment, Net": "6.57",
"Other Expenses": "10.3",
"Expenses": "-34.9",
"Revenues": "-44.7",
"Net Income": "-65.6",
"Research and Development": "-59.4",
"General and Administrative Expense": "10.7",
"Other Revenues": "-44.7",
"Comprehensive Net Income": "-65.5",
"Other Net Income": "10.5",
"Economic Capital Ratio": "-50.8"
},
"2021": {
"Liabilities, Non-Current": "0.623",
"Liabilities": "0.459",
"Stockholders Equity": "0.393",
"Assets, Current": "12.0",
"Liabilities, Current": "-0.230",
"Other Liabilities": "0.174",
"Other Expenses": "1.31",
"Expenses": "-43.5",
"Net Income": "-79.6",
"Research and Development": "-49.4",
"General and Administrative Expense": "-0.329",
"Other Revenues": "-38.2",
"Revenues": "-38.2",
"Comprehensive Net Income": "-79.6",
"ECR before LimitedLiability": "-70.2",
"Assets, Non-Current": "-7.85",
"Other Assets": "0.125",
"Goodwill": "-18.9",
"Property, Plant and Equipment, Net": "0.145",
"Other Net Income": "0.563",
"Economic Capital Ratio": "-74.6"
},
"2022": {
"Liabilities, Non-Current": "0.814",
"Liabilities": "-9.50",
"Stockholders Equity": "-38.2",
"ECR before LimitedLiability": "-99.2",
"Other Liabilities": "0.498",
"Liabilities, Current": "-11.9",
"Assets": "-29.5",
"Assets, Current": "-5.23",
"Property, Plant and Equipment, Net": "0.553",
"Assets, Non-Current": "-11.4",
"Goodwill": "-18.6",
"General and Administrative Expense": "-7.32",
"Expenses": "-22.3",
"Revenues": "-17.6",
"Net Income": "-35.6",
"Research and Development": "-20.2",
"Other Expenses": "4.93",
"Other Revenues": "-17.6",
"Other Net Income": "0.752",
"Comprehensive Net Income": "-35.5",
"Economic Capital Ratio": "-110"
},
"2023": {
"Liabilities, Non-Current": "1.21",
"Liabilities": "-13.7",
"Stockholders Equity": "-30.0",
"ECR before LimitedLiability": "-72.9",
"Other Liabilities": "0.607",
"Liabilities, Current": "-16.7",
"Other Assets": "-1.54",
"Assets": "-18.5",
"Property, Plant and Equipment, Net": "-4.55",
"Goodwill": "-15.2",
"Assets, Current": "16.1",
"Assets, Non-Current": "-12.1",
"Other Expenses": "5.81",
"Expenses": "-12.3",
"Revenues": "-14.6",
"Net Income": "-24.5",
"Research and Development": "-17.2",
"General and Administrative Expense": "-0.365",
"Other Revenues": "-14.6",
"Comprehensive Net Income": "-24.6",
"Economic Capital Ratio": "-88.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000093314_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "695",
"Assets, Non-Current": "0",
"General and Administrative Expense": "448",
"Goodwill": "1,430",
"Liabilities, Current": "748",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-39",
"Other Expenses": "847",
"Other Liabilities": "635",
"Other Net Income": "0",
"Other Revenues": "55",
"Property, Plant and Equipment, Net": "91",
"Research and Development": "2,843"
},
"output_variables": {
"Liabilities": "1,383",
"Assets": "2,217",
"Expenses": "4,138",
"Revenues": "55",
"Stockholders Equity": "834",
"Net Income": "-4,083",
"Comprehensive Net Income": "-4,103",
"BaseVar": "3,916",
"ECR before LimitedLiability": "-164%",
"Economic Capital Ratio": "46%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,005",
"Assets, Non-Current": "0",
"General and Administrative Expense": "434",
"Goodwill": "1,002",
"Liabilities, Current": "957",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-26",
"Other Expenses": "1,638",
"Other Liabilities": "433",
"Other Net Income": "866",
"Other Revenues": "55",
"Property, Plant and Equipment, Net": "63",
"Research and Development": "2,504"
},
"output_variables": {
"Liabilities": "1,390",
"Assets": "2,071",
"Expenses": "4,576",
"Revenues": "55",
"Stockholders Equity": "681",
"Net Income": "-3,655",
"Comprehensive Net Income": "-3,668",
"BaseVar": "4,491",
"ECR before LimitedLiability": "-158%",
"Economic Capital Ratio": "49%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "2,336",
"Assets, Non-Current": "0",
"General and Administrative Expense": "299",
"Goodwill": "809",
"Liabilities, Current": "2,713",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-44",
"Other Expenses": "1,609",
"Other Liabilities": "352",
"Other Net Income": "-2,276",
"Other Revenues": "15",
"Property, Plant and Equipment, Net": "289",
"Research and Development": "4,044"
},
"output_variables": {
"Liabilities": "3,065",
"Assets": "3,433",
"Expenses": "5,952",
"Revenues": "15",
"Stockholders Equity": "368",
"Net Income": "-8,214",
"Comprehensive Net Income": "-8,236",
"BaseVar": "7,393",
"ECR before LimitedLiability": "-238%",
"Economic Capital Ratio": "24%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "6,223",
"Assets, Non-Current": "0",
"General and Administrative Expense": "669",
"Goodwill": "705",
"Liabilities, Current": "1,120",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "20",
"Other Expenses": "7,144",
"Other Liabilities": "548",
"Other Net Income": "471",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "784",
"Research and Development": "6,102"
},
"output_variables": {
"Liabilities": "1,668",
"Assets": "7,712",
"Expenses": "13,914",
"Revenues": "0",
"Stockholders Equity": "6,044",
"Net Income": "-13,443",
"Comprehensive Net Income": "-13,434",
"BaseVar": "11,892",
"ECR before LimitedLiability": "-110%",
"Economic Capital Ratio": "65%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "22,012",
"Assets, Non-Current": "0",
"General and Administrative Expense": "742",
"Goodwill": "602",
"Liabilities, Current": "2,033",
"Liabilities, Non-Current": "432",
"Other Assets": "0",
"Other Compr. Net Income": "-109",
"Other Expenses": "4,687",
"Other Liabilities": "1,092",
"Other Net Income": "361",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "2,119",
"Research and Development": "6,838"
},
"output_variables": {
"Liabilities": "3,558",
"Assets": "24,733",
"Expenses": "12,267",
"Revenues": "0",
"Stockholders Equity": "21,175",
"Net Income": "-11,905",
"Comprehensive Net Income": "-11,960",
"BaseVar": "20,514",
"ECR before LimitedLiability": "121%",
"Economic Capital Ratio": "182%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "10,567",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,140",
"Goodwill": "576",
"Liabilities, Current": "2,290",
"Liabilities, Non-Current": "1,313",
"Other Assets": "0",
"Other Compr. Net Income": "64",
"Other Expenses": "0",
"Other Liabilities": "1,063",
"Other Net Income": "277",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,481",
"Research and Development": "8,906"
},
"output_variables": {
"Liabilities": "4,667",
"Assets": "14,624",
"Expenses": "15,046",
"Revenues": "0",
"Stockholders Equity": "9,958",
"Net Income": "-14,769",
"Comprehensive Net Income": "-14,737",
"BaseVar": "17,339",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,902",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,991",
"Goodwill": "467",
"Liabilities, Current": "2,333",
"Liabilities, Non-Current": "1,984",
"Other Assets": "0",
"Other Compr. Net Income": "353",
"Other Expenses": "111",
"Other Liabilities": "1,031",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,120",
"Research and Development": "10,907"
},
"output_variables": {
"Liabilities": "5,349",
"Assets": "17,489",
"Expenses": "18,009",
"Revenues": "0",
"Stockholders Equity": "12,140",
"Net Income": "-18,009",
"Comprehensive Net Income": "-17,832",
"BaseVar": "20,600",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "20,332",
"Assets, Non-Current": "326",
"General and Administrative Expense": "6,727",
"Goodwill": "322",
"Liabilities, Current": "6,237",
"Liabilities, Non-Current": "2,759",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "862",
"Other Net Income": "849",
"Other Revenues": "13",
"Property, Plant and Equipment, Net": "5,171",
"Research and Development": "14,534"
},
"output_variables": {
"Liabilities": "9,857",
"Assets": "26,151",
"Expenses": "21,261",
"Revenues": "13",
"Stockholders Equity": "16,294",
"Net Income": "-20,399",
"Comprehensive Net Income": "-20,399",
"BaseVar": "29,065",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "95%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "21,979",
"Assets, Non-Current": "384",
"General and Administrative Expense": "12,881",
"Goodwill": "217",
"Liabilities, Current": "6,516",
"Liabilities, Non-Current": "2,442",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "810",
"Other Net Income": "1,343",
"Other Revenues": "90",
"Property, Plant and Equipment, Net": "4,911",
"Research and Development": "15,542"
},
"output_variables": {
"Liabilities": "9,768",
"Assets": "27,490",
"Expenses": "28,423",
"Revenues": "90",
"Stockholders Equity": "17,722",
"Net Income": "-26,990",
"Comprehensive Net Income": "-26,990",
"BaseVar": "33,558",
"ECR before LimitedLiability": "-15%",
"Economic Capital Ratio": "84%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "12,172",
"Assets, Non-Current": "619",
"General and Administrative Expense": "17,514",
"Goodwill": "111",
"Liabilities, Current": "17,386",
"Liabilities, Non-Current": "3,179",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "857",
"Other Net Income": "0",
"Other Revenues": "1,488",
"Property, Plant and Equipment, Net": "5,393",
"Research and Development": "14,573"
},
"output_variables": {
"Liabilities": "21,422",
"Assets": "18,295",
"Expenses": "32,086",
"Revenues": "1,488",
"Stockholders Equity": "-3,127",
"Net Income": "-30,598",
"Comprehensive Net Income": "-30,598",
"BaseVar": "36,646",
"ECR before LimitedLiability": "-176%",
"Economic Capital Ratio": "43%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "21,854",
"Assets, Non-Current": "550",
"General and Administrative Expense": "17,211",
"Goodwill": "24",
"Liabilities, Current": "31,837",
"Liabilities, Non-Current": "4,003",
"Other Assets": "0",
"Other Compr. Net Income": "-341",
"Other Expenses": "0",
"Other Liabilities": "823",
"Other Net Income": "311",
"Other Revenues": "775",
"Property, Plant and Equipment, Net": "5,523",
"Research and Development": "19,552"
},
"output_variables": {
"Liabilities": "36,663",
"Assets": "27,950",
"Expenses": "36,763",
"Revenues": "775",
"Stockholders Equity": "-8,712",
"Net Income": "-35,677",
"Comprehensive Net Income": "-35,848",
"BaseVar": "51,402",
"ECR before LimitedLiability": "-148%",
"Economic Capital Ratio": "52%"
}
}
},
"top_rated": false,
"trend": 11.0,
"value": 0.5204627809376446,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000093314.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000093314.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000093314.svg"
},
{
"company_id": "0001697834",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001697834.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001697834.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001697834.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001697834_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001697834_main_keyfigs.svg",
"name": "Stem Holdings Inc",
"rank": 43,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001697834.svg",
"report_text": "The relative strengths and weaknesses of Stem Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Stem Holdings Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Stem Holdings Inc is the variable Other Net Income, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 52%, being 88% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001697834_2024_Stem_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "11.5",
"Liabilities": "65.0",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "57.8",
"Liabilities, Current": "37.4",
"Liabilities, Non-Current": "21.1",
"Assets": "59.0",
"Other Assets": "11.6",
"Assets, Current": "-14.5",
"Goodwill": "-8.94",
"Property, Plant and Equipment, Net": "112",
"Research and Development": "12.6",
"Expenses": "-24.5",
"Revenues": "-27.3",
"Net Income": "-56.7",
"Other Expenses": "-47.2",
"General and Administrative Expense": "9.94",
"Other Revenues": "-27.3",
"Comprehensive Net Income": "-57.0",
"Other Net Income": "-3.80",
"Economic Capital Ratio": "36.2"
},
"2018": {
"Liabilities, Non-Current": "-7.97",
"Liabilities": "-12.8",
"Stockholders Equity": "39.5",
"Economic Capital Ratio": "-19.0",
"Other Liabilities": "9.59",
"Liabilities, Current": "-14.7",
"Property, Plant and Equipment, Net": "44.9",
"Assets": "40.5",
"Other Assets": "40.1",
"Assets, Current": "-29.3",
"Goodwill": "-13.2",
"Assets, Non-Current": "1.63",
"Other Expenses": "-32.1",
"Expenses": "3.77",
"Revenues": "-30.0",
"Net Income": "-28.9",
"Research and Development": "12.7",
"General and Administrative Expense": "27.6",
"Other Revenues": "-30.0",
"Comprehensive Net Income": "-28.7",
"Other Net Income": "-2.40"
},
"2019": {
"Liabilities, Non-Current": "16.8",
"Liabilities": "17.1",
"Stockholders Equity": "22.5",
"ECR before LimitedLiability": "-5.09",
"Other Liabilities": "14.9",
"Liabilities, Current": "-6.33",
"Assets, Non-Current": "-10.5",
"Assets": "18.1",
"Goodwill": "16.8",
"Property, Plant and Equipment, Net": "25.7",
"Other Assets": "16.7",
"Assets, Current": "-38.9",
"Research and Development": "13.6",
"Expenses": "-15.0",
"Revenues": "-42.4",
"Net Income": "-75.9",
"Other Expenses": "-22.7",
"Other Revenues": "-42.4",
"Other Net Income": "-26.5",
"Comprehensive Net Income": "-75.8",
"Economic Capital Ratio": "-34.6"
},
"2020": {
"Liabilities, Current": "-19.8",
"Liabilities": "-1.07",
"Stockholders Equity": "16.6",
"ECR before LimitedLiability": "45.3",
"Liabilities, Non-Current": "12.1",
"Other Liabilities": "5.54",
"Goodwill": "48.3",
"Assets": "13.4",
"Other Assets": "4.95",
"Assets, Current": "-28.1",
"Assets, Non-Current": "-8.19",
"Property, Plant and Equipment, Net": "24.5",
"Other Expenses": "-4.02",
"Expenses": "3.40",
"Revenues": "-5.53",
"Net Income": "-1.63",
"Research and Development": "7.48",
"Other Revenues": "-5.53",
"Comprehensive Net Income": "-1.55",
"Other Net Income": "0.581",
"Economic Capital Ratio": "7.48"
},
"2021": {
"Liabilities, Non-Current": "3.16",
"Liabilities": "6.57",
"Stockholders Equity": "-32.5",
"ECR before LimitedLiability": "-73.4",
"Liabilities, Current": "1.65",
"Other Liabilities": "1.43",
"Assets, Current": "-52.7",
"Assets": "-50.6",
"Assets, Non-Current": "-2.68",
"Other Assets": "0.796",
"Goodwill": "8.49",
"Property, Plant and Equipment, Net": "-1.44",
"Other Expenses": "-71.4",
"Expenses": "-68.0",
"Revenues": "0.499",
"Net Income": "-58.4",
"Research and Development": "4.34",
"General and Administrative Expense": "-2.30",
"Other Revenues": "0.499",
"Comprehensive Net Income": "-58.4",
"Other Net Income": "1.66",
"Economic Capital Ratio": "-77.8"
},
"2023": {
"Liabilities, Non-Current": "3.82",
"Liabilities": "-8.47",
"Stockholders Equity": "-25.6",
"ECR before LimitedLiability": "-73.1",
"Liabilities, Current": "-17.0",
"Other Assets": "-1.51",
"Assets": "-17.4",
"Property, Plant and Equipment, Net": "-15.6",
"Goodwill": "-16.2",
"Assets, Current": "36.7",
"Assets, Non-Current": "-13.9",
"Other Expenses": "3.57",
"Expenses": "18.2",
"Revenues": "-16.5",
"Net Income": "-30.0",
"Research and Development": "2.79",
"General and Administrative Expense": "12.3",
"Other Revenues": "-16.5",
"Other Net Income": "-30.7",
"Comprehensive Net Income": "-30.0",
"Economic Capital Ratio": "-88.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001697834_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "598",
"Assets, Non-Current": "0",
"General and Administrative Expense": "828",
"Goodwill": "0",
"Liabilities, Current": "166",
"Liabilities, Non-Current": "0",
"Other Assets": "494",
"Other Compr. Net Income": "0",
"Other Expenses": "2,249",
"Other Liabilities": "0",
"Other Net Income": "4.2",
"Other Revenues": "326",
"Property, Plant and Equipment, Net": "3,259",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "166",
"Assets": "4,350",
"Expenses": "3,077",
"Revenues": "326",
"Stockholders Equity": "4,185",
"Net Income": "-2,747",
"Comprehensive Net Income": "-2,747",
"BaseVar": "3,962",
"ECR before LimitedLiability": "132%",
"Economic Capital Ratio": "190%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,905",
"Assets, Non-Current": "1,301",
"General and Administrative Expense": "3,021",
"Goodwill": "0",
"Liabilities, Current": "4,177",
"Liabilities, Non-Current": "1,913",
"Other Assets": "3,684",
"Other Compr. Net Income": "0",
"Other Expenses": "5,834",
"Other Liabilities": "0",
"Other Net Income": "-301",
"Other Revenues": "1,296",
"Property, Plant and Equipment, Net": "8,325",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,090",
"Assets": "15,215",
"Expenses": "8,855",
"Revenues": "1,296",
"Stockholders Equity": "9,125",
"Net Income": "-7,860",
"Comprehensive Net Income": "-7,860",
"BaseVar": "15,878",
"ECR before LimitedLiability": "44%",
"Economic Capital Ratio": "125%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,868",
"Assets, Non-Current": "1,771",
"General and Administrative Expense": "16,855",
"Goodwill": "7,386",
"Liabilities, Current": "7,503",
"Liabilities, Non-Current": "0",
"Other Assets": "2,366",
"Other Compr. Net Income": "0",
"Other Expenses": "7,659",
"Other Liabilities": "0",
"Other Net Income": "-6,922",
"Other Revenues": "2,451",
"Property, Plant and Equipment, Net": "14,706",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,503",
"Assets": "31,097",
"Expenses": "24,514",
"Revenues": "2,451",
"Stockholders Equity": "23,594",
"Net Income": "-28,985",
"Comprehensive Net Income": "-28,985",
"BaseVar": "36,244",
"ECR before LimitedLiability": "17%",
"Economic Capital Ratio": "101%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "5,265",
"Assets, Non-Current": "767",
"General and Administrative Expense": "18,568",
"Goodwill": "20,490",
"Liabilities, Current": "14,500",
"Liabilities, Non-Current": "3,685",
"Other Assets": "2,141",
"Other Compr. Net Income": "0",
"Other Expenses": "5,072",
"Other Liabilities": "0",
"Other Net Income": "-1,827",
"Other Revenues": "13,974",
"Property, Plant and Equipment, Net": "16,354",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "18,185",
"Assets": "45,017",
"Expenses": "23,640",
"Revenues": "13,974",
"Stockholders Equity": "26,832",
"Net Income": "-11,493",
"Comprehensive Net Income": "-11,493",
"BaseVar": "51,322",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "153%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "12,843",
"Assets, Non-Current": "5,570",
"General and Administrative Expense": "44,628",
"Goodwill": "25,894",
"Liabilities, Current": "15,798",
"Liabilities, Non-Current": "6,063",
"Other Assets": "271",
"Other Compr. Net Income": "0",
"Other Expenses": "59,005",
"Other Liabilities": "1,093",
"Other Net Income": "3,258",
"Other Revenues": "35,769",
"Property, Plant and Equipment, Net": "12,610",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "22,954",
"Assets": "57,188",
"Expenses": "103,633",
"Revenues": "35,769",
"Stockholders Equity": "34,234",
"Net Income": "-64,606",
"Comprehensive Net Income": "-64,606",
"BaseVar": "111,401",
"ECR before LimitedLiability": "-44%",
"Economic Capital Ratio": "81%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "13,319",
"Assets, Non-Current": "0",
"General and Administrative Expense": "2,673",
"Goodwill": "0",
"Liabilities, Current": "13,978",
"Liabilities, Non-Current": "0",
"Other Assets": "28",
"Other Compr. Net Income": "0",
"Other Expenses": "1,074",
"Other Liabilities": "0",
"Other Net Income": "-15,662",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "13,978",
"Assets": "13,347",
"Expenses": "3,747",
"Revenues": "0",
"Stockholders Equity": "-631",
"Net Income": "-19,409",
"Comprehensive Net Income": "-19,409",
"BaseVar": "23,367",
"ECR before LimitedLiability": "-148%",
"Economic Capital Ratio": "52%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.5188144580889215,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001697834.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001697834.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001697834.svg"
},
{
"company_id": "0001310630",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001310630.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001310630.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001310630_main_keyfigs.svg",
"name": "China Foods Holdings Ltd",
"rank": 44,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001310630.svg",
"report_text": "The relative strengths and weaknesses of China Foods Holdings Ltd are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of China Foods Holdings Ltd compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 11% points.The greatest weakness of China Foods Holdings Ltd is the variable Stockholders Equity, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 45%, being 95% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001310630_2024_China_Foods_Holdings_Ltd.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-1.06",
"Liabilities": "-11.5",
"Stockholders Equity": "-72.1",
"ECR before LimitedLiability": "-71.8",
"Other Liabilities": "-4.85",
"Property, Plant and Equipment, Net": "-6.95",
"Assets": "-31.4",
"Assets, Non-Current": "-2.82",
"Other Assets": "11.4",
"Goodwill": "-6.35",
"Assets, Current": "-29.3",
"General and Administrative Expense": "3.53",
"Expenses": "7.12",
"Revenues": "-12.4",
"Net Income": "-3.76",
"Research and Development": "2.47",
"Other Expenses": "1.83",
"Other Revenues": "-12.4",
"Comprehensive Net Income": "-3.78",
"Other Net Income": "-1.24",
"Economic Capital Ratio": "-134"
},
"2012": {
"Liabilities, Current": "-0.547",
"Liabilities": "-6.29",
"Stockholders Equity": "-79.5",
"ECR before LimitedLiability": "-108",
"Other Liabilities": "-2.62",
"Assets, Current": "-28.9",
"Assets": "-34.1",
"Other Assets": "9.35",
"Assets, Non-Current": "-2.91",
"Property, Plant and Equipment, Net": "-6.78",
"Goodwill": "-6.98",
"Other Expenses": "2.11",
"Expenses": "6.71",
"Revenues": "-12.3",
"Net Income": "-2.71",
"Research and Development": "2.50",
"General and Administrative Expense": "2.85",
"Other Revenues": "-12.3",
"Other Net Income": "-0.0949",
"Comprehensive Net Income": "-2.70",
"Economic Capital Ratio": "-141"
},
"2013": {
"Liabilities, Current": "0.221",
"Liabilities": "0.706",
"Stockholders Equity": "-81.0",
"ECR before LimitedLiability": "-98.7",
"Other Liabilities": "0.110",
"Goodwill": "-6.94",
"Assets": "-36.7",
"Assets, Non-Current": "-2.51",
"Property, Plant and Equipment, Net": "-5.86",
"Other Assets": "5.65",
"Assets, Current": "-27.6",
"General and Administrative Expense": "2.35",
"Expenses": "7.31",
"Revenues": "-10.1",
"Net Income": "-2.17",
"Research and Development": "1.96",
"Other Expenses": "4.07",
"Other Revenues": "-10.1",
"Other Net Income": "-2.84",
"Comprehensive Net Income": "-2.19",
"Economic Capital Ratio": "-139"
},
"2014": {
"Liabilities": "2.73",
"Stockholders Equity": "-69.8",
"ECR before LimitedLiability": "-69.3",
"Liabilities, Current": "2.29",
"Other Liabilities": "0.103",
"Assets, Current": "-25.4",
"Assets": "-34.7",
"Goodwill": "-7.12",
"Other Assets": "5.31",
"Assets, Non-Current": "-2.14",
"Property, Plant and Equipment, Net": "-5.49",
"Other Expenses": "2.98",
"Expenses": "7.69",
"Revenues": "-9.32",
"Net Income": "-0.242",
"Research and Development": "2.11",
"General and Administrative Expense": "3.97",
"Other Revenues": "-9.32",
"Other Net Income": "-2.45",
"Comprehensive Net Income": "-0.231",
"Economic Capital Ratio": "-119"
},
"2015": {
"Other Liabilities": "0.105",
"Liabilities": "2.44",
"Stockholders Equity": "-70.0",
"ECR before LimitedLiability": "-75.1",
"Liabilities, Current": "2.08",
"Assets, Current": "-25.5",
"Assets": "-37.9",
"Other Assets": "2.91",
"Goodwill": "-7.24",
"Assets, Non-Current": "-1.72",
"Property, Plant and Equipment, Net": "-5.93",
"Research and Development": "1.66",
"Expenses": "5.21",
"Revenues": "-8.22",
"Net Income": "-0.817",
"General and Administrative Expense": "2.62",
"Other Expenses": "1.47",
"Other Revenues": "-8.22",
"Comprehensive Net Income": "-0.763",
"Other Net Income": "0.149",
"Economic Capital Ratio": "-121"
},
"2016": {
"Liabilities": "0.179",
"Stockholders Equity": "-87.7",
"ECR before LimitedLiability": "-111",
"Liabilities, Current": "0.152",
"Property, Plant and Equipment, Net": "-8.61",
"Assets": "-40.2",
"Other Assets": "5.92",
"Assets, Non-Current": "-2.08",
"Assets, Current": "-29.4",
"Goodwill": "-7.20",
"Research and Development": "2.34",
"Expenses": "5.92",
"Revenues": "-9.05",
"Net Income": "-1.12",
"General and Administrative Expense": "2.63",
"Other Expenses": "1.62",
"Other Revenues": "-9.05",
"Comprehensive Net Income": "-1.09",
"Other Net Income": "-0.334",
"Other Compr. Net Income": "0.0366",
"Economic Capital Ratio": "-131"
},
"2017": {
"Liabilities": "1.30",
"Stockholders Equity": "-87.4",
"ECR before LimitedLiability": "-116",
"Liabilities, Current": "1.27",
"Assets, Non-Current": "-2.36",
"Assets": "-40.5",
"Other Assets": "5.16",
"Assets, Current": "-25.2",
"Goodwill": "-7.92",
"Property, Plant and Equipment, Net": "-11.0",
"Research and Development": "2.24",
"Expenses": "5.48",
"Revenues": "-8.16",
"Net Income": "-1.43",
"Other Expenses": "0.752",
"General and Administrative Expense": "3.01",
"Other Revenues": "-8.16",
"Comprehensive Net Income": "-1.49",
"Other Net Income": "-0.759",
"Other Compr. Net Income": "-0.0532",
"Economic Capital Ratio": "-138"
},
"2019": {
"Liabilities": "5.14",
"Stockholders Equity": "-71.7",
"ECR before LimitedLiability": "-96.0",
"Other Liabilities": "9.28",
"Liabilities, Current": "-0.605",
"Assets, Non-Current": "-7.37",
"Assets": "-44.1",
"Goodwill": "-8.35",
"Property, Plant and Equipment, Net": "-10.3",
"Other Assets": "0.355",
"Assets, Current": "-13.7",
"Research and Development": "1.59",
"Expenses": "-3.69",
"Revenues": "-9.68",
"Net Income": "-14.1",
"Other Expenses": "1.59",
"General and Administrative Expense": "-8.40",
"Other Revenues": "-9.68",
"Other Net Income": "0.674",
"Comprehensive Net Income": "-14.1",
"Economic Capital Ratio": "-126"
},
"2020": {
"Liabilities, Current": "5.35",
"Liabilities": "16.4",
"Stockholders Equity": "-17.3",
"ECR before LimitedLiability": "32.5",
"Liabilities, Non-Current": "35.1",
"Other Liabilities": "-26.7",
"Goodwill": "-17.0",
"Assets": "-20.3",
"Other Assets": "-13.2",
"Assets, Current": "29.5",
"Property, Plant and Equipment, Net": "-10.7",
"Other Expenses": "10.7",
"Expenses": "-21.3",
"Revenues": "18.1",
"Net Income": "2.51",
"Research and Development": "10.6",
"General and Administrative Expense": "-39.6",
"Other Revenues": "18.1",
"Comprehensive Net Income": "4.74",
"Other Net Income": "7.62",
"Economic Capital Ratio": "-5.30"
},
"2023": {
"Liabilities, Non-Current": "3.06",
"Liabilities": "-18.5",
"Stockholders Equity": "-43.1",
"ECR before LimitedLiability": "-79.7",
"Other Liabilities": "0.972",
"Liabilities, Current": "-29.1",
"Other Assets": "-3.67",
"Assets": "-30.7",
"Property, Plant and Equipment, Net": "-15.0",
"Goodwill": "-16.7",
"Assets, Current": "10.5",
"Assets, Non-Current": "-12.7",
"Other Expenses": "5.86",
"Expenses": "-7.11",
"Revenues": "-6.89",
"Net Income": "-14.0",
"Research and Development": "2.63",
"General and Administrative Expense": "-15.7",
"Other Revenues": "-6.89",
"Comprehensive Net Income": "-14.1",
"Economic Capital Ratio": "-94.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001310630_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "14",
"Goodwill": "0",
"Liabilities, Current": "29",
"Liabilities, Non-Current": "0",
"Other Assets": "10.0",
"Other Compr. Net Income": "0",
"Other Expenses": "5.1",
"Other Liabilities": "50",
"Other Net Income": "0",
"Other Revenues": "0.050",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "79",
"Assets": "10.0",
"Expenses": "19",
"Revenues": "0.050",
"Stockholders Equity": "-69",
"Net Income": "-19",
"Comprehensive Net Income": "-19",
"BaseVar": "54",
"ECR before LimitedLiability": "-256%",
"Economic Capital Ratio": "20%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "18",
"Goodwill": "0",
"Liabilities, Current": "36",
"Liabilities, Non-Current": "0",
"Other Assets": "11",
"Other Compr. Net Income": "0",
"Other Expenses": "7.1",
"Other Liabilities": "70",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "106",
"Assets": "11",
"Expenses": "25",
"Revenues": "0",
"Stockholders Equity": "-95",
"Net Income": "-25",
"Comprehensive Net Income": "-25",
"BaseVar": "71",
"ECR before LimitedLiability": "-264%",
"Economic Capital Ratio": "18%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "21",
"Goodwill": "0",
"Liabilities, Current": "85",
"Liabilities, Non-Current": "0",
"Other Assets": "11",
"Other Compr. Net Income": "0",
"Other Expenses": "0.10",
"Other Liabilities": "50",
"Other Net Income": "-8.4",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "135",
"Assets": "11",
"Expenses": "21",
"Revenues": "0",
"Stockholders Equity": "-125",
"Net Income": "-30",
"Comprehensive Net Income": "-30",
"BaseVar": "88",
"ECR before LimitedLiability": "-275%",
"Economic Capital Ratio": "16%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "20",
"Goodwill": "0",
"Liabilities, Current": "147",
"Liabilities, Non-Current": "0",
"Other Assets": "9.8",
"Other Compr. Net Income": "0",
"Other Expenses": "0.10",
"Other Liabilities": "20",
"Other Net Income": "-12",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "167",
"Assets": "9.8",
"Expenses": "20",
"Revenues": "0",
"Stockholders Equity": "-157",
"Net Income": "-32",
"Comprehensive Net Income": "-32",
"BaseVar": "104",
"ECR before LimitedLiability": "-280%",
"Economic Capital Ratio": "15%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "26",
"Goodwill": "0",
"Liabilities, Current": "186",
"Liabilities, Non-Current": "0",
"Other Assets": "14",
"Other Compr. Net Income": "0",
"Other Expenses": "19",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "0.011",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "216",
"Assets": "14",
"Expenses": "45",
"Revenues": "0.011",
"Stockholders Equity": "-202",
"Net Income": "-45",
"Comprehensive Net Income": "-45",
"BaseVar": "137",
"ECR before LimitedLiability": "-280%",
"Economic Capital Ratio": "15%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "27",
"Goodwill": "0",
"Liabilities, Current": "239",
"Liabilities, Non-Current": "0",
"Other Assets": "18",
"Other Compr. Net Income": "0",
"Other Expenses": "22",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "269",
"Assets": "18",
"Expenses": "49",
"Revenues": "0",
"Stockholders Equity": "-251",
"Net Income": "-49",
"Comprehensive Net Income": "-49",
"BaseVar": "168",
"ECR before LimitedLiability": "-274%",
"Economic Capital Ratio": "16%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "29",
"Goodwill": "0",
"Liabilities, Current": "294",
"Liabilities, Non-Current": "0",
"Other Assets": "18",
"Other Compr. Net Income": "0",
"Other Expenses": "26",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "324",
"Assets": "18",
"Expenses": "55",
"Revenues": "0",
"Stockholders Equity": "-306",
"Net Income": "-55",
"Comprehensive Net Income": "-55",
"BaseVar": "199",
"ECR before LimitedLiability": "-277%",
"Economic Capital Ratio": "15%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "23",
"Assets, Non-Current": "0",
"General and Administrative Expense": "89",
"Goodwill": "0",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "131",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "131",
"Assets": "23",
"Expenses": "89",
"Revenues": "0",
"Stockholders Equity": "-107",
"Net Income": "-89",
"Comprehensive Net Income": "-89",
"BaseVar": "122",
"ECR before LimitedLiability": "-307%",
"Economic Capital Ratio": "10%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,334",
"Assets, Non-Current": "198",
"General and Administrative Expense": "1,484",
"Goodwill": "4.4",
"Liabilities, Current": "418",
"Liabilities, Non-Current": "0",
"Other Assets": "-198",
"Other Compr. Net Income": "59",
"Other Expenses": "8.2",
"Other Liabilities": "280",
"Other Net Income": "9.6",
"Other Revenues": "1,013",
"Property, Plant and Equipment, Net": "194",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "697",
"Assets": "1,532",
"Expenses": "1,492",
"Revenues": "1,013",
"Stockholders Equity": "835",
"Net Income": "-469",
"Comprehensive Net Income": "-440",
"BaseVar": "2,402",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "350",
"Assets, Non-Current": "16",
"General and Administrative Expense": "563",
"Goodwill": "2.6",
"Liabilities, Current": "756",
"Liabilities, Non-Current": "0",
"Other Assets": "-16",
"Other Compr. Net Income": "-4.5",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0.94",
"Other Revenues": "158",
"Property, Plant and Equipment, Net": "13",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "756",
"Assets": "365",
"Expenses": "563",
"Revenues": "158",
"Stockholders Equity": "-391",
"Net Income": "-404",
"Comprehensive Net Income": "-406",
"BaseVar": "924",
"ECR before LimitedLiability": "-168%",
"Economic Capital Ratio": "45%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.4522288140638627,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001310630.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001310630.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001310630.svg"
},
{
"company_id": "0001590695",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0001590695.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0001590695.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001590695.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001590695_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001590695_main_keyfigs.svg",
"name": "Twinlab Consolidated Holdings Inc",
"rank": 45,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0001590695.svg",
"report_text": "The relative strengths and weaknesses of Twinlab Consolidated Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Twinlab Consolidated Holdings Inc compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 7.6% points.The greatest weakness of Twinlab Consolidated Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 104% points.
The company's Economic Capital Ratio, given in the ranking table, is 19%, being 121% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0001590695_2024_Twinlab_Consolidated_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "-3.39",
"Liabilities": "-0.909",
"Stockholders Equity": "-34.8",
"ECR before LimitedLiability": "-7.23",
"Liabilities, Current": "-0.530",
"Other Liabilities": "3.17",
"Assets, Current": "-6.92",
"Assets": "-24.7",
"Goodwill": "-3.67",
"Other Assets": "0.285",
"Assets, Non-Current": "-2.40",
"Property, Plant and Equipment, Net": "-4.88",
"Other Revenues": "13.8",
"Revenues": "13.8",
"Net Income": "8.05",
"Other Expenses": "-15.4",
"Comprehensive Net Income": "8.08",
"General and Administrative Expense": "12.6",
"Other Net Income": "-3.66",
"Research and Development": "7.23",
"Economic Capital Ratio": "-56.6"
},
"2015": {
"Other Liabilities": "2.98",
"Liabilities": "-2.28",
"Stockholders Equity": "-30.7",
"ECR before LimitedLiability": "-8.66",
"Liabilities, Current": "-4.86",
"Assets, Current": "-21.8",
"Assets": "-10.3",
"Other Assets": "-2.09",
"Goodwill": "21.9",
"Assets, Non-Current": "-0.933",
"Property, Plant and Equipment, Net": "-2.58",
"Research and Development": "3.06",
"Expenses": "3.54",
"Revenues": "5.06",
"Net Income": "3.85",
"General and Administrative Expense": "8.05",
"Other Expenses": "-3.25",
"Other Revenues": "5.06",
"Comprehensive Net Income": "3.97",
"Other Net Income": "-2.73",
"Economic Capital Ratio": "-54.5"
},
"2016": {
"Liabilities, Non-Current": "-61.3",
"Liabilities": "-39.5",
"Stockholders Equity": "-77.7",
"Liabilities, Current": "1.95",
"Other Liabilities": "2.02",
"Property, Plant and Equipment, Net": "-26.1",
"Assets": "-41.9",
"Assets, Non-Current": "-6.49",
"Assets, Current": "-48.4",
"Goodwill": "8.20",
"Research and Development": "2.69",
"Expenses": "2.26",
"Revenues": "2.72",
"Net Income": "6.11",
"General and Administrative Expense": "2.68",
"Other Expenses": "-27.3",
"Other Revenues": "2.72",
"ECR before LimitedLiability": "-40.1",
"Comprehensive Net Income": "6.17",
"Other Net Income": "2.03",
"Economic Capital Ratio": "-60.1"
},
"2017": {
"Other Liabilities": "2.68",
"Liabilities": "-8.67",
"Stockholders Equity": "-64.6",
"ECR before LimitedLiability": "-57.7",
"Liabilities, Current": "-24.5",
"Liabilities, Non-Current": "3.63",
"Assets, Non-Current": "-2.50",
"Assets": "-17.1",
"Assets, Current": "-10.2",
"Goodwill": "12.2",
"Property, Plant and Equipment, Net": "-8.88",
"Other Revenues": "8.56",
"Revenues": "8.56",
"Net Income": "3.20",
"Comprehensive Net Income": "3.05",
"Other Compr. Net Income": "-0.132",
"Other Expenses": "-9.37",
"Other Net Income": "-4.15",
"Research and Development": "6.44",
"General and Administrative Expense": "8.52",
"Economic Capital Ratio": "-79.2"
},
"2018": {
"Liabilities, Non-Current": "-0.563",
"Liabilities": "-12.9",
"Stockholders Equity": "-76.3",
"ECR before LimitedLiability": "-51.6",
"Other Liabilities": "2.35",
"Liabilities, Current": "-26.8",
"Property, Plant and Equipment, Net": "-8.74",
"Assets": "-12.7",
"Assets, Current": "-11.7",
"Goodwill": "14.5",
"Assets, Non-Current": "-4.98",
"Other Expenses": "5.11",
"Expenses": "5.17",
"Revenues": "4.22",
"Net Income": "7.58",
"Research and Development": "5.45",
"General and Administrative Expense": "-4.67",
"Other Revenues": "4.22",
"Comprehensive Net Income": "7.69",
"Other Net Income": "-1.85",
"Economic Capital Ratio": "-72.1"
},
"2019": {
"Liabilities, Non-Current": "1.38",
"Liabilities": "-11.1",
"Stockholders Equity": "-105",
"ECR before LimitedLiability": "-78.1",
"Other Liabilities": "0.923",
"Liabilities, Current": "-23.7",
"Assets, Non-Current": "-14.9",
"Assets": "-53.8",
"Goodwill": "-5.28",
"Property, Plant and Equipment, Net": "-20.7",
"Other Assets": "0.870",
"Assets, Current": "-37.7",
"Research and Development": "4.60",
"Expenses": "-4.83",
"Revenues": "5.93",
"Net Income": "1.51",
"Other Expenses": "-4.58",
"General and Administrative Expense": "-5.30",
"Other Revenues": "5.93",
"Comprehensive Net Income": "1.54",
"Economic Capital Ratio": "-108"
},
"2020": {
"Liabilities, Current": "-39.7",
"Liabilities": "-28.0",
"Stockholders Equity": "-120",
"ECR before LimitedLiability": "-66.7",
"Liabilities, Non-Current": "2.58",
"Other Liabilities": "0.742",
"Goodwill": "-5.15",
"Assets": "-42.1",
"Assets, Current": "-32.8",
"Assets, Non-Current": "-7.62",
"Property, Plant and Equipment, Net": "-18.4",
"Other Expenses": "3.90",
"Expenses": "2.35",
"Revenues": "5.78",
"Net Income": "7.12",
"Research and Development": "3.70",
"General and Administrative Expense": "-5.43",
"Other Revenues": "5.78",
"Comprehensive Net Income": "7.16",
"Other Net Income": "-0.959",
"Economic Capital Ratio": "-105"
},
"2021": {
"Liabilities, Non-Current": "1.35",
"Liabilities": "-24.3",
"Stockholders Equity": "-148",
"ECR before LimitedLiability": "-123",
"Liabilities, Current": "-38.7",
"Assets, Current": "-38.6",
"Assets": "-52.3",
"Assets, Non-Current": "-8.65",
"Other Assets": "1.15",
"Goodwill": "-20.2",
"Property, Plant and Equipment, Net": "-18.5",
"Other Expenses": "1.10",
"Expenses": "0.855",
"Revenues": "7.16",
"Net Income": "5.91",
"Research and Development": "4.48",
"General and Administrative Expense": "-5.08",
"Other Revenues": "7.16",
"Comprehensive Net Income": "5.91",
"Other Net Income": "-2.32",
"Economic Capital Ratio": "-127"
},
"2022": {
"Liabilities, Non-Current": "1.13",
"Liabilities": "-27.2",
"Stockholders Equity": "-130",
"ECR before LimitedLiability": "-112",
"Other Liabilities": "0.551",
"Liabilities, Current": "-42.2",
"Assets": "-50.4",
"Assets, Current": "-29.0",
"Property, Plant and Equipment, Net": "-16.6",
"Assets, Non-Current": "-7.81",
"Goodwill": "-17.8",
"General and Administrative Expense": "-1.27",
"Expenses": "5.80",
"Revenues": "2.52",
"Net Income": "6.69",
"Research and Development": "3.44",
"Other Expenses": "3.71",
"Other Revenues": "2.52",
"Other Net Income": "-1.58",
"Comprehensive Net Income": "6.82",
"Economic Capital Ratio": "-122"
},
"2023": {
"Liabilities, Non-Current": "0.166",
"Liabilities": "-7.47",
"Stockholders Equity": "-104",
"ECR before LimitedLiability": "-106",
"Liabilities, Current": "-11.7",
"Other Assets": "-1.00",
"Assets": "-47.5",
"Property, Plant and Equipment, Net": "-11.6",
"Goodwill": "-12.1",
"Assets, Current": "-19.0",
"Assets, Non-Current": "-7.42",
"Other Expenses": "2.77",
"Expenses": "7.64",
"Revenues": "-4.62",
"Net Income": "1.32",
"Research and Development": "1.28",
"General and Administrative Expense": "4.43",
"Other Revenues": "-4.62",
"Other Net Income": "-3.64",
"Comprehensive Net Income": "1.30",
"Economic Capital Ratio": "-121"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0001590695_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "28,279",
"Assets, Non-Current": "986",
"General and Administrative Expense": "25,924",
"Goodwill": "7,564",
"Liabilities, Current": "29,322",
"Liabilities, Non-Current": "14,824",
"Other Assets": "0",
"Other Compr. Net Income": "-31",
"Other Expenses": "47,715",
"Other Liabilities": "0",
"Other Net Income": "-8,917",
"Other Revenues": "61,426",
"Property, Plant and Equipment, Net": "2,680",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "44,146",
"Assets": "39,509",
"Expenses": "73,639",
"Revenues": "61,426",
"Stockholders Equity": "-4,637",
"Net Income": "-21,130",
"Comprehensive Net Income": "-21,146",
"BaseVar": "113,834",
"ECR before LimitedLiability": "-66%",
"Economic Capital Ratio": "77%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "24,504",
"Assets, Non-Current": "1,475",
"General and Administrative Expense": "25,521",
"Goodwill": "56,509",
"Liabilities, Current": "71,720",
"Liabilities, Non-Current": "14,751",
"Other Assets": "0",
"Other Compr. Net Income": "83",
"Other Expenses": "70,097",
"Other Liabilities": "0",
"Other Net Income": "-22,464",
"Other Revenues": "81,672",
"Property, Plant and Equipment, Net": "3,712",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "86,471",
"Assets": "86,200",
"Expenses": "95,618",
"Revenues": "81,672",
"Stockholders Equity": "-271",
"Net Income": "-36,410",
"Comprehensive Net Income": "-36,368",
"BaseVar": "186,254",
"ECR before LimitedLiability": "-43%",
"Economic Capital Ratio": "81%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "33,336",
"Assets, Non-Current": "1,667",
"General and Administrative Expense": "33,452",
"Goodwill": "54,295",
"Liabilities, Current": "37,386",
"Liabilities, Non-Current": "53,674",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "66,189",
"Other Liabilities": "0",
"Other Net Income": "12,634",
"Other Revenues": "86,323",
"Property, Plant and Equipment, Net": "3,528",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "91,060",
"Assets": "92,826",
"Expenses": "99,641",
"Revenues": "86,323",
"Stockholders Equity": "1,766",
"Net Income": "-684",
"Comprehensive Net Income": "-684",
"BaseVar": "191,242",
"ECR before LimitedLiability": "1.9%",
"Economic Capital Ratio": "87%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "27,302",
"Assets, Non-Current": "1,762",
"General and Administrative Expense": "29,032",
"Goodwill": "40,860",
"Liabilities, Current": "95,366",
"Liabilities, Non-Current": "4,948",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "76,651",
"Other Liabilities": "0",
"Other Net Income": "-9,309",
"Other Revenues": "85,501",
"Property, Plant and Equipment, Net": "3,169",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "100,314",
"Assets": "73,093",
"Expenses": "105,683",
"Revenues": "85,501",
"Stockholders Equity": "-27,221",
"Net Income": "-29,491",
"Comprehensive Net Income": "-29,491",
"BaseVar": "186,950",
"ECR before LimitedLiability": "-77%",
"Economic Capital Ratio": "74%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "29,298",
"Assets, Non-Current": "1,720",
"General and Administrative Expense": "87,281",
"Goodwill": "39,105",
"Liabilities, Current": "98,803",
"Liabilities, Non-Current": "16,324",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "29",
"Other Liabilities": "0",
"Other Net Income": "-6,390",
"Other Revenues": "73,291",
"Property, Plant and Equipment, Net": "1,117",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "115,127",
"Assets": "71,240",
"Expenses": "87,310",
"Revenues": "73,291",
"Stockholders Equity": "-43,887",
"Net Income": "-20,409",
"Comprehensive Net Income": "-20,409",
"BaseVar": "176,679",
"ECR before LimitedLiability": "-86%",
"Economic Capital Ratio": "72%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "16,300",
"Assets, Non-Current": "834",
"General and Administrative Expense": "87,820",
"Goodwill": "13,181",
"Liabilities, Current": "118,147",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "24,486",
"Other Liabilities": "0",
"Other Net Income": "-5,655",
"Other Revenues": "73,460",
"Property, Plant and Equipment, Net": "72",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "118,147",
"Assets": "30,387",
"Expenses": "112,306",
"Revenues": "73,460",
"Stockholders Equity": "-87,760",
"Net Income": "-44,501",
"Comprehensive Net Income": "-44,501",
"BaseVar": "169,978",
"ECR before LimitedLiability": "-222%",
"Economic Capital Ratio": "28%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "17,345",
"Assets, Non-Current": "5,470",
"General and Administrative Expense": "71,757",
"Goodwill": "12,071",
"Liabilities, Current": "132,032",
"Liabilities, Non-Current": "5,068",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "38",
"Other Liabilities": "0",
"Other Net Income": "-8,943",
"Other Revenues": "66,349",
"Property, Plant and Equipment, Net": "65",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "137,100",
"Assets": "34,951",
"Expenses": "71,795",
"Revenues": "66,349",
"Stockholders Equity": "-102,149",
"Net Income": "-14,389",
"Comprehensive Net Income": "-14,389",
"BaseVar": "159,569",
"ECR before LimitedLiability": "-179%",
"Economic Capital Ratio": "41%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "17,371",
"Assets, Non-Current": "6,781",
"General and Administrative Expense": "68,663",
"Goodwill": "576",
"Liabilities, Current": "136,760",
"Liabilities, Non-Current": "5,197",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "11,131",
"Other Liabilities": "0",
"Other Net Income": "-7,235",
"Other Revenues": "72,089",
"Property, Plant and Equipment, Net": "140",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "141,957",
"Assets": "24,868",
"Expenses": "79,794",
"Revenues": "72,089",
"Stockholders Equity": "-117,089",
"Net Income": "-14,940",
"Comprehensive Net Income": "-14,940",
"BaseVar": "162,972",
"ECR before LimitedLiability": "-210%",
"Economic Capital Ratio": "32%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "15,138",
"Assets, Non-Current": "5,466",
"General and Administrative Expense": "54,215",
"Goodwill": "120",
"Liabilities, Current": "142,185",
"Liabilities, Non-Current": "4,038",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "365",
"Other Liabilities": "0",
"Other Net Income": "-6,226",
"Other Revenues": "52,584",
"Property, Plant and Equipment, Net": "188",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "146,223",
"Assets": "20,912",
"Expenses": "54,580",
"Revenues": "52,584",
"Stockholders Equity": "-125,311",
"Net Income": "-8,222",
"Comprehensive Net Income": "-8,222",
"BaseVar": "140,262",
"ECR before LimitedLiability": "-215%",
"Economic Capital Ratio": "30%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "5,687",
"Assets, Non-Current": "3,179",
"General and Administrative Expense": "15,006",
"Goodwill": "120",
"Liabilities, Current": "145,823",
"Liabilities, Non-Current": "2,197",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "43",
"Other Liabilities": "0",
"Other Net Income": "-12,282",
"Other Revenues": "13,617",
"Property, Plant and Equipment, Net": "9.0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "148,020",
"Assets": "8,995",
"Expenses": "15,049",
"Revenues": "13,617",
"Stockholders Equity": "-139,025",
"Net Income": "-13,714",
"Comprehensive Net Income": "-13,714",
"BaseVar": "98,982",
"ECR before LimitedLiability": "-260%",
"Economic Capital Ratio": "19%"
}
}
},
"top_rated": false,
"trend": 9.0,
"value": 0.18824952689562316,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0001590695.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0001590695.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0001590695.svg"
},
{
"company_id": "0000926617",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution_0000926617.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2023/graphs/IME_0000926617.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000926617.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000926617_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000926617_main_keyfigs.svg",
"name": "Aspira Women s Health Inc",
"rank": 46,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_0000926617.svg",
"report_text": "The relative strengths and weaknesses of Aspira Women s Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aspira Women s Health Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 6.7% points.The greatest weakness of Aspira Women s Health Inc is the variable Assets, reducing the Economic Capital Ratio by 67% points.
The company's Economic Capital Ratio, given in the ranking table, is 17%, being 123% points below the market average of 140%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2023/report/0000926617_2024_Aspira_Women_s_Health_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-27.4",
"Liabilities": "-16.5",
"Stockholders Equity": "1.22",
"Liabilities, Non-Current": "0.717",
"Other Liabilities": "0.0331",
"Property, Plant and Equipment, Net": "-0.750",
"Assets": "10.6",
"Assets, Non-Current": "-0.512",
"Goodwill": "-0.750",
"Assets, Current": "38.8",
"General and Administrative Expense": "-0.698",
"Expenses": "-0.271",
"Revenues": "-30.5",
"Net Income": "-40.2",
"Research and Development": "-0.703",
"Other Expenses": "3.05",
"Other Revenues": "-30.5",
"ECR before LimitedLiability": "-7.59",
"Comprehensive Net Income": "-40.3",
"Other Net Income": "-0.448",
"Economic Capital Ratio": "-69.6"
},
"2012": {
"Assets, Current": "16.6",
"Assets": "-0.140",
"Other Liabilities": "0.301",
"Stockholders Equity": "-0.140",
"Assets, Non-Current": "-2.31",
"Property, Plant and Equipment, Net": "-14.0",
"Goodwill": "-17.1",
"Other Expenses": "4.58",
"Expenses": "-21.6",
"Revenues": "-44.6",
"Net Income": "-41.3",
"Research and Development": "-1.11",
"General and Administrative Expense": "-46.7",
"Other Revenues": "-44.6",
"ECR before LimitedLiability": "-41.5",
"Liabilities, Current": "-9.91",
"Liabilities, Non-Current": "0.785",
"Other Net Income": "3.96",
"Comprehensive Net Income": "-40.2",
"Other Compr. Net Income": "0.0563",
"Economic Capital Ratio": "-74.0"
},
"2013": {
"Liabilities, Current": "7.06",
"Liabilities": "26.4",
"Stockholders Equity": "113",
"ECR before LimitedLiability": "94.4",
"Other Liabilities": "8.35",
"Liabilities, Non-Current": "12.6",
"Goodwill": "-4.97",
"Assets": "62.6",
"Assets, Non-Current": "-1.95",
"Property, Plant and Equipment, Net": "-3.52",
"Assets, Current": "125",
"General and Administrative Expense": "-1.21",
"Expenses": "15.3",
"Revenues": "-24.5",
"Net Income": "-10.5",
"Research and Development": "-1.71",
"Other Expenses": "18.2",
"Other Revenues": "-24.5",
"Other Net Income": "-1.65",
"Comprehensive Net Income": "-10.5",
"Economic Capital Ratio": "54.3"
},
"2014": {
"Liabilities, Non-Current": "17.8",
"Liabilities": "43.3",
"Stockholders Equity": "55.7",
"ECR before LimitedLiability": "45.4",
"Liabilities, Current": "15.5",
"Other Liabilities": "11.9",
"Assets, Current": "82.0",
"Assets": "48.5",
"Goodwill": "-16.2",
"Assets, Non-Current": "-5.60",
"Property, Plant and Equipment, Net": "-10.3",
"Other Expenses": "16.2",
"Expenses": "-24.0",
"Revenues": "-36.7",
"Net Income": "-56.4",
"Research and Development": "-10.7",
"General and Administrative Expense": "-28.1",
"Other Revenues": "-36.7",
"Other Net Income": "1.56",
"Comprehensive Net Income": "-56.3",
"Economic Capital Ratio": "-4.05"
},
"2015": {
"Other Liabilities": "17.7",
"Liabilities": "38.3",
"Stockholders Equity": "51.8",
"ECR before LimitedLiability": "32.1",
"Liabilities, Current": "24.9",
"Liabilities, Non-Current": "22.2",
"Assets, Current": "69.1",
"Assets": "39.1",
"Other Assets": "-8.79",
"Goodwill": "-18.6",
"Assets, Non-Current": "-5.20",
"Property, Plant and Equipment, Net": "-5.31",
"Research and Development": "-12.7",
"Expenses": "-43.9",
"Revenues": "-35.3",
"Net Income": "-72.6",
"General and Administrative Expense": "-48.9",
"Other Expenses": "20.1",
"Other Revenues": "-35.3",
"Comprehensive Net Income": "-72.3",
"Economic Capital Ratio": "-13.8"
},
"2016": {
"Liabilities, Non-Current": "-1.04",
"Liabilities": "3.87",
"Stockholders Equity": "-12.9",
"ECR before LimitedLiability": "-78.7",
"Liabilities, Current": "3.11",
"Other Liabilities": "1.84",
"Property, Plant and Equipment, Net": "-1.99",
"Assets": "-27.2",
"Assets, Non-Current": "-6.15",
"Assets, Current": "-6.93",
"Goodwill": "-18.1",
"Research and Development": "-2.20",
"Expenses": "-34.8",
"Revenues": "-15.8",
"Net Income": "-55.4",
"General and Administrative Expense": "-52.6",
"Other Expenses": "17.5",
"Other Revenues": "-15.8",
"Comprehensive Net Income": "-55.0",
"Other Net Income": "-1.40",
"Economic Capital Ratio": "-98.6"
},
"2017": {
"Other Liabilities": "3.10",
"Liabilities": "4.38",
"Stockholders Equity": "-7.42",
"ECR before LimitedLiability": "-64.3",
"Liabilities, Current": "2.00",
"Liabilities, Non-Current": "-0.645",
"Assets, Non-Current": "-4.65",
"Assets": "-13.8",
"Assets, Current": "14.3",
"Goodwill": "-12.0",
"Property, Plant and Equipment, Net": "-8.98",
"Research and Development": "3.65",
"Expenses": "-17.0",
"Revenues": "-6.68",
"Net Income": "-44.0",
"Other Expenses": "13.1",
"General and Administrative Expense": "-60.2",
"Other Revenues": "-6.68",
"Comprehensive Net Income": "-44.5",
"Other Net Income": "-2.71",
"Economic Capital Ratio": "-85.8"
},
"2018": {
"Liabilities, Non-Current": "0.0605",
"Liabilities": "1.66",
"Stockholders Equity": "2.14",
"ECR before LimitedLiability": "-39.4",
"Other Liabilities": "1.21",
"Liabilities, Current": "0.256",
"Property, Plant and Equipment, Net": "-7.68",
"Assets": "0.0872",
"Assets, Current": "28.8",
"Goodwill": "-8.99",
"Assets, Non-Current": "-0.974",
"Other Expenses": "2.14",
"Expenses": "-37.2",
"Revenues": "-12.9",
"Net Income": "-63.8",
"Research and Development": "1.37",
"General and Administrative Expense": "-64.0",
"Other Revenues": "-12.9",
"Comprehensive Net Income": "-63.5",
"Other Net Income": "-0.0401",
"Economic Capital Ratio": "-59.9"
},
"2019": {
"Liabilities, Non-Current": "1.57",
"Liabilities": "4.10",
"Stockholders Equity": "1.77",
"ECR before LimitedLiability": "-24.0",
"Other Liabilities": "2.33",
"Assets, Non-Current": "-2.18",
"Assets": "-1.83",
"Goodwill": "-2.36",
"Property, Plant and Equipment, Net": "-3.98",
"Other Assets": "0.254",
"Assets, Current": "35.4",
"Research and Development": "0.897",
"Expenses": "-39.5",
"Revenues": "-2.14",
"Net Income": "-56.6",
"Other Expenses": "2.68",
"General and Administrative Expense": "-58.9",
"Other Revenues": "-2.14",
"Other Net Income": "1.04",
"Comprehensive Net Income": "-56.5",
"Economic Capital Ratio": "-53.5"
},
"2020": {
"Liabilities, Current": "-0.785",
"Liabilities": "0.0403",
"Stockholders Equity": "-1.65",
"ECR before LimitedLiability": "-25.3",
"Liabilities, Non-Current": "0.203",
"Other Liabilities": "0.751",
"Goodwill": "-1.80",
"Assets": "-1.68",
"Assets, Current": "21.0",
"Assets, Non-Current": "-1.60",
"Property, Plant and Equipment, Net": "-3.81",
"Other Expenses": "1.71",
"Expenses": "-28.5",
"Revenues": "-1.80",
"Net Income": "-47.0",
"Research and Development": "-0.270",
"General and Administrative Expense": "-37.3",
"Other Revenues": "-1.80",
"Comprehensive Net Income": "-46.9",
"Other Net Income": "1.07",
"Economic Capital Ratio": "-63.1"
},
"2021": {
"Liabilities, Non-Current": "12.6",
"Liabilities": "25.0",
"Stockholders Equity": "25.0",
"ECR before LimitedLiability": "-35.2",
"Liabilities, Current": "3.69",
"Other Liabilities": "9.29",
"Other Expenses": "14.9",
"Expenses": "-43.3",
"Net Income": "-62.9",
"Research and Development": "-4.37",
"General and Administrative Expense": "-51.4",
"Other Revenues": "-26.7",
"Revenues": "-26.7",
"Assets, Current": "48.8",
"Assets, Non-Current": "-16.6",
"Other Assets": "2.63",
"Goodwill": "-24.7",
"Property, Plant and Equipment, Net": "-21.1",
"Comprehensive Net Income": "-62.9",
"Other Net Income": "3.96",
"Economic Capital Ratio": "-39.5"
},
"2022": {
"Liabilities, Non-Current": "2.53",
"Liabilities": "2.85",
"Stockholders Equity": "-22.4",
"ECR before LimitedLiability": "-83.1",
"Other Liabilities": "-1.50",
"Liabilities, Current": "1.76",
"Assets": "-25.2",
"Assets, Current": "16.3",
"Property, Plant and Equipment, Net": "-17.2",
"Assets, Non-Current": "-13.1",
"Goodwill": "-18.9",
"General and Administrative Expense": "-53.5",
"Expenses": "-25.8",
"Revenues": "-7.77",
"Net Income": "-38.6",
"Research and Development": "-7.67",
"Other Expenses": "20.2",
"Other Revenues": "-7.77",
"Other Net Income": "1.35",
"Comprehensive Net Income": "-37.8",
"Economic Capital Ratio": "-93.6"
},
"2023": {
"Liabilities, Non-Current": "0.0988",
"Liabilities": "0.173",
"Stockholders Equity": "-61.7",
"ECR before LimitedLiability": "-108",
"Liabilities, Current": "0.139",
"Other Assets": "-0.820",
"Assets": "-67.3",
"Property, Plant and Equipment, Net": "-32.0",
"Goodwill": "-34.7",
"Assets, Current": "-22.7",
"Assets, Non-Current": "-24.3",
"Other Expenses": "6.75",
"Expenses": "-59.3",
"Revenues": "3.05",
"Net Income": "-46.9",
"Research and Development": "-8.68",
"General and Administrative Expense": "-59.8",
"Other Revenues": "3.05",
"Other Net Income": "5.20",
"Comprehensive Net Income": "-47.0",
"Economic Capital Ratio": "-123"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/plot_over_time/0000926617_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "22,893",
"Assets, Non-Current": "2.0",
"General and Administrative Expense": "14,177",
"Goodwill": "0",
"Liabilities, Current": "11,476",
"Liabilities, Non-Current": "52",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "114",
"Other Liabilities": "1,224",
"Other Net Income": "-35",
"Other Revenues": "1,923",
"Property, Plant and Equipment, Net": "216",
"Research and Development": "5,387"
},
"output_variables": {
"Liabilities": "12,752",
"Assets": "23,111",
"Expenses": "19,678",
"Revenues": "1,923",
"Stockholders Equity": "10,359",
"Net Income": "-17,790",
"Comprehensive Net Income": "-17,790",
"BaseVar": "28,750",
"ECR before LimitedLiability": "-20%",
"Economic Capital Ratio": "84%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "8,492",
"Assets, Non-Current": "0",
"General and Administrative Expense": "9,292",
"Goodwill": "0",
"Liabilities, Current": "3,197",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "153",
"Other Expenses": "118",
"Other Liabilities": "770",
"Other Net Income": "2,386",
"Other Revenues": "2,094",
"Property, Plant and Equipment, Net": "142",
"Research and Development": "2,216"
},
"output_variables": {
"Liabilities": "3,967",
"Assets": "8,634",
"Expenses": "11,626",
"Revenues": "2,094",
"Stockholders Equity": "4,667",
"Net Income": "-7,146",
"Comprehensive Net Income": "-7,070",
"BaseVar": "14,430",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "30,249",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,834",
"Goodwill": "0",
"Liabilities, Current": "3,558",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "316",
"Other Net Income": "44",
"Other Revenues": "2,566",
"Property, Plant and Equipment, Net": "391",
"Research and Development": "2,595"
},
"output_variables": {
"Liabilities": "3,874",
"Assets": "30,640",
"Expenses": "11,429",
"Revenues": "2,566",
"Stockholders Equity": "26,766",
"Net Income": "-8,819",
"Comprehensive Net Income": "-8,819",
"BaseVar": "24,276",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "23,666",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,835",
"Goodwill": "0",
"Liabilities, Current": "4,919",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,230",
"Other Liabilities": "0",
"Other Net Income": "2.0",
"Other Revenues": "2,521",
"Property, Plant and Equipment, Net": "508",
"Research and Development": "4,667"
},
"output_variables": {
"Liabilities": "4,919",
"Assets": "24,174",
"Expenses": "21,732",
"Revenues": "2,521",
"Stockholders Equity": "19,255",
"Net Income": "-19,209",
"Comprehensive Net Income": "-19,209",
"BaseVar": "26,674",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "19,366",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,366",
"Goodwill": "0",
"Liabilities, Current": "3,351",
"Liabilities, Non-Current": "0",
"Other Assets": "90",
"Other Compr. Net Income": "0",
"Other Expenses": "2,309",
"Other Liabilities": "63",
"Other Net Income": "134",
"Other Revenues": "2,177",
"Property, Plant and Equipment, Net": "1,504",
"Research and Development": "3,751"
},
"output_variables": {
"Liabilities": "3,414",
"Assets": "20,960",
"Expenses": "21,426",
"Revenues": "2,177",
"Stockholders Equity": "17,546",
"Net Income": "-19,115",
"Comprehensive Net Income": "-19,115",
"BaseVar": "24,056",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "122%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "6,108",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,424",
"Goodwill": "0",
"Liabilities, Current": "2,561",
"Liabilities, Non-Current": "1,696",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-14",
"Other Revenues": "2,642",
"Property, Plant and Equipment, Net": "1,911",
"Research and Development": "2,172"
},
"output_variables": {
"Liabilities": "4,257",
"Assets": "8,019",
"Expenses": "17,596",
"Revenues": "2,642",
"Stockholders Equity": "3,762",
"Net Income": "-14,968",
"Comprehensive Net Income": "-14,968",
"BaseVar": "16,264",
"ECR before LimitedLiability": "-160%",
"Economic Capital Ratio": "48%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "6,305",
"Assets, Non-Current": "11",
"General and Administrative Expense": "12,725",
"Goodwill": "0",
"Liabilities, Current": "2,609",
"Liabilities, Non-Current": "1,481",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-56",
"Other Revenues": "3,121",
"Property, Plant and Equipment, Net": "1,181",
"Research and Development": "837"
},
"output_variables": {
"Liabilities": "4,090",
"Assets": "7,497",
"Expenses": "13,562",
"Revenues": "3,121",
"Stockholders Equity": "3,407",
"Net Income": "-10,497",
"Comprehensive Net Income": "-10,497",
"BaseVar": "14,163",
"ECR before LimitedLiability": "-101%",
"Economic Capital Ratio": "68%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "10,788",
"Assets, Non-Current": "12",
"General and Administrative Expense": "13,836",
"Goodwill": "0",
"Liabilities, Current": "2,964",
"Liabilities, Non-Current": "1,292",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-38",
"Other Revenues": "3,053",
"Property, Plant and Equipment, Net": "608",
"Research and Development": "550"
},
"output_variables": {
"Liabilities": "4,256",
"Assets": "11,408",
"Expenses": "14,386",
"Revenues": "3,053",
"Stockholders Equity": "7,152",
"Net Income": "-11,371",
"Comprehensive Net Income": "-11,371",
"BaseVar": "16,570",
"ECR before LimitedLiability": "-20%",
"Economic Capital Ratio": "84%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,410",
"Assets, Non-Current": "65",
"General and Administrative Expense": "18,798",
"Goodwill": "0",
"Liabilities, Current": "3,978",
"Liabilities, Non-Current": "1,112",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "41",
"Other Revenues": "4,538",
"Property, Plant and Equipment, Net": "353",
"Research and Development": "1,018"
},
"output_variables": {
"Liabilities": "5,090",
"Assets": "13,828",
"Expenses": "19,816",
"Revenues": "4,538",
"Stockholders Equity": "8,738",
"Net Income": "-15,237",
"Comprehensive Net Income": "-15,237",
"BaseVar": "21,656",
"ECR before LimitedLiability": "-35%",
"Economic Capital Ratio": "82%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "18,603",
"Assets, Non-Current": "419",
"General and Administrative Expense": "20,528",
"Goodwill": "0",
"Liabilities, Current": "6,400",
"Liabilities, Non-Current": "3,486",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "76",
"Other Revenues": "4,651",
"Property, Plant and Equipment, Net": "583",
"Research and Development": "2,104"
},
"output_variables": {
"Liabilities": "9,886",
"Assets": "19,605",
"Expenses": "22,632",
"Revenues": "4,651",
"Stockholders Equity": "9,719",
"Net Income": "-17,905",
"Comprehensive Net Income": "-17,905",
"BaseVar": "28,425",
"ECR before LimitedLiability": "-31%",
"Economic Capital Ratio": "83%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "40,005",
"Assets, Non-Current": "360",
"General and Administrative Expense": "34,093",
"Goodwill": "0",
"Liabilities, Current": "7,840",
"Liabilities, Non-Current": "3,067",
"Other Assets": "250",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "933",
"Other Revenues": "6,812",
"Property, Plant and Equipment, Net": "464",
"Research and Development": "5,314"
},
"output_variables": {
"Liabilities": "10,907",
"Assets": "41,079",
"Expenses": "39,407",
"Revenues": "6,812",
"Stockholders Equity": "30,172",
"Net Income": "-31,662",
"Comprehensive Net Income": "-31,662",
"BaseVar": "49,569",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "119%"
}
},
"2022": {
"input_variables": {
"Assets, Current": "16,309",
"Assets, Non-Current": "445",
"General and Administrative Expense": "34,996",
"Goodwill": "0",
"Liabilities, Current": "5,775",
"Liabilities, Non-Current": "2,587",
"Other Assets": "251",
"Other Compr. Net Income": "0",
"Other Expenses": "-5,472",
"Other Liabilities": "2,280",
"Other Net Income": "123",
"Other Revenues": "8,184",
"Property, Plant and Equipment, Net": "368",
"Research and Development": "5,953"
},
"output_variables": {
"Liabilities": "10,642",
"Assets": "17,373",
"Expenses": "35,477",
"Revenues": "8,184",
"Stockholders Equity": "6,731",
"Net Income": "-27,170",
"Comprehensive Net Income": "-27,170",
"BaseVar": "35,900",
"ECR before LimitedLiability": "-128%",
"Economic Capital Ratio": "59%"
}
},
"2023": {
"input_variables": {
"Assets, Current": "5,280",
"Assets, Non-Current": "559",
"General and Administrative Expense": "23,971",
"Goodwill": "0",
"Liabilities, Current": "5,119",
"Liabilities, Non-Current": "1,857",
"Other Assets": "258",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "1,651",
"Other Net Income": "2,162",
"Other Revenues": "9,154",
"Property, Plant and Equipment, Net": "165",
"Research and Development": "4,035"
},
"output_variables": {
"Liabilities": "8,627",
"Assets": "6,262",
"Expenses": "28,006",
"Revenues": "9,154",
"Stockholders Equity": "-2,365",
"Net Income": "-16,690",
"Comprehensive Net Income": "-16,690",
"BaseVar": "27,106",
"ECR before LimitedLiability": "-268%",
"Economic Capital Ratio": "17%"
}
}
},
"top_rated": false,
"trend": 5.0,
"value": 0.1721142199876881,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2023/industry_indexes/0000926617.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/equity/0000926617.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2023/analytics/profit_loss/0000926617.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"32.8 B"
],
[
"Assets",
"60.1 B"
],
[
"Expenses",
"32.1 B"
],
[
"Stockholders Equity",
"32.6 B"
]
],
"industry_id": "us_medicinal_products",
"industry_label": "Medicinal Products",
"num_companies": 46,
"num_top_companies": 11,
"ecr_records": {
"2009": {
"0000794172": {
"rank": 1,
"ecr": "278"
},
"0000037785": {
"rank": 2,
"ecr": "225"
},
"0001056358": {
"rank": 3,
"ecr": "145"
}
},
"2010": {
"0000899923": {
"rank": 1,
"ecr": "304"
},
"0000794172": {
"rank": 2,
"ecr": "279"
},
"0000037785": {
"rank": 3,
"ecr": "209"
},
"0000874716": {
"rank": 4,
"ecr": "203"
},
"0001056358": {
"rank": 5,
"ecr": "150"
},
"0000074303": {
"rank": 6,
"ecr": "149"
},
"0001315695": {
"rank": 7,
"ecr": "132"
},
"0001145460": {
"rank": 8,
"ecr": "130"
},
"0001307954": {
"rank": 9,
"ecr": "115"
},
"0000722104": {
"rank": 10,
"ecr": "102"
}
},
"2011": {
"0000885462": {
"rank": 1,
"ecr": "287"
},
"0000899923": {
"rank": 2,
"ecr": "285"
},
"0000794172": {
"rank": 3,
"ecr": "276"
},
"0000736822": {
"rank": 4,
"ecr": "270"
},
"0000787253": {
"rank": 5,
"ecr": "256"
},
"0000711377": {
"rank": 6,
"ecr": "253"
},
"0000353569": {
"rank": 7,
"ecr": "250"
},
"0000768408": {
"rank": 8,
"ecr": "238"
},
"0000896264": {
"rank": 9,
"ecr": "235"
},
"0000811641": {
"rank": 10,
"ecr": "224"
},
"0000037785": {
"rank": 11,
"ecr": "221"
},
"0001054905": {
"rank": 12,
"ecr": "219"
},
"0001086303": {
"rank": 13,
"ecr": "216"
},
"0000810509": {
"rank": 14,
"ecr": "213"
},
"0001050007": {
"rank": 15,
"ecr": "208"
},
"0001374328": {
"rank": 16,
"ecr": "199"
},
"0000722830": {
"rank": 17,
"ecr": "183"
},
"0000874716": {
"rank": 18,
"ecr": "180"
},
"0000722104": {
"rank": 19,
"ecr": "176"
},
"0001063665": {
"rank": 20,
"ecr": "175"
},
"0001141240": {
"rank": 21,
"ecr": "168"
},
"0000074303": {
"rank": 22,
"ecr": "154"
},
"0000744218": {
"rank": 23,
"ecr": "152"
},
"0001315695": {
"rank": 24,
"ecr": "148"
},
"0001407038": {
"rank": 25,
"ecr": "146"
},
"0000949858": {
"rank": 26,
"ecr": "132"
},
"0001145460": {
"rank": 27,
"ecr": "127"
},
"0001307954": {
"rank": 28,
"ecr": "115"
},
"0001056358": {
"rank": 29,
"ecr": "104"
},
"0001402785": {
"rank": 30,
"ecr": "85"
},
"0000926617": {
"rank": 31,
"ecr": "84"
},
"0001124608": {
"rank": 32,
"ecr": "80"
},
"0001346526": {
"rank": 33,
"ecr": "80"
},
"0001386570": {
"rank": 34,
"ecr": "73"
},
"0000776008": {
"rank": 35,
"ecr": "34"
},
"0001037649": {
"rank": 36,
"ecr": "24"
},
"0001310630": {
"rank": 37,
"ecr": "20"
},
"0001119643": {
"rank": 38,
"ecr": "0.99"
},
"0001134765": {
"rank": 39,
"ecr": "0.077"
},
"0000880242": {
"rank": 40,
"ecr": "0.028"
},
"0000907654": {
"rank": 41,
"ecr": "0.0000000000000000000015"
}
},
"2012": {
"0000899923": {
"rank": 1,
"ecr": "282"
},
"0000885462": {
"rank": 2,
"ecr": "278"
},
"0000794172": {
"rank": 3,
"ecr": "275"
},
"0000073290": {
"rank": 4,
"ecr": "263"
},
"0000009326": {
"rank": 5,
"ecr": "260"
},
"0000353569": {
"rank": 6,
"ecr": "256"
},
"0000711377": {
"rank": 7,
"ecr": "254"
},
"0000787253": {
"rank": 8,
"ecr": "246"
},
"0000768408": {
"rank": 9,
"ecr": "245"
},
"0000722830": {
"rank": 10,
"ecr": "240"
},
"0001374328": {
"rank": 11,
"ecr": "239"
},
"0000896264": {
"rank": 12,
"ecr": "234"
},
"0000811641": {
"rank": 13,
"ecr": "233"
},
"0001054905": {
"rank": 14,
"ecr": "232"
},
"0000037785": {
"rank": 15,
"ecr": "219"
},
"0001086303": {
"rank": 16,
"ecr": "211"
},
"0001050007": {
"rank": 17,
"ecr": "209"
},
"0001510518": {
"rank": 18,
"ecr": "204"
},
"0001063665": {
"rank": 19,
"ecr": "199"
},
"0000949858": {
"rank": 20,
"ecr": "196"
},
"0001028215": {
"rank": 21,
"ecr": "194"
},
"0000874716": {
"rank": 22,
"ecr": "191"
},
"0000744218": {
"rank": 23,
"ecr": "163"
},
"0001056358": {
"rank": 24,
"ecr": "146"
},
"0001124608": {
"rank": 25,
"ecr": "146"
},
"0001134765": {
"rank": 26,
"ecr": "144"
},
"0000074303": {
"rank": 27,
"ecr": "142"
},
"0001315695": {
"rank": 28,
"ecr": "138"
},
"0000776008": {
"rank": 29,
"ecr": "137"
},
"0001145460": {
"rank": 30,
"ecr": "129"
},
"0001307954": {
"rank": 31,
"ecr": "118"
},
"0000722104": {
"rank": 32,
"ecr": "87"
},
"0000926617": {
"rank": 33,
"ecr": "84"
},
"0001346526": {
"rank": 34,
"ecr": "77"
},
"0001386570": {
"rank": 35,
"ecr": "72"
},
"0001407038": {
"rank": 36,
"ecr": "50"
},
"0000093314": {
"rank": 37,
"ecr": "46"
},
"0001141240": {
"rank": 38,
"ecr": "46"
},
"0001037649": {
"rank": 39,
"ecr": "23"
},
"0000810509": {
"rank": 40,
"ecr": "22"
},
"0001402785": {
"rank": 41,
"ecr": "21"
},
"0001310630": {
"rank": 42,
"ecr": "18"
},
"0001119643": {
"rank": 43,
"ecr": "2.1"
},
"0001142790": {
"rank": 44,
"ecr": "0.0000013"
}
},
"2013": {
"0000907654": {
"rank": 1,
"ecr": "474"
},
"0000885462": {
"rank": 2,
"ecr": "283"
},
"0000899923": {
"rank": 3,
"ecr": "279"
},
"0000794172": {
"rank": 4,
"ecr": "273"
},
"0000073290": {
"rank": 5,
"ecr": "268"
},
"0000009326": {
"rank": 6,
"ecr": "261"
},
"0000711377": {
"rank": 7,
"ecr": "261"
},
"0000353569": {
"rank": 8,
"ecr": "259"
},
"0000811641": {
"rank": 9,
"ecr": "240"
},
"0001054905": {
"rank": 10,
"ecr": "235"
},
"0000896264": {
"rank": 11,
"ecr": "231"
},
"0001063665": {
"rank": 12,
"ecr": "229"
},
"0000744218": {
"rank": 13,
"ecr": "228"
},
"0000768408": {
"rank": 14,
"ecr": "216"
},
"0001050007": {
"rank": 15,
"ecr": "212"
},
"0000722830": {
"rank": 16,
"ecr": "211"
},
"0000926617": {
"rank": 17,
"ecr": "209"
},
"0000037785": {
"rank": 18,
"ecr": "191"
},
"0001324736": {
"rank": 19,
"ecr": "185"
},
"0001374328": {
"rank": 20,
"ecr": "179"
},
"0000874716": {
"rank": 21,
"ecr": "162"
},
"0001086303": {
"rank": 22,
"ecr": "158"
},
"0001028215": {
"rank": 23,
"ecr": "156"
},
"0001056358": {
"rank": 24,
"ecr": "153"
},
"0000074303": {
"rank": 25,
"ecr": "150"
},
"0001578932": {
"rank": 26,
"ecr": "145"
},
"0001386570": {
"rank": 27,
"ecr": "144"
},
"0001124608": {
"rank": 28,
"ecr": "138"
},
"0000949858": {
"rank": 29,
"ecr": "131"
},
"0000736822": {
"rank": 30,
"ecr": "130"
},
"0001145460": {
"rank": 31,
"ecr": "127"
},
"0001307954": {
"rank": 32,
"ecr": "121"
},
"0001566978": {
"rank": 33,
"ecr": "117"
},
"0001037649": {
"rank": 34,
"ecr": "86"
},
"0001134765": {
"rank": 35,
"ecr": "83"
},
"0001510518": {
"rank": 36,
"ecr": "79"
},
"0000810509": {
"rank": 37,
"ecr": "63"
},
"0001346526": {
"rank": 38,
"ecr": "56"
},
"0000093314": {
"rank": 39,
"ecr": "49"
},
"0001407038": {
"rank": 40,
"ecr": "43"
},
"0001310630": {
"rank": 41,
"ecr": "16"
},
"0000776008": {
"rank": 42,
"ecr": "9.7"
},
"0001141240": {
"rank": 43,
"ecr": "7.6"
},
"0001569737": {
"rank": 44,
"ecr": "6.5"
},
"0001402785": {
"rank": 45,
"ecr": "5.0"
},
"0001504678": {
"rank": 46,
"ecr": "0.42"
},
"0000880242": {
"rank": 47,
"ecr": "0.000030"
}
},
"2014": {
"0000885462": {
"rank": 1,
"ecr": "284"
},
"0000794172": {
"rank": 2,
"ecr": "282"
},
"0000899923": {
"rank": 3,
"ecr": "271"
},
"0000711377": {
"rank": 4,
"ecr": "259"
},
"0000353569": {
"rank": 5,
"ecr": "256"
},
"0000073290": {
"rank": 6,
"ecr": "252"
},
"0001086303": {
"rank": 7,
"ecr": "237"
},
"0000811641": {
"rank": 8,
"ecr": "231"
},
"0000787253": {
"rank": 9,
"ecr": "230"
},
"0001054905": {
"rank": 10,
"ecr": "229"
},
"0001321834": {
"rank": 11,
"ecr": "225"
},
"0001374328": {
"rank": 12,
"ecr": "210"
},
"0001050007": {
"rank": 13,
"ecr": "206"
},
"0000768408": {
"rank": 14,
"ecr": "195"
},
"0000037785": {
"rank": 15,
"ecr": "192"
},
"0000907654": {
"rank": 16,
"ecr": "181"
},
"0000744218": {
"rank": 17,
"ecr": "181"
},
"0001056358": {
"rank": 18,
"ecr": "165"
},
"0000009326": {
"rank": 19,
"ecr": "160"
},
"0001028215": {
"rank": 20,
"ecr": "158"
},
"0000722830": {
"rank": 21,
"ecr": "148"
},
"0001578932": {
"rank": 22,
"ecr": "142"
},
"0001141240": {
"rank": 23,
"ecr": "142"
},
"0000074303": {
"rank": 24,
"ecr": "141"
},
"0000949858": {
"rank": 25,
"ecr": "132"
},
"0000926617": {
"rank": 26,
"ecr": "129"
},
"0001145460": {
"rank": 27,
"ecr": "125"
},
"0000736822": {
"rank": 28,
"ecr": "112"
},
"0001307954": {
"rank": 29,
"ecr": "111"
},
"0000874716": {
"rank": 30,
"ecr": "109"
},
"0001045309": {
"rank": 31,
"ecr": "103"
},
"0001566978": {
"rank": 32,
"ecr": "98"
},
"0001037649": {
"rank": 33,
"ecr": "85"
},
"0001590695": {
"rank": 34,
"ecr": "77"
},
"0001134765": {
"rank": 35,
"ecr": "67"
},
"0001346526": {
"rank": 36,
"ecr": "67"
},
"0001124608": {
"rank": 37,
"ecr": "65"
},
"0001407038": {
"rank": 38,
"ecr": "52"
},
"0000093314": {
"rank": 39,
"ecr": "24"
},
"0000810509": {
"rank": 40,
"ecr": "20"
},
"0001408299": {
"rank": 41,
"ecr": "18"
},
"0001310630": {
"rank": 42,
"ecr": "15"
},
"0001119643": {
"rank": 43,
"ecr": "6.4"
},
"0001569737": {
"rank": 44,
"ecr": "5.9"
},
"0001402785": {
"rank": 45,
"ecr": "5.6"
},
"0000776008": {
"rank": 46,
"ecr": "3.9"
},
"0000880242": {
"rank": 47,
"ecr": "0.00000029"
},
"0001562733": {
"rank": 48,
"ecr": "0.00000012"
}
},
"2015": {
"0000794172": {
"rank": 1,
"ecr": "279"
},
"0000885462": {
"rank": 2,
"ecr": "278"
},
"0000711377": {
"rank": 3,
"ecr": "261"
},
"0000353569": {
"rank": 4,
"ecr": "258"
},
"0000899923": {
"rank": 5,
"ecr": "253"
},
"0000073290": {
"rank": 6,
"ecr": "249"
},
"0001054905": {
"rank": 7,
"ecr": "236"
},
"0000787253": {
"rank": 8,
"ecr": "234"
},
"0000907654": {
"rank": 9,
"ecr": "234"
},
"0000037785": {
"rank": 10,
"ecr": "223"
},
"0001050007": {
"rank": 11,
"ecr": "219"
},
"0000896264": {
"rank": 12,
"ecr": "219"
},
"0000811641": {
"rank": 13,
"ecr": "214"
},
"0001038133": {
"rank": 14,
"ecr": "210"
},
"0000768408": {
"rank": 15,
"ecr": "199"
},
"0000744218": {
"rank": 16,
"ecr": "195"
},
"0000722830": {
"rank": 17,
"ecr": "192"
},
"0001056358": {
"rank": 18,
"ecr": "181"
},
"0001324736": {
"rank": 19,
"ecr": "176"
},
"0000009326": {
"rank": 20,
"ecr": "173"
},
"0001374328": {
"rank": 21,
"ecr": "169"
},
"0001028215": {
"rank": 22,
"ecr": "166"
},
"0000949858": {
"rank": 23,
"ecr": "159"
},
"0001562733": {
"rank": 24,
"ecr": "141"
},
"0001578932": {
"rank": 25,
"ecr": "139"
},
"0001569737": {
"rank": 26,
"ecr": "132"
},
"0000926617": {
"rank": 27,
"ecr": "122"
},
"0000074303": {
"rank": 28,
"ecr": "121"
},
"0000736822": {
"rank": 29,
"ecr": "113"
},
"0001566978": {
"rank": 30,
"ecr": "98"
},
"0001045309": {
"rank": 31,
"ecr": "96"
},
"0000874716": {
"rank": 32,
"ecr": "89"
},
"0001627223": {
"rank": 33,
"ecr": "85"
},
"0001141240": {
"rank": 34,
"ecr": "83"
},
"0001590695": {
"rank": 35,
"ecr": "81"
},
"0000776008": {
"rank": 36,
"ecr": "72"
},
"0000093314": {
"rank": 37,
"ecr": "65"
},
"0001134765": {
"rank": 38,
"ecr": "54"
},
"0001037649": {
"rank": 39,
"ecr": "53"
},
"0001498380": {
"rank": 40,
"ecr": "46"
},
"0000810509": {
"rank": 41,
"ecr": "23"
},
"0000880242": {
"rank": 42,
"ecr": "18"
},
"0001310630": {
"rank": 43,
"ecr": "15"
},
"0001598323": {
"rank": 44,
"ecr": "14"
},
"0001402785": {
"rank": 45,
"ecr": "12"
},
"0001552189": {
"rank": 46,
"ecr": "4.1"
},
"0001408299": {
"rank": 47,
"ecr": "2.6"
},
"0001119643": {
"rank": 48,
"ecr": "0.59"
},
"0001142790": {
"rank": 49,
"ecr": "0.0029"
}
},
"2016": {
"0000885462": {
"rank": 1,
"ecr": "281"
},
"0000711377": {
"rank": 2,
"ecr": "262"
},
"0000899923": {
"rank": 3,
"ecr": "254"
},
"0000353569": {
"rank": 4,
"ecr": "252"
},
"0001054905": {
"rank": 5,
"ecr": "243"
},
"0001652130": {
"rank": 6,
"ecr": "237"
},
"0001351573": {
"rank": 7,
"ecr": "231"
},
"0000811641": {
"rank": 8,
"ecr": "225"
},
"0000073290": {
"rank": 9,
"ecr": "222"
},
"0000896264": {
"rank": 10,
"ecr": "222"
},
"0000787253": {
"rank": 11,
"ecr": "218"
},
"0000037785": {
"rank": 12,
"ecr": "218"
},
"0001050007": {
"rank": 13,
"ecr": "214"
},
"0001141240": {
"rank": 14,
"ecr": "212"
},
"0000794172": {
"rank": 15,
"ecr": "204"
},
"0001038133": {
"rank": 16,
"ecr": "201"
},
"0001374328": {
"rank": 17,
"ecr": "198"
},
"0001028215": {
"rank": 18,
"ecr": "188"
},
"0000093314": {
"rank": 19,
"ecr": "182"
},
"0000009326": {
"rank": 20,
"ecr": "176"
},
"0000907654": {
"rank": 21,
"ecr": "170"
},
"0001056358": {
"rank": 22,
"ecr": "170"
},
"0000744218": {
"rank": 23,
"ecr": "163"
},
"0000768408": {
"rank": 24,
"ecr": "161"
},
"0000074303": {
"rank": 25,
"ecr": "121"
},
"0001552189": {
"rank": 26,
"ecr": "116"
},
"0000949858": {
"rank": 27,
"ecr": "115"
},
"0001653477": {
"rank": 28,
"ecr": "112"
},
"0001578932": {
"rank": 29,
"ecr": "110"
},
"0001642380": {
"rank": 30,
"ecr": "107"
},
"0001045309": {
"rank": 31,
"ecr": "106"
},
"0000874716": {
"rank": 32,
"ecr": "89"
},
"0001627223": {
"rank": 33,
"ecr": "87"
},
"0001590695": {
"rank": 34,
"ecr": "87"
},
"0000722830": {
"rank": 35,
"ecr": "85"
},
"0001644440": {
"rank": 36,
"ecr": "84"
},
"0001504678": {
"rank": 37,
"ecr": "80"
},
"0001134765": {
"rank": 38,
"ecr": "55"
},
"0000926617": {
"rank": 39,
"ecr": "48"
},
"0001037649": {
"rank": 40,
"ecr": "30"
},
"0000810509": {
"rank": 41,
"ecr": "26"
},
"0001310630": {
"rank": 42,
"ecr": "16"
},
"0001408299": {
"rank": 43,
"ecr": "13"
},
"0001498380": {
"rank": 44,
"ecr": "4.1"
},
"0001586554": {
"rank": 45,
"ecr": "2.3"
}
},
"2017": {
"0000810509": {
"rank": 1,
"ecr": "620"
},
"0000885462": {
"rank": 2,
"ecr": "284"
},
"0000711377": {
"rank": 3,
"ecr": "260"
},
"0000787253": {
"rank": 4,
"ecr": "246"
},
"0001141240": {
"rank": 5,
"ecr": "243"
},
"0001054905": {
"rank": 6,
"ecr": "235"
},
"0001652130": {
"rank": 7,
"ecr": "234"
},
"0000073290": {
"rank": 8,
"ecr": "227"
},
"0000037785": {
"rank": 9,
"ecr": "221"
},
"0000896264": {
"rank": 10,
"ecr": "219"
},
"0001038133": {
"rank": 11,
"ecr": "216"
},
"0000794172": {
"rank": 12,
"ecr": "204"
},
"0000009326": {
"rank": 13,
"ecr": "197"
},
"0000811641": {
"rank": 14,
"ecr": "197"
},
"0001697834": {
"rank": 15,
"ecr": "190"
},
"0000899923": {
"rank": 16,
"ecr": "188"
},
"0000744218": {
"rank": 17,
"ecr": "179"
},
"0001351573": {
"rank": 18,
"ecr": "171"
},
"0000768408": {
"rank": 19,
"ecr": "170"
},
"0001056358": {
"rank": 20,
"ecr": "167"
},
"0001644440": {
"rank": 21,
"ecr": "158"
},
"0001522767": {
"rank": 22,
"ecr": "145"
},
"0001653477": {
"rank": 23,
"ecr": "143"
},
"0001708035": {
"rank": 24,
"ecr": "142"
},
"0001606645": {
"rank": 25,
"ecr": "139"
},
"0000074303": {
"rank": 26,
"ecr": "133"
},
"0001578932": {
"rank": 27,
"ecr": "121"
},
"0001028215": {
"rank": 28,
"ecr": "119"
},
"0001627223": {
"rank": 29,
"ecr": "112"
},
"0001045309": {
"rank": 30,
"ecr": "97"
},
"0000874716": {
"rank": 31,
"ecr": "95"
},
"0000949858": {
"rank": 32,
"ecr": "88"
},
"0000093314": {
"rank": 33,
"ecr": "84"
},
"0001632275": {
"rank": 34,
"ecr": "79"
},
"0000907654": {
"rank": 35,
"ecr": "78"
},
"0001590695": {
"rank": 36,
"ecr": "74"
},
"0000926617": {
"rank": 37,
"ecr": "68"
},
"0000722830": {
"rank": 38,
"ecr": "61"
},
"0001374328": {
"rank": 39,
"ecr": "57"
},
"0001642380": {
"rank": 40,
"ecr": "45"
},
"0001134765": {
"rank": 41,
"ecr": "18"
},
"0001310630": {
"rank": 42,
"ecr": "15"
},
"0001119643": {
"rank": 43,
"ecr": "4.1"
},
"0001498380": {
"rank": 44,
"ecr": "2.6"
}
},
"2018": {
"0000711377": {
"rank": 1,
"ecr": "268"
},
"0001742924": {
"rank": 2,
"ecr": "250"
},
"0001141240": {
"rank": 3,
"ecr": "248"
},
"0000885462": {
"rank": 4,
"ecr": "244"
},
"0000899923": {
"rank": 5,
"ecr": "242"
},
"0000787253": {
"rank": 6,
"ecr": "230"
},
"0000896264": {
"rank": 7,
"ecr": "230"
},
"0001054905": {
"rank": 8,
"ecr": "228"
},
"0001038133": {
"rank": 9,
"ecr": "223"
},
"0001652130": {
"rank": 10,
"ecr": "216"
},
"0001522767": {
"rank": 11,
"ecr": "213"
},
"0000794172": {
"rank": 12,
"ecr": "209"
},
"0000037785": {
"rank": 13,
"ecr": "204"
},
"0000073290": {
"rank": 14,
"ecr": "198"
},
"0000811641": {
"rank": 15,
"ecr": "185"
},
"0000768408": {
"rank": 16,
"ecr": "185"
},
"0001028215": {
"rank": 17,
"ecr": "171"
},
"0001606645": {
"rank": 18,
"ecr": "161"
},
"0000949858": {
"rank": 19,
"ecr": "154"
},
"0001374328": {
"rank": 20,
"ecr": "152"
},
"0001708035": {
"rank": 21,
"ecr": "143"
},
"0001307954": {
"rank": 22,
"ecr": "141"
},
"0001644440": {
"rank": 23,
"ecr": "141"
},
"0001142790": {
"rank": 24,
"ecr": "139"
},
"0001056358": {
"rank": 25,
"ecr": "139"
},
"0001653477": {
"rank": 26,
"ecr": "135"
},
"0000074303": {
"rank": 27,
"ecr": "132"
},
"0001586554": {
"rank": 28,
"ecr": "132"
},
"0001697834": {
"rank": 29,
"ecr": "125"
},
"0001709542": {
"rank": 30,
"ecr": "121"
},
"0001731348": {
"rank": 31,
"ecr": "119"
},
"0001627223": {
"rank": 32,
"ecr": "117"
},
"0000874716": {
"rank": 33,
"ecr": "107"
},
"0000744218": {
"rank": 34,
"ecr": "104"
},
"0001045309": {
"rank": 35,
"ecr": "103"
},
"0000907654": {
"rank": 36,
"ecr": "93"
},
"0000093314": {
"rank": 37,
"ecr": "84"
},
"0000926617": {
"rank": 38,
"ecr": "84"
},
"0001321834": {
"rank": 39,
"ecr": "83"
},
"0001590695": {
"rank": 40,
"ecr": "72"
},
"0001632275": {
"rank": 41,
"ecr": "33"
},
"0000810509": {
"rank": 42,
"ecr": "29"
},
"0001134765": {
"rank": 43,
"ecr": "18"
},
"0001086303": {
"rank": 44,
"ecr": "8.3"
},
"0001078799": {
"rank": 45,
"ecr": "1.1"
},
"0001498380": {
"rank": 46,
"ecr": "0.97"
}
},
"2019": {
"0000711377": {
"rank": 1,
"ecr": "269"
},
"0000885462": {
"rank": 2,
"ecr": "252"
},
"0001141240": {
"rank": 3,
"ecr": "247"
},
"0000787253": {
"rank": 4,
"ecr": "243"
},
"0001054905": {
"rank": 5,
"ecr": "230"
},
"0000896264": {
"rank": 6,
"ecr": "228"
},
"0001652130": {
"rank": 7,
"ecr": "213"
},
"0000037785": {
"rank": 8,
"ecr": "209"
},
"0000811641": {
"rank": 9,
"ecr": "207"
},
"0001374328": {
"rank": 10,
"ecr": "205"
},
"0000899923": {
"rank": 11,
"ecr": "199"
},
"0001321834": {
"rank": 12,
"ecr": "196"
},
"0000009326": {
"rank": 13,
"ecr": "195"
},
"0001742924": {
"rank": 14,
"ecr": "192"
},
"0001038133": {
"rank": 15,
"ecr": "185"
},
"0000794172": {
"rank": 16,
"ecr": "184"
},
"0001351573": {
"rank": 17,
"ecr": "183"
},
"0000907654": {
"rank": 18,
"ecr": "171"
},
"0000744218": {
"rank": 19,
"ecr": "170"
},
"0000073290": {
"rank": 20,
"ecr": "163"
},
"0001056358": {
"rank": 21,
"ecr": "155"
},
"0001642380": {
"rank": 22,
"ecr": "154"
},
"0001644440": {
"rank": 23,
"ecr": "151"
},
"0000768408": {
"rank": 24,
"ecr": "150"
},
"0001708035": {
"rank": 25,
"ecr": "149"
},
"0000949858": {
"rank": 26,
"ecr": "145"
},
"0001307954": {
"rank": 27,
"ecr": "141"
},
"0001653477": {
"rank": 28,
"ecr": "129"
},
"0000074303": {
"rank": 29,
"ecr": "122"
},
"0000874716": {
"rank": 30,
"ecr": "120"
},
"0001731348": {
"rank": 31,
"ecr": "117"
},
"0001586554": {
"rank": 32,
"ecr": "109"
},
"0001045309": {
"rank": 33,
"ecr": "102"
},
"0001697834": {
"rank": 34,
"ecr": "101"
},
"0001627223": {
"rank": 35,
"ecr": "99"
},
"0000722830": {
"rank": 36,
"ecr": "86"
},
"0001632275": {
"rank": 37,
"ecr": "84"
},
"0001386570": {
"rank": 38,
"ecr": "84"
},
"0000926617": {
"rank": 39,
"ecr": "82"
},
"0001134765": {
"rank": 40,
"ecr": "79"
},
"0001552189": {
"rank": 41,
"ecr": "77"
},
"0001606645": {
"rank": 42,
"ecr": "68"
},
"0001522767": {
"rank": 43,
"ecr": "60"
},
"0001590695": {
"rank": 44,
"ecr": "28"
},
"0001510518": {
"rank": 45,
"ecr": "19"
},
"0000810509": {
"rank": 46,
"ecr": "18"
},
"0001310630": {
"rank": 47,
"ecr": "10"
},
"0001709542": {
"rank": 48,
"ecr": "9.6"
},
"0001691430": {
"rank": 49,
"ecr": "0.53"
},
"0001078799": {
"rank": 50,
"ecr": "0.13"
}
},
"2020": {
"0000885462": {
"rank": 1,
"ecr": "267"
},
"0001141240": {
"rank": 2,
"ecr": "265"
},
"0000711377": {
"rank": 3,
"ecr": "265"
},
"0001374328": {
"rank": 4,
"ecr": "259"
},
"0001656472": {
"rank": 5,
"ecr": "243"
},
"0000907654": {
"rank": 6,
"ecr": "234"
},
"0001054905": {
"rank": 7,
"ecr": "231"
},
"0001652130": {
"rank": 8,
"ecr": "228"
},
"0000073290": {
"rank": 9,
"ecr": "214"
},
"0000949858": {
"rank": 10,
"ecr": "213"
},
"0000037785": {
"rank": 11,
"ecr": "211"
},
"0000009326": {
"rank": 12,
"ecr": "210"
},
"0001321834": {
"rank": 13,
"ecr": "203"
},
"0001038133": {
"rank": 14,
"ecr": "202"
},
"0000744218": {
"rank": 15,
"ecr": "202"
},
"0001731348": {
"rank": 16,
"ecr": "201"
},
"0000811641": {
"rank": 17,
"ecr": "197"
},
"0000794172": {
"rank": 18,
"ecr": "193"
},
"0001737927": {
"rank": 19,
"ecr": "193"
},
"0001742924": {
"rank": 20,
"ecr": "179"
},
"0000787253": {
"rank": 21,
"ecr": "177"
},
"0000768408": {
"rank": 22,
"ecr": "163"
},
"0001644440": {
"rank": 23,
"ecr": "162"
},
"0001307954": {
"rank": 24,
"ecr": "160"
},
"0001056358": {
"rank": 25,
"ecr": "154"
},
"0001697834": {
"rank": 26,
"ecr": "153"
},
"0000874716": {
"rank": 27,
"ecr": "148"
},
"0001310630": {
"rank": 28,
"ecr": "141"
},
"0001708035": {
"rank": 29,
"ecr": "136"
},
"0001653477": {
"rank": 30,
"ecr": "132"
},
"0001522767": {
"rank": 31,
"ecr": "132"
},
"0001627223": {
"rank": 32,
"ecr": "104"
},
"0000074303": {
"rank": 33,
"ecr": "98"
},
"0000093314": {
"rank": 34,
"ecr": "95"
},
"0001386570": {
"rank": 35,
"ecr": "93"
},
"0001045309": {
"rank": 36,
"ecr": "93"
},
"0001351573": {
"rank": 37,
"ecr": "84"
},
"0000926617": {
"rank": 38,
"ecr": "83"
},
"0001596946": {
"rank": 39,
"ecr": "80"
},
"0001421819": {
"rank": 40,
"ecr": "74"
},
"0001586554": {
"rank": 41,
"ecr": "73"
},
"0000810509": {
"rank": 42,
"ecr": "62"
},
"0001632275": {
"rank": 43,
"ecr": "50"
},
"0001134765": {
"rank": 44,
"ecr": "47"
},
"0001590695": {
"rank": 45,
"ecr": "41"
},
"0001746563": {
"rank": 46,
"ecr": "2.4"
},
"0001078799": {
"rank": 47,
"ecr": "2.2"
},
"0001691430": {
"rank": 48,
"ecr": "0.056"
},
"0001709542": {
"rank": 49,
"ecr": "0.0000000085"
}
},
"2021": {
"0000711377": {
"rank": 1,
"ecr": "266"
},
"0000885462": {
"rank": 2,
"ecr": "262"
},
"0001141240": {
"rank": 3,
"ecr": "260"
},
"0000744218": {
"rank": 4,
"ecr": "245"
},
"0001850902": {
"rank": 5,
"ecr": "232"
},
"0001656472": {
"rank": 6,
"ecr": "232"
},
"0001054905": {
"rank": 7,
"ecr": "226"
},
"0001652130": {
"rank": 8,
"ecr": "226"
},
"0000794172": {
"rank": 9,
"ecr": "223"
},
"0001775194": {
"rank": 10,
"ecr": "217"
},
"0000907654": {
"rank": 11,
"ecr": "216"
},
"0000009326": {
"rank": 12,
"ecr": "214"
},
"0000811641": {
"rank": 13,
"ecr": "207"
},
"0000899923": {
"rank": 14,
"ecr": "205"
},
"0001731348": {
"rank": 15,
"ecr": "204"
},
"0001038133": {
"rank": 16,
"ecr": "203"
},
"0000787253": {
"rank": 17,
"ecr": "202"
},
"0000037785": {
"rank": 18,
"ecr": "200"
},
"0001742924": {
"rank": 19,
"ecr": "192"
},
"0001813814": {
"rank": 20,
"ecr": "189"
},
"0001754195": {
"rank": 21,
"ecr": "186"
},
"0001134765": {
"rank": 22,
"ecr": "180"
},
"0000768408": {
"rank": 23,
"ecr": "174"
},
"0001307954": {
"rank": 24,
"ecr": "170"
},
"0001056358": {
"rank": 25,
"ecr": "159"
},
"0001644440": {
"rank": 26,
"ecr": "156"
},
"0000874716": {
"rank": 27,
"ecr": "154"
},
"0000073290": {
"rank": 28,
"ecr": "147"
},
"0000074303": {
"rank": 29,
"ecr": "146"
},
"0001737927": {
"rank": 30,
"ecr": "140"
},
"0001708035": {
"rank": 31,
"ecr": "135"
},
"0001653477": {
"rank": 32,
"ecr": "129"
},
"0001386570": {
"rank": 33,
"ecr": "121"
},
"0000926617": {
"rank": 34,
"ecr": "119"
},
"0001504678": {
"rank": 35,
"ecr": "115"
},
"0001627223": {
"rank": 36,
"ecr": "112"
},
"0001642380": {
"rank": 37,
"ecr": "104"
},
"0001321834": {
"rank": 38,
"ecr": "103"
},
"0001756390": {
"rank": 39,
"ecr": "103"
},
"0000949858": {
"rank": 40,
"ecr": "100"
},
"0000093314": {
"rank": 41,
"ecr": "84"
},
"0001586554": {
"rank": 42,
"ecr": "84"
},
"0001697834": {
"rank": 43,
"ecr": "81"
},
"0001596946": {
"rank": 44,
"ecr": "76"
},
"0001421819": {
"rank": 45,
"ecr": "72"
},
"0001138608": {
"rank": 46,
"ecr": "72"
},
"0001078799": {
"rank": 47,
"ecr": "59"
},
"0000810509": {
"rank": 48,
"ecr": "44"
},
"0001590695": {
"rank": 49,
"ecr": "32"
}
},
"2022": {
"0001141240": {
"rank": 1,
"ecr": "263"
},
"0000885462": {
"rank": 2,
"ecr": "261"
},
"0000711377": {
"rank": 3,
"ecr": "255"
},
"0001906324": {
"rank": 4,
"ecr": "255"
},
"0001374328": {
"rank": 5,
"ecr": "252"
},
"0001656472": {
"rank": 6,
"ecr": "244"
},
"0000907654": {
"rank": 7,
"ecr": "243"
},
"0000794172": {
"rank": 8,
"ecr": "231"
},
"0000896264": {
"rank": 9,
"ecr": "224"
},
"0000744218": {
"rank": 10,
"ecr": "219"
},
"0001652130": {
"rank": 11,
"ecr": "217"
},
"0001731348": {
"rank": 12,
"ecr": "216"
},
"0001742924": {
"rank": 13,
"ecr": "212"
},
"0001813814": {
"rank": 14,
"ecr": "207"
},
"0001038133": {
"rank": 15,
"ecr": "200"
},
"0000899923": {
"rank": 16,
"ecr": "198"
},
"0000037785": {
"rank": 17,
"ecr": "197"
},
"0001054905": {
"rank": 18,
"ecr": "194"
},
"0000811641": {
"rank": 19,
"ecr": "189"
},
"0000787253": {
"rank": 20,
"ecr": "189"
},
"0000768408": {
"rank": 21,
"ecr": "188"
},
"0001442999": {
"rank": 22,
"ecr": "186"
},
"0000009326": {
"rank": 23,
"ecr": "182"
},
"0001754195": {
"rank": 24,
"ecr": "166"
},
"0001775194": {
"rank": 25,
"ecr": "165"
},
"0000073290": {
"rank": 26,
"ecr": "164"
},
"0001307954": {
"rank": 27,
"ecr": "161"
},
"0001850902": {
"rank": 28,
"ecr": "159"
},
"0001880319": {
"rank": 29,
"ecr": "159"
},
"0000074303": {
"rank": 30,
"ecr": "147"
},
"0001708035": {
"rank": 31,
"ecr": "145"
},
"0001737927": {
"rank": 32,
"ecr": "144"
},
"0000874716": {
"rank": 33,
"ecr": "139"
},
"0001386570": {
"rank": 34,
"ecr": "136"
},
"0001321834": {
"rank": 35,
"ecr": "129"
},
"0001653477": {
"rank": 36,
"ecr": "128"
},
"0001056358": {
"rank": 37,
"ecr": "115"
},
"0001870144": {
"rank": 38,
"ecr": "113"
},
"0001627223": {
"rank": 39,
"ecr": "113"
},
"0001756390": {
"rank": 40,
"ecr": "102"
},
"0001134765": {
"rank": 41,
"ecr": "96"
},
"0001642380": {
"rank": 42,
"ecr": "84"
},
"0001909747": {
"rank": 43,
"ecr": "83"
},
"0000880242": {
"rank": 44,
"ecr": "79"
},
"0001819253": {
"rank": 45,
"ecr": "79"
},
"0001138608": {
"rank": 46,
"ecr": "78"
},
"0001552189": {
"rank": 47,
"ecr": "78"
},
"0001886799": {
"rank": 48,
"ecr": "76"
},
"0000949858": {
"rank": 49,
"ecr": "61"
},
"0001586554": {
"rank": 50,
"ecr": "60"
},
"0000926617": {
"rank": 51,
"ecr": "59"
},
"0001902700": {
"rank": 52,
"ecr": "55"
},
"0000093314": {
"rank": 53,
"ecr": "43"
},
"0001590695": {
"rank": 54,
"ecr": "30"
},
"0000810509": {
"rank": 55,
"ecr": "9.7"
}
},
"2023": {
"0001656472": {
"rank": 1,
"ecr": "266"
},
"0001141240": {
"rank": 2,
"ecr": "265"
},
"0000896264": {
"rank": 3,
"ecr": "238"
},
"0001086303": {
"rank": 4,
"ecr": "225"
},
"0000744218": {
"rank": 5,
"ecr": "220"
},
"0000885462": {
"rank": 6,
"ecr": "218"
},
"0000037785": {
"rank": 7,
"ecr": "215"
},
"0001442999": {
"rank": 8,
"ecr": "207"
},
"0000009326": {
"rank": 9,
"ecr": "199"
},
"0000787253": {
"rank": 10,
"ecr": "193"
},
"0001321834": {
"rank": 11,
"ecr": "180"
},
"0001731348": {
"rank": 12,
"ecr": "180"
},
"0000874716": {
"rank": 13,
"ecr": "178"
},
"0001906324": {
"rank": 14,
"ecr": "177"
},
"0000899923": {
"rank": 15,
"ecr": "173"
},
"0000073290": {
"rank": 16,
"ecr": "170"
},
"0001374328": {
"rank": 17,
"ecr": "168"
},
"0001504678": {
"rank": 18,
"ecr": "167"
},
"0001880319": {
"rank": 19,
"ecr": "164"
},
"0000811641": {
"rank": 20,
"ecr": "161"
},
"0001307954": {
"rank": 21,
"ecr": "160"
},
"0000768408": {
"rank": 22,
"ecr": "159"
},
"0001386570": {
"rank": 23,
"ecr": "156"
},
"0001522767": {
"rank": 24,
"ecr": "146"
},
"0001708035": {
"rank": 25,
"ecr": "146"
},
"0001754195": {
"rank": 26,
"ecr": "145"
},
"0000074303": {
"rank": 27,
"ecr": "133"
},
"0001653477": {
"rank": 28,
"ecr": "120"
},
"0001775194": {
"rank": 29,
"ecr": "119"
},
"0001056358": {
"rank": 30,
"ecr": "115"
},
"0000880242": {
"rank": 31,
"ecr": "110"
},
"0001756390": {
"rank": 32,
"ecr": "101"
},
"0001886799": {
"rank": 33,
"ecr": "100"
},
"0001642380": {
"rank": 34,
"ecr": "96"
},
"0001909747": {
"rank": 35,
"ecr": "84"
},
"0001134765": {
"rank": 36,
"ecr": "82"
},
"0001586554": {
"rank": 37,
"ecr": "73"
},
"0001673431": {
"rank": 38,
"ecr": "72"
},
"0001552189": {
"rank": 39,
"ecr": "71"
},
"0001902700": {
"rank": 40,
"ecr": "55"
},
"0001870144": {
"rank": 41,
"ecr": "53"
},
"0000093314": {
"rank": 42,
"ecr": "52"
},
"0001697834": {
"rank": 43,
"ecr": "52"
},
"0001310630": {
"rank": 44,
"ecr": "45"
},
"0001590695": {
"rank": 45,
"ecr": "19"
},
"0000926617": {
"rank": 46,
"ecr": "17"
}
}
},
"rating_box": [
[
"Top rated",
"11 of 46"
],
[
"Best, worst rating",
"266 %, 17.2 %"
],
[
"New companies",
"6"
]
],
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2023/backtesting_correlation/regression_2023.svg",
"scentences": [
"Q C Technologies INC climbed 24 positions from 35 to 11 due to its excellent Assets, Non-Current.",
"Fitlife Brands INC lost 12 positions from 5 to 17 due to its bad General and Administrative Expense.",
"Hongchang International Co Ltd entered the 2024 ranking at rank 4, making it the best newcomer."
],
"url_segment": "2024-us-medicinal-products",
"year": 2024,
"feature_importance": "https://www.realrate-archive.com/us_medicinal_products/2023/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000037785": {
"2011": {
"obs_EconomicCapitalRatio": 1.9637052598410045
},
"2012": {
"obs_EconomicCapitalRatio": 2.2187352745223867
},
"2013": {
"obs_EconomicCapitalRatio": 2.0998789372222704
},
"2014": {
"obs_EconomicCapitalRatio": 1.641537801830664
},
"2015": {
"obs_EconomicCapitalRatio": 1.0723385245823782
},
"2016": {
"obs_EconomicCapitalRatio": 1.6108835909734713
},
"2017": {
"obs_EconomicCapitalRatio": 1.8056499758638158
},
"2018": {
"obs_EconomicCapitalRatio": 1.2287717494570867
},
"2019": {
"obs_EconomicCapitalRatio": 1.7092843014022376
},
"2020": {
"obs_EconomicCapitalRatio": 1.9284688934634902
},
"2021": {
"obs_EconomicCapitalRatio": 1.6770740146552199
},
"2022": {
"obs_EconomicCapitalRatio": 1.834863173719622
},
"2023": {
"obs_EconomicCapitalRatio": 0.9158901623685305
}
},
"0001056358": {
"2011": {
"obs_EconomicCapitalRatio": 0.18783097649548078
},
"2012": {
"obs_EconomicCapitalRatio": 0.3196597323000155
},
"2013": {
"obs_EconomicCapitalRatio": 0.7370346023559032
},
"2014": {
"obs_EconomicCapitalRatio": 1.0406162753683343
},
"2015": {
"obs_EconomicCapitalRatio": 0.7323625964348088
},
"2016": {
"obs_EconomicCapitalRatio": 0.753066668490597
},
"2017": {
"obs_EconomicCapitalRatio": 0.5232637759318683
},
"2018": {
"obs_EconomicCapitalRatio": 0.7338326629079127
},
"2019": {
"obs_EconomicCapitalRatio": 0.6223996309643847
},
"2020": {
"obs_EconomicCapitalRatio": 0.6307022721006672
},
"2021": {
"obs_EconomicCapitalRatio": 1.4634619355072704
},
"2022": {
"obs_EconomicCapitalRatio": 0.820186420650827
},
"2023": {
"obs_EconomicCapitalRatio": 0.42412588511273297
},
"2024": {
"obs_EconomicCapitalRatio": 0.6963642400059836
},
"2025": {
"obs_EconomicCapitalRatio": 0.47545840734858463
}
},
"0000074303": {
"2011": {
"obs_EconomicCapitalRatio": 0.5221628155371295
},
"2012": {
"obs_EconomicCapitalRatio": 0.5016941351915414
},
"2013": {
"obs_EconomicCapitalRatio": 0.7067485666124749
},
"2014": {
"obs_EconomicCapitalRatio": 0.5800072775923082
},
"2015": {
"obs_EconomicCapitalRatio": 0.26932516949788865
},
"2016": {
"obs_EconomicCapitalRatio": 0.4320388824657905
},
"2017": {
"obs_EconomicCapitalRatio": 0.5856850809511247
},
"2018": {
"obs_EconomicCapitalRatio": 0.3494568183316394
},
"2019": {
"obs_EconomicCapitalRatio": 0.2952768225185927
},
"2020": {
"obs_EconomicCapitalRatio": 0.48260038439530095
},
"2021": {
"obs_EconomicCapitalRatio": 1.1559183950584917
},
"2022": {
"obs_EconomicCapitalRatio": 0.9955682298738215
},
"2023": {
"obs_EconomicCapitalRatio": 0.939616887252673
},
"2024": {
"obs_EconomicCapitalRatio": 0.5703504787209263
},
"2025": {
"obs_EconomicCapitalRatio": 0.3659536949506686
}
},
"0001307954": {
"2011": {
"obs_EconomicCapitalRatio": 0.18938003655153654
},
"2012": {
"obs_EconomicCapitalRatio": 0.3154058367754545
},
"2013": {
"obs_EconomicCapitalRatio": 0.4780017903384275
},
"2014": {
"obs_EconomicCapitalRatio": 0.384792729924332
},
"2018": {
"obs_EconomicCapitalRatio": 0.5095392164405845
},
"2019": {
"obs_EconomicCapitalRatio": 0.6235372978487372
},
"2020": {
"obs_EconomicCapitalRatio": 0.6619386066086855
},
"2021": {
"obs_EconomicCapitalRatio": 0.8463350886179348
},
"2022": {
"obs_EconomicCapitalRatio": 0.7115101902118032
},
"2023": {
"obs_EconomicCapitalRatio": 0.7137373813546445
},
"2024": {
"obs_EconomicCapitalRatio": 0.5244746605193847
},
"2025": {
"obs_EconomicCapitalRatio": 0.3141640811372542
}
},
"0000874716": {
"2011": {
"obs_EconomicCapitalRatio": 5.678189619495421
},
"2012": {
"obs_EconomicCapitalRatio": 6.62985272864075
},
"2013": {
"obs_EconomicCapitalRatio": 5.637583008591172
},
"2014": {
"obs_EconomicCapitalRatio": 5.3378472038789315
},
"2015": {
"obs_EconomicCapitalRatio": 4.359021798706142
},
"2016": {
"obs_EconomicCapitalRatio": 6.735635676724686
},
"2017": {
"obs_EconomicCapitalRatio": 7.882744231502931
},
"2018": {
"obs_EconomicCapitalRatio": 10.363928250251758
},
"2019": {
"obs_EconomicCapitalRatio": 12.865202087427075
},
"2020": {
"obs_EconomicCapitalRatio": 21.31825222425334
},
"2021": {
"obs_EconomicCapitalRatio": 26.268423294328166
},
"2022": {
"obs_EconomicCapitalRatio": 13.828898358817076
},
"2023": {
"obs_EconomicCapitalRatio": 18.252894151087883
},
"2024": {
"obs_EconomicCapitalRatio": 13.560026821642062
},
"2025": {
"obs_EconomicCapitalRatio": 21.570882602865723
}
},
"0000899923": {
"2011": {
"obs_EconomicCapitalRatio": 5.286603114326388
},
"2012": {
"obs_EconomicCapitalRatio": 5.947932077650038
},
"2013": {
"obs_EconomicCapitalRatio": 4.09378437010731
},
"2014": {
"obs_EconomicCapitalRatio": 5.490507086553531
},
"2015": {
"obs_EconomicCapitalRatio": 6.944372988710795
},
"2016": {
"obs_EconomicCapitalRatio": 2.339757271124506
},
"2017": {
"obs_EconomicCapitalRatio": 2.8740508316547966
},
"2018": {
"obs_EconomicCapitalRatio": 3.0914586906825567
},
"2019": {
"obs_EconomicCapitalRatio": 1.9630081673133826
},
"2021": {
"obs_EconomicCapitalRatio": 2.606632146369483
},
"2022": {
"obs_EconomicCapitalRatio": 1.7004450020894173
},
"2023": {
"obs_EconomicCapitalRatio": 2.215290054291016
},
"2024": {
"obs_EconomicCapitalRatio": 1.823931615329854
},
"2025": {
"obs_EconomicCapitalRatio": 1.1682929523136367
}
},
"0000885462": {
"2011": {
"obs_EconomicCapitalRatio": 0.477594589877508
},
"2012": {
"obs_EconomicCapitalRatio": 0.2925556156090612
},
"2013": {
"obs_EconomicCapitalRatio": 0.5361327962905387
},
"2014": {
"obs_EconomicCapitalRatio": 0.2505281175819798
},
"2015": {
"obs_EconomicCapitalRatio": 0.43387267254203915
},
"2016": {
"obs_EconomicCapitalRatio": 0.5022902813318385
},
"2017": {
"obs_EconomicCapitalRatio": 0.34065719753844165
},
"2018": {
"obs_EconomicCapitalRatio": 0.22997496410238202
},
"2019": {
"obs_EconomicCapitalRatio": 0.1659154208060553
},
"2020": {
"obs_EconomicCapitalRatio": 0.26901950354979465
},
"2021": {
"obs_EconomicCapitalRatio": 0.2838385361778253
},
"2022": {
"obs_EconomicCapitalRatio": 0.2067987843408893
},
"2023": {
"obs_EconomicCapitalRatio": 0.11983703427943283
},
"2024": {
"obs_EconomicCapitalRatio": 0.06649192725741328
}
},
"0001054905": {
"2011": {
"obs_EconomicCapitalRatio": 1.4579074706215878
},
"2012": {
"obs_EconomicCapitalRatio": 1.7997149963883579
},
"2013": {
"obs_EconomicCapitalRatio": 1.964317914289097
},
"2014": {
"obs_EconomicCapitalRatio": 1.4734327096252018
},
"2015": {
"obs_EconomicCapitalRatio": 1.8591617658964918
},
"2016": {
"obs_EconomicCapitalRatio": 2.185789648905985
},
"2017": {
"obs_EconomicCapitalRatio": 1.7880006703658458
},
"2018": {
"obs_EconomicCapitalRatio": 1.5318875768219857
},
"2019": {
"obs_EconomicCapitalRatio": 2.6164701172132556
},
"2020": {
"obs_EconomicCapitalRatio": 2.4715120247319406
},
"2021": {
"obs_EconomicCapitalRatio": 2.201354917056966
},
"2022": {
"obs_EconomicCapitalRatio": 2.262740511238834
}
},
"0001141240": {
"2011": {
"obs_EconomicCapitalRatio": 5.502360615827963
},
"2012": {
"obs_EconomicCapitalRatio": 2.4369547526522646
},
"2013": {
"obs_EconomicCapitalRatio": 11.581935819020808
},
"2014": {
"obs_EconomicCapitalRatio": 7.5454875670319685
},
"2015": {
"obs_EconomicCapitalRatio": 5.634514556207966
},
"2016": {
"obs_EconomicCapitalRatio": 5.458003060729301
},
"2017": {
"obs_EconomicCapitalRatio": 6.7960569922086025
},
"2018": {
"obs_EconomicCapitalRatio": 4.351678898468258
},
"2019": {
"obs_EconomicCapitalRatio": 4.24355658618375
},
"2020": {
"obs_EconomicCapitalRatio": 3.6370684560423614
},
"2021": {
"obs_EconomicCapitalRatio": 4.458556769073509
},
"2022": {
"obs_EconomicCapitalRatio": 3.1784879275692157
},
"2023": {
"obs_EconomicCapitalRatio": 3.3273144132655075
},
"2024": {
"obs_EconomicCapitalRatio": 2.3178398698599603
},
"2025": {
"obs_EconomicCapitalRatio": 5.890984282760348
}
},
"0000768408": {
"2011": {
"obs_EconomicCapitalRatio": 5.715133312847765
},
"2012": {
"obs_EconomicCapitalRatio": 2.3017018284798714
},
"2013": {
"obs_EconomicCapitalRatio": 1.425277475641039
},
"2014": {
"obs_EconomicCapitalRatio": 1.8803973873475237
},
"2015": {
"obs_EconomicCapitalRatio": 1.4412650279511978
},
"2016": {
"obs_EconomicCapitalRatio": 1.0071551396713583
},
"2017": {
"obs_EconomicCapitalRatio": 1.1153169457297638
},
"2018": {
"obs_EconomicCapitalRatio": 0.924011890899123
},
"2019": {
"obs_EconomicCapitalRatio": 0.6138635192851674
},
"2020": {
"obs_EconomicCapitalRatio": 0.7664774974857526
},
"2021": {
"obs_EconomicCapitalRatio": 0.871286208388657
},
"2022": {
"obs_EconomicCapitalRatio": 0.27420450138403873
},
"2023": {
"obs_EconomicCapitalRatio": 0.26934082796065434
},
"2024": {
"obs_EconomicCapitalRatio": 0.14158948221183076
}
},
"0000787253": {
"2011": {
"obs_EconomicCapitalRatio": 2.526353775920534
},
"2012": {
"obs_EconomicCapitalRatio": 1.3160543270878733
},
"2014": {
"obs_EconomicCapitalRatio": 1.1960142220158665
},
"2015": {
"obs_EconomicCapitalRatio": 2.1497060764213507
},
"2016": {
"obs_EconomicCapitalRatio": 1.6596075035664513
},
"2017": {
"obs_EconomicCapitalRatio": 1.820275172276164
},
"2018": {
"obs_EconomicCapitalRatio": 1.4250126839098163
},
"2019": {
"obs_EconomicCapitalRatio": 0.8714870157425864
},
"2020": {
"obs_EconomicCapitalRatio": 0.8186963761612863
},
"2021": {
"obs_EconomicCapitalRatio": 0.9963355986876283
},
"2022": {
"obs_EconomicCapitalRatio": 0.4935946735445941
},
"2023": {
"obs_EconomicCapitalRatio": 0.4463203114259345
},
"2024": {
"obs_EconomicCapitalRatio": 0.21764563032603712
}
},
"0000896264": {
"2011": {
"obs_EconomicCapitalRatio": 2.987080353491173
},
"2012": {
"obs_EconomicCapitalRatio": 2.8476111068826424
},
"2013": {
"obs_EconomicCapitalRatio": 4.5724271596679005
},
"2015": {
"obs_EconomicCapitalRatio": 7.320772852461824
},
"2016": {
"obs_EconomicCapitalRatio": 2.5202405198959905
},
"2017": {
"obs_EconomicCapitalRatio": 5.400078197143357
},
"2018": {
"obs_EconomicCapitalRatio": 7.8437625855710635
},
"2019": {
"obs_EconomicCapitalRatio": 5.208661448534275
},
"2022": {
"obs_EconomicCapitalRatio": 2.794889038132937
},
"2023": {
"obs_EconomicCapitalRatio": 2.6884992698433976
},
"2024": {
"obs_EconomicCapitalRatio": 1.4865583930571376
}
},
"0001086303": {
"2012": {
"obs_EconomicCapitalRatio": 0.050408616621473605
},
"2013": {
"obs_EconomicCapitalRatio": 0.3592188918384183
},
"2014": {
"obs_EconomicCapitalRatio": 0.5202291430401021
},
"2018": {
"obs_EconomicCapitalRatio": 75.60385532024324
},
"2023": {
"obs_EconomicCapitalRatio": 5.825073650532234
}
},
"0001134765": {
"2013": {
"obs_EconomicCapitalRatio": 84.83868255676903
},
"2014": {
"obs_EconomicCapitalRatio": 93.1111485713505
},
"2015": {
"obs_EconomicCapitalRatio": 199.2672351710133
},
"2016": {
"obs_EconomicCapitalRatio": 216.93321071912177
},
"2017": {
"obs_EconomicCapitalRatio": 60.02178473917171
},
"2018": {
"obs_EconomicCapitalRatio": 12.822507944414118
},
"2019": {
"obs_EconomicCapitalRatio": 455.3649181791688
},
"2020": {
"obs_EconomicCapitalRatio": 668.0565240083155
},
"2021": {
"obs_EconomicCapitalRatio": 3.604592501252785
},
"2022": {
"obs_EconomicCapitalRatio": 3.9983823737615998
},
"2023": {
"obs_EconomicCapitalRatio": 4.432317616137024
},
"2024": {
"obs_EconomicCapitalRatio": 2.934393508015559
},
"2025": {
"obs_EconomicCapitalRatio": 7.17941906968866
}
},
"0001310630": {
"2011": {
"obs_EconomicCapitalRatio": 118.5920894437218
},
"2012": {
"obs_EconomicCapitalRatio": 90.47339849409984
},
"2013": {
"obs_EconomicCapitalRatio": 72.75975087344283
},
"2014": {
"obs_EconomicCapitalRatio": 60.05301282758653
},
"2015": {
"obs_EconomicCapitalRatio": 46.147679617159916
},
"2016": {
"obs_EconomicCapitalRatio": 37.04924725418156
},
"2017": {
"obs_EconomicCapitalRatio": 30.944660874575487
},
"2019": {
"obs_EconomicCapitalRatio": 85.1712892994052
},
"2020": {
"obs_EconomicCapitalRatio": 24.70852870017063
},
"2023": {
"obs_EconomicCapitalRatio": 90.31718007058653
},
"2024": {
"obs_EconomicCapitalRatio": 18.12427183566627
},
"2025": {
"obs_EconomicCapitalRatio": 15.788052734849284
}
},
"0001374328": {
"2011": {
"obs_EconomicCapitalRatio": 1.843040104492836
},
"2012": {
"obs_EconomicCapitalRatio": 1.406513180725925
},
"2013": {
"obs_EconomicCapitalRatio": 2.5629155706742086
},
"2014": {
"obs_EconomicCapitalRatio": 3.2200542353297674
},
"2015": {
"obs_EconomicCapitalRatio": 1.2965403490667224
},
"2016": {
"obs_EconomicCapitalRatio": 0.9353195843240845
},
"2017": {
"obs_EconomicCapitalRatio": 0.4394415225694401
},
"2018": {
"obs_EconomicCapitalRatio": 0.9423630321081906
},
"2019": {
"obs_EconomicCapitalRatio": 2.6565609559613317
},
"2020": {
"obs_EconomicCapitalRatio": 9.948498907383927
},
"2022": {
"obs_EconomicCapitalRatio": 4.994024545393992
},
"2023": {
"obs_EconomicCapitalRatio": 2.2965761578523303
},
"2024": {
"obs_EconomicCapitalRatio": 3.6843422189586965
},
"2025": {
"obs_EconomicCapitalRatio": 1.821523711080343
}
},
"0001386570": {
"2011": {
"obs_EconomicCapitalRatio": 8.338141326290996
},
"2012": {
"obs_EconomicCapitalRatio": 8.392729648541112
},
"2013": {
"obs_EconomicCapitalRatio": 26.219216155099797
},
"2019": {
"obs_EconomicCapitalRatio": 8.591985092140105
},
"2020": {
"obs_EconomicCapitalRatio": 10.063615397839953
},
"2021": {
"obs_EconomicCapitalRatio": 6.442513704241379
},
"2022": {
"obs_EconomicCapitalRatio": 2.8215640716473835
},
"2023": {
"obs_EconomicCapitalRatio": 2.6556157143776864
},
"2024": {
"obs_EconomicCapitalRatio": 9.237391489557004
},
"2025": {
"obs_EconomicCapitalRatio": 7.630478708487693
}
},
"0000711377": {
"2011": {
"obs_EconomicCapitalRatio": 5.820904874555574
},
"2012": {
"obs_EconomicCapitalRatio": 7.7503288458074415
},
"2013": {
"obs_EconomicCapitalRatio": 10.377788751403328
},
"2014": {
"obs_EconomicCapitalRatio": 9.392743252183534
},
"2015": {
"obs_EconomicCapitalRatio": 10.034849829461312
},
"2016": {
"obs_EconomicCapitalRatio": 10.103194801881472
},
"2017": {
"obs_EconomicCapitalRatio": 14.452119850474038
},
"2018": {
"obs_EconomicCapitalRatio": 8.566992718065048
},
"2019": {
"obs_EconomicCapitalRatio": 9.17563055998759
},
"2020": {
"obs_EconomicCapitalRatio": 9.88631712937769
},
"2021": {
"obs_EconomicCapitalRatio": 9.735723882656965
},
"2022": {
"obs_EconomicCapitalRatio": 5.856026588966056
}
},
"0000744218": {
"2011": {
"obs_EconomicCapitalRatio": 1.8965131603685095
},
"2012": {
"obs_EconomicCapitalRatio": 5.333855573956268
},
"2013": {
"obs_EconomicCapitalRatio": 10.230725112264693
},
"2014": {
"obs_EconomicCapitalRatio": 11.553522232787866
},
"2015": {
"obs_EconomicCapitalRatio": 8.22074780222265
},
"2016": {
"obs_EconomicCapitalRatio": 1.4980547705405713
},
"2017": {
"obs_EconomicCapitalRatio": 2.021188969442516
},
"2018": {
"obs_EconomicCapitalRatio": 0.3696518300152486
},
"2019": {
"obs_EconomicCapitalRatio": 0.48016381910130834
},
"2020": {
"obs_EconomicCapitalRatio": 5.262656817463394
},
"2021": {
"obs_EconomicCapitalRatio": 7.793666490988671
},
"2022": {
"obs_EconomicCapitalRatio": 10.883731101898258
},
"2023": {
"obs_EconomicCapitalRatio": 7.286143405813059
}
},
"0000811641": {
"2011": {
"obs_EconomicCapitalRatio": 2.136690390726703
},
"2012": {
"obs_EconomicCapitalRatio": 1.849039798017059
},
"2013": {
"obs_EconomicCapitalRatio": 2.010189247495304
},
"2014": {
"obs_EconomicCapitalRatio": 2.34474040567545
},
"2015": {
"obs_EconomicCapitalRatio": 2.4785461696903734
},
"2016": {
"obs_EconomicCapitalRatio": 1.9865134449583703
},
"2017": {
"obs_EconomicCapitalRatio": 1.6949100276813254
},
"2018": {
"obs_EconomicCapitalRatio": 1.7852801061870174
},
"2019": {
"obs_EconomicCapitalRatio": 1.5240857269328754
},
"2020": {
"obs_EconomicCapitalRatio": 1.7195565413895542
},
"2021": {
"obs_EconomicCapitalRatio": 2.367024189117178
},
"2022": {
"obs_EconomicCapitalRatio": 1.6292353884860042
},
"2023": {
"obs_EconomicCapitalRatio": 1.1622002191801761
},
"2025": {
"obs_EconomicCapitalRatio": 1.9024392280197613
}
},
"0000907654": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 2.2151696375266194
},
"2014": {
"obs_EconomicCapitalRatio": 1.8158262418443614
},
"2015": {
"obs_EconomicCapitalRatio": 1.28497308211443
},
"2016": {
"obs_EconomicCapitalRatio": 1.0818389503384735
},
"2017": {
"obs_EconomicCapitalRatio": 1.3032495591532267
},
"2018": {
"obs_EconomicCapitalRatio": 0.6794655548784231
},
"2019": {
"obs_EconomicCapitalRatio": 1.027889384231902
},
"2020": {
"obs_EconomicCapitalRatio": 0.7572061787169263
},
"2021": {
"obs_EconomicCapitalRatio": 0.6116995115921646
},
"2022": {
"obs_EconomicCapitalRatio": 0.8326777832489594
}
},
"0000926617": {
"2011": {
"obs_EconomicCapitalRatio": 0.936747166508658
},
"2012": {
"obs_EconomicCapitalRatio": 3.2987773210340476
},
"2013": {
"obs_EconomicCapitalRatio": 3.310250104657181
},
"2014": {
"obs_EconomicCapitalRatio": 4.317801092124128
},
"2015": {
"obs_EconomicCapitalRatio": 7.655824111431128
},
"2016": {
"obs_EconomicCapitalRatio": 8.900428301796273
},
"2017": {
"obs_EconomicCapitalRatio": 20.503758003717643
},
"2018": {
"obs_EconomicCapitalRatio": 3.2888488055796508
},
"2019": {
"obs_EconomicCapitalRatio": 8.83333842031845
},
"2020": {
"obs_EconomicCapitalRatio": 45.47327065656971
},
"2021": {
"obs_EconomicCapitalRatio": 7.933579854593867
},
"2022": {
"obs_EconomicCapitalRatio": 2.857163597552752
},
"2023": {
"obs_EconomicCapitalRatio": 3.901740100848714
},
"2024": {
"obs_EconomicCapitalRatio": 1.8703748454852225
}
},
"0000949858": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 2.518997627887442
},
"2018": {
"obs_EconomicCapitalRatio": 0.7422482465262066
},
"2019": {
"obs_EconomicCapitalRatio": 0.35343147435010663
},
"2020": {
"obs_EconomicCapitalRatio": 1.3239430629183255
},
"2021": {
"obs_EconomicCapitalRatio": 2.1718168400927897
},
"2022": {
"obs_EconomicCapitalRatio": 0.9346116862802668
}
},
"0000009326": {
"2012": {
"obs_EconomicCapitalRatio": 5.656587982913678
},
"2013": {
"obs_EconomicCapitalRatio": 7.79966708407013
},
"2014": {
"obs_EconomicCapitalRatio": 2.9084764827636236
},
"2015": {
"obs_EconomicCapitalRatio": 2.8483648673741246
},
"2016": {
"obs_EconomicCapitalRatio": 3.648755401436501
},
"2017": {
"obs_EconomicCapitalRatio": 3.787889348418163
},
"2019": {
"obs_EconomicCapitalRatio": 4.035821822778718
},
"2020": {
"obs_EconomicCapitalRatio": 4.735832660774467
},
"2021": {
"obs_EconomicCapitalRatio": 6.878840843345401
},
"2022": {
"obs_EconomicCapitalRatio": 3.32579266803479
},
"2023": {
"obs_EconomicCapitalRatio": 4.327515096253764
},
"2024": {
"obs_EconomicCapitalRatio": 5.341740174720832
},
"2025": {
"obs_EconomicCapitalRatio": 4.797400698850301
}
},
"0000073290": {
"2012": {
"obs_EconomicCapitalRatio": 1.8838244732270972
},
"2013": {
"obs_EconomicCapitalRatio": 1.6432390281123206
},
"2014": {
"obs_EconomicCapitalRatio": 1.9239557658497293
},
"2015": {
"obs_EconomicCapitalRatio": 2.669474942212977
},
"2016": {
"obs_EconomicCapitalRatio": 5.686234008415378
},
"2017": {
"obs_EconomicCapitalRatio": 12.426535116483144
},
"2018": {
"obs_EconomicCapitalRatio": 6.023112230267755
},
"2019": {
"obs_EconomicCapitalRatio": 8.71810270966778
},
"2020": {
"obs_EconomicCapitalRatio": 5.758603861413226
},
"2021": {
"obs_EconomicCapitalRatio": 7.171288908839465
},
"2022": {
"obs_EconomicCapitalRatio": 6.5820905271862715
},
"2023": {
"obs_EconomicCapitalRatio": 2.3689702399551757
},
"2024": {
"obs_EconomicCapitalRatio": 0.8328246370864223
}
},
"0000093314": {
"2012": {
"obs_EconomicCapitalRatio": 17.719277991697727
},
"2013": {
"obs_EconomicCapitalRatio": 16.172791954794842
},
"2014": {
"obs_EconomicCapitalRatio": 17.12412941207431
},
"2015": {
"obs_EconomicCapitalRatio": 17.094853012648368
},
"2016": {
"obs_EconomicCapitalRatio": 7.646119704869701
},
"2017": {
"obs_EconomicCapitalRatio": 7.835630820870826
},
"2018": {
"obs_EconomicCapitalRatio": 5.69389490958303
},
"2020": {
"obs_EconomicCapitalRatio": 10.494231213006202
},
"2021": {
"obs_EconomicCapitalRatio": 9.325363829987609
},
"2022": {
"obs_EconomicCapitalRatio": 7.038632118707036
},
"2023": {
"obs_EconomicCapitalRatio": 1.692739776873626
},
"2024": {
"obs_EconomicCapitalRatio": 2.538095829463765
},
"2025": {
"obs_EconomicCapitalRatio": 1.267911014322384
}
},
"0001504678": {
"2021": {
"obs_EconomicCapitalRatio": 21.761860501462678
},
"2023": {
"obs_EconomicCapitalRatio": 7.712264043121101
},
"2024": {
"obs_EconomicCapitalRatio": 4.273885183694472
}
},
"0001321834": {
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2019": {
"obs_EconomicCapitalRatio": 0.0
},
"2020": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 0.0
},
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.25079529133050554
},
"2025": {
"obs_EconomicCapitalRatio": 0.6661650116856921
}
},
"0001627223": {
"2015": {
"obs_EconomicCapitalRatio": 0.11531512461593406
},
"2016": {
"obs_EconomicCapitalRatio": 0.5041107353269599
},
"2017": {
"obs_EconomicCapitalRatio": 0.9792616137942283
},
"2018": {
"obs_EconomicCapitalRatio": 0.5037929444305274
},
"2019": {
"obs_EconomicCapitalRatio": 0.33457321143007535
},
"2020": {
"obs_EconomicCapitalRatio": 0.5470460275521768
},
"2021": {
"obs_EconomicCapitalRatio": 0.6499364328629865
},
"2022": {
"obs_EconomicCapitalRatio": 0.5809502304277893
}
},
"0001552189": {
"2022": {
"obs_EconomicCapitalRatio": 0.051966645127577905
},
"2023": {
"obs_EconomicCapitalRatio": 0.16744960403999323
}
},
"0001653477": {
"2016": {
"obs_EconomicCapitalRatio": 2.9965230053381644
},
"2017": {
"obs_EconomicCapitalRatio": 3.7915367442390675
},
"2018": {
"obs_EconomicCapitalRatio": 2.922808947052789
},
"2019": {
"obs_EconomicCapitalRatio": 1.959253575073628
},
"2020": {
"obs_EconomicCapitalRatio": 1.5143708031469667
},
"2021": {
"obs_EconomicCapitalRatio": 1.3249257731828572
},
"2022": {
"obs_EconomicCapitalRatio": 1.1004777222391815
},
"2023": {
"obs_EconomicCapitalRatio": 0.7369191018660393
},
"2024": {
"obs_EconomicCapitalRatio": 0.7736223011953498
},
"2025": {
"obs_EconomicCapitalRatio": 1.3076730606119293
}
},
"0001586554": {
"2016": {
"obs_EconomicCapitalRatio": 0.48058259081278015
},
"2018": {
"obs_EconomicCapitalRatio": 1.4962619054091728
},
"2019": {
"obs_EconomicCapitalRatio": 0.891464023479221
},
"2020": {
"obs_EconomicCapitalRatio": 0.5424015614406267
},
"2021": {
"obs_EconomicCapitalRatio": 0.4143393157324369
},
"2022": {
"obs_EconomicCapitalRatio": 0.23894685685583492
},
"2023": {
"obs_EconomicCapitalRatio": 0.10261033505859418
}
},
"0001642380": {
"2016": {
"obs_EconomicCapitalRatio": 21.72207919293821
},
"2017": {
"obs_EconomicCapitalRatio": 21.3709545386487
},
"2019": {
"obs_EconomicCapitalRatio": 4.529546805842379
},
"2021": {
"obs_EconomicCapitalRatio": 1.6309746744371012
},
"2022": {
"obs_EconomicCapitalRatio": 0.4521509520900019
},
"2023": {
"obs_EconomicCapitalRatio": 0.3591924761920325
}
},
"0001652130": {
"2016": {
"obs_EconomicCapitalRatio": 3.199958649296
},
"2017": {
"obs_EconomicCapitalRatio": 3.3067347442937
},
"2018": {
"obs_EconomicCapitalRatio": 2.957402513032481
},
"2019": {
"obs_EconomicCapitalRatio": 4.091879539456148
},
"2020": {
"obs_EconomicCapitalRatio": 9.369785151591545
},
"2021": {
"obs_EconomicCapitalRatio": 12.780171311702386
},
"2022": {
"obs_EconomicCapitalRatio": 3.4031614469183005
}
},
"0001708035": {
"2017": {
"obs_EconomicCapitalRatio": 0.4391634781975079
},
"2018": {
"obs_EconomicCapitalRatio": 0.3838203482983531
},
"2019": {
"obs_EconomicCapitalRatio": 0.48129649674893044
},
"2020": {
"obs_EconomicCapitalRatio": 0.6013288369758395
},
"2021": {
"obs_EconomicCapitalRatio": 0.8978665871292398
},
"2022": {
"obs_EconomicCapitalRatio": 0.7567918532035208
},
"2023": {
"obs_EconomicCapitalRatio": 0.7709750516345434
},
"2024": {
"obs_EconomicCapitalRatio": 0.6033738356189466
},
"2025": {
"obs_EconomicCapitalRatio": 1.152367959333189
}
},
"0001522767": {
"2017": {
"obs_EconomicCapitalRatio": 4.28352597297854
},
"2018": {
"obs_EconomicCapitalRatio": 11.84484946199016
},
"2019": {
"obs_EconomicCapitalRatio": 1.6647152363257145
},
"2020": {
"obs_EconomicCapitalRatio": 1.8939909944990796
},
"2023": {
"obs_EconomicCapitalRatio": 0.7154614969958419
},
"2024": {
"obs_EconomicCapitalRatio": 0.2730915686403338
},
"2025": {
"obs_EconomicCapitalRatio": 0.22748336782703915
}
},
"0001731348": {
"2020": {
"obs_EconomicCapitalRatio": 1.0343902967287055
},
"2021": {
"obs_EconomicCapitalRatio": 0.9151944120269997
},
"2022": {
"obs_EconomicCapitalRatio": 0.5292237994678327
},
"2023": {
"obs_EconomicCapitalRatio": 0.5873188828335296
},
"2024": {
"obs_EconomicCapitalRatio": 0.48595324362468467
}
},
"0001656472": {
"2020": {
"obs_EconomicCapitalRatio": 2.4846037628909143
},
"2021": {
"obs_EconomicCapitalRatio": 2.1068641047612973
},
"2022": {
"obs_EconomicCapitalRatio": 1.5226433295914465
},
"2023": {
"obs_EconomicCapitalRatio": 1.2617458734917226
},
"2024": {
"obs_EconomicCapitalRatio": 1.2298351104750205
},
"2025": {
"obs_EconomicCapitalRatio": 1.6798919218022832
}
},
"0001737927": {
"2020": {
"obs_EconomicCapitalRatio": 2.2413009969523126
},
"2021": {
"obs_EconomicCapitalRatio": 0.722105723732089
},
"2022": {
"obs_EconomicCapitalRatio": 0.49880311487341555
}
},
"0001754195": {
"2025": {
"obs_EconomicCapitalRatio": 0.6572335792654658
}
},
"0001756390": {
"2021": {
"obs_EconomicCapitalRatio": 1.6656381745552173
},
"2022": {
"obs_EconomicCapitalRatio": 0.2766604451340951
},
"2023": {
"obs_EconomicCapitalRatio": 0.2521606213881799
},
"2024": {
"obs_EconomicCapitalRatio": 0.09670274277596863
},
"2025": {
"obs_EconomicCapitalRatio": 0.15693027900478207
}
},
"0001813814": {
"2022": {
"obs_EconomicCapitalRatio": 1.017428702644666
}
},
"0001850902": {
"2021": {
"obs_EconomicCapitalRatio": 5.898441690535421
},
"2022": {
"obs_EconomicCapitalRatio": 1.4117684980890728
}
},
"0001906324": {
"2022": {
"obs_EconomicCapitalRatio": 3.794104483895451
},
"2023": {
"obs_EconomicCapitalRatio": 0.8130511823271402
},
"2024": {
"obs_EconomicCapitalRatio": 0.6055538968322262
},
"2025": {
"obs_EconomicCapitalRatio": 0.4114130862644389
}
}
}
}